| patient_id,site_id,diagnosis_date,age_at_diagnosis,sex,race,insurance,smoking_status,pack_years,cigarettes_per_day,smoking_duration_years,years_since_quitting,low_dose_ct_screening_history,second_hand_smoke_exposure,occupational_exposure,radon_exposure_flag,family_history_lung_cancer,bmi,histology_primary,histology_subtype,clinical_stage,t_stage,n_stage,m_stage,tumor_size_cm,tumor_location,tumor_laterality,pleural_invasion_flag,vascular_invasion_flag,lymphovascular_invasion_flag,satellite_nodule_flag,brain_metastasis_flag,bone_metastasis_flag,liver_metastasis_flag,adrenal_metastasis_flag,metastasis_sites,egfr_mutation,alk_fusion,ros1_fusion,kras_mutation,braf_mutation,met_exon14_skip,ret_fusion,ntrk_fusion,her2_alteration,stk11_mutation,keap1_mutation,tp53_mutation,pd_l1_tumor_proportion_score,pd_l1_combined_positive_score,pd_l1_category,tmb_mutations_per_mb,tmb_high_flag,microsatellite_status,treatment_regimen,targeted_therapy,immunotherapy_agent,chemotherapy_regimen,surgery_type,surgical_margin_status,radiation_type,radiation_dose_gy,treatment_cycles_completed,treatment_adherence_pct,dose_reduction_flag,bevacizumab_flag,adjuvant_chemotherapy_flag,adjuvant_osimertinib_flag,progression_free_survival_months,pfs_event_flag,overall_survival_months,os_event_flag,time_to_treatment_failure_months,best_overall_response,objective_response_flag,disease_control_flag,time_to_response_months,duration_of_response_months,ct_response_pct_change,pseudoprogression_flag,hyperprogression_flag,next_line_therapy_flag,ldh_at_progression_u_l,pet_ct_suv_max,pet_ct_mtv_ml,ctdna_detection_flag,ctdna_vaf_pct,ctdna_clearance_flag,pathology_grade,ihc_ttf1,ihc_p40,ihc_synaptophysin_cd56,ecog_performance_status,fev1_pct_predicted,dlco_pct_predicted,copd_flag,copd_gold_stage,cardiovascular_disease_flag,diabetes_flag,hypertension_flag,prior_malignancy_flag,charlson_comorbidity_index,albumin_g_dl,ldh_baseline_u_l,hemoglobin_g_dl,neutrophil_lymphocyte_ratio,platelet_lymphocyte_ratio,c_reactive_protein_mg_l,irae_flag,irae_type,irae_grade,nausea_grade,peripheral_neuropathy_grade,cytopenias_grade,hospitalization_flag,g_csf_use_flag |
| 0b6c9344-4ff806dd-42245b9cc-0934-000094837a7b,SITE_006,2023-01-29,66.08630009922834,Female,White,Medicaid,Never,0.0,0.0,0.0,0.0,0,1,None,0,0,22.3,Adenocarcinoma,Acinar,IVA,T2b,N0,M1a,4.7,RLL,Left,0,0,1,1,1,1,0,0,Brain|Bone,None,EML4-ALK,None,None,None,0,0,0,None,0,0,1,97,100,>=50%,19.8,1,MSS,Targeted_TKI,Brigatinib,None,None,None,NA,None,0.0,6,70.8,0,0,0,0,36.5,1,36.5,1,32.0,SD,0,1,0.5,0.0,6.4,0,0,0,407.7,4.9,31.5,1,14.63,1,G3,Negative,Negative,Negative,0,65.4,94.5,0,None,0,0,0,1,1,3.5,155.9,15.6,8.2,500.0,28.0,0,None,0,0,1,1,0,0 |
| 6310fde6-2b576f14b-412932f9b2-0fde-000507dce4b5,SITE_033,2022-05-12,77.71617914481837,Female,White,Medicare,Current,120.0,4.0,60.0,0.0,0,0,None,0,0,30.9,SCLC_Extensive,NA,Exte,T4,N2,M0,10.8,Central,Left,0,0,1,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,23.8,1,MSS,Chemotherapy_Only,None,Atezolizumab,Etoposide_Platinum,None,NA,None,0.0,5,78.8,0,0,0,0,5.4,1,5.4,1,4.6,SD,0,1,2.3,0.0,18.4,0,0,0,235.6,4.6,17.7,0,0.0,0,G2,Negative,Negative,Positive,1,49.2,85.1,1,I,1,0,0,0,3,2.7,481.2,13.5,10.4,120.8,2.7,1,Colitis,1,0,2,2,0,0 |
| 53c8ffe0-24a7eff21-4fb5affa0-0ffe-00044134fe67,SITE_049,2020-07-30,45.33299046896673,Female,Black,Medicaid,Current,57.1,3.0,60.0,0.0,1,0,None,0,0,20.2,SCLC_Limited,NA,Limi,T3,N0,M0,5.5,RLL,Right,0,0,1,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,0,0,<1%,3.4,0,MSS,Chemotherapy_Only,None,Atezolizumab,Etoposide_Platinum,None,NA,Conventional_EBRT,55.6,10,72.0,0,0,0,0,4.8,1,10.4,1,3.4,PD,0,0,1.7,0.0,25.9,0,0,0,281.9,1.8,19.6,0,0.0,0,G3,Negative,Negative,Positive,4,98.3,84.6,1,II,0,0,0,0,1,4.0,201.4,10.9,5.8,223.1,10.0,0,None,0,0,2,0,0,1 |
| 382d2b30-1893c2e51-4a8878190-02b3-0002da4b3177,SITE_044,2023-11-10,52.7819324459184,Female,White,Medicare,Current,4.3,1.0,28.4,0.0,0,0,None,0,1,26.6,Squamous_Cell,Non-keratinizing,IVB,T4,N0,M1c,11.6,RML,Left,1,0,1,0,1,1,0,0,Brain|Bone,None,None,None,None,None,0,0,0,None,0,0,1,94,100,>=50%,3.9,0,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,6,96.9,1,0,0,0,22.0,1,22.0,1,21.9,SD,0,1,0.9,0.0,-17.4,0,0,0,214.6,9.9,78.7,1,35.66,0,G1,Negative,Positive,Negative,0,55.1,58.3,1,II,0,0,0,0,1,3.2,155.7,12.8,8.5,182.1,50.3,1,Dermatitis,1,0,0,2,0,0 |
| 376d0b12-183fb4d7f-4a6472136-00b1-0002d0898ff1,SITE_014,2016-04-13,58.23257880199496,Male,White,Private,Former,37.9,1.6,60.0,0.7,0,1,None,0,1,31.2,Adenocarcinoma,Micropapillary,IA,T4,N0,M0,11.9,LLL,Right,1,0,0,0,0,0,0,0,None,None,None,None,G12C,None,0,0,0,None,1,0,1,0,0,<1%,43.4,1,MSI-L,SBRT,None,None,None,None,NA,SBRT,51.8,3,79.7,0,0,0,0,2.3,1,6.1,0,1.8,SD,0,1,1.2,0.0,11.8,0,0,0,458.4,5.2,32.0,0,0.0,0,G3,Positive,Negative,Negative,0,101.6,76.2,0,None,0,1,0,0,2,3.0,307.0,13.0,2.8,120.8,61.5,0,None,0,2,3,3,0,0 |
| 6de68961-3014dc1a8-4149b39c23-0896-000594b4f9f4,SITE_023,2024-03-15,80.88119923384312,Male,White,Private,Former,30.1,1.1,60.0,8.2,0,0,None,0,0,16.3,Adenocarcinoma,Acinar,IVA,T3,N0,M1a,6.3,RUL,Right,1,0,0,0,0,0,1,0,Liver,None,None,None,None,None,0,0,0,None,0,0,1,29,67,1-49%,8.5,0,MSS,Chemo_IO_Combination,None,Pembrolizumab,Carboplatin_Pemetrexed,None,NA,None,0.0,3,92.3,0,0,0,0,9.1,1,17.2,1,7.5,PD,0,0,0.5,0.0,21.4,0,0,0,461.6,13.5,25.3,1,15.31,0,G2,Positive,Negative,Negative,1,92.2,78.0,0,None,0,1,1,0,1,4.0,268.5,13.5,2.5,326.0,11.6,0,None,0,1,2,1,0,1 |
| 0b004446-4d01ddeb-42100ccd2-0444-00008f037795,SITE_027,2023-07-01,69.68457633773332,Male,White,Private,Former,70.0,1.5,60.0,4.7,1,0,None,0,1,35.1,Adenocarcinoma,Lepidic,IVB,T4,N2,M1b,11.7,RML,Left,0,0,1,0,0,1,0,1,Bone|Adrenal,None,None,None,None,None,0,0,0,Overexpression,0,0,1,100,100,>=50%,5.0,0,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,5,78.3,0,0,0,0,13.2,0,13.2,0,11.2,SD,0,1,4.4,0.0,-6.2,0,0,0,534.3,7.6,27.6,1,0.99,0,G2,Positive,Negative,Negative,4,79.0,34.1,0,None,0,0,0,0,0,4.5,122.2,12.6,5.7,87.0,200.0,0,None,0,1,0,1,0,0 |
| 59435b07-270d77d32-410bca1115-05b0-0004886b9f62,SITE_013,2020-01-13,74.28951378438165,Female,White,Private,Never,0.0,0.0,0.0,0.0,0,0,None,0,1,24.1,SCLC_Limited,NA,Limi,T1a,N1,M0,0.5,Central,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,3.5,0,MSS,Chemo_IO_Combination,None,Durvalumab,Etoposide_Platinum,None,NA,Conventional_EBRT,54.6,5,95.8,0,0,0,0,5.5,1,5.5,1,5.3,CR,1,1,0.5,0.5,-80.4,0,0,0,279.5,1.3,3.6,0,0.0,0,G2,Negative,Negative,Negative,1,95.4,74.3,0,None,1,0,1,0,2,3.7,200.9,14.4,2.7,50.0,96.3,0,None,0,1,2,1,0,1 |
| 19c9c0f5-b48446b4-44d5d42df-0c0f-00014f3ecc78,SITE_014,2022-04-30,56.168471268300806,Female,White,Private,Never,0.0,0.0,0.0,0.0,1,0,None,0,0,26.6,Adenocarcinoma,Micropapillary,IVB,T4,N2,M1c,9.8,RUL,Left,0,1,0,0,0,0,1,0,Liver,None,None,None,None,None,0,0,0,None,0,0,0,100,100,>=50%,7.9,0,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,8,67.0,0,0,0,0,17.5,1,23.8,0,16.5,SD,0,1,7.7,0.0,12.8,0,0,1,723.4,2.0,32.1,1,28.78,0,G2,Positive,Negative,Negative,1,58.0,81.8,0,None,0,0,1,0,0,4.4,100.0,10.0,5.5,137.6,6.3,0,None,0,0,1,1,0,0 |
| 0c0e00da-546205f7-4242a028e-000d-00009cb60b19,SITE_012,2020-03-14,56.36440918493,Female,White,Private,Never,0.0,0.0,0.0,0.0,0,1,None,0,0,28.6,Squamous_Cell,Non-keratinizing,IIB,T4,N2,M0,9.5,RLL,Left,1,1,0,0,0,0,0,0,None,None,None,None,G12A,None,0,0,0,None,0,0,1,93,100,>=50%,35.1,1,MSS,Surgery_Adjuvant,None,None,None,Robotic,R0,None,0.0,5,79.7,0,0,1,0,3.6,1,21.6,1,2.7,CR,1,1,0.5,26.3,-62.0,0,0,0,235.5,7.9,7.0,1,26.12,1,G3,Negative,Positive,Negative,2,61.2,49.4,0,None,0,1,1,0,1,4.1,197.0,12.2,5.5,127.2,3.0,0,None,0,0,2,2,0,0 |
| 4363a9c6-1d7b9a46b-4ca2afd52-0a9c-00036c0f9f15,SITE_050,2017-09-07,71.25423030886574,Male,White,Private,Current,8.6,1.0,57.5,0.0,0,0,None,0,0,29.3,Adenocarcinoma,Acinar,IB,T4,N0,M0,11.9,LUL,Right,0,0,0,0,0,0,0,0,None,None,None,None,G12D,None,0,0,0,None,0,0,0,56,98,>=50%,16.7,1,MSS,Surgery_Adjuvant,None,None,None,Lobectomy,R0,None,0.0,6,93.4,0,0,0,0,42.5,1,51.1,0,38.9,PR,1,1,0.5,63.3,-37.9,0,0,1,680.9,10.7,32.2,0,0.0,0,G2,Negative,Negative,Negative,1,91.6,81.6,0,None,1,0,1,0,2,3.1,234.4,16.1,4.3,280.8,49.0,0,None,0,1,2,2,0,0 |
| 7ce13176-36a285a3b-4176a39462-0317-0006576f8305,SITE_038,2022-12-29,67.55360614388674,Female,White,Private,Never,0.0,0.0,0.0,0.0,0,0,None,0,0,27.2,SCLC_Extensive,NA,Exte,T2a,N0,M0,3.8,RUL,Right,0,0,1,1,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,10.6,1,MSS,Chemo_IO_Combination,None,Durvalumab,Etoposide_Platinum,None,NA,None,0.0,8,53.9,0,0,0,0,3.6,1,3.6,1,3.5,PD,0,0,0.5,0.0,48.7,0,0,0,194.1,1.3,8.3,1,18.25,1,G2,Negative,Negative,Positive,0,58.1,73.6,0,None,0,0,0,0,0,3.5,250.6,11.8,5.5,70.1,10.2,0,None,0,2,3,3,1,1 |
| 5e2d2238-2933bef89-411a8766a8-0223-0004c84abcdf,SITE_043,2017-06-16,72.21301877920921,Male,White,Private,Never,0.0,0.0,0.0,0.0,1,0,None,0,0,30.5,SCLC_Limited,NA,Limi,T3,N2,M0,6.4,RML,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,74,100,>=50%,37.7,1,MSS,Chemotherapy_Only,None,Atezolizumab,Etoposide_Platinum,None,NA,Conventional_EBRT,51.7,5,85.5,0,0,0,0,12.2,1,32.0,1,11.1,PR,1,1,1.1,3.4,-46.3,0,0,0,127.9,6.9,40.8,1,4.59,0,GX,Negative,Negative,Positive,0,51.1,94.1,0,None,0,0,1,0,1,4.3,121.5,13.0,7.0,203.2,7.7,0,None,0,2,0,2,0,0 |
| 616d0697-2a9fb2e22-41244713c5-0069-0004f28955b2,SITE_041,2018-02-21,65.2171255861797,Male,White,Medicare,Current,7.6,1.0,50.8,0.0,0,0,None,0,0,28.3,Adenocarcinoma,Acinar,IIIA,T1b,N2,M0,1.1,RUL,Right,0,0,1,0,0,0,0,0,None,None,None,None,G12A,None,0,0,0,None,0,0,1,0,0,<1%,31.7,1,MSS,CCRT,None,Durvalumab,Carboplatin_Paclitaxel,None,NA,IMRT,56.7,4,81.9,1,0,0,0,14.0,0,14.0,0,10.4,CR,1,1,0.5,4.7,-76.8,0,0,0,674.5,3.3,16.7,1,11.34,1,G2,Positive,Negative,Negative,1,69.2,65.4,1,III,0,1,1,0,2,3.5,138.5,10.5,4.2,189.0,28.1,0,None,0,3,2,1,0,1 |
| 5bd64ba0-282dc1161-411382e2e0-04ba-0004a9e1d727,SITE_048,2020-03-10,69.64236540131895,Female,White,Medicare,Former,34.0,1.9,60.0,36.2,0,0,None,0,0,33.9,Adenocarcinoma,Lepidic,IIIA,T2b,N1,M0,4.1,RLL,Right,0,0,1,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,12.2,1,MSS,Chemo_RT,None,None,Carboplatin_Paclitaxel,None,NA,IMRT,57.0,6,73.0,1,0,0,0,3.4,1,7.8,1,2.9,PR,1,1,1.4,6.9,-53.1,0,0,0,340.4,3.0,5.1,0,0.0,0,G2,Negative,Negative,Negative,2,59.1,74.8,0,None,1,0,0,0,1,4.2,226.7,16.8,3.2,180.1,59.1,0,None,0,1,0,1,0,0 |
| 649dc151-2c0504938-412dd943f3-0c15-00051c02d124,SITE_006,2023-05-15,68.50213130659854,Male,Hispanic,Medicaid,Current,5.2,1.0,34.9,0.0,0,0,Asbestos,0,0,28.4,Adenocarcinoma,Micropapillary,IVB,T2a,N0,M1b,3.1,Central,Right,0,0,1,0,0,0,0,1,Adrenal,None,None,None,None,None,0,0,0,None,0,0,0,100,100,>=50%,80.0,1,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,6,85.2,0,0,0,0,14.5,1,14.7,0,13.8,SD,0,1,5.2,0.0,-8.2,0,0,1,317.2,4.4,14.2,0,0.0,0,G3,Positive,Negative,Negative,2,108.6,77.5,1,II,0,0,0,1,5,3.6,374.4,13.1,8.0,277.7,65.9,1,Dermatitis,3,2,3,2,0,0 |
| 41b16889-1cbd9dbc0-4c514399b-0688-000356024efc,SITE_045,2018-11-02,74.38879019630679,Male,White,Medicare,Current,5.7,1.0,38.1,0.0,1,0,Radon,1,0,34.8,Squamous_Cell,Keratinizing,IIIB,T2b,N2,M0,4.0,RLL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,46,100,1-49%,7.2,0,MSS,Chemo_RT,None,None,Carboplatin_Paclitaxel,None,NA,IMRT,62.7,5,82.6,0,0,0,0,7.2,0,7.2,0,5.5,PD,0,0,0.6,0.0,33.5,0,0,0,204.3,8.2,283.5,1,19.01,1,G3,Negative,Positive,Negative,0,89.0,30.0,1,II,1,0,0,0,2,4.2,209.8,10.0,5.4,146.3,21.8,0,None,0,2,0,0,0,1 |
| 1066070b-72ca314e-431321521-0070-0000d52e5b96,SITE_004,2019-12-09,74.66657867847248,Female,Asian,Medicaid,Current,92.6,3.6,60.0,0.0,0,0,None,0,0,30.1,Squamous_Cell,Basaloid,IVA,T3,N0,M1a,6.3,RLL,Right,0,0,1,0,0,0,1,0,Liver,None,None,None,None,None,0,0,0,None,0,0,1,6,14,1-49%,24.2,1,MSS,Chemo_IO_Combination,None,Pembrolizumab,Carboplatin_Paclitaxel,None,NA,None,0.0,6,81.5,0,0,0,0,6.6,1,14.4,0,5.7,SD,0,1,2.4,0.0,-4.4,0,0,1,160.4,4.2,1.3,1,14.78,0,G2,Negative,Positive,Negative,1,64.6,66.3,0,None,0,0,0,0,1,4.0,151.6,14.7,6.1,153.1,0.6,1,Colitis,2,3,0,1,0,0 |
| 6b7cdeb7-2f06a1702-4142769c25-0deb-000575574f52,SITE_024,2015-06-02,51.611216053278184,Male,White,Medicare,Current,109.4,3.1,60.0,0.0,0,1,None,0,0,17.9,Squamous_Cell,Non-keratinizing,IVB,T2a,N2,M1a,3.5,RLL,Left,0,0,0,0,0,1,1,1,Bone|Liver|Adrenal,None,None,None,None,None,0,0,0,None,0,0,0,0,0,<1%,6.3,0,MSS,Chemotherapy_Only,None,None,Carboplatin_Paclitaxel,None,NA,None,0.0,4,91.5,0,0,0,0,1.0,1,37.2,1,0.9,PD,0,0,5.0,0.0,32.4,0,0,0,168.2,1.5,24.5,0,0.0,0,G2,Negative,Positive,Negative,0,57.0,73.4,0,None,1,0,1,1,3,3.7,325.4,10.4,6.7,194.4,84.1,0,None,0,0,2,2,0,1 |
| 39a63f14-1938bb98d-4acf2bd3c-03f1-0002ed71340b,SITE_030,2016-02-27,45.65094872426187,Male,White,Private,Former,82.6,4.7,60.0,6.8,1,0,None,0,0,37.7,Adenocarcinoma,Solid,IVA,T1b,N0,M1b,1.4,Endobronchial,Left,0,1,0,0,0,0,1,1,Liver|Adrenal,None,None,None,G13C,None,0,0,0,None,1,0,0,5,12,1-49%,20.3,1,MSS,Chemo_IO_Combination,None,Pembrolizumab,Carboplatin_Pemetrexed,None,NA,None,0.0,6,70.6,0,0,0,0,5.5,1,9.8,1,4.9,SD,0,1,1.2,0.0,-17.0,0,0,0,262.2,8.1,6.0,1,12.6,0,G3,Positive,Negative,Negative,1,81.1,34.3,0,None,0,0,1,0,0,4.1,213.7,13.9,5.0,139.6,6.0,0,None,0,2,1,2,0,0 |
| 400b8814-1c050b88d-4c022983c-0881-00034095e90b,SITE_018,2015-07-24,76.51658127768931,Male,White,VA,Current,52.4,3.3,60.0,0.0,1,0,None,0,0,23.4,Squamous_Cell,Keratinizing,IVB,T2a,N2,M1c,3.6,RUL,Bilateral,0,0,1,0,1,1,1,0,Brain|Bone|Liver,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,7.2,0,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,3,81.3,1,0,0,0,6.2,1,17.8,1,4.5,SD,0,1,4.2,0.0,6.6,0,0,0,227.0,5.6,104.8,0,0.0,0,G3,Negative,Positive,Negative,1,96.4,82.8,1,II,0,0,1,0,1,2.7,219.1,14.6,3.5,65.9,31.9,0,None,0,1,1,0,0,0 |
| 2f764f45-14c3c2ae4-48e62edcf-04f4-000269020688,SITE_008,2015-09-21,78.2833883859884,Male,White,Private,Former,15.7,1.0,60.0,0.7,0,0,None,0,0,32.7,Adenocarcinoma,Acinar,IVB,T3,N1,M1b,6.0,Central,Right,0,0,0,0,0,0,1,0,Liver,None,None,None,G13C,None,0,0,0,None,1,0,0,100,100,>=50%,13.7,1,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,5,97.3,0,0,0,0,9.4,1,17.7,1,7.3,PD,0,0,0.5,0.0,64.8,0,1,0,100.0,3.5,53.5,1,15.8,1,G3,Positive,Negative,Negative,4,80.2,73.4,0,None,0,1,1,0,1,3.3,298.5,16.6,2.9,116.0,16.7,0,None,0,1,0,1,0,0 |
| 175dc957-a3908162-446195c05-0c95-00012fc33972,SITE_010,2023-09-06,57.304081314623296,Female,Black,Medicare,Former,16.1,1.0,60.0,1.0,0,1,None,0,0,26.1,Adenocarcinoma,Lepidic,IIIA,T3,N2,M0,5.8,RML,Left,0,1,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,94,100,>=50%,77.6,1,MSS,CCRT,None,Durvalumab,Carboplatin_Paclitaxel,None,NA,IMRT,63.7,3,83.4,1,0,0,0,16.0,1,41.2,1,13.9,CR,1,1,3.7,3.0,-84.6,0,0,0,570.7,5.8,25.1,0,0.0,0,G1,Positive,Negative,Negative,1,57.9,73.3,0,None,0,0,0,1,1,3.6,190.9,12.9,4.2,127.1,200.0,1,Dermatitis,3,1,1,2,0,1 |
| 76a03c33-33e61a566-4163e0b499-03c3-000606230e9e,SITE_042,2023-06-01,49.33156363781653,Female,Asian,Medicare,Former,74.9,2.1,60.0,0.8,0,1,None,0,0,30.8,Adenocarcinoma,Papillary,IVB,T3,N0,M1a,6.5,Endobronchial,Left,0,0,1,0,0,0,1,0,Liver,None,None,None,G12D,None,0,0,0,None,0,0,0,100,100,>=50%,21.3,1,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,3,79.6,0,0,0,0,10.4,1,10.4,1,7.9,PR,1,1,1.5,5.4,-47.7,0,0,0,198.4,5.6,60.4,1,23.98,0,G2,Positive,Negative,Negative,0,49.1,83.5,0,None,0,0,0,0,0,4.4,125.6,12.6,6.3,105.9,200.0,1,Colitis,3,1,2,3,0,0 |
| 640a6703-2bc48d116-412c1f3509-0670-000514873b2e,SITE_016,2023-03-19,67.9408307995684,Male,White,Private,Former,120.0,7.3,60.0,3.8,0,0,None,0,0,22.9,Squamous_Cell,Keratinizing,IIIC,T1b,N1,M0,1.9,RML,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,5,10,1-49%,13.9,1,MSS,Chemo_RT,None,None,Carboplatin_Paclitaxel,None,NA,IMRT,58.5,5,91.7,0,0,0,0,15.2,1,15.2,1,12.2,SD,0,1,1.3,0.0,-2.8,0,0,0,454.5,7.7,26.9,1,17.63,0,G3,Negative,Positive,Negative,1,68.2,65.4,0,None,1,0,1,0,1,3.1,185.4,8.4,6.5,122.7,10.1,0,None,0,3,2,2,0,1 |
| 526a2c18-240e734a9-4f73e8448-02c1-00042f643d3f,SITE_016,2015-07-22,75.84296315033004,Male,Black,Medicare,Current,0.5,1.0,3.3,0.0,0,1,None,0,0,28.8,SCLC_Limited,NA,Limi,T4,N0,M0,8.1,RUL,Right,0,0,1,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,4.5,0,MSS,Chemotherapy_Only,None,Durvalumab,Etoposide_Platinum,None,NA,Conventional_EBRT,51.1,1,84.7,0,0,0,0,4.6,1,18.3,0,3.8,PR,1,1,2.3,5.8,-31.4,0,0,0,171.9,6.1,20.2,1,21.34,1,G2,Negative,Negative,Positive,3,80.7,72.7,1,III,0,0,1,0,3,3.8,349.3,11.6,5.0,165.3,2.7,1,Dermatitis,2,3,1,3,0,0 |
| 3382505b-16890327e-49a86f111-0505-00029d9e14a6,SITE_047,2015-10-11,84.07714796312598,Male,White,Private,Former,120.0,2.4,60.0,3.3,0,1,None,0,0,24.9,Adenocarcinoma,Micropapillary,IIA,T3,N2,M0,5.6,LUL,Right,0,0,0,0,0,0,0,0,None,Exon19del,None,None,None,None,0,0,0,None,0,0,1,70,100,>=50%,10.7,1,MSS,Surgery_Adjuvant,Osimertinib,None,None,Lobectomy,R0,None,0.0,5,92.5,0,0,1,1,32.7,1,41.7,0,23.0,PR,1,1,1.1,65.4,-33.9,0,0,1,264.4,8.4,9.8,1,7.95,0,G2,Positive,Negative,Negative,1,66.5,85.8,1,II,0,0,0,0,2,4.0,516.1,11.1,5.7,125.9,3.0,0,None,0,2,1,2,1,0 |
| 695040a6-2e131c48b-413bf0c1f2-040a-000559134875,SITE_008,2017-10-21,71.90482693496378,Female,White,Private,Former,8.5,1.0,56.6,32.9,0,0,None,0,0,33.1,Squamous_Cell,Basaloid,IVA,T1a,N0,M1b,0.9,RUL,Left,0,0,1,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,83,100,>=50%,3.6,0,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,8,84.9,0,0,0,0,11.2,1,13.6,0,9.5,PR,1,1,0.5,9.2,-56.6,0,0,1,397.9,7.1,13.0,1,18.68,0,G1,Negative,Positive,Negative,2,93.1,72.9,0,None,0,0,1,0,0,3.9,108.9,12.1,2.1,247.7,30.2,0,None,0,0,1,3,0,0 |
| 45d09f11-1e8b45978-4d171dd33-09f1-00038b9813e4,SITE_046,2020-08-25,63.4686913824359,Female,Asian,Private,Former,70.6,1.5,60.0,1.8,0,0,None,0,0,28.0,Squamous_Cell,Non-keratinizing,IA,T2a,N0,M0,3.9,LLL,Left,1,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,58,100,>=50%,20.1,1,MSS,Surgery_Adjuvant,None,None,Carboplatin_Paclitaxel,VATS,R0,None,0.0,5,68.3,0,0,0,0,50.9,0,50.9,0,50.9,CR,1,1,0.6,73.8,-69.7,0,0,0,371.4,14.2,11.5,1,6.46,0,G3,Negative,Positive,Negative,1,84.5,42.5,1,I,1,0,1,0,3,3.8,454.2,11.5,3.2,250.1,8.9,0,None,0,1,3,3,0,0 |
| 38c1cbe5-18d4c9344-4aa4563af-0cbe-0002e1d75aa8,SITE_047,2018-05-04,58.5152590949438,Female,White,Private,Current,9.6,1.0,60.0,0.0,0,1,None,0,0,30.2,Adenocarcinoma,Papillary,IVA,T2a,N2,M1b,3.8,LUL,Right,0,0,0,1,0,0,0,0,None,None,None,None,G12D,None,0,0,0,None,0,0,0,19,26,1-49%,19.6,1,MSS,Chemo_IO_Combination,None,Atezolizumab,Carboplatin_Pemetrexed,None,NA,None,0.0,8,85.1,1,0,0,0,2.3,1,28.3,0,1.9,PR,1,1,0.5,2.5,-40.4,0,0,0,214.0,25.0,20.3,1,2.34,1,GX,Positive,Negative,Negative,1,79.3,72.8,0,None,0,0,1,0,1,3.5,166.8,14.1,7.2,50.0,3.8,0,None,0,1,1,2,0,0 |
| 39a8a89d-1939c9c4c-4acf9f9d7-0a89-0002ed909000,SITE_030,2019-11-15,67.10878727087122,Male,White,Private,Former,18.1,1.1,60.0,10.2,0,1,None,0,1,16.3,Squamous_Cell,Non-keratinizing,IIIA,T2a,N0,M0,3.8,LUL,Left,0,0,1,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,7.7,0,MSS,Chemo_RT,None,None,Carboplatin_Paclitaxel,None,NA,IMRT,64.3,7,91.4,0,0,0,0,5.5,1,20.4,0,4.3,SD,0,1,0.5,0.0,-7.7,0,0,0,315.7,7.3,2.1,1,16.28,1,GX,Negative,Positive,Negative,1,84.1,73.0,0,None,0,0,1,0,2,3.7,202.4,11.4,2.5,62.8,9.2,0,None,0,2,0,3,0,0 |
| 1d16288f-cb9b1bea-4574279ad-0288-00017a200f4a,SITE_009,2016-09-23,64.15698531309006,Male,Hispanic,Medicare,Current,41.3,1.4,60.0,0.0,0,0,None,0,0,25.6,Adenocarcinoma,Acinar,IIIC,T1a,N0,M0,0.3,RUL,Right,0,0,1,0,0,0,0,0,None,None,None,None,G13C,None,0,0,0,None,0,0,1,82,100,>=50%,40.3,1,MSS,CCRT,None,Durvalumab,Carboplatin_Paclitaxel,None,NA,IMRT,56.4,3,85.0,0,0,0,0,8.0,1,24.7,1,6.2,PR,1,1,3.7,15.2,-52.1,0,0,0,343.1,4.5,69.1,1,5.4,0,G2,Positive,Negative,Negative,2,50.0,86.4,0,None,0,0,1,0,0,4.3,468.7,13.5,4.9,50.0,39.5,0,None,0,0,1,0,0,0 |
| 0bcb1c11-528dc478-423615433-01c1-000099506ce4,SITE_008,2022-04-21,57.35685489557625,Male,Other,Medicare,Current,11.1,1.0,60.0,0.0,1,0,None,0,0,27.8,Adenocarcinoma,Lepidic,IA,T1b,N2,M0,1.9,LUL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,75,100,>=50%,35.5,1,MSS,Surgery_Adjuvant,None,None,Cisplatin_Pemetrexed,Lobectomy,R0,None,0.0,2,83.3,0,0,0,0,12.0,0,12.0,0,10.3,PR,1,1,3.1,12.3,-42.1,0,0,0,227.2,2.3,207.7,0,0.0,0,G1,Positive,Negative,Negative,1,66.0,66.5,0,None,0,0,0,0,0,3.5,163.2,12.3,4.6,125.9,17.9,0,None,0,2,0,2,1,0 |
| 46fca261-1f0e870a8-4d4f5e723-0a26-00039ad43ef4,SITE_015,2018-02-19,86.46317868320122,Female,White,Private,Never,0.0,0.0,0.0,0.0,0,0,None,0,0,27.0,SCLC_Extensive,NA,Exte,T1a,N2,M0,0.8,RML,Left,0,0,0,1,0,0,0,0,None,None,None,None,None,None,1,0,0,None,0,0,1,0,0,<1%,10.3,1,MSS,Chemotherapy_Only,None,Durvalumab,Etoposide_Platinum,None,NA,None,0.0,2,82.5,0,0,0,0,5.3,1,8.8,1,4.4,SD,0,1,2.8,0.0,9.5,0,0,0,140.2,12.4,12.0,0,0.0,0,GX,Negative,Negative,Positive,1,56.3,56.4,0,None,0,0,1,0,0,2.7,174.7,11.3,4.1,121.3,9.7,1,Dermatitis,2,1,3,3,0,1 |
| 71a65fd7-31b8c9ee2-4154f31f85-05fd-0005c572ddf2,SITE_029,2015-08-31,83.95909981968525,Male,White,Medicare,Current,97.3,4.0,60.0,0.0,0,1,Asbestos,0,0,30.3,SCLC_Extensive,NA,Exte,T1a,N2,M0,0.9,Endobronchial,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,15.0,1,MSS,Chemotherapy_Only,None,Atezolizumab,Etoposide_Platinum,None,NA,None,0.0,4,83.3,0,0,0,0,4.4,1,7.6,1,4.2,PD,0,0,0.7,0.0,38.6,0,0,0,179.1,3.6,82.3,0,0.0,0,G3,Negative,Negative,Positive,2,81.9,56.4,0,None,1,0,1,0,2,4.0,145.3,11.1,7.2,162.5,11.8,1,Colitis,4,0,0,0,0,1 |
| 082b29f1-392e2598-418817dd3-029f-00006a312144,SITE_008,2022-06-03,77.79246249377657,Female,Asian,Private,Former,6.2,1.0,41.2,4.8,0,1,None,0,1,24.4,SCLC_Limited,NA,Limi,T1c,N0,M0,2.2,LLL,Left,1,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,5.3,0,MSS,Chemo_IO_Combination,None,Atezolizumab,Etoposide_Platinum,None,NA,Conventional_EBRT,59.8,5,89.6,0,0,0,0,5.7,1,5.7,1,5.1,SD,0,1,2.1,0.0,16.8,0,0,0,202.4,25.0,17.1,0,0.0,0,G3,Negative,Negative,Positive,0,56.5,95.1,0,None,1,0,1,1,2,4.5,204.2,13.0,5.3,246.0,15.8,1,Colitis,2,0,0,0,1,0 |
| 6ddc7d37-301076c82-41499577a5-07d3-000594325bd2,SITE_023,2024-01-09,58.25192122081329,Female,White,Private,Former,2.8,1.0,18.6,10.7,1,0,None,0,0,26.2,Adenocarcinoma,Lepidic,IIIB,T4,N1,M0,7.9,LUL,Right,0,0,1,0,0,0,0,0,None,L858R,None,None,None,None,0,0,0,None,0,0,0,0,0,<1%,7.1,0,MSS,Chemo_RT,None,None,Carboplatin_Paclitaxel,None,NA,IMRT,64.2,3,76.8,0,0,0,0,10.7,1,38.7,1,8.7,CR,1,1,2.2,18.8,-86.2,0,0,0,247.9,25.0,9.7,1,20.7,1,G3,Negative,Negative,Negative,1,76.5,76.6,1,II,0,0,1,0,1,3.3,234.1,15.2,1.9,144.7,28.0,0,None,0,0,1,1,0,1 |
| 69efd178-2e58eba49-413dcf7468-0d17-0005612da31f,SITE_006,2015-02-23,75.12268358082414,Male,White,Medicare,Current,120.0,6.1,60.0,0.0,0,0,None,0,0,31.3,Adenocarcinoma,Papillary,IIIB,T2b,N2,M0,4.2,Central,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,39,52,1-49%,3.4,0,MSS,CCRT,None,Durvalumab,Carboplatin_Paclitaxel,None,NA,IMRT,59.9,4,72.6,1,0,0,0,8.0,0,8.0,0,6.5,SD,0,1,1.2,0.0,15.9,0,0,0,542.5,6.2,12.7,1,23.14,0,G2,Positive,Negative,Negative,1,72.0,94.3,1,I,0,0,1,0,1,4.5,142.1,11.0,6.4,103.4,30.6,1,Endocrinopathy,1,3,1,2,0,1 |
| 236cdc96-f7fa081b-46a4695c2-0dc9-0001cc8733a5,SITE_028,2019-05-13,73.07645089023006,Male,White,Uninsured,Current,66.0,2.1,60.0,0.0,0,0,Asbestos,0,0,16.0,SCLC_Limited,NA,Limi,T2a,N0,M0,3.4,LUL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,5.9,0,MSS,Chemotherapy_Only,None,Atezolizumab,Etoposide_Platinum,None,NA,Conventional_EBRT,50.2,9,96.1,0,0,0,0,8.4,1,29.6,0,7.2,CR,1,1,0.8,1.2,-68.3,0,0,1,385.2,2.0,22.3,0,0.0,0,G2,Negative,Negative,Positive,1,85.8,96.6,1,III,1,0,1,0,3,4.1,413.7,12.6,3.1,148.0,1.7,0,None,0,1,1,2,0,0 |
| 50da6108-235f8a739-4f28f2318-0610-00041b16ed6f,SITE_002,2023-04-08,71.2041834299385,Male,Hispanic,Private,Former,18.8,1.0,60.0,3.4,0,0,Asbestos,0,1,28.7,Squamous_Cell,Non-keratinizing,IIIC,T3,N2,M0,5.4,LUL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,0,0,<1%,8.2,0,MSS,CCRT,None,Durvalumab,Carboplatin_Paclitaxel,None,NA,IMRT,55.0,4,88.7,0,0,0,0,28.0,1,32.4,1,21.7,SD,0,1,5.3,0.0,-28.7,0,0,0,162.7,12.5,8.5,1,9.27,0,G3,Negative,Positive,Negative,2,53.5,60.1,1,III,0,0,1,1,3,3.2,137.9,13.5,1.7,110.4,25.8,1,Colitis,1,1,0,2,1,0 |
| 152639fa-940b95d7-43f72adee-039f-000112f0f1b9,SITE_036,2022-01-21,78.87182003691588,Male,Hispanic,Private,Former,25.6,1.1,60.0,0.6,1,0,Radon,1,0,24.5,Adenocarcinoma,Lepidic,IA,T2b,N0,M0,4.9,RUL,Right,0,0,1,1,0,0,0,0,None,None,None,None,G12D,None,0,0,0,None,0,0,0,0,0,<1%,2.0,0,MSS,Surgery_Adjuvant,None,None,None,Robotic,R0,None,0.0,5,95.9,0,0,0,0,6.6,0,6.6,0,5.5,CR,1,1,0.5,18.3,-78.5,0,0,0,612.9,25.0,41.6,0,0.0,0,G2,Positive,Negative,Negative,1,83.1,58.9,0,None,0,0,1,0,0,3.4,257.0,12.5,7.5,61.2,11.7,0,None,0,0,0,1,0,0 |
| 610904e1-2a73f2228-41231b0ea3-004e-0004ed753f74,SITE_003,2023-07-24,73.03602585718214,Male,Black,Medicare,Former,43.6,2.4,60.0,2.2,1,0,None,0,1,21.9,Squamous_Cell,Keratinizing,IVB,T1b,N3,M1a,1.8,LUL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,0,0,<1%,15.2,1,MSS,Chemo_IO_Combination,None,Nivolumab_Ipilimumab,Carboplatin_Paclitaxel,None,NA,None,0.0,4,68.2,0,0,0,0,8.6,1,8.6,1,6.8,PD,0,0,3.2,0.0,28.9,0,0,0,235.2,2.6,10.8,1,30.36,0,G3,Negative,Positive,Negative,1,55.7,70.0,0,None,0,0,0,0,0,3.4,203.0,9.0,2.0,263.7,4.4,1,Hepatitis,3,2,0,3,0,0 |
| 59aabc8f-273ab27ea-410d0035ad-0bc8-00048dab934a,SITE_010,2019-02-24,74.03013524489118,Female,White,Medicaid,Former,64.4,2.9,60.0,4.1,0,0,None,0,0,27.5,Adenocarcinoma,Acinar,IIIB,T1c,N2,M0,2.7,RLL,Left,1,0,0,0,0,0,0,0,None,None,None,None,G12C,None,0,0,0,None,0,0,1,0,0,<1%,22.6,1,MSS,Chemo_RT,None,None,Carboplatin_Paclitaxel,None,NA,IMRT,56.8,5,81.9,0,0,0,0,3.6,1,11.3,1,3.1,PD,0,0,3.3,0.0,62.7,0,0,0,342.5,25.0,5.5,1,1.81,0,GX,Negative,Negative,Negative,0,57.6,81.8,0,None,0,0,1,0,0,3.9,373.1,13.5,3.5,191.5,11.5,0,None,0,0,1,1,0,1 |
| 2d611b5f-13da7bf9a-48823521d-01b5-00024dee63da,SITE_009,2018-09-20,73.05060969203599,Male,White,Private,Current,19.0,1.0,60.0,0.0,0,1,None,0,0,31.5,SCLC_Extensive,NA,Exte,T1c,N1,M0,2.4,RUL,Right,1,0,0,0,0,0,0,0,None,None,None,None,None,None,1,0,0,None,0,0,1,0,0,<1%,9.0,0,MSS,Chemo_IO_Combination,None,Atezolizumab,Etoposide_Platinum,None,NA,None,0.0,4,83.6,0,0,0,0,10.3,1,10.3,1,8.9,PR,1,1,0.5,0.5,-40.4,0,0,0,153.0,1.7,19.6,0,0.0,0,G2,Negative,Negative,Positive,3,72.4,49.6,1,I,0,0,0,0,2,3.7,134.0,9.5,5.5,354.0,113.8,0,None,0,1,3,3,0,1 |
| 08b19a44-3cdb37dd-41a14cecc-09a4-00007104d57b,SITE_042,2022-02-01,70.23751837602,Male,White,Private,Current,40.8,2.4,60.0,0.0,0,0,None,0,1,30.7,Adenocarcinoma,Acinar,IVB,T2b,N1,M1b,4.8,LLL,Right,0,0,0,0,1,0,0,0,Brain,None,None,None,None,None,0,0,0,None,0,0,0,0,0,<1%,0.8,0,MSS,Chemotherapy_Only,None,None,Carboplatin_Pemetrexed,None,NA,None,0.0,2,74.2,1,0,0,0,2.0,1,3.3,1,1.9,SD,0,1,1.1,0.0,0.2,0,0,0,195.2,2.3,8.7,0,0.0,0,G3,Positive,Negative,Negative,1,96.5,79.3,1,III,1,0,0,0,2,4.4,266.7,9.5,4.3,70.7,67.6,0,None,0,1,2,1,0,0 |
| 7c3fd536-365bed47b-4174bf7fa2-0d53-00064f3dd3c5,SITE_003,2016-07-14,50.05569426771525,Female,Hispanic,Private,Current,12.6,1.0,60.0,0.0,0,0,None,0,1,25.4,Large_Cell,NA,IVA,T2a,N0,M1a,3.1,RUL,Right,1,0,0,0,0,1,0,0,Bone,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,7.2,0,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,7,75.2,0,0,0,0,9.5,0,9.5,0,7.4,SD,0,1,1.4,0.0,-19.3,0,0,0,411.2,9.5,13.6,1,7.06,0,G2,Negative,Negative,Negative,0,59.9,78.5,0,None,0,1,1,1,2,4.2,600.0,9.9,2.9,56.3,23.2,0,None,0,0,1,0,0,0 |
| 390c499e-18f560353-4ab24dcda-0499-0002e59fbd0d,SITE_022,2017-05-23,67.79440023540029,Female,White,Medicare,Never,0.0,0.0,0.0,0.0,0,0,None,0,0,29.9,Adenocarcinoma,Acinar,IVA,T2a,N0,M1c,3.7,LUL,Right,1,0,0,0,1,1,0,0,Brain|Bone,None,None,None,None,None,0,0,0,None,0,0,1,11,11,1-49%,2.6,0,MSS,Chemo_IO_Combination,None,Pembrolizumab,Carboplatin_Pemetrexed,None,NA,None,0.0,5,98.7,0,0,0,0,17.7,0,17.7,0,17.2,PD,0,0,0.5,0.0,52.1,0,0,0,157.7,16.7,18.8,1,32.11,1,GX,Negative,Negative,Negative,2,43.0,54.0,1,III,0,0,1,0,1,3.0,100.0,12.2,2.2,84.6,5.2,0,None,0,2,0,1,0,0 |
| 7251cafb-3203c8cde-4156f560f1-0caf-0005ce274ec6,SITE_030,2021-01-02,61.71617639093331,Male,White,Uninsured,Current,1.3,1.0,9.0,0.0,0,0,None,0,0,29.9,Squamous_Cell,Non-keratinizing,IIIA,T2b,N2,M0,4.5,RUL,Left,0,0,0,1,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,12,24,1-49%,5.2,0,MSS,Chemo_RT,None,None,Carboplatin_Paclitaxel,None,NA,IMRT,55.6,7,89.9,0,0,0,0,3.2,1,6.5,1,2.8,PD,0,0,8.0,0.0,41.6,0,0,0,251.5,7.0,4.0,0,0.0,0,G2,Negative,Positive,Negative,2,58.0,54.6,1,I,0,0,1,0,1,3.1,127.7,10.6,2.6,188.5,2.6,0,None,0,2,0,2,0,1 |
| 56c60cd8-25f6a59e9-4104522688-00cd-0004680ea6ff,SITE_026,2021-09-05,54.841510902419806,Female,Black,Medicare,Current,72.5,3.2,60.0,0.0,0,0,Radon,1,0,25.6,Squamous_Cell,Basaloid,IIIA,T4,N1,M0,11.8,RLL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,1,0,0,None,0,0,1,70,100,>=50%,33.3,1,MSS,CCRT,None,Durvalumab,Carboplatin_Paclitaxel,None,NA,IMRT,64.1,4,88.6,0,0,0,0,9.5,1,16.4,0,8.7,SD,0,1,1.6,0.0,15.7,0,0,1,309.7,10.6,115.7,0,0.0,0,G2,Negative,Positive,Negative,1,68.1,79.1,0,None,1,0,0,0,1,4.1,567.9,9.6,2.1,248.5,4.9,1,Colitis,1,1,2,3,0,1 |
| 63a21207-2b96e7e32-412ae63615-0120-00050f3aea62,SITE_035,2016-03-12,82.97725788335782,Female,White,Private,Current,4.4,1.0,29.3,0.0,0,0,None,0,0,22.9,Adenocarcinoma,Papillary,IIIC,T1c,N1,M0,2.8,Central,Left,0,0,1,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,1.0,0,MSS,CCRT,None,Durvalumab,Carboplatin_Paclitaxel,None,NA,IMRT,61.3,4,86.3,0,0,0,0,4.3,1,21.5,0,3.8,PR,1,1,2.0,5.1,-57.7,0,0,0,146.7,17.9,53.3,1,28.0,0,G3,Negative,Negative,Negative,1,108.6,105.2,0,None,1,0,1,0,1,3.5,187.3,13.3,4.1,176.2,20.5,0,None,0,1,1,2,0,1 |
| 61446288-2a8deb1b9-4123cd2798-0628-0004f07900ef,SITE_041,2020-01-30,83.42545573841419,Female,Asian,Medicare,Never,0.0,0.0,0.0,0.0,0,0,None,0,0,23.1,SCLC_Extensive,NA,Exte,T2b,N0,M0,5.0,RUL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,4.3,0,MSS,Chemo_IO_Combination,None,Durvalumab,Etoposide_Platinum,None,NA,None,0.0,5,85.1,1,0,0,0,12.3,1,14.8,0,11.6,PD,0,0,1.5,0.0,23.4,0,0,0,100.6,19.6,9.4,1,12.55,1,GX,Negative,Negative,Positive,2,82.0,67.3,0,None,0,1,1,0,1,3.7,212.0,12.4,3.1,161.8,21.1,1,Hepatitis,3,0,0,4,0,1 |
| 18e9ebd2-ae6572bf-44abdc376-0ebd-000143e0f9b1,SITE_020,2018-08-24,79.91259570280832,Female,White,Medicaid,Former,0.8,1.0,5.5,21.1,0,0,None,0,0,29.8,SCLC_Limited,NA,Limi,T2a,N2,M0,3.2,LUL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,100,100,>=50%,19.0,1,MSS,Chemotherapy_Only,None,Durvalumab,Etoposide_Platinum,None,NA,Conventional_EBRT,47.2,3,85.6,0,0,0,0,8.0,1,13.4,1,7.2,SD,0,1,0.5,0.0,-28.7,0,0,0,385.2,4.5,19.6,1,15.75,0,G3,Negative,Negative,Positive,0,61.4,77.3,0,None,0,0,1,0,2,4.1,169.7,14.0,1.7,247.8,7.6,1,Colitis,2,2,0,1,0,0 |
| 2e94790b-1460f4f4e-48bbd6b21-0790-00025d8a2596,SITE_042,2020-01-06,69.4245274601308,Male,Asian,Private,Former,87.5,2.5,60.0,11.8,0,0,Radon,1,0,25.8,SCLC_Extensive,NA,Exte,T3,N1,M0,6.1,LUL,Bilateral,1,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,4.8,0,MSS,Chemo_IO_Combination,None,Atezolizumab,Etoposide_Platinum,None,NA,None,0.0,6,66.2,0,0,0,0,4.7,1,4.7,1,3.3,PD,0,0,0.7,0.0,22.2,0,0,0,800.0,3.7,43.1,0,0.0,0,G3,Negative,Negative,Positive,4,72.5,62.3,1,II,0,0,1,0,1,4.2,458.1,11.0,3.7,112.7,74.9,0,None,0,1,1,1,0,1 |
| 3bbd838b-1a22e98ce-4b3388aa1-0838-0003089fae16,SITE_016,2024-07-30,79.83093864905024,Female,White,Medicaid,Never,0.0,0.0,0.0,0.0,0,1,Radon,1,0,21.3,SCLC_Limited,NA,Limi,T3,N0,M0,5.5,Central,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,16,16,1-49%,4.5,0,MSS,Chemo_IO_Combination,None,Atezolizumab,Etoposide_Platinum,None,NA,Conventional_EBRT,45.9,4,98.0,0,0,0,0,1.1,1,22.3,0,0.9,SD,0,1,2.1,0.0,-4.5,0,0,0,307.8,17.2,25.8,1,7.4,0,GX,Negative,Negative,Positive,1,103.3,75.8,0,None,0,0,0,0,0,3.2,100.0,12.4,2.9,279.7,35.8,0,None,0,2,1,1,0,0 |
| 3fb7a21c-1be056ec5-4bf26e654-0a21-00033c533b73,SITE_050,2015-10-07,67.11450521571734,Male,White,Private,Former,92.3,2.1,60.0,2.3,0,0,None,0,0,18.4,Squamous_Cell,Keratinizing,IIIA,T3,N3,M0,5.1,RUL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,1,None,0,0,1,100,100,>=50%,56.2,1,MSS,CCRT,None,Durvalumab,Carboplatin_Paclitaxel,None,NA,IMRT,58.0,8,96.3,0,0,0,0,5.7,1,34.7,0,5.6,PD,0,0,1.0,0.0,57.6,0,0,0,338.8,10.6,191.7,1,21.41,0,G3,Negative,Positive,Negative,1,70.7,62.0,1,II,1,0,0,0,2,2.7,371.9,14.1,5.4,488.3,0.4,1,Endocrinopathy,2,2,3,2,0,0 |
| 059b5c9e-273f8853-410d215da-05c9-000048e3b40d,SITE_026,2024-12-12,68.9265741305289,Female,White,Private,Former,23.8,1.0,60.0,5.7,0,0,Silica,0,0,29.7,SCLC_Extensive,NA,Exte,T1b,N1,M0,1.2,LLL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,12.7,1,MSS,Chemotherapy_Only,None,Atezolizumab,Etoposide_Platinum,None,NA,None,0.0,3,87.4,0,0,0,0,0.8,1,5.2,1,0.7,CR,1,1,0.5,3.2,-80.2,0,0,0,157.3,11.8,15.1,0,0.0,0,G3,Negative,Negative,Positive,0,70.9,67.9,0,None,0,0,1,0,0,3.7,100.0,9.9,5.8,78.4,23.7,0,None,0,1,0,0,0,0 |
| 45f5fd50-1e9b9ed31-4d1e1f7f0-0fd5-00038d7ddd17,SITE_037,2019-06-29,56.61202198061116,Female,White,Medicare,Current,32.5,1.0,60.0,0.0,0,0,Radon,1,0,23.5,Adenocarcinoma,Acinar,IVB,T2a,N1,M1c,3.6,RLL,Right,0,0,0,0,0,1,0,0,Bone,None,None,None,G12V,None,0,0,0,None,0,0,0,66,77,>=50%,20.9,1,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,7,87.2,0,0,0,0,21.1,1,21.1,1,20.0,SD,0,1,0.5,0.0,-20.0,0,0,0,510.2,4.4,83.7,1,28.66,0,G1,Positive,Negative,Negative,0,67.7,111.2,0,None,0,0,1,0,0,3.4,100.0,11.2,11.5,127.4,62.4,0,None,0,0,2,0,1,0 |
| 13bfc211-8a3e4e78-43b3f4633-0c21-000100bcdae4,SITE_044,2022-09-19,70.77141739273898,Male,White,Private,Former,17.8,1.0,60.0,3.6,0,1,Asbestos,0,0,27.5,Adenocarcinoma,Papillary,IIA,T4,N3,M0,10.4,RLL,Right,0,1,0,0,0,0,0,0,None,None,None,None,G12C,None,0,0,0,None,0,0,1,17,37,1-49%,14.1,1,MSS,Surgery_Adjuvant,None,None,None,Robotic,R0,None,0.0,6,66.2,0,0,0,0,12.4,1,52.9,0,11.9,CR,1,1,0.5,14.3,-63.9,0,0,1,202.7,12.3,4.0,0,0.0,0,G2,Positive,Negative,Negative,0,87.5,73.7,0,None,1,0,0,0,1,3.8,116.3,14.5,7.1,64.5,27.2,0,None,0,1,2,2,0,0 |
| 5f26f115-29a109794-411d74d33f-0f11-0004d4fa3e18,SITE_040,2019-03-30,67.57366632003196,Male,White,VA,Current,21.3,1.1,60.0,0.0,0,0,Radon,1,0,31.6,Adenocarcinoma,Acinar,IA,T2a,N0,M0,4.0,RLL,Right,0,0,0,0,0,0,0,0,None,None,None,None,G12A,None,0,0,0,None,1,0,1,33,32,1-49%,10.4,1,MSS,Surgery_Adjuvant,None,None,Cisplatin_Pemetrexed,Lobectomy,R0,None,0.0,4,81.2,0,0,0,0,41.0,0,41.0,0,32.8,CR,1,1,4.1,43.4,-86.9,0,0,0,437.8,3.1,4.9,0,0.0,0,G2,Negative,Negative,Negative,1,65.5,47.0,1,II,1,1,0,0,3,3.8,187.9,12.5,2.1,83.2,48.1,0,None,0,1,0,1,0,1 |
| 576e25e9-264030960-41064a71bb-025e-00047097ecdc,SITE_043,2018-02-09,54.62480489007259,Female,White,Medicare,Former,11.1,1.0,60.0,0.2,0,1,None,0,0,20.1,Adenocarcinoma,Solid,IA,T4,N3,M0,9.7,RLL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,62,85,>=50%,28.2,1,MSS,SBRT,None,None,None,None,NA,SBRT,50.3,7,79.3,0,0,0,0,5.4,1,5.6,1,5.1,PD,0,0,3.0,0.0,68.1,0,0,0,331.5,9.0,151.6,0,0.0,0,GX,Positive,Negative,Negative,3,90.7,82.3,0,None,1,0,1,0,1,3.3,140.2,12.2,1.0,187.8,13.5,0,None,0,3,0,3,0,0 |
| 7615646a-33a95bee7-4162402d3e-0646-0005ff161969,SITE_027,2022-09-13,66.51362743774233,Female,Black,Private,Current,9.8,1.0,60.0,0.0,1,1,Asbestos,0,1,25.8,Squamous_Cell,Non-keratinizing,IVB,T2a,N2,M1a,3.6,LUL,Right,0,1,0,1,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,50.1,1,MSS,Chemo_IO_Combination,None,Pembrolizumab,Carboplatin_Paclitaxel,None,NA,None,0.0,7,87.0,0,0,0,0,8.1,1,8.1,1,6.6,SD,0,1,0.5,0.0,-25.9,0,0,0,335.6,8.1,12.0,1,19.57,0,G2,Negative,Positive,Negative,1,94.1,90.1,0,None,1,0,0,0,3,4.8,136.1,12.4,1.5,54.0,18.2,0,None,0,1,0,1,0,0 |
| 5f545dc7-29b4e9072-411dfd1955-05dc-0004d748c322,SITE_003,2021-11-14,66.24256914336031,Male,White,Private,Former,16.6,1.0,60.0,1.5,0,0,None,0,0,25.2,Adenocarcinoma,Solid,IVA,T2a,N2,M1b,3.6,RUL,Right,0,1,0,1,1,0,0,1,Brain|Adrenal,None,None,None,None,None,0,1,0,None,0,0,1,100,100,>=50%,2.0,0,MSS,Targeted_TKI,Selpercatinib,None,None,None,NA,None,0.0,4,63.7,0,0,0,0,5.1,1,22.4,1,3.6,PD,0,0,0.5,0.0,61.4,0,0,0,329.2,8.1,4.9,0,0.0,0,G2,Positive,Negative,Negative,1,86.0,82.8,1,II,1,0,0,0,2,3.8,126.0,14.9,3.2,93.0,18.8,0,None,0,2,1,1,0,0 |
| 2eee2585-1488306a4-48cca708f-0258-00026217e7c8,SITE_025,2016-06-09,84.07683108312408,Female,Black,Medicare,Former,71.7,2.3,60.0,12.2,0,1,None,0,0,27.7,SCLC_Limited,NA,Limi,T2a,N0,M0,3.7,RLL,Left,1,0,0,1,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,31,56,1-49%,8.7,0,MSS,Chemotherapy_Only,None,Durvalumab,Etoposide_Platinum,None,NA,Conventional_EBRT,48.6,5,90.1,0,0,0,0,5.8,1,16.3,1,5.3,PR,1,1,0.5,9.3,-44.8,0,0,0,324.0,13.8,19.0,0,0.0,0,G1,Negative,Negative,Positive,1,71.0,69.2,0,None,0,0,1,0,0,3.5,127.1,12.5,1.5,279.3,26.5,1,Hepatitis,2,0,0,2,0,1 |
| 7bd75be1-362e38328-41738613a3-05be-000649efaa74,SITE_010,2022-01-18,75.49502662087738,Female,Black,Private,Current,120.0,3.7,60.0,0.0,0,0,None,0,0,31.6,Squamous_Cell,Keratinizing,IA,T2a,N0,M0,3.8,LUL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,31,61,1-49%,8.7,0,MSS,Surgery_Adjuvant,None,None,Carboplatin_Paclitaxel,Lobectomy,R0,None,0.0,2,86.2,1,0,0,0,8.8,1,40.5,0,8.3,CR,1,1,0.5,24.9,-69.6,0,0,0,281.9,3.3,91.5,1,12.93,1,G1,Negative,Positive,Negative,1,49.8,57.3,0,None,0,0,1,1,2,3.9,125.7,12.6,2.9,169.7,8.4,0,None,0,1,2,3,1,1 |
| 3496be91-1701f35f8-49dc43bb3-0be9-0002aba7ad64,SITE_045,2022-07-11,67.10873167136893,Male,White,Medicare,Current,64.5,1.6,60.0,0.0,0,0,None,0,1,20.0,Adenocarcinoma,Micropapillary,IVA,T4,N1,M1b,7.7,RLL,Right,0,0,0,0,0,0,1,0,Liver,None,None,None,G12D,None,0,0,0,None,0,0,0,51,97,>=50%,6.1,0,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,7,80.5,1,0,0,0,7.7,1,13.9,0,6.4,SD,0,1,2.0,0.0,12.1,0,0,0,397.3,12.7,8.0,0,0.0,0,G3,Positive,Negative,Negative,1,71.0,57.7,1,III,0,0,1,1,3,4.1,225.3,12.5,4.6,235.3,103.4,0,None,0,1,2,0,0,0 |
| 29b4a534-123f0846d-47d1def9c-0a53-00021e2c63ab,SITE_012,2018-11-16,69.3634794431103,Male,Asian,Private,Former,49.1,1.5,60.0,8.7,1,0,Silica,0,0,28.6,Squamous_Cell,Keratinizing,IVA,T1b,N0,M1c,1.2,RUL,Right,0,0,0,0,1,0,0,0,Brain,None,None,None,None,None,0,0,0,None,0,0,1,75,100,>=50%,21.8,1,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,2,95.4,0,0,0,0,15.5,1,39.4,1,11.6,PR,1,1,1.8,12.3,-59.8,0,0,0,170.2,7.5,19.1,1,26.12,1,G1,Negative,Positive,Negative,1,63.0,69.0,1,II,1,0,1,1,3,3.5,145.8,9.3,3.0,68.3,169.7,1,Endocrinopathy,2,4,2,1,0,0 |
| 73e89891-32b5c2bf8-415bb9c9b3-0989-0005e2cfbf64,SITE_012,2024-04-01,67.42001759198988,Male,White,Private,Former,26.1,1.6,60.0,4.7,0,0,None,0,0,30.6,Adenocarcinoma,Acinar,IVA,T2b,N0,M1b,4.1,RLL,Right,1,0,0,0,0,0,0,0,None,None,None,CD74-ROS1,None,None,1,0,0,None,0,0,1,0,0,<1%,11.4,1,MSS,Targeted_TKI,Entrectinib,None,None,None,NA,None,0.0,8,78.1,0,0,0,0,1.3,1,6.8,1,1.1,CR,1,1,0.5,2.0,-75.5,0,0,0,217.2,3.9,2.2,1,16.27,0,G3,Positive,Negative,Negative,1,61.0,66.1,1,III,1,0,1,0,2,5.0,100.0,13.5,5.4,154.6,9.1,0,None,0,2,2,0,0,0 |
| 2f6b3940-14bee90c1-48e41abc0-0394-00026871e847,SITE_013,2021-05-28,65.0723171444423,Female,White,Medicare,Current,13.5,1.0,60.0,0.0,0,0,Silica,0,0,25.2,SCLC_Limited,NA,Limi,T2b,N2,M0,4.6,RLL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,51.1,1,MSS,Chemo_IO_Combination,None,Durvalumab,Etoposide_Platinum,None,NA,Conventional_EBRT,56.3,5,84.6,0,0,0,0,17.9,1,17.9,1,16.5,SD,0,1,1.6,0.0,11.5,0,0,0,509.8,2.6,11.4,0,0.0,0,G3,Negative,Negative,Positive,1,70.7,63.1,0,None,0,1,0,0,1,3.0,196.6,10.9,2.9,460.4,3.5,1,Endocrinopathy,1,0,0,4,0,0 |
| 09c59d0f-44674b6a-41d50d72d-09d0-00007f08f9ca,SITE_033,2018-05-02,56.71694162481128,Male,White,Private,Current,40.2,1.1,60.0,0.0,1,0,None,0,0,25.4,Adenocarcinoma,Solid,IVB,T4,N2,M1b,9.6,LUL,Right,0,0,0,0,0,1,0,0,Bone,None,None,None,None,None,0,0,0,None,0,1,0,0,0,<1%,24.3,1,MSS,Chemo_IO_Combination,None,Atezolizumab,Carboplatin_Pemetrexed,None,NA,None,0.0,4,95.2,0,0,0,0,0.5,1,14.7,0,0.5,SD,0,1,1.0,0.0,-9.1,0,0,1,266.8,25.0,66.5,0,0.0,0,G3,Positive,Negative,Negative,1,83.6,91.4,0,None,1,1,0,0,4,3.1,291.4,10.0,2.6,99.8,2.7,1,Endocrinopathy,2,4,2,0,1,0 |
| 3c1a67a2-1a4b8d56f-4b44f36e6-067a-00030d574341,SITE_029,2015-02-09,65.56500716273418,Female,Asian,Medicare,Never,0.0,0.0,0.0,0.0,0,0,None,0,0,27.9,SCLC_Extensive,NA,Exte,T2b,N0,M0,4.2,Central,Left,0,0,1,1,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,30.8,1,MSS,Chemotherapy_Only,None,Atezolizumab,Etoposide_Platinum,None,NA,None,0.0,5,72.3,0,0,0,0,2.4,1,19.6,1,1.9,CR,1,1,0.5,1.4,-74.8,0,0,0,207.9,7.0,7.8,0,0.0,0,G2,Negative,Negative,Positive,2,63.8,86.7,0,None,0,0,0,1,2,3.0,174.3,9.0,14.8,110.7,36.9,0,None,0,0,1,3,0,1 |
| 65d8d768-2c8ede3d9-41318a8638-0d76-00052c02f04f,SITE_048,2021-09-29,59.912066561801126,Male,White,Medicare,Former,2.7,1.0,18.0,10.4,1,0,None,0,0,27.6,SCLC_Limited,NA,Limi,T4,N2,M0,11.7,LUL,Right,0,1,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,3.1,0,MSS,Chemo_IO_Combination,None,Durvalumab,Etoposide_Platinum,None,NA,Conventional_EBRT,46.7,6,95.3,0,0,0,0,12.3,1,30.3,0,10.0,CR,1,1,0.9,11.5,-74.7,0,0,1,410.5,5.6,4.4,0,0.0,0,G3,Negative,Negative,Positive,1,50.3,92.3,0,None,1,0,0,1,2,3.8,106.7,9.4,4.4,210.4,48.5,0,None,0,1,0,2,0,0 |
| 184098f5-a9c42eb4-448c1cadf-098f-00013b47c478,SITE_021,2017-02-02,55.12200238023011,Female,White,Private,Former,120.0,2.5,60.0,16.9,0,0,Asbestos,0,0,28.6,Adenocarcinoma,Acinar,IB,T4,N3,M0,10.0,LUL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,100,100,>=50%,4.4,0,MSS,Surgery_Adjuvant,None,None,None,Lobectomy,R0,None,0.0,6,87.9,0,0,0,0,30.7,0,30.7,0,26.6,CR,1,1,1.9,17.3,-76.1,0,0,0,371.9,3.0,7.9,0,0.0,0,G2,Negative,Negative,Negative,0,57.7,59.4,0,None,0,0,0,0,2,4.0,290.8,8.0,4.8,86.5,37.1,0,None,0,3,0,3,0,0 |
| 3b41a2fb-19ecb74de-4b1c4e8f1-0a2f-0003025546c6,SITE_015,2022-07-24,71.85660723820158,Male,Other,Medicare,Current,49.4,2.5,60.0,0.0,0,0,None,0,0,28.5,Adenocarcinoma,Solid,IVA,T2a,N2,M1a,3.4,RUL,Left,1,1,0,0,0,1,0,1,Bone|Adrenal,None,None,None,None,None,0,0,0,None,0,0,0,0,0,<1%,4.7,0,MSS,Chemotherapy_Only,None,None,Carboplatin_Pemetrexed,None,NA,None,0.0,6,90.7,0,0,0,0,3.2,1,17.0,1,2.4,SD,0,1,7.3,0.0,9.6,0,0,0,127.8,17.7,9.7,0,0.0,0,G2,Positive,Negative,Negative,0,105.4,57.3,1,II,0,0,0,0,2,3.6,100.9,10.4,8.1,228.2,42.2,0,None,0,1,0,1,0,0 |
| 10a14494-7468e00d-431e3cdbc-0449-0000d8307b8b,SITE_003,2020-03-31,70.71701426936573,Male,White,Medicare,Former,84.2,3.5,60.0,16.2,0,1,None,0,0,21.6,SCLC_Limited,NA,Limi,T4,N2,M0,9.0,Endobronchial,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,50,100,>=50%,29.7,1,MSS,Chemotherapy_Only,None,Atezolizumab,Etoposide_Platinum,None,NA,Conventional_EBRT,52.1,7,98.0,0,0,0,0,24.1,0,24.1,0,23.0,PD,0,0,4.6,0.0,40.4,0,0,0,352.5,16.6,50.3,0,0.0,0,G2,Negative,Negative,Negative,1,84.9,73.2,1,II,1,0,0,0,2,4.0,170.6,11.6,8.3,50.5,8.6,1,Hepatitis,2,3,1,1,0,0 |
| 57de849c-26715a045-41079b8dd4-0849-0004764cbbf3,SITE_001,2019-08-31,50.02627864200326,Female,Hispanic,Medicaid,Former,0.5,1.0,3.5,1.3,0,0,None,0,0,30.5,Large_Cell,NA,IA,T4,N2,M0,9.8,RML,Right,1,0,1,1,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,100,100,>=50%,3.8,0,MSS,SBRT,None,None,None,None,NA,SBRT,46.8,3,94.9,0,0,0,0,1.3,1,10.6,0,0.9,SD,0,1,3.2,0.0,18.2,0,0,0,262.1,14.2,31.7,0,0.0,0,G2,Negative,Negative,Negative,3,57.8,78.6,0,None,0,0,0,0,2,4.0,198.2,14.6,3.5,50.0,1.0,0,None,0,2,0,4,1,0 |
| 3ce3e626-1aa3b4b0b-4b6abb272-0e62-00031792aff5,SITE_019,2016-08-20,65.8344959437963,Male,Black,Private,Current,4.2,1.0,28.1,0.0,1,0,None,0,0,31.3,SCLC_Limited,NA,Limi,T1c,N0,M0,2.1,RLL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,39,37,1-49%,3.9,0,MSS,Chemo_IO_Combination,None,Durvalumab,Etoposide_Platinum,None,NA,Conventional_EBRT,54.9,3,97.8,0,0,0,0,12.6,1,22.0,1,10.7,PR,1,1,0.5,5.5,-35.1,0,0,0,349.3,7.0,39.9,0,0.0,0,G3,Negative,Negative,Positive,2,98.2,73.1,0,None,0,0,1,0,0,3.6,343.6,12.6,9.3,179.2,9.5,1,Pneumonitis,2,0,1,0,1,0 |
| 2a43df9a-127db1d37-47ecb9ece-0df9-000225725ad9,SITE_047,2022-02-09,76.45916316604928,Female,Hispanic,Private,Former,56.9,2.1,60.0,24.1,1,1,None,0,0,26.8,SCLC_Limited,NA,Limi,T2b,N0,M0,4.3,RUL,Left,0,1,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,18,28,1-49%,3.3,0,MSS,Chemo_IO_Combination,None,Atezolizumab,Etoposide_Platinum,None,NA,Conventional_EBRT,59.2,4,69.1,0,0,0,0,3.2,1,10.2,1,3.1,PD,0,0,2.1,0.0,46.4,0,0,0,246.0,13.5,20.8,0,0.0,0,G2,Negative,Negative,Positive,3,70.7,77.5,0,None,1,0,0,0,3,4.0,267.4,13.0,3.3,82.4,200.0,0,None,0,2,3,2,1,1 |
| 1d0b5d94-cb4f8f0d-4572218bc-05d9-00017993c08b,SITE_027,2016-08-28,77.06262551951505,Female,Hispanic,Medicare,Former,1.1,1.0,7.3,1.7,1,0,Radon,1,1,19.3,Adenocarcinoma,Micropapillary,IIIA,T1c,N3,M0,2.3,RUL,Right,0,0,0,1,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,100,100,>=50%,80.0,1,MSS,Chemo_RT,None,None,Carboplatin_Paclitaxel,None,NA,IMRT,58.9,3,84.2,0,0,0,0,1.0,1,14.7,1,0.8,PR,1,1,1.1,0.8,-40.3,0,0,0,308.6,3.8,9.5,1,1.48,1,G3,Positive,Negative,Negative,2,116.0,97.4,1,III,0,0,0,0,1,3.7,225.7,15.1,9.1,105.7,29.9,0,None,0,2,0,4,0,0 |
| 48418853-1f9caba46-4d8c498f9-0885-0003ab53ec3e,SITE_045,2019-03-05,76.74545000740977,Female,Other,Medicare,Former,30.7,1.0,60.0,12.8,0,0,None,0,1,25.5,Adenocarcinoma,Papillary,IVB,T3,N2,M1b,5.1,LLL,Left,0,0,0,0,0,0,0,1,Adrenal,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,7.9,0,MSS,Chemotherapy_Only,None,None,Carboplatin_Pemetrexed,None,NA,None,0.0,4,95.2,1,0,0,0,2.8,1,2.9,1,2.6,SD,0,1,1.7,0.0,-23.4,0,0,0,100.0,8.8,7.9,1,14.17,0,G3,Positive,Negative,Negative,3,79.7,68.5,0,None,0,0,1,0,0,3.6,319.0,7.0,1.9,251.1,38.0,0,None,0,1,0,0,0,0 |
| 55bc7708-258274139-4101356518-0770-00045a920b6f,SITE_006,2023-05-11,67.36967546556387,Female,White,Medicare,Never,0.0,0.0,0.0,0.0,0,0,Asbestos,0,0,26.9,Adenocarcinoma,Acinar,IIIC,T1a,N2,M0,0.6,RUL,Left,0,1,1,0,0,0,0,0,None,L858R,None,None,None,None,0,0,0,None,0,1,0,0,0,<1%,14.5,1,MSS,Chemo_RT,None,None,Carboplatin_Paclitaxel,None,NA,IMRT,63.3,6,74.3,0,0,0,0,13.6,1,13.6,1,10.5,SD,0,1,2.7,0.0,13.1,0,0,0,156.4,7.1,33.7,1,21.77,0,G2,Positive,Negative,Negative,1,85.2,84.9,0,None,0,1,0,0,1,3.6,112.3,13.3,3.6,215.8,78.0,0,None,0,3,1,3,0,0 |
| 785bf33d-34a83a6ac-416913d9b7-0f33-00061cab5a20,SITE_005,2024-03-13,58.972069384293064,Male,Asian,Medicare,Never,0.0,0.0,0.0,0.0,0,1,None,0,0,20.8,SCLC_Limited,NA,Limi,T3,N3,M0,6.4,RML,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,30,28,1-49%,3.2,0,MSS,Chemo_IO_Combination,None,Atezolizumab,Etoposide_Platinum,None,NA,Conventional_EBRT,48.9,2,80.0,0,0,0,0,8.0,1,8.0,1,6.7,PD,0,0,1.1,0.0,51.7,0,0,0,354.3,9.1,135.2,0,0.0,0,G2,Negative,Negative,Negative,1,90.1,80.3,0,None,1,0,1,0,1,3.9,441.4,13.1,5.2,71.1,5.7,0,None,0,2,1,1,0,1 |
| 37f49815-187b02894-4a7ddc83f-0981-0002d76bb918,SITE_042,2024-11-19,56.70486114009842,Female,Asian,Medicare,Former,10.2,1.0,60.0,1.0,0,1,Silica,0,0,24.4,Squamous_Cell,Keratinizing,IA,T2a,N0,M0,3.5,RUL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,21.4,1,MSS,Surgery_Adjuvant,None,None,Carboplatin_Paclitaxel,Lobectomy,R0,None,0.0,4,97.5,0,0,0,0,16.2,0,16.2,0,14.8,CR,1,1,0.7,39.2,-89.9,0,0,0,800.0,1.7,6.5,0,0.0,0,G3,Negative,Positive,Negative,1,101.7,73.5,1,III,0,0,1,0,2,4.4,100.0,14.1,5.8,202.7,28.1,0,None,0,1,3,1,0,0 |
| 14916e00-8ffa0201-43db44a00-06e0-00010b629607,SITE_006,2024-07-28,70.2737465951284,Female,Black,Private,Current,15.0,1.0,60.0,0.0,0,0,None,0,0,19.7,Squamous_Cell,Basaloid,IVA,T2b,N0,M1c,4.9,Endobronchial,Right,0,0,0,0,1,0,0,0,Brain,None,None,None,None,None,0,0,0,None,0,0,1,69,100,>=50%,1.8,0,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,1,73.8,0,0,0,0,0.7,1,27.9,0,0.7,CR,1,1,0.5,4.9,-71.1,0,0,1,294.0,25.0,5.9,1,8.17,1,G2,Negative,Positive,Negative,2,67.1,84.2,0,None,0,0,0,0,1,3.2,409.1,8.9,2.5,123.9,43.3,0,None,0,0,1,0,0,0 |
| 6a9532fa-2ea1464d7-413fbf98ee-032f-0005699396b9,SITE_003,2020-07-22,70.60316032646905,Male,White,Medicare,Current,49.9,2.2,60.0,0.0,0,0,None,0,0,28.7,Adenocarcinoma,Solid,IA,T1a,N2,M0,0.4,LLL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,94,87,>=50%,3.7,0,MSS,Surgery_Adjuvant,None,None,Cisplatin_Pemetrexed,Segmentectomy,R0,None,0.0,3,92.3,1,0,0,0,32.6,0,32.6,0,29.1,CR,1,1,2.6,122.9,-79.8,0,0,0,173.1,25.0,5.1,0,0.0,0,G1,Negative,Negative,Negative,4,100.2,59.7,1,IV,0,0,1,0,3,3.6,131.5,11.4,1.4,190.6,5.0,0,None,0,0,0,2,0,0 |
| 509c1ddb-23444d0fe-4f1d45991-01dd-000417ed8426,SITE_021,2017-01-01,79.22964556024812,Male,Other,Private,Never,0.0,0.0,0.0,0.0,0,0,None,0,0,26.7,Adenocarcinoma,Lepidic,IIIB,T3,N0,M0,6.9,Central,Right,0,0,0,1,0,0,0,0,None,L858R,None,None,None,None,0,0,0,None,0,0,0,28,64,1-49%,4.7,0,MSS,CCRT,None,Durvalumab,Carboplatin_Paclitaxel,None,NA,IMRT,57.3,3,85.9,1,0,0,0,6.6,1,34.2,0,5.1,PR,1,1,0.5,4.9,-33.9,0,0,1,261.8,2.9,54.5,1,18.33,0,G3,Negative,Negative,Negative,2,63.8,56.5,0,None,1,0,0,0,1,3.9,242.3,10.6,6.2,146.6,34.7,0,None,0,0,0,0,0,0 |
| 59a2496f-27370020a-410ce6dc4d-0496-00048d3dbaaa,SITE_047,2023-05-21,77.44980667824979,Female,White,Private,Former,10.9,1.0,60.0,2.2,0,0,None,0,0,18.6,Adenocarcinoma,Micropapillary,IIA,T2a,N1,M0,3.2,Central,Left,0,0,0,0,0,0,0,0,None,None,None,None,G12V,None,0,0,0,None,1,0,0,7,12,1-49%,11.0,1,MSS,SBRT,None,None,None,None,NA,SBRT,45.0,7,85.2,1,0,0,0,5.9,1,12.2,1,4.4,SD,0,1,2.0,0.0,-0.5,0,0,0,156.5,11.7,19.1,0,0.0,0,G2,Positive,Negative,Negative,2,68.5,78.9,1,I,1,0,1,1,4,4.7,413.3,9.9,3.9,60.2,140.2,0,None,0,1,0,1,0,0 |
| 0c71ec1f-571d74da-42555c45d-0ec1-0000a1c8fd9a,SITE_035,2023-01-04,65.74382776295387,Male,White,Medicare,Former,15.1,1.0,60.0,13.1,0,1,None,0,0,27.6,SCLC_Limited,NA,Limi,T3,N2,M0,5.9,Central,Left,1,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,4.4,0,MSS,Chemotherapy_Only,None,Atezolizumab,Etoposide_Platinum,None,NA,Conventional_EBRT,53.6,9,78.2,0,0,0,0,0.5,1,10.0,1,0.5,PR,1,1,0.5,3.5,-43.0,0,0,0,457.1,2.2,39.1,0,0.0,0,G2,Negative,Negative,Positive,2,75.2,45.8,0,None,0,0,1,0,0,4.0,265.2,17.0,3.4,96.7,11.0,0,None,0,1,2,2,0,1 |
| 27fba14e-117e16923-477f2e3ea-0a14-000207c730fd,SITE_005,2024-11-23,55.18004415082174,Female,White,Medicare,Current,38.5,1.6,60.0,0.0,0,1,None,0,0,25.7,Large_Cell,NA,IIIC,T1c,N2,M0,2.3,RLL,Left,1,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,100,100,>=50%,35.6,1,MSS,CCRT,None,Durvalumab,Carboplatin_Paclitaxel,None,NA,IMRT,63.1,6,80.1,1,0,0,0,4.0,1,44.7,0,3.5,SD,0,1,2.2,0.0,11.4,0,0,1,250.6,7.9,10.9,1,27.47,0,G2,Negative,Negative,Negative,0,91.6,80.2,0,None,0,0,0,1,1,3.4,241.3,11.4,14.3,50.0,1.5,0,None,0,0,0,0,0,0 |
| 6248b59a-2affcf737-4126da20ce-0b59-0004fdb138d9,SITE_042,2021-07-03,63.96848732839647,Female,White,Private,Former,7.0,1.0,46.7,3.2,0,0,None,0,0,28.3,SCLC_Extensive,NA,Exte,T1b,N0,M0,1.9,RUL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,100,85,>=50%,14.2,1,MSS,Chemotherapy_Only,None,Durvalumab,Etoposide_Platinum,None,NA,None,0.0,2,86.5,1,0,0,0,2.3,1,3.3,1,1.7,PD,0,0,1.9,0.0,52.5,0,0,0,414.3,1.3,42.2,1,13.87,0,G3,Negative,Negative,Positive,1,69.1,53.9,1,II,0,0,0,0,1,3.3,308.9,14.4,3.7,165.9,26.0,1,Colitis,2,1,2,1,0,0 |
| 6a877d3a-2e9b46c97-413f9677ae-07d3-000568e15bf9,SITE_043,2016-05-31,69.06369635069998,Female,Black,Medicaid,Current,48.8,1.0,60.0,0.0,1,0,None,0,0,24.2,Squamous_Cell,Keratinizing,IIA,T2a,N2,M0,3.6,RML,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,100,100,>=50%,4.9,0,MSS,Surgery_Adjuvant,None,None,None,Lobectomy,R0,None,0.0,4,67.2,1,0,0,0,6.7,1,38.5,0,5.7,CR,1,1,8.0,24.3,-67.6,0,0,0,226.6,5.8,14.2,0,0.0,0,G1,Negative,Positive,Negative,2,104.7,96.3,1,I,0,0,1,0,1,4.3,100.0,13.9,3.1,188.3,7.5,0,None,0,0,1,0,0,0 |
| 37b52e05-185f44224-4a71f8a0f-02e0-0002d4335648,SITE_041,2020-01-10,65.08020916880066,Male,White,Medicare,Former,75.4,3.1,60.0,3.0,1,0,None,0,0,22.4,Adenocarcinoma,Lepidic,IVB,T4,N0,M1c,11.4,RML,Right,1,0,0,0,0,0,1,0,Liver,None,None,None,G12C,None,0,0,0,None,0,0,1,32,51,1-49%,22.2,1,MSS,Targeted_TKI,Adagrasib,None,None,None,NA,None,0.0,4,86.8,0,0,0,0,5.4,1,9.8,1,4.0,SD,0,1,1.1,0.0,4.0,0,0,0,433.1,5.0,3.1,1,28.39,1,G3,Positive,Negative,Negative,1,98.9,65.7,0,None,0,0,1,0,2,3.6,103.0,9.6,1.3,97.3,26.4,0,None,0,3,1,0,0,0 |
| 670284ba-2d111a117-4135078e2e-084b-00053b20bd79,SITE_046,2019-06-25,61.51000597326227,Male,Black,Medicare,Current,95.7,3.4,60.0,0.0,0,0,Silica,0,0,22.5,SCLC_Limited,NA,Limi,T1c,N3,M0,2.7,LLL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,0,0,<1%,6.3,0,MSS,Chemotherapy_Only,None,Atezolizumab,Etoposide_Platinum,None,NA,Conventional_EBRT,50.0,11,82.9,0,0,0,0,5.6,1,15.5,1,4.1,PD,0,0,1.4,0.0,65.7,0,0,0,108.7,18.6,60.8,0,0.0,0,G2,Negative,Negative,Positive,1,75.7,95.3,0,None,0,0,1,1,1,3.2,229.4,11.4,2.1,138.5,5.7,0,None,0,2,0,1,0,0 |
| 6bbc8f25-2f227ea04-414335ad6f-08f2-0005789344e8,SITE_012,2023-06-04,69.40240574221404,Male,Asian,Uninsured,Former,30.1,1.0,60.0,25.6,0,0,None,0,0,23.6,SCLC_Limited,NA,Limi,T3,N0,M0,5.3,RUL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,1,0,0,None,0,0,1,100,100,>=50%,5.3,0,MSS,Chemotherapy_Only,None,Durvalumab,Etoposide_Platinum,None,NA,Conventional_EBRT,49.3,5,79.0,0,0,0,0,14.9,1,20.7,1,14.5,PR,1,1,5.1,15.8,-53.3,0,0,0,247.7,25.0,19.2,1,31.77,1,G1,Negative,Negative,Positive,1,57.6,68.6,1,I,0,1,1,0,2,4.3,181.5,12.6,8.3,82.7,22.0,0,None,0,0,0,1,0,1 |
| 3198e43a-15b2e3d97-494caacae-0e43-000284c396f9,SITE_049,2018-12-03,62.2124014565992,Male,White,Private,Current,10.1,1.0,60.0,0.0,0,0,None,0,1,26.1,Squamous_Cell,Keratinizing,IIB,T1a,N3,M0,0.9,RUL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,63,94,>=50%,20.2,1,MSS,Surgery_Adjuvant,None,None,None,Wedge_Resection,R0,None,0.0,1,56.9,0,0,1,0,14.0,1,19.4,0,12.1,CR,1,1,0.7,4.6,-75.5,0,0,1,320.5,25.0,13.8,0,0.0,0,G3,Negative,Positive,Negative,0,93.0,67.9,1,I,0,0,1,1,2,4.0,171.3,13.3,2.7,315.4,126.6,0,None,0,0,0,3,0,0 |
| 72f4890b-324afbf4e-4158dd9b21-0890-0005d66af596,SITE_017,2018-04-14,61.033372204608945,Female,Black,Medicare,Former,7.3,1.0,48.8,1.6,0,0,None,0,0,26.7,SCLC_Limited,NA,Limi,T3,N1,M0,6.6,LUL,Right,1,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,1.0,0,MSS,Chemotherapy_Only,None,Atezolizumab,Etoposide_Platinum,None,NA,Conventional_EBRT,50.2,5,94.9,0,0,0,0,8.7,1,13.1,0,6.7,SD,0,1,1.8,0.0,17.5,0,0,1,214.0,18.7,28.2,0,0.0,0,G3,Negative,Negative,Negative,3,37.3,85.9,0,None,0,0,1,0,0,3.2,372.1,13.2,7.0,68.6,19.3,0,None,0,3,0,2,0,0 |
| 24e7ef70-102578c11-46eb7ce50-0ef7-0001dfc728b7,SITE_041,2015-10-20,69.95880192588268,Female,White,Private,Current,7.2,1.0,48.0,0.0,0,0,None,0,0,25.1,Squamous_Cell,Non-keratinizing,IVA,T1c,N1,M1a,2.8,RUL,Left,0,0,0,0,0,1,1,0,Bone|Liver,None,None,None,None,None,1,0,0,None,0,0,1,97,100,>=50%,17.5,1,MSS,Targeted_TKI,Tepotinib,None,None,None,NA,None,0.0,10,73.2,0,0,0,0,7.4,1,21.8,0,7.1,PD,0,0,1.4,0.0,38.3,0,0,1,292.9,7.9,3.6,1,19.78,1,GX,Negative,Positive,Negative,2,88.3,76.7,1,III,1,0,0,1,3,3.1,356.3,16.0,1.8,123.1,1.7,0,None,0,0,1,4,0,0 |
| 1ea9d458-d6a4ce69-45bfd7d08-0d45-00018e9fc87f,SITE_029,2023-05-08,63.181070488772555,Male,Asian,Private,Former,1.4,1.0,9.2,9.0,0,0,None,0,1,24.1,Squamous_Cell,Keratinizing,IB,T2a,N1,M0,3.3,RUL,Right,1,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,4.8,0,MSS,Surgery_Adjuvant,None,None,Carboplatin_Paclitaxel,Lobectomy,R2,None,0.0,5,83.7,0,0,0,0,27.9,0,27.9,0,27.9,CR,1,1,1.1,65.2,-68.4,0,0,0,290.4,10.1,33.7,0,0.0,0,G2,Negative,Positive,Negative,1,60.2,70.9,1,I,0,0,1,0,1,2.7,126.4,14.3,2.4,68.1,35.3,0,None,0,2,2,2,0,0 |
| 575c033e-2638416b3-41061409ba-0033-00046fac2a2d,SITE_039,2022-07-19,69.31899169529434,Male,Hispanic,Private,Current,53.9,1.3,60.0,0.0,0,0,None,0,0,24.4,Squamous_Cell,Non-keratinizing,IIIB,T2a,N0,M0,3.5,RUL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,4.7,0,MSS,CCRT,None,Durvalumab,Carboplatin_Paclitaxel,None,NA,IMRT,57.7,3,88.1,0,0,0,0,4.6,1,43.5,1,4.5,PD,0,0,3.1,0.0,25.7,0,0,0,413.4,10.0,9.8,1,1.21,1,G2,Negative,Positive,Negative,0,97.6,65.5,1,III,1,1,0,0,3,3.5,249.9,13.8,2.4,170.9,20.7,0,None,0,0,3,4,0,0 |
| 51816958-23a89e169-4f4843c08-0695-00042392597f,SITE_032,2015-05-31,69.59543821709516,Female,White,Private,Current,26.8,1.0,60.0,0.0,0,0,None,0,0,37.3,Adenocarcinoma,Lepidic,IVA,T1a,N1,M1b,0.9,LUL,Left,1,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,75,100,>=50%,52.6,1,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,5,92.9,0,0,0,0,0.8,1,17.7,0,0.7,CR,1,1,1.5,18.4,-71.3,0,0,0,333.9,2.9,16.7,1,6.79,0,G3,Negative,Negative,Negative,0,50.1,65.7,0,None,0,0,1,0,0,4.0,100.0,14.4,6.3,276.7,27.7,1,Hepatitis,2,1,1,1,0,0 |
| 11e368cd-7d37dd9c-435aa3a67-068c-0000e88c5270,SITE_033,2019-05-03,56.17542448963004,Male,Black,Medicare,Current,87.5,2.3,60.0,0.0,1,0,None,0,0,22.5,Adenocarcinoma,Acinar,IIB,T2a,N2,M0,3.8,RUL,Right,0,0,1,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,100,100,>=50%,5.6,0,MSS,SBRT,None,None,None,None,NA,SBRT,48.5,9,86.0,1,0,0,0,0.5,1,4.4,1,0.5,CR,1,1,1.9,2.2,-77.8,0,0,0,297.8,18.5,78.8,0,0.0,0,GX,Positive,Negative,Negative,1,63.1,109.7,0,None,0,0,0,0,0,4.3,100.0,15.2,3.9,50.0,86.5,0,None,0,1,0,0,0,0 |
| 6a971e22-2ea21d2ef-413fc55a66-01e2-000569ac87c1,SITE_031,2019-10-17,62.42820932327859,Female,White,Private,Former,5.1,1.0,34.0,17.3,0,1,None,0,0,23.5,Adenocarcinoma,Solid,IVB,T2a,N2,M1c,3.0,RUL,Right,0,0,0,0,0,0,1,0,Liver,L858R,None,None,None,None,0,0,0,None,0,0,0,0,0,<1%,21.3,1,MSS,Targeted_TKI,Osimertinib,None,None,None,NA,None,0.0,12,82.3,0,0,0,0,10.3,0,10.3,0,7.8,PR,1,1,2.6,9.9,-57.7,0,0,0,379.8,12.8,43.4,1,22.24,0,G3,Positive,Negative,Negative,0,82.9,45.2,0,None,0,0,1,0,1,4.0,128.2,11.3,2.1,219.7,9.1,0,None,0,1,0,1,0,0 |
| 1996978b-b31e24ce-44cc3c6a1-0978-00014ca5b216,SITE_039,2019-09-10,80.65888092920639,Male,White,Medicare,Former,120.0,8.0,60.0,8.8,0,1,None,0,0,40.8,Squamous_Cell,Basaloid,IVB,T2b,N0,M1a,4.9,RUL,Left,1,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,11.6,1,MSS,Chemo_IO_Combination,None,Pembrolizumab,Carboplatin_Paclitaxel,None,NA,None,0.0,7,83.4,0,0,0,0,0.5,1,7.9,1,0.5,PR,1,1,1.5,0.7,-55.7,0,0,0,124.4,13.3,16.3,1,7.4,1,G3,Negative,Positive,Negative,0,85.8,52.8,0,None,0,0,1,0,3,3.1,195.1,9.3,7.4,395.0,13.0,0,None,0,2,3,1,0,0 |
| 6706ef23-2d13089f6-413514cd69-0ef2-00053b5a24ce,SITE_037,2024-03-08,55.960244629024274,Female,Black,Private,Former,23.0,1.0,60.0,5.0,0,0,Radon,1,0,27.9,Adenocarcinoma,Papillary,IA,T4,N2,M0,11.6,LLL,Left,0,1,0,0,0,0,0,0,None,None,None,None,G12V,None,0,0,0,None,0,0,0,100,100,>=50%,12.7,1,MSS,SBRT,None,None,None,None,NA,SBRT,47.2,7,50.9,1,0,0,0,2.2,1,4.3,1,1.7,PR,1,1,1.0,2.8,-32.0,0,0,0,168.0,1.2,17.8,0,0.0,0,G3,Positive,Negative,Negative,0,63.7,90.8,0,None,0,1,1,0,1,3.7,144.5,11.3,6.3,160.4,4.3,0,None,0,4,0,3,0,0 |
| 00f13f31-698ba58-42d3bd93-03f3-00000c403584,SITE_007,2016-07-03,46.89178273477995,Male,White,Private,Former,4.7,1.0,31.3,0.2,0,0,None,0,0,19.8,Squamous_Cell,Keratinizing,IIB,T2a,N2,M0,3.6,RUL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,7.2,0,MSS,Surgery_Adjuvant,None,None,None,VATS,R0,None,0.0,5,93.7,0,0,1,0,31.4,0,31.4,0,22.3,CR,1,1,1.1,5.5,-71.5,0,0,0,122.4,10.6,1.0,0,0.0,0,G1,Negative,Positive,Negative,1,69.0,89.6,1,III,1,0,1,1,3,4.5,251.0,9.8,5.7,99.0,26.8,0,None,0,1,0,2,0,0 |
| 65fef018-2c9f890a9-4131fcd048-0f01-00052df2313f,SITE_042,2018-01-23,49.312471044196144,Female,White,Uninsured,Former,0.7,1.0,5.0,11.1,0,0,None,0,0,29.8,SCLC_Extensive,NA,Exte,T4,N2,M0,9.0,RUL,Left,0,0,1,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,6.9,0,MSS,Chemo_IO_Combination,None,Durvalumab,Etoposide_Platinum,None,NA,None,0.0,5,94.5,0,0,0,0,2.3,1,15.8,0,1.6,SD,0,1,1.3,0.0,-16.9,0,0,1,321.9,16.5,7.5,0,0.0,0,G3,Negative,Negative,Positive,0,92.1,57.2,0,None,0,0,0,0,0,3.5,198.8,10.5,5.5,145.1,25.8,0,None,0,1,3,4,0,0 |
| 64b9f020-2c11590e1-412e2dd060-0f02-00051d7131a7,SITE_027,2016-10-22,67.27654449247835,Male,White,Medicare,Current,8.8,1.0,58.9,0.0,0,0,None,0,0,21.9,Adenocarcinoma,Papillary,IB,T2a,N1,M0,3.2,Central,Right,0,0,0,0,0,0,0,0,None,Other,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,35.7,1,MSS,SBRT,None,None,None,None,NA,SBRT,57.3,2,80.4,0,0,0,0,1.3,1,5.6,1,1.0,SD,0,1,2.3,0.0,6.9,0,0,0,300.9,7.3,24.5,0,0.0,0,G3,Positive,Negative,Negative,2,93.1,44.0,1,II,0,0,1,0,1,4.2,349.7,12.7,2.5,107.0,13.6,0,None,0,2,0,1,0,0 |
| 63e2fa5d-2bb34d88c-412ba8ef17-0fa5-00051286b6c0,SITE_017,2017-06-09,67.29371414131064,Female,White,Uninsured,Current,75.9,1.7,60.0,0.0,0,0,None,0,0,30.1,Squamous_Cell,Keratinizing,IIIB,T1a,N0,M0,0.5,Central,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,20.9,1,MSS,CCRT,None,Durvalumab,Carboplatin_Paclitaxel,None,NA,IMRT,58.9,5,96.4,0,0,0,0,8.1,1,36.6,0,7.6,PD,0,0,2.5,0.0,53.2,0,0,0,489.1,5.0,8.0,0,0.0,0,G2,Negative,Positive,Negative,1,68.7,92.4,0,None,1,0,1,1,2,4.1,263.2,11.4,10.8,482.3,61.6,0,None,0,2,2,2,0,1 |
| 5519d536-253b4d47b-4ff4d7fa2-0d53-0004524fd3c5,SITE_026,2024-01-24,65.88269687346136,Male,Asian,Medicare,Former,8.8,1.0,58.8,10.9,0,0,Radon,1,0,25.1,SCLC_Limited,NA,Limi,T1c,N3,M0,2.5,RUL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,100,100,>=50%,5.8,0,MSS,Chemo_IO_Combination,None,Atezolizumab,Etoposide_Platinum,None,NA,Conventional_EBRT,51.5,7,83.4,0,0,0,0,9.0,1,9.1,1,8.7,PR,1,1,2.4,4.6,-34.9,0,0,0,291.7,2.5,4.1,0,0.0,0,G2,Negative,Negative,Positive,1,64.1,55.3,1,II,1,0,0,0,3,4.2,119.2,13.8,4.2,244.9,4.2,1,Pneumonitis,2,0,0,2,0,0 |
| 3c5c4feb-1a6862f6e-4b514efc1-04fe-000310b00ef6,SITE_049,2024-05-26,78.53480337482077,Male,White,Private,Current,49.1,1.1,60.0,0.0,1,0,None,0,0,24.0,Adenocarcinoma,Acinar,IIIA,T2a,N1,M0,3.3,RML,Bilateral,0,0,0,0,0,0,0,0,None,None,None,None,G12C,None,0,0,0,None,0,0,1,0,0,<1%,3.5,0,MSS,CCRT,None,Durvalumab,Carboplatin_Paclitaxel,None,NA,IMRT,64.0,5,98.9,1,0,0,0,28.5,0,28.5,0,21.0,SD,0,1,2.3,0.0,-8.5,0,0,0,178.4,2.3,35.7,1,1.81,0,G2,Negative,Negative,Negative,4,50.4,64.1,0,None,0,0,1,0,0,4.0,314.3,13.1,5.4,254.7,24.3,0,None,0,1,1,0,0,0 |
| 5a42dbef-277d4038a-410ec893cd-0dbe-000495652b2a,SITE_043,2015-06-12,41.60807288552209,Female,White,Medicare,Current,3.2,1.0,21.6,0.0,0,0,None,0,0,33.2,Adenocarcinoma,Lepidic,IIA,T2a,N0,M0,3.0,RUL,Left,0,0,1,0,0,0,0,0,None,None,None,None,G12D,None,0,0,0,None,0,0,0,17,19,1-49%,5.3,0,MSS,SBRT,None,None,None,None,NA,SBRT,59.9,4,86.2,0,0,0,0,0.6,1,11.1,1,0.6,PR,1,1,2.3,0.5,-59.5,0,0,0,261.6,8.4,96.3,1,2.49,0,G2,Negative,Negative,Negative,1,79.6,73.5,0,None,0,0,0,0,0,4.2,130.2,13.2,5.9,500.0,49.5,0,None,0,1,0,3,0,0 |
| 2378b8ae-f84d0cc3-46a6a2a0a-0b8a-0001cd2160dd,SITE_042,2021-04-26,70.76137180709283,Male,White,Medicare,Current,23.3,1.0,60.0,0.0,0,0,None,0,0,28.5,Adenocarcinoma,Solid,IIA,T4,N2,M0,10.0,LLL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,1,0,100,100,>=50%,21.8,1,MSS,Surgery_Adjuvant,None,None,None,Lobectomy,R0,None,0.0,4,96.9,1,0,1,0,5.1,1,26.0,0,4.7,CR,1,1,3.8,37.6,-62.4,0,0,0,100.0,6.1,8.5,0,0.0,0,G2,Positive,Negative,Negative,2,89.6,54.8,0,None,0,0,1,1,1,3.1,246.1,10.0,2.3,332.5,8.9,0,None,0,1,2,2,0,0 |
| 63eeedcb-2bb88808e-412bccc961-0edc-000513221356,SITE_024,2017-04-29,81.83366291713395,Male,Asian,Private,Former,39.2,1.6,60.0,8.3,1,1,None,0,0,30.4,Adenocarcinoma,Acinar,IVB,T3,N0,M1b,5.5,RML,Right,0,0,0,0,0,1,1,0,Bone|Liver,None,None,None,G12D,None,0,0,0,None,0,0,0,64,82,>=50%,26.1,1,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,5,78.7,0,0,0,0,15.9,0,15.9,0,11.4,SD,0,1,0.5,0.0,-16.3,0,0,0,199.5,6.1,57.4,1,18.54,1,G1,Positive,Negative,Negative,0,77.7,86.8,0,None,0,1,0,0,2,4.6,156.6,10.7,16.9,138.0,2.6,0,None,0,2,0,0,0,0 |
| 471f708a-1f1dc13c7-4d55e519e-0708-00039c98b709,SITE_040,2016-12-03,56.286082733528715,Male,White,Medicaid,Former,69.9,1.6,60.0,8.0,0,0,Radon,1,0,28.0,SCLC_Extensive,NA,Exte,T2b,N2,M0,4.1,Central,Right,1,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,56,47,>=50%,14.9,1,MSS,Chemo_IO_Combination,None,Durvalumab,Etoposide_Platinum,None,NA,None,0.0,2,76.6,0,0,0,0,2.1,1,8.8,1,1.9,PR,1,1,3.4,2.4,-57.7,0,0,0,100.0,25.0,47.9,0,0.0,0,G3,Negative,Negative,Positive,1,58.4,72.3,0,None,0,0,0,0,1,2.9,388.4,8.7,4.4,150.7,1.6,1,Endocrinopathy,3,3,0,1,1,0 |
| 3abdc08b-19b3043ce-4b03941a1-0c08-0002fba2c716,SITE_020,2017-12-02,63.391838137996,Male,White,Medicare,Current,43.1,1.7,60.0,0.0,0,0,None,0,0,24.0,SCLC_Limited,NA,Limi,T2a,N0,M0,3.2,LLL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,100,100,>=50%,2.1,0,MSS,Chemo_IO_Combination,None,Atezolizumab,Etoposide_Platinum,None,NA,Conventional_EBRT,48.9,7,91.5,1,0,0,0,5.0,1,17.3,1,3.5,SD,0,1,2.7,0.0,-14.3,0,0,0,288.4,2.7,6.2,1,22.54,1,G3,Negative,Negative,Negative,1,107.2,57.9,0,None,1,0,1,0,1,4.0,288.8,13.6,4.6,500.0,25.4,0,None,0,2,2,2,0,1 |
| 40b7b4a4-1c505f07d-4c2271dec-0b4a-000349542c5b,SITE_035,2016-12-10,59.8475267863281,Male,White,Medicare,Former,1.8,1.0,12.3,11.6,0,0,None,0,0,28.8,Squamous_Cell,Basaloid,IVA,T2a,N2,M1c,4.0,LUL,Left,1,0,0,0,0,0,0,1,Adrenal,None,EML4-ALK,None,None,None,0,0,0,None,0,0,1,79,100,>=50%,17.8,1,MSS,Targeted_TKI,Alectinib,None,None,None,NA,None,0.0,4,61.9,0,0,0,0,34.2,0,34.2,0,26.6,PR,1,1,3.9,22.8,-33.0,0,0,0,212.8,5.6,8.4,1,1.86,0,G2,Negative,Positive,Negative,4,37.1,59.3,1,III,0,0,1,0,1,3.8,141.7,16.3,3.4,95.2,200.0,0,None,0,1,1,2,1,0 |
| 48cc82f2-1fd97949f-4da6588d6-082f-0003b262a651,SITE_032,2019-11-25,58.50371256226347,Female,White,Medicare,Former,60.2,1.4,60.0,1.5,1,0,Asbestos,0,0,31.4,SCLC_Extensive,NA,Exte,T2b,N3,M0,4.2,RUL,Left,0,1,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,15,21,1-49%,29.2,1,MSS,Chemotherapy_Only,None,Atezolizumab,Etoposide_Platinum,None,NA,None,0.0,3,81.5,0,0,0,0,5.9,1,7.0,1,5.1,SD,0,1,0.5,0.0,11.7,0,0,0,229.0,25.0,174.8,0,0.0,0,G3,Negative,Negative,Positive,3,90.8,92.8,0,None,0,0,0,0,0,3.5,165.2,12.9,10.0,133.9,8.0,0,None,0,2,0,1,1,1 |
| 04c502ed-2163147c-4e4f08c7-002e-00003e012610,SITE_013,2024-12-12,63.900510952281124,Male,Hispanic,Medicare,Current,0.5,1.0,3.3,0.0,0,0,None,0,0,26.6,SCLC_Limited,NA,Limi,T1b,N3,M0,1.1,Central,Left,0,0,0,0,0,0,0,0,None,None,None,None,G12V,None,0,0,0,None,0,0,1,0,0,<1%,10.6,1,MSS,Chemo_IO_Combination,None,Durvalumab,Etoposide_Platinum,None,NA,Conventional_EBRT,59.3,4,99.0,0,0,0,0,12.6,1,21.8,1,12.2,SD,0,1,0.5,0.0,-20.2,0,0,0,153.6,5.8,5.3,1,7.06,1,G2,Negative,Negative,Positive,1,78.9,67.5,1,I,0,0,0,0,1,3.3,600.0,13.0,10.3,80.8,39.5,0,None,0,0,0,2,1,1 |
| 11e4de37-7d421382-435ae9aa5-0de3-0000e89f48d2,SITE_014,2020-11-10,80.5611101950028,Female,White,Private,Current,7.9,1.0,52.9,0.0,1,0,None,0,0,34.1,Adenocarcinoma,Papillary,IVA,T1b,N3,M1c,1.6,LLL,Right,0,0,1,0,0,0,0,0,None,None,KIF5B-ALK,None,None,None,0,0,0,Overexpression,0,0,1,100,100,>=50%,53.6,1,MSS,Targeted_TKI,Alectinib,None,None,None,NA,None,0.0,6,63.8,1,0,0,0,1.2,1,6.4,0,0.9,SD,0,1,0.5,0.0,-13.0,0,0,0,175.1,7.8,9.7,1,8.15,0,G2,Positive,Negative,Negative,2,83.4,81.8,0,None,1,0,0,0,2,4.1,106.6,11.4,5.0,50.0,0.5,0,None,0,0,1,1,0,0 |
| 1f6bed47-dbf37cf2-45e43c7d5-0ed4-0001987b0ca2,SITE_004,2022-03-24,84.45517341713145,Female,White,VA,Current,96.1,3.5,60.0,0.0,0,0,None,0,0,29.8,SCLC_Extensive,NA,Exte,T1c,N3,M0,2.5,LLL,Left,1,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,25,24,1-49%,2.7,0,MSS,Chemotherapy_Only,None,Atezolizumab,Etoposide_Platinum,None,NA,None,0.0,4,89.5,1,0,0,0,1.8,1,4.9,1,1.5,CR,1,1,3.6,2.4,-61.2,0,0,0,346.0,6.4,212.5,1,14.22,1,GX,Negative,Negative,Positive,0,60.8,71.8,1,II,0,1,1,1,3,4.2,139.8,12.1,1.6,87.5,35.2,1,Pneumonitis,1,1,4,1,0,0 |
| 0ea8ebe4-669e733d-42bfac3ac-0ebe-0000be93fa9b,SITE_007,2019-12-06,63.8085773621186,Male,Black,Private,Current,50.0,1.1,60.0,0.0,0,0,None,0,0,27.0,Squamous_Cell,Keratinizing,IA,T1b,N0,M0,1.4,RUL,Right,0,0,1,1,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,48,100,1-49%,16.7,1,MSS,SBRT,None,None,None,None,NA,SBRT,55.9,4,79.0,1,0,0,0,2.5,1,7.4,1,2.2,PD,0,0,6.9,0.0,69.1,0,0,0,119.3,13.0,10.1,1,2.71,1,G3,Negative,Positive,Negative,1,72.3,43.9,0,None,0,0,1,0,0,3.7,143.2,15.0,4.0,88.6,3.9,0,None,0,1,1,0,0,0 |
| 384541f3-189e4cda6-4a8cfc5d9-041f-0002db84595e,SITE_022,2015-02-20,85.09807203361247,Female,White,Private,Former,46.8,1.6,60.0,4.5,1,0,Asbestos,0,1,27.1,SCLC_Limited,NA,Limi,T3,N3,M0,7.0,LUL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,3.6,0,MSS,Chemotherapy_Only,None,Durvalumab,Etoposide_Platinum,None,NA,Conventional_EBRT,59.1,6,63.5,0,0,0,0,12.4,1,12.4,1,11.4,CR,1,1,1.6,1.5,-89.8,0,0,0,315.1,1.4,101.9,0,0.0,0,G3,Negative,Negative,Positive,0,80.3,83.9,0,None,0,1,0,1,2,3.7,112.2,12.7,4.3,102.0,11.1,0,None,0,3,1,1,0,1 |
| 558e3a6e-256e39903-4100aaaf4a-03a6-00045838f79d,SITE_024,2015-11-04,67.33797653135393,Female,White,Private,Former,27.9,1.0,60.0,21.0,1,1,None,0,0,26.6,SCLC_Extensive,NA,Exte,T1a,N3,M0,0.7,LLL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,23.4,1,MSS,Chemo_IO_Combination,None,Durvalumab,Etoposide_Platinum,None,NA,None,0.0,6,93.7,1,0,0,0,3.7,1,12.4,1,3.6,SD,0,1,2.1,0.0,-4.5,0,0,0,163.1,6.3,5.9,1,26.26,1,G3,Negative,Negative,Positive,1,73.5,89.2,1,I,1,0,1,0,2,4.4,118.3,13.8,3.3,214.3,22.6,1,Colitis,3,2,0,0,0,0 |
| 53c4532b-24a5e462e-4fb4cf981-0532-000440f83936,SITE_009,2017-09-08,83.66006475366027,Female,White,Medicare,Former,48.5,2.4,60.0,0.7,1,1,None,0,0,20.4,Adenocarcinoma,Papillary,IB,T1b,N1,M0,1.3,Endobronchial,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,V600E,0,0,0,None,0,0,0,74,100,>=50%,15.7,1,MSS,SBRT,None,None,None,None,NA,SBRT,49.0,8,86.1,1,0,0,0,3.1,1,28.6,1,2.6,PD,0,0,1.0,0.0,49.9,0,0,0,105.6,7.7,23.7,0,0.0,0,G1,Negative,Negative,Negative,0,42.7,101.5,0,None,1,0,1,0,1,3.6,189.7,15.1,2.3,147.4,1.7,0,None,0,1,1,2,1,0 |
| 3c4ce167-1a61a29d2-4b4e6a435-0e16-00030fe77242,SITE_021,2017-06-08,66.11366282829182,Male,White,VA,Former,8.0,1.0,53.5,29.5,0,1,Asbestos,0,0,25.6,Adenocarcinoma,Solid,IA,T4,N1,M0,8.4,LUL,Right,1,0,1,0,0,0,0,0,None,None,None,None,G12C,None,0,0,0,None,0,0,1,100,100,>=50%,45.7,1,MSS,SBRT,None,None,None,None,NA,SBRT,56.7,7,71.4,0,0,0,0,12.4,1,12.4,1,11.8,SD,0,1,0.5,0.0,8.4,0,0,0,451.8,3.3,73.9,0,0.0,0,G2,Negative,Negative,Negative,1,105.8,41.6,0,None,0,1,1,0,1,3.8,254.2,14.7,1.5,272.2,200.0,0,None,0,0,3,4,0,0 |
| 6d7342fe-2fe26d4f3-414859c8fa-042f-00058eda66ed,SITE_031,2023-05-27,68.24504934743837,Male,Black,Medicaid,Former,30.8,1.1,60.0,14.1,0,1,None,0,0,27.0,Adenocarcinoma,Lepidic,IVB,T4,N0,M1b,9.3,RLL,Right,1,0,0,0,1,0,0,0,Brain,L858R,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,14.2,1,MSS,Targeted_TKI,Osimertinib,None,None,None,NA,None,0.0,4,98.2,0,0,0,0,6.3,0,6.3,0,5.5,SD,0,1,2.1,0.0,15.8,0,0,0,475.6,9.7,11.5,1,7.66,1,G2,Positive,Negative,Negative,1,86.7,30.0,0,None,0,1,1,0,1,3.7,100.0,12.6,12.6,162.5,8.1,0,None,0,0,0,4,0,0 |
| 4859a81f-1fa7398da-4d90cf85d-0a81-0003ac8d899a,SITE_012,2023-06-07,70.47200749010693,Male,Hispanic,Medicare,Current,17.8,1.0,60.0,0.0,1,0,None,0,0,24.1,Squamous_Cell,Keratinizing,IVB,T2a,N2,M1a,4.0,RLL,Right,0,0,0,0,1,0,0,0,Brain,None,None,None,None,None,0,0,0,None,0,0,0,100,100,>=50%,6.3,0,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,6,90.5,0,0,0,0,3.6,1,17.2,0,2.8,SD,0,1,3.0,0.0,15.5,0,0,1,186.8,13.9,22.6,1,14.4,0,G2,Negative,Positive,Negative,1,75.6,82.2,1,I,1,0,0,0,2,5.0,155.9,12.7,7.5,165.2,49.9,0,None,0,1,0,1,0,0 |
| 0a2323f9-46f5fbd0-41e696beb-023f-000083c8d3ac,SITE_017,2023-07-15,90.0,Female,Hispanic,VA,Former,15.8,1.0,60.0,4.1,1,0,None,0,0,27.5,SCLC_Limited,NA,Limi,T2a,N2,M0,3.7,LUL,Left,0,0,1,0,0,0,0,0,None,None,None,None,None,None,1,0,0,None,0,0,1,100,100,>=50%,5.8,0,MSS,Chemotherapy_Only,None,Atezolizumab,Etoposide_Platinum,None,NA,Conventional_EBRT,57.6,3,77.4,0,0,0,0,11.4,0,11.4,0,10.0,PD,0,0,4.3,0.0,31.9,0,0,0,185.9,10.6,49.1,0,0.0,0,GX,Negative,Negative,Positive,0,76.8,62.4,0,None,0,0,1,0,0,3.4,134.0,11.7,4.6,124.6,188.5,0,None,0,2,0,2,0,0 |
| 61eb7b89-2ad7060c0-4125c2729b-07b8-0004f8f545fc,SITE_019,2021-05-16,75.0872129610255,Female,Hispanic,Medicare,Current,42.7,1.3,60.0,0.0,0,0,Radon,1,0,26.1,SCLC_Extensive,NA,Exte,T3,N1,M0,6.1,Central,Right,0,0,1,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,68,70,>=50%,7.2,0,MSS,Chemo_IO_Combination,None,Durvalumab,Etoposide_Platinum,None,NA,None,0.0,8,82.6,1,0,0,0,4.7,1,10.9,1,3.7,CR,1,1,1.2,1.5,-78.3,0,0,0,215.8,25.0,6.8,0,0.0,0,G3,Negative,Negative,Positive,1,105.3,49.1,1,II,1,0,1,0,2,4.2,111.6,13.5,2.8,477.3,31.2,1,Hepatitis,2,3,1,4,0,0 |
| 498c8363-202d797b6-4dca58a29-0836-0003bc22ac0e,SITE_026,2020-07-23,60.280986965461096,Female,White,Private,Former,11.6,1.0,60.0,6.4,0,0,None,0,0,29.5,Adenocarcinoma,Papillary,IVA,T1a,N1,M1b,0.9,LUL,Right,0,0,0,0,0,0,0,0,None,Exon19del,None,None,None,None,0,0,0,None,0,0,1,87,100,>=50%,5.7,0,MSI-L,Targeted_TKI,Osimertinib,None,None,None,NA,None,0.0,6,71.6,0,0,0,0,14.0,0,14.0,0,12.7,PR,1,1,0.7,1.5,-55.9,0,0,0,163.2,5.2,295.4,0,0.0,0,G3,Positive,Negative,Negative,1,61.6,73.7,0,None,0,0,0,1,1,3.0,329.6,11.7,5.8,115.1,3.2,0,None,0,0,2,2,0,0 |
| 513e732d-238b5263c-4f3bb5987-0732-0004202bd950,SITE_019,2021-06-27,76.20547976762064,Male,White,Medicare,Former,38.3,2.0,60.0,11.9,0,0,None,0,0,29.0,Squamous_Cell,Basaloid,IA,T2a,N1,M0,3.6,RUL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,30.3,1,MSS,Surgery_Adjuvant,None,None,Carboplatin_Paclitaxel,Segmentectomy,R1,None,0.0,5,54.0,0,0,0,0,39.6,0,39.6,0,31.1,CR,1,1,1.6,40.2,-63.1,0,0,0,178.2,11.0,69.8,0,0.0,0,G3,Negative,Positive,Negative,0,57.6,64.8,0,None,1,1,0,0,3,3.3,136.7,13.2,5.2,257.2,23.4,0,None,0,2,1,1,0,0 |
| 485e2733-1fa931266-4d91a7599-0273-0003acc7fd9e,SITE_037,2019-01-24,63.562590897698755,Female,Black,Private,Never,0.0,0.0,0.0,0.0,0,0,None,0,0,26.8,Adenocarcinoma,Papillary,IVA,T1a,N0,M1b,0.4,RUL,Right,0,0,0,0,0,0,0,0,None,L858R,None,None,None,None,0,0,0,None,0,0,0,56,73,>=50%,28.4,1,MSS,Targeted_TKI,Osimertinib,None,None,None,NA,None,0.0,6,70.3,0,0,0,0,19.9,1,23.4,1,15.5,CR,1,1,2.5,11.9,-64.0,0,0,0,306.4,10.8,13.1,1,22.06,1,G3,Positive,Negative,Negative,1,90.3,51.6,0,None,1,0,0,0,1,3.6,101.0,14.6,3.4,73.0,1.3,0,None,0,2,2,0,0,0 |
| 46dbb096-1f001d41b-4d49311c2-0b09-00039927f7a5,SITE_017,2021-09-12,62.34737326243851,Male,Hispanic,Private,Former,20.9,1.1,60.0,0.8,0,1,None,0,0,19.8,Adenocarcinoma,Micropapillary,IVB,T2a,N3,M1a,3.8,LUL,Left,0,0,1,1,1,0,0,0,Brain,None,None,None,G12V,None,0,0,0,None,0,1,0,0,0,<1%,2.3,0,MSS,Chemotherapy_Only,None,None,Carboplatin_Pemetrexed,None,NA,None,0.0,3,65.9,0,0,0,0,6.3,1,9.6,0,6.2,SD,0,1,6.6,0.0,-5.2,0,0,1,690.2,6.1,15.2,0,0.0,0,G2,Positive,Negative,Negative,0,83.3,70.7,1,II,1,0,0,0,2,3.7,311.1,9.1,5.9,128.2,12.2,0,None,0,1,2,0,0,0 |
| 0b97ae3d-5125c3ac-422c70ab7-0ae3-000096b3d920,SITE_022,2022-12-09,75.63171291897505,Female,Black,Private,Current,120.0,2.5,60.0,0.0,0,0,None,0,0,34.1,Adenocarcinoma,Papillary,IVB,T4,N0,M1a,8.1,Central,Left,0,0,0,0,1,0,0,0,Brain,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,9.3,0,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,9,45.7,1,0,0,0,2.9,1,10.4,0,2.8,SD,0,1,2.3,0.0,19.1,0,0,1,204.9,18.3,199.2,1,14.75,1,G3,Positive,Negative,Negative,1,56.8,81.1,1,II,0,1,0,0,2,3.7,374.5,8.8,6.4,495.0,200.0,1,Endocrinopathy,2,0,3,3,0,0 |
| 479419a9-1f50cb3a0-4d6bc4cfb-019a-0003a2854d9c,SITE_019,2022-08-16,67.29531308382595,Male,White,Private,Former,10.7,1.0,60.0,7.2,0,1,None,0,1,25.4,Adenocarcinoma,Papillary,IB,T3,N0,M0,5.5,RUL,Left,1,1,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,9.5,0,MSS,SBRT,None,None,None,None,NA,SBRT,50.5,4,61.4,0,0,0,0,6.1,1,17.5,1,5.1,PD,0,0,2.2,0.0,62.1,0,0,0,408.1,9.3,13.1,0,0.0,0,G3,Positive,Negative,Negative,1,94.6,74.8,1,III,0,1,1,0,4,3.8,225.6,12.4,7.3,223.9,2.4,0,None,0,0,1,1,0,0 |
| 65bfb255-2c83de054-41313f16ff-0b25-00052abc0e58,SITE_010,2021-02-18,69.64647118786216,Female,Black,Uninsured,Former,2.9,1.0,19.5,9.4,0,0,None,0,0,25.6,SCLC_Extensive,NA,Exte,T4,N0,M0,9.7,RLL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,4.5,0,MSS,Chemotherapy_Only,None,Durvalumab,Etoposide_Platinum,None,NA,None,0.0,6,82.6,1,0,0,0,6.0,1,6.6,1,5.5,SD,0,1,1.1,0.0,16.8,0,0,0,291.9,2.8,11.4,0,0.0,0,G3,Negative,Negative,Positive,1,80.3,74.9,1,II,1,0,1,0,3,3.5,125.2,13.8,2.4,64.1,5.8,1,Colitis,2,1,0,1,0,1 |
| 26e7d639-11056db90-474b782ab-0d63-0001f9c5e0ec,SITE_035,2015-08-01,67.13285960772028,Female,Asian,VA,Current,88.6,3.8,60.0,0.0,0,1,Radon,1,0,24.5,Squamous_Cell,Basaloid,IVB,T3,N2,M1b,6.0,Central,Right,0,0,0,0,0,1,1,0,Bone|Liver,None,None,None,None,None,0,0,0,None,0,0,1,33,56,1-49%,13.4,1,MSS,Chemo_IO_Combination,None,Pembrolizumab,Carboplatin_Paclitaxel,None,NA,None,0.0,5,55.5,0,0,0,0,11.6,1,13.0,1,11.6,PD,0,0,0.8,0.0,62.5,0,0,0,106.0,13.5,79.5,1,13.53,1,G1,Negative,Positive,Negative,1,58.8,79.1,1,II,0,0,1,0,1,4.4,174.4,13.1,6.1,79.9,200.0,0,None,0,2,1,2,1,0 |
| 4d29cdb7-21c24a002-4e77d6925-0cdb-0003eb1f7252,SITE_012,2022-03-31,70.19753970275163,Male,Hispanic,Private,Former,120.0,3.7,60.0,16.0,1,0,Asbestos,0,0,23.8,Squamous_Cell,Non-keratinizing,IIA,T2b,N3,M0,4.6,RLL,Right,0,0,0,1,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,33.6,1,MSS,SBRT,None,None,None,None,NA,SBRT,55.2,5,44.5,0,0,0,0,4.2,1,12.4,1,3.0,SD,0,1,4.8,0.0,-7.2,0,0,0,241.7,5.0,3.7,0,0.0,0,G3,Negative,Positive,Negative,0,83.8,44.9,0,None,0,0,1,0,1,3.3,144.4,10.1,10.2,388.1,15.5,0,None,0,1,2,3,0,0 |
| 03f1d6bb-1b9cdf1e-4bd58431-0d6b-00003347e786,SITE_015,2018-08-31,71.03717602564342,Male,Asian,Medicare,Never,0.0,0.0,0.0,0.0,0,0,None,0,1,32.9,Squamous_Cell,Non-keratinizing,IA,T3,N0,M0,5.7,RUL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,20.1,1,MSS,Surgery_Adjuvant,None,None,Carboplatin_Paclitaxel,Lobectomy,R0,None,0.0,2,63.4,0,0,0,0,16.1,0,16.1,0,14.2,CR,1,1,1.3,4.0,-82.2,0,0,0,227.0,5.7,18.3,1,20.47,1,G2,Negative,Positive,Negative,1,81.1,71.2,0,None,0,0,1,0,0,4.2,195.4,14.3,5.5,156.5,5.3,0,None,0,2,0,1,0,1 |
| 2c7ada96-1375bfa1b-485708fc2-0da9-0002423d19a5,SITE_040,2022-06-07,48.598814139298554,Female,White,Private,Former,45.0,1.5,60.0,17.6,1,1,None,0,0,32.2,Adenocarcinoma,Acinar,IVB,T3,N0,M1a,6.6,RLL,Left,0,0,0,0,0,1,0,1,Bone|Adrenal,None,EML4-ALK,None,None,None,0,0,0,None,0,1,1,100,100,>=50%,30.3,1,MSS,Targeted_TKI,Alectinib,None,None,None,NA,None,0.0,3,61.5,0,0,0,0,16.7,0,16.7,0,12.9,PR,1,1,5.9,10.8,-53.1,0,0,0,508.9,6.1,22.2,0,0.0,0,G1,Negative,Negative,Negative,1,73.4,75.8,0,None,0,0,1,0,2,4.1,286.6,16.3,20.0,125.8,36.0,0,None,0,1,0,2,1,0 |
| 37e65afc-1874c7ce5-4a7b310f4-05af-0002d6b29ed3,SITE_048,2020-05-23,73.33244035179057,Male,White,Private,Former,1.9,1.0,12.4,28.1,0,1,Radon,1,1,28.0,SCLC_Extensive,NA,Exte,T2a,N1,M0,3.9,RLL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,4.7,0,MSS,Chemo_IO_Combination,None,Atezolizumab,Etoposide_Platinum,None,NA,None,0.0,3,73.4,1,0,0,0,9.0,1,9.0,1,8.4,SD,0,1,0.6,0.0,-11.4,0,0,0,519.3,13.3,8.6,1,2.01,0,G3,Negative,Negative,Positive,2,81.9,66.0,0,None,0,0,1,1,2,3.3,197.8,10.8,4.0,93.0,9.9,0,None,0,0,2,1,0,0 |
| 7dca5f27-370889a12-41795f1d75-05f2-00066346d502,SITE_034,2023-10-22,57.67081551161215,Female,White,Private,Current,0.7,1.0,4.9,0.0,0,0,Radon,1,0,25.5,SCLC_Extensive,NA,Exte,T1c,N0,M0,2.1,RUL,Left,0,1,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,36,34,1-49%,9.3,0,MSS,Chemo_IO_Combination,None,Durvalumab,Etoposide_Platinum,None,NA,None,0.0,3,89.1,0,0,0,0,4.0,1,19.7,1,2.9,PR,1,1,1.1,2.6,-41.0,0,0,0,295.4,17.5,3.1,0,0.0,0,GX,Negative,Negative,Positive,0,86.3,58.7,0,None,1,0,1,0,1,3.6,200.0,11.0,1.3,122.7,0.3,0,None,0,0,0,1,0,0 |
| 1b7782b3-c04492e6-452668819-082b-00016511a31e,SITE_046,2018-05-20,53.29815821218559,Female,White,Private,Former,4.3,1.0,28.8,7.3,0,0,None,0,0,28.8,Adenocarcinoma,Acinar,IA,T2b,N2,M0,4.1,LUL,Right,0,0,0,0,0,0,0,0,None,Exon19del,None,None,None,None,0,0,0,None,0,1,1,100,100,>=50%,4.5,0,MSS,Surgery_Adjuvant,None,None,None,VATS,R0,None,0.0,3,85.3,0,0,0,0,38.7,0,38.7,0,36.3,CR,1,1,4.2,0.7,-88.1,0,0,0,449.0,6.5,21.8,1,1.14,1,G3,Negative,Negative,Negative,0,91.5,60.1,0,None,0,1,1,0,1,3.8,155.0,12.6,2.5,346.7,2.6,0,None,0,2,1,2,0,0 |
| 2365ef8b-f7c98cce-46a31cea1-0ef8-0001cc2d2a16,SITE_043,2024-04-22,66.44509318334252,Female,Hispanic,Private,Never,0.0,0.0,0.0,0.0,0,0,None,0,0,26.3,Adenocarcinoma,Papillary,IA,T1c,N0,M0,2.7,LUL,Right,0,1,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,100,100,>=50%,11.2,1,MSS,Surgery_Adjuvant,None,None,None,Lobectomy,R1,None,0.0,6,81.8,0,0,0,0,34.6,0,34.6,0,26.3,CR,1,1,0.5,31.7,-67.0,0,0,0,227.4,6.2,45.9,0,0.0,0,G1,Positive,Negative,Negative,2,76.9,67.3,1,I,0,0,1,0,3,4.6,279.3,12.2,2.8,97.5,200.0,0,None,0,1,1,2,0,0 |
| 344aaaa6-16e0aaa8b-49cdffff2-0aaa-0002a7caaa75,SITE_025,2023-06-10,67.79781953148732,Male,White,Private,Never,0.0,0.0,0.0,0.0,0,1,None,0,0,25.1,Adenocarcinoma,Lepidic,IVB,T2a,N1,M1a,3.5,LUL,Right,1,0,0,0,0,0,0,0,None,Exon19del,None,None,None,None,0,0,0,None,0,0,1,100,89,>=50%,12.1,1,MSS,Targeted_TKI,Osimertinib,None,None,None,NA,None,0.0,3,82.0,1,0,0,0,15.7,1,48.1,1,13.2,PR,1,1,0.6,11.7,-44.8,0,0,0,428.2,1.4,8.9,1,15.88,0,G1,Positive,Negative,Negative,1,70.1,86.6,0,None,0,0,0,0,0,3.6,240.8,14.9,6.6,103.4,32.9,0,None,0,3,3,0,0,0 |
| 7f0faac0-3796dab41-417d2f0040-0aac-000673cbabc7,SITE_039,2018-04-23,60.41169143656333,Male,White,Private,Former,84.7,2.9,60.0,18.9,0,0,Asbestos,0,0,27.5,Adenocarcinoma,Papillary,IIIB,T1b,N1,M0,1.7,LUL,Left,0,0,0,0,0,0,0,0,None,None,None,None,G12V,None,0,0,0,None,0,0,0,0,0,<1%,21.4,1,MSS,Chemo_RT,None,None,Carboplatin_Paclitaxel,None,NA,IMRT,62.9,5,97.9,0,0,0,0,5.2,1,20.9,1,4.9,PR,1,1,0.8,13.1,-43.3,0,0,0,257.3,4.2,4.9,1,21.49,0,G2,Positive,Negative,Negative,1,79.3,96.4,1,I,0,0,0,0,1,5.0,100.0,13.1,8.0,212.7,180.5,0,None,0,1,1,0,0,1 |
| 6d3c4fd8-2fca62ee9-4147b4ef88-04fd-00058c100dff,SITE_017,2019-10-28,74.89480264784575,Male,White,Private,Never,0.0,0.0,0.0,0.0,0,0,None,0,0,24.0,Adenocarcinoma,Acinar,IA,T2b,N1,M0,4.6,RUL,Left,0,0,1,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,46,100,1-49%,29.4,1,MSS,Surgery_Adjuvant,None,None,Cisplatin_Pemetrexed,Segmentectomy,R0,None,0.0,6,86.8,0,0,0,0,20.2,0,20.2,0,14.6,CR,1,1,0.6,101.3,-71.7,0,0,0,423.6,3.5,90.7,1,25.49,1,G2,Positive,Negative,Negative,0,96.4,93.2,0,None,0,0,0,0,0,4.2,100.0,11.9,4.9,79.5,4.3,0,None,0,0,0,3,0,1 |
| 0470d1ae-1f15bbc3-4d52750a-0d1a-000039baa5dd,SITE_024,2020-04-23,54.24933591947638,Female,Black,Uninsured,Current,120.0,3.1,60.0,0.0,0,0,None,0,1,27.1,Squamous_Cell,Basaloid,IIB,T1c,N1,M0,3.0,RUL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,87,100,>=50%,16.8,1,MSS,SBRT,None,None,None,None,NA,SBRT,56.3,9,88.8,1,0,0,0,6.1,1,13.9,1,6.0,PD,0,0,1.9,0.0,55.1,0,0,0,445.7,9.5,37.9,1,16.91,1,G1,Negative,Positive,Negative,3,86.3,47.0,0,None,0,0,0,0,2,4.0,169.7,11.3,5.5,84.7,18.5,0,None,0,2,1,4,0,0 |
| 1df1baa4-d19c1a7d-459d52fec-0baa-000185467a5b,SITE_027,2022-09-06,63.13403438666069,Male,White,Private,Former,6.1,1.0,40.9,2.9,0,0,None,0,0,26.9,Squamous_Cell,Non-keratinizing,IA,T1c,N0,M0,2.8,RUL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,95,100,>=50%,4.2,0,MSS,Surgery_Adjuvant,None,None,Carboplatin_Paclitaxel,Lobectomy,R0,None,0.0,3,75.1,0,0,0,0,24.6,1,31.8,0,18.8,PD,0,0,1.2,0.0,42.3,0,0,1,350.1,6.8,13.0,0,0.0,0,G1,Negative,Positive,Negative,1,69.1,57.0,0,None,0,0,1,0,0,4.2,325.5,9.4,17.1,149.0,15.6,0,None,0,1,0,2,1,1 |
| 692ca0dd-2e038660c-413b85e297-0a0d-000557442b40,SITE_049,2021-11-20,61.443695718136496,Male,White,Private,Current,7.0,1.0,46.6,0.0,0,0,Radon,1,0,28.7,Adenocarcinoma,Solid,IA,T2a,N0,M0,3.0,RUL,Left,1,0,0,0,0,0,0,0,None,Exon19del,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,2.7,0,MSS,Surgery_Adjuvant,Osimertinib,None,None,Lobectomy,R0,None,0.0,3,77.4,0,0,0,0,27.5,0,27.5,0,23.4,PR,1,1,0.5,93.2,-45.2,0,0,0,168.9,3.6,60.6,1,17.16,1,G2,Negative,Negative,Negative,0,76.0,82.5,1,II,0,1,0,1,3,2.9,359.0,15.2,2.5,151.2,8.8,0,None,0,2,0,0,0,0 |
| 077676d8-343d3fe9-416636488-076d-0000610408ff,SITE_043,2023-07-07,66.55742093177628,Male,Asian,Medicare,Former,8.7,1.0,57.9,7.7,0,0,Radon,1,0,23.2,Adenocarcinoma,Lepidic,IIA,T1b,N0,M0,2.0,LLL,Right,0,1,0,0,0,0,0,0,None,None,None,None,G13C,None,0,0,0,None,0,0,0,0,0,<1%,14.4,1,MSS,Surgery_Adjuvant,None,None,None,Segmentectomy,R2,None,0.0,4,88.6,1,0,1,0,37.1,1,37.1,1,34.1,PR,1,1,0.5,4.9,-36.3,0,0,0,198.3,8.3,26.8,0,0.0,0,G2,Negative,Negative,Negative,1,105.0,92.8,1,II,0,0,1,0,1,4.4,293.4,13.8,4.3,91.3,27.5,0,None,0,0,2,0,1,0 |
| 6d869f5d-2feae5b8c-414893de17-09f5-00058fd617c0,SITE_025,2018-09-12,69.64921070414877,Female,White,Private,Former,77.8,1.7,60.0,10.0,1,1,Silica,0,0,29.2,SCLC_Extensive,NA,Exte,T4,N0,M0,9.9,RUL,Left,1,0,1,0,0,0,0,0,None,None,None,None,None,None,1,0,0,None,0,0,0,100,100,>=50%,34.8,1,MSS,Chemo_IO_Combination,None,Atezolizumab,Etoposide_Platinum,None,NA,None,0.0,5,86.7,0,0,0,0,2.8,1,11.9,0,2.1,SD,0,1,2.1,0.0,-26.6,0,0,1,356.4,7.0,171.9,1,36.89,0,G2,Negative,Negative,Positive,1,88.5,56.5,0,None,0,0,1,0,0,3.1,185.8,12.3,3.3,197.1,3.8,1,Endocrinopathy,2,0,1,0,1,0 |
| 2404632a-fc1eb627-46c0d297e-0632-0001d4390929,SITE_033,2020-01-17,57.42501697857632,Male,White,Medicare,Never,0.0,0.0,0.0,0.0,0,0,None,0,0,21.9,Adenocarcinoma,Papillary,IB,T2a,N3,M0,3.7,LUL,Right,0,0,0,0,0,0,0,0,None,Exon19del,None,None,None,None,0,0,0,None,0,0,0,22,28,1-49%,8.8,0,MSS,SBRT,None,None,None,None,NA,SBRT,50.9,7,79.2,0,0,0,0,0.5,1,7.2,1,0.5,CR,1,1,8.0,8.2,-63.6,0,0,0,382.5,1.0,44.6,0,0.0,0,G3,Negative,Negative,Negative,0,77.7,74.9,0,None,1,0,0,0,2,4.2,416.7,12.7,2.0,169.2,123.3,0,None,0,1,2,1,0,0 |
| 7575a002-33637600f-416060e006-0a00-0005f6f92021,SITE_011,2019-04-22,73.88068543583417,Female,White,Private,Current,39.2,1.4,60.0,0.0,0,1,Asbestos,0,0,23.4,Adenocarcinoma,Acinar,IIB,T2a,N0,M0,4.0,RUL,Right,0,0,1,0,0,0,0,0,None,None,None,None,G13C,None,0,0,0,None,0,1,0,100,100,>=50%,2.3,0,MSS,Surgery_Adjuvant,None,None,None,Lobectomy,R0,None,0.0,4,69.8,0,0,1,0,10.5,1,18.5,1,9.0,CR,1,1,2.0,52.0,-68.7,0,0,0,264.9,17.9,3.8,0,0.0,0,GX,Positive,Negative,Negative,3,95.5,53.9,1,III,0,0,0,1,3,3.5,139.6,12.3,1.1,50.0,40.5,0,None,0,1,2,2,0,0 |
| 25947af1-1070f5c98-470bd70d3-07af-0001e88a3e44,SITE_041,2024-02-02,67.59852249917965,Female,White,Medicare,Current,37.1,1.7,60.0,0.0,1,0,Asbestos,0,1,23.6,Squamous_Cell,Non-keratinizing,IIIB,T1a,N0,M0,0.7,RUL,Right,1,0,0,1,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,15,24,1-49%,58.9,1,MSS,Chemo_RT,None,None,Carboplatin_Paclitaxel,None,NA,IMRT,58.5,5,76.7,0,0,0,0,2.8,1,9.7,1,2.5,SD,0,1,1.6,0.0,-6.3,0,0,0,209.3,16.6,9.1,1,14.14,1,G3,Negative,Negative,Negative,1,65.2,76.4,1,I,0,0,1,0,2,3.4,168.9,9.0,11.1,237.1,15.5,0,None,0,0,1,0,0,1 |
| 3797b16e-18525da03-4a6c7144a-0b16-0002d2b4029d,SITE_028,2018-01-18,49.026510593536855,Female,Black,Medicare,Never,0.0,0.0,0.0,0.0,0,0,None,0,0,21.2,SCLC_Extensive,NA,Exte,T4,N0,M0,8.7,RUL,Right,1,0,0,1,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,99,100,>=50%,14.0,1,MSS,Chemo_IO_Combination,None,Atezolizumab,Etoposide_Platinum,None,NA,None,0.0,1,84.5,0,0,0,0,0.8,1,6.9,1,0.7,CR,1,1,0.5,0.8,-79.9,0,0,0,269.3,6.1,9.6,0,0.0,0,G2,Negative,Negative,Positive,1,80.9,61.7,0,None,1,0,1,1,2,4.7,100.0,9.7,2.6,105.5,24.5,0,None,0,1,2,0,1,0 |
| 54b9ae2b-25113c32e-4fe2d0a81-0ae2-00044d6dd836,SITE_027,2020-11-13,48.3933813162282,Female,Hispanic,Medicare,Former,0.5,1.0,3.3,5.6,0,0,None,0,0,30.6,Adenocarcinoma,Micropapillary,IA,T3,N2,M0,5.2,RLL,Right,0,0,0,1,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,0,0,<1%,10.5,1,MSS,Surgery_Adjuvant,None,None,None,Wedge_Resection,R0,None,0.0,6,85.7,1,0,0,0,16.3,1,32.8,0,13.5,CR,1,1,2.6,16.5,-74.7,0,0,0,212.9,9.8,29.1,0,0.0,0,G2,Positive,Negative,Negative,2,108.8,74.9,0,None,0,0,0,0,1,3.8,168.6,12.1,3.8,240.7,12.8,0,None,0,1,0,2,0,0 |
| 1029f796-7125c51b-4307de6c2-0f79-0000d22192a5,SITE_039,2016-03-14,66.88296671717154,Female,White,Medicare,Current,24.4,1.1,60.0,0.0,1,1,Silica,0,0,21.6,Large_Cell,NA,IA,T2a,N3,M0,3.3,LUL,Right,1,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,100,100,>=50%,3.2,0,MSS,Surgery_Adjuvant,None,None,None,Robotic,R0,None,0.0,5,89.3,0,0,0,0,8.7,0,8.7,0,6.9,CR,1,1,1.0,70.0,-64.9,0,0,0,213.5,5.7,14.0,0,0.0,0,G3,Negative,Negative,Negative,0,86.8,52.6,0,None,1,1,1,1,3,3.0,130.2,12.1,6.1,500.0,1.5,0,None,0,1,0,1,1,0 |
| 474cd45e-1f319ce93-4d5e67d1a-0d45-00039ee6c8cd,SITE_032,2023-07-01,64.90081048102964,Female,Other,Private,Former,26.8,1.0,60.0,8.7,0,0,None,0,1,22.9,SCLC_Limited,NA,Limi,T1c,N2,M0,2.2,LLL,Right,0,1,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,70,100,>=50%,9.2,0,MSS,Chemo_IO_Combination,None,Durvalumab,Etoposide_Platinum,None,NA,Conventional_EBRT,48.1,7,97.9,0,0,0,0,11.4,1,36.0,1,8.6,PD,0,0,8.0,0.0,46.5,0,0,0,652.0,2.0,5.2,1,17.75,0,G3,Negative,Negative,Positive,0,104.2,45.9,0,None,1,0,1,1,2,4.3,432.2,12.5,1.9,142.6,4.5,0,None,0,0,0,1,0,0 |
| 40a45906-1c47e6f2b-4c1ed0b12-0590-000348588555,SITE_004,2018-11-03,66.01750892104099,Male,Black,Private,Former,10.8,1.0,60.0,23.1,1,0,None,0,0,31.6,Adenocarcinoma,Papillary,IIB,T3,N2,M0,6.7,RUL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,16.7,1,MSS,Surgery_Adjuvant,None,None,Cisplatin_Pemetrexed,VATS,R2,None,0.0,6,81.0,0,0,1,0,48.2,0,48.2,0,47.3,CR,1,1,0.7,14.7,-67.3,0,0,0,192.9,25.0,40.7,0,0.0,0,G3,Negative,Negative,Negative,1,73.5,120.0,0,None,0,0,1,0,0,3.2,391.7,15.9,2.5,100.8,15.3,0,None,0,3,2,2,0,1 |
| 6456c6c9-2be5f6f80-412d04545b-0c6c-00051868183c,SITE_015,2018-05-28,66.73416666296293,Female,White,Private,Former,1.8,1.0,12.3,10.4,0,0,None,0,0,23.4,SCLC_Limited,NA,Limi,T4,N2,M0,8.4,LUL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,89,100,>=50%,14.2,1,MSS,Chemo_IO_Combination,None,Durvalumab,Etoposide_Platinum,None,NA,Conventional_EBRT,46.9,4,63.1,0,0,0,0,7.5,1,7.5,1,6.2,PR,1,1,8.0,13.0,-44.3,0,0,0,315.4,13.5,66.7,0,0.0,0,G3,Negative,Negative,Positive,2,66.4,73.1,1,III,1,0,1,0,3,4.5,206.8,11.9,4.4,339.4,11.8,1,Dermatitis,1,0,3,0,0,0 |
| 7f806e5e-37c830493-417e814b1a-06e5-000679859acd,SITE_009,2020-10-28,69.14281847534671,Female,White,Medicare,Current,42.4,1.2,60.0,0.0,1,0,None,0,0,25.2,Squamous_Cell,Non-keratinizing,IA,T2a,N1,M0,3.5,LLL,Right,0,1,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,4.9,0,MSS,Surgery_Adjuvant,None,None,Carboplatin_Paclitaxel,Segmentectomy,R0,None,0.0,6,63.3,0,0,0,0,31.9,0,31.9,0,25.1,CR,1,1,0.9,2.5,-69.0,0,0,0,264.1,15.7,17.8,0,0.0,0,G2,Negative,Positive,Negative,1,95.9,106.2,0,None,0,0,1,0,0,3.8,253.0,11.0,3.3,89.7,53.1,0,None,0,0,3,2,1,0 |
| 550839e0-253399521-4ff18ada0-039e-0004516af067,SITE_037,2019-12-26,76.00267129355885,Female,White,Private,Current,41.1,1.6,60.0,0.0,0,1,None,0,0,21.4,Large_Cell,NA,IVB,T1b,N2,M1a,1.8,RML,Right,0,1,1,0,0,1,0,0,Bone,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,8.6,0,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,8,69.7,0,0,0,0,14.1,1,22.5,1,10.1,PD,0,0,5.4,0.0,58.1,0,0,0,132.5,5.9,25.8,1,29.18,0,GX,Negative,Negative,Negative,1,42.1,96.1,0,None,0,0,1,0,3,3.2,148.1,12.6,1.8,462.0,46.6,0,None,0,0,0,0,0,0 |
| 346038a9-16ea18ca0-49d20a9fb-038a-0002a8e2e09c,SITE_002,2023-06-23,56.444503441283196,Female,Hispanic,Private,Former,14.5,1.0,60.0,6.7,0,0,None,0,0,29.7,Squamous_Cell,Non-keratinizing,IVA,T1a,N2,M1b,0.6,RUL,Right,0,1,0,0,1,1,0,0,Brain|Bone,None,None,None,None,None,0,0,0,None,0,0,0,100,100,>=50%,5.2,0,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,3,85.8,0,0,0,0,7.0,1,18.6,0,6.4,PD,0,0,2.0,0.0,29.2,0,0,0,130.3,18.2,6.3,1,24.09,0,G3,Negative,Positive,Negative,0,78.2,45.8,0,None,1,0,1,0,1,4.2,100.0,9.7,6.9,112.4,8.7,0,None,0,0,4,1,0,0 |
| 34047c13-16c1f6486-49c0d7439-07c1-0002a43a4cfe,SITE_011,2020-04-23,55.86626986744245,Female,White,Medicare,Current,71.0,2.3,60.0,0.0,0,0,None,0,0,29.8,Squamous_Cell,Non-keratinizing,IA,T1a,N0,M0,0.4,RUL,Left,0,1,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,40.4,1,MSS,Surgery_Adjuvant,None,None,Carboplatin_Paclitaxel,Segmentectomy,R0,None,0.0,6,79.2,0,0,0,0,38.3,0,38.3,0,32.9,PR,1,1,5.1,3.2,-38.0,0,0,0,235.0,2.5,10.7,1,6.74,0,G1,Negative,Positive,Negative,0,93.6,77.8,0,None,1,0,0,1,2,4.1,136.8,12.8,3.2,101.9,4.8,0,None,0,2,2,1,0,0 |
| 357fac13-1767db486-4a07f0439-0ac1-0002b77bbcfe,SITE_030,2020-03-02,56.613423350069866,Female,White,Private,Former,65.7,3.9,60.0,21.7,1,0,Asbestos,0,0,29.3,Adenocarcinoma,Micropapillary,IA,T3,N1,M0,6.5,RUL,Left,0,1,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,100,100,>=50%,20.2,1,MSS,Surgery_Adjuvant,None,None,Cisplatin_Pemetrexed,Robotic,R0,None,0.0,5,92.2,0,0,0,0,40.1,0,40.1,0,30.3,PR,1,1,2.5,19.5,-55.2,0,0,0,100.0,6.1,11.3,0,0.0,0,G2,Positive,Negative,Negative,1,85.1,51.3,0,None,1,0,0,0,2,2.7,291.2,11.1,4.9,500.0,62.3,0,None,0,0,0,2,0,0 |
| 6831d1e9-2d95cbd60-41389575bb-0d1e-00054a87a8dc,SITE_035,2016-01-19,69.74470833810271,Male,Black,Private,Former,52.6,2.0,60.0,23.6,0,1,None,0,0,28.4,SCLC_Limited,NA,Limi,T4,N0,M0,7.8,Central,Right,1,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,54,88,>=50%,5.6,0,MSS,Chemo_IO_Combination,None,Durvalumab,Etoposide_Platinum,None,NA,Conventional_EBRT,47.0,5,86.1,0,0,0,0,24.9,1,24.9,1,24.1,PR,1,1,2.5,2.0,-58.0,0,0,0,611.1,13.4,39.3,0,0.0,0,G3,Negative,Negative,Negative,0,37.2,67.3,0,None,0,0,1,1,3,3.8,249.4,13.0,4.7,184.5,26.7,1,Pneumonitis,2,0,1,1,0,0 |
| 291d98dd-11fcf2e0c-47b58ca97-098d-00021680c340,SITE_026,2015-03-22,78.82700009714124,Male,Hispanic,Medicare,Former,25.4,1.1,60.0,8.2,0,0,None,0,0,26.3,Adenocarcinoma,Acinar,IA,T4,N0,M0,7.7,RLL,Left,0,0,1,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,87,100,>=50%,3.2,0,MSS,SBRT,None,None,None,None,NA,SBRT,55.1,3,66.8,0,0,0,0,2.5,1,15.0,1,2.4,SD,0,1,1.1,0.0,6.6,0,0,0,204.2,4.5,27.3,0,0.0,0,G2,Positive,Negative,Negative,2,50.8,41.8,0,None,0,0,1,0,0,3.9,164.7,12.1,8.8,392.8,7.9,0,None,0,0,4,3,0,0 |
| 155f5e5f-959b949a-4401e1b1d-05e5-000115d7cada,SITE_044,2018-12-25,62.90227533672465,Male,Black,Private,Former,120.0,5.7,60.0,6.5,0,0,Asbestos,0,0,23.6,Adenocarcinoma,Acinar,IIIC,T3,N2,M0,6.7,LUL,Left,0,0,0,1,0,0,0,0,None,None,None,None,G12D,None,0,0,0,None,1,0,0,0,0,<1%,11.6,1,MSS,CCRT,None,Durvalumab,Carboplatin_Paclitaxel,None,NA,IMRT,60.3,4,83.9,0,0,0,0,24.6,1,47.0,1,23.7,SD,0,1,8.0,0.0,-13.4,0,0,0,196.1,15.3,13.5,0,0.0,0,G2,Positive,Negative,Negative,3,72.9,46.8,1,II,0,0,0,0,1,3.9,290.0,12.2,5.7,146.1,3.6,0,None,0,0,1,3,1,0 |
| 2aca0fde-12b866f13-4805e2f9a-00fd-00022c42ce4d,SITE_046,2024-12-22,43.23385148048328,Male,Asian,Medicaid,Former,11.8,1.0,60.0,16.5,0,0,None,0,0,22.3,Adenocarcinoma,Papillary,IA,T1b,N0,M0,1.5,LLL,Bilateral,0,0,1,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,27,32,1-49%,5.8,0,MSS,Surgery_Adjuvant,None,None,Cisplatin_Pemetrexed,VATS,R0,None,0.0,2,91.0,0,0,0,0,12.8,0,12.8,0,11.1,SD,0,1,1.4,0.0,-26.0,0,0,0,451.0,9.4,12.9,0,0.0,0,G3,Positive,Negative,Negative,3,83.5,58.3,1,II,1,0,0,0,2,3.7,158.3,13.8,2.5,140.0,7.3,0,None,0,1,3,1,1,1 |
| 02e83aad-14599abc-48b8b007-03aa-000025cafad0,SITE_007,2024-03-02,50.81206780520144,Male,White,Uninsured,Never,0.0,0.0,0.0,0.0,0,0,None,0,0,31.8,Adenocarcinoma,Solid,IVB,T4,N2,M1c,10.6,RLL,Right,1,0,0,0,0,0,0,0,None,Exon19del,None,None,None,None,0,0,0,None,0,0,0,43,45,1-49%,6.2,0,MSS,Targeted_TKI,Osimertinib,None,None,None,NA,None,0.0,2,59.5,0,0,0,0,6.9,1,50.1,0,5.6,CR,1,1,1.2,24.6,-65.2,0,0,0,228.1,8.7,1.9,1,21.54,1,G3,Positive,Negative,Negative,1,84.3,63.3,0,None,0,0,0,0,1,4.2,113.2,14.0,10.1,50.0,36.2,0,None,0,0,1,1,0,0 |
| 0d961485-5f1a8fa4-428c23d8f-0148-0000b09f0ac8,SITE_048,2021-04-14,59.08615113343789,Male,Hispanic,Uninsured,Former,25.9,1.0,60.0,26.6,0,0,Asbestos,0,1,29.4,Large_Cell,NA,IIIB,T2a,N3,M0,3.4,LUL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,0,0,<1%,3.2,0,MSS,Chemo_RT,None,None,Carboplatin_Paclitaxel,None,NA,IMRT,63.2,2,58.2,0,0,0,0,4.5,1,7.3,1,3.3,SD,0,1,0.5,0.0,15.3,0,0,0,338.8,4.2,138.0,0,0.0,0,G3,Negative,Negative,Negative,1,74.9,72.6,0,None,0,1,0,0,2,4.1,290.0,16.6,3.2,272.3,200.0,0,None,0,1,0,0,1,0 |
| 0b86b034-50aed16d-42294109c-0b03-000095d6f2ab,SITE_031,2021-04-21,61.70157556879546,Male,White,Private,Current,78.2,2.0,60.0,0.0,0,1,None,0,0,22.9,Adenocarcinoma,Papillary,IVB,T2a,N1,M1b,3.4,RUL,Left,0,0,0,1,0,0,0,0,None,None,None,None,G12C,None,0,0,0,None,0,0,0,100,100,>=50%,3.6,0,MSS,Targeted_TKI,Adagrasib,None,None,None,NA,None,0.0,1,63.2,0,0,0,0,4.6,1,4.6,1,3.8,PR,1,1,0.5,4.5,-34.4,0,0,0,183.8,10.2,1.6,1,15.0,1,G2,Positive,Negative,Negative,1,88.1,55.4,1,III,0,0,0,0,2,3.8,147.5,13.9,2.5,187.0,14.6,0,None,0,2,0,3,1,0 |
| 62c23ac0-2b34f9b41-412846b040-03ac-000503dcfbc7,SITE_032,2018-11-29,63.1203080410801,Female,White,Private,Never,0.0,0.0,0.0,0.0,1,0,None,0,0,26.2,Adenocarcinoma,Acinar,IVB,T3,N0,M1b,6.8,RLL,Right,0,0,0,0,1,1,0,0,Brain|Bone,None,None,None,None,V600E,0,0,0,None,0,0,1,100,100,>=50%,10.4,1,MSS,Targeted_TKI,Dabrafenib_Trametinib,None,None,None,NA,None,0.0,3,70.6,0,0,0,0,3.2,1,17.3,1,2.9,PD,0,0,0.9,0.0,62.2,0,0,0,250.3,25.0,33.3,1,1.82,0,GX,Positive,Negative,Negative,0,82.9,74.4,0,None,0,1,1,0,1,3.7,334.7,12.0,2.3,138.8,5.8,0,None,0,1,0,0,1,0 |
| 5c76456d-2873be5fc-411562d047-0456-0004b2018690,SITE_005,2016-10-09,67.36652066831871,Male,Other,Medicare,Former,57.2,3.1,60.0,5.5,0,0,None,0,0,24.6,Adenocarcinoma,Papillary,IIIC,T1a,N2,M0,0.9,RUL,Right,1,0,0,0,0,0,0,0,None,None,None,CD74-ROS1,None,None,0,0,0,None,0,0,0,27,26,1-49%,7.1,0,MSS,Chemo_RT,None,None,Carboplatin_Paclitaxel,None,NA,IMRT,54.7,10,71.3,1,0,0,0,1.2,1,18.1,1,0.9,SD,0,1,0.9,0.0,11.8,0,0,0,397.1,8.5,21.0,1,14.13,0,G2,Positive,Negative,Negative,3,72.7,90.2,1,III,1,0,1,0,3,3.9,100.0,11.2,1.0,211.7,200.0,0,None,0,0,1,1,0,0 |
| 592fc90a-2704e7f47-410b8f5b1e-0c90-0004876d3589,SITE_032,2015-02-01,64.03840985718675,Female,White,Medicare,Current,27.7,1.0,60.0,0.0,0,0,Radon,1,1,20.9,Large_Cell,NA,IVB,T4,N2,M1b,8.1,RUL,Right,0,0,0,1,0,1,0,0,Bone,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,80.0,1,MSS,Chemo_IO_Combination,None,Atezolizumab,Carboplatin_Paclitaxel,None,NA,None,0.0,2,84.1,0,0,0,0,0.8,1,3.5,1,0.6,PD,0,0,6.3,0.0,64.4,0,0,0,159.0,11.5,14.6,1,14.56,0,GX,Negative,Negative,Negative,1,84.7,76.4,1,II,1,0,1,0,4,3.5,150.7,13.2,2.9,151.9,11.5,0,None,0,1,0,1,0,1 |
| 3b1ecb07-19dd78d32-4b15c6115-0cb0-000300904f62,SITE_037,2018-05-21,76.96872630016237,Female,White,Medicare,Current,37.1,1.2,60.0,0.0,0,1,None,0,0,26.8,Adenocarcinoma,Solid,IVB,T4,N0,M1b,7.6,RML,Right,0,0,1,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,15.4,1,MSS,Chemo_IO_Combination,None,Pembrolizumab,Carboplatin_Pemetrexed,None,NA,None,0.0,5,89.3,0,0,0,0,6.6,1,6.6,1,5.7,PD,0,0,4.1,0.0,25.4,0,0,0,318.6,13.0,19.9,0,0.0,0,G2,Positive,Negative,Negative,1,63.3,70.9,0,None,0,0,1,0,0,3.3,270.0,15.4,5.9,84.3,6.1,0,None,0,0,0,1,0,0 |
| 5bc892c6-2827c036b-411359b852-092c-0004a92f7415,SITE_030,2018-03-01,60.577835596027,Male,White,Private,Current,66.8,2.2,60.0,0.0,0,0,None,0,0,24.1,SCLC_Limited,NA,Limi,T3,N0,M0,5.5,LLL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,61,78,>=50%,3.2,0,MSS,Chemotherapy_Only,None,Atezolizumab,Etoposide_Platinum,None,NA,Conventional_EBRT,59.4,6,67.1,0,0,0,0,15.6,0,15.6,0,14.3,PR,1,1,1.2,4.9,-44.9,0,0,0,100.0,3.0,9.1,0,0.0,0,G3,Negative,Negative,Positive,2,86.5,77.5,0,None,0,0,1,0,0,3.2,256.4,14.2,1.7,184.5,10.9,0,None,0,0,3,0,0,0 |
| 14a48dbc-907fe025-43deda934-08db-00010c5b3293,SITE_005,2016-11-30,58.80797938498234,Male,White,Private,Current,24.8,1.2,60.0,0.0,0,0,Silica,0,0,21.7,Squamous_Cell,Keratinizing,IA,T3,N2,M0,6.0,LUL,Left,1,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,2.3,0,MSS,Surgery_Adjuvant,None,None,None,Lobectomy,R0,None,0.0,6,70.2,0,0,0,0,55.6,0,55.6,0,40.4,PR,1,1,0.7,54.8,-57.3,0,0,0,460.7,6.6,44.0,1,7.92,1,GX,Negative,Positive,Negative,0,59.8,49.0,1,I,0,0,0,0,1,3.7,179.4,11.1,14.8,132.4,10.1,0,None,0,1,0,1,0,0 |
| 7347923d-326f4ffac-4159d6b6b7-0923-0005daa26d20,SITE_027,2017-08-03,71.54931761594439,Male,White,Private,Current,4.9,1.0,33.0,0.0,0,0,None,0,0,19.3,SCLC_Extensive,NA,Exte,T2a,N3,M0,3.7,LLL,Right,1,1,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,53,86,>=50%,12.9,1,MSS,Chemo_IO_Combination,None,Atezolizumab,Etoposide_Platinum,None,NA,None,0.0,7,52.8,1,0,0,0,2.8,1,9.0,1,2.7,PR,1,1,1.4,3.2,-41.0,0,0,0,185.3,6.5,4.2,0,0.0,0,G2,Negative,Negative,Negative,2,83.8,87.2,0,None,1,0,1,0,1,3.4,231.3,13.4,1.0,231.5,135.1,0,None,0,0,0,2,0,1 |
| 40223c35-1c0efa574-4c066b49f-03c3-000341bd0eb8,SITE_047,2015-04-01,52.41140033570187,Female,White,Private,Never,0.0,0.0,0.0,0.0,0,0,None,0,1,19.0,Adenocarcinoma,Acinar,IB,T1a,N0,M0,0.5,RUL,Left,0,0,0,0,0,0,0,0,None,Exon19del,None,None,None,None,0,0,0,None,0,0,0,42,94,1-49%,6.3,0,MSS,Surgery_Adjuvant,Osimertinib,None,None,VATS,R0,None,0.0,6,65.5,0,0,0,1,21.0,0,21.0,0,17.6,PR,1,1,3.0,100.8,-49.0,0,0,0,234.4,1.3,29.8,0,0.0,0,G3,Positive,Negative,Negative,1,83.3,52.8,0,None,0,0,1,0,0,3.7,214.9,12.9,2.6,125.4,1.6,0,None,0,0,3,1,0,0 |
| 78121168-3487e79d9-4168363438-0116-000618eae24f,SITE_037,2021-01-28,70.70207120054002,Male,Asian,Private,Former,10.0,1.0,60.0,5.9,0,0,None,0,0,24.3,Adenocarcinoma,Micropapillary,IIIC,T3,N0,M0,6.7,Endobronchial,Right,0,1,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,0,0,<1%,29.9,1,MSS,CCRT,None,Durvalumab,Carboplatin_Paclitaxel,None,NA,IMRT,61.6,7,87.0,0,0,0,0,8.0,1,21.0,0,7.0,SD,0,1,0.5,0.0,-15.9,0,0,1,233.0,13.9,8.9,1,10.77,0,G3,Negative,Negative,Negative,2,69.6,96.8,1,II,0,0,0,1,4,4.5,100.0,14.6,1.6,112.0,49.0,1,Dermatitis,2,0,3,2,0,1 |
| 137ef685-8878bda4-43a7ce38f-0f68-0000fd7284c8,SITE_007,2024-04-08,67.97425524539953,Male,Asian,Uninsured,Current,31.9,1.2,60.0,0.0,0,1,None,0,1,25.6,Adenocarcinoma,Micropapillary,IIIA,T2b,N3,M0,4.6,RUL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,Overexpression,0,0,1,100,100,>=50%,11.6,1,MSS,CCRT,None,Durvalumab,Carboplatin_Paclitaxel,None,NA,IMRT,60.1,3,79.4,0,0,0,0,13.5,1,39.0,0,13.3,SD,0,1,2.5,0.0,1.6,0,0,1,150.3,3.5,12.0,1,10.88,1,G2,Positive,Negative,Negative,4,86.4,84.3,0,None,0,0,0,0,1,3.7,167.0,13.1,8.5,107.1,19.8,0,None,0,1,2,1,1,0 |
| 3fa8830e-1bd9b9563-4bef9892a-0830-00033b8ea7bd,SITE_048,2021-11-26,65.5992963457774,Female,White,Private,Former,2.1,1.0,14.2,17.4,0,0,None,0,0,22.1,SCLC_Extensive,NA,Exte,T4,N0,M0,12.0,LLL,Right,0,1,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,1.5,0,MSS,Chemo_IO_Combination,None,Durvalumab,Etoposide_Platinum,None,NA,None,0.0,1,86.0,1,0,0,0,3.7,1,10.1,0,2.8,SD,0,1,0.5,0.0,-18.6,0,0,1,144.6,12.7,12.4,0,0.0,0,G3,Negative,Negative,Positive,1,102.8,80.9,1,III,0,0,1,0,1,3.9,224.5,13.0,7.1,87.3,8.7,0,None,0,0,0,0,0,0 |
| 592106ab-26fe72eae-410b631401-006a-000486ad56b6,SITE_048,2019-06-24,82.088623017918,Female,White,Medicare,Never,0.0,0.0,0.0,0.0,1,0,None,0,0,28.9,SCLC_Limited,NA,Limi,T1a,N0,M0,1.0,LLL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,3.6,0,MSS,Chemotherapy_Only,None,Durvalumab,Etoposide_Platinum,None,NA,Conventional_EBRT,56.0,8,90.9,0,0,0,0,4.6,1,35.3,1,4.4,SD,0,1,1.8,0.0,-18.1,0,0,0,317.6,4.0,16.5,0,0.0,0,G2,Negative,Negative,Positive,1,56.6,81.6,0,None,0,0,1,0,0,3.7,258.0,10.1,3.7,108.5,12.1,0,None,0,0,0,3,0,0 |
| 3f70ab25-1bc14ae04-4be52016f-0ab2-000338b8b0e8,SITE_009,2019-03-14,61.08902926970018,Male,Asian,Uninsured,Former,43.0,1.9,60.0,6.8,0,0,None,0,1,25.7,Adenocarcinoma,Papillary,IIA,T1c,N2,M0,2.6,LUL,Left,1,0,0,0,0,0,0,0,None,None,None,None,None,None,1,0,0,None,0,0,1,25,60,1-49%,4.9,0,MSS,SBRT,None,None,None,None,NA,SBRT,59.5,5,69.9,0,0,0,0,7.3,1,7.3,1,6.9,PD,0,0,1.2,0.0,62.0,0,0,0,325.1,25.0,36.7,0,0.0,0,G3,Positive,Negative,Negative,0,92.2,72.0,0,None,0,1,1,0,1,4.5,193.9,14.1,1.7,192.3,13.8,0,None,0,3,2,2,0,0 |
| 391ba61a-18fc18ab7-4ab52f24e-0a61-0002e6676f59,SITE_041,2018-01-27,86.57283261997874,Male,White,Private,Former,3.4,1.0,22.7,7.1,0,0,None,0,0,28.6,Squamous_Cell,Non-keratinizing,IIIC,T2a,N0,M0,3.4,RLL,Left,0,0,1,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,68,100,>=50%,13.4,1,MSS,Chemo_RT,None,None,Carboplatin_Paclitaxel,None,NA,IMRT,59.4,3,73.6,0,0,0,0,8.1,1,8.1,1,8.1,SD,0,1,1.5,0.0,-19.7,0,0,0,157.2,5.9,19.2,1,4.63,0,G2,Negative,Positive,Negative,2,94.6,59.4,0,None,0,0,1,0,0,4.6,152.0,9.7,1.9,94.7,22.9,0,None,0,2,2,2,0,0 |
| 154680e1-94ed8628-43fd382a3-080e-000114948b74,SITE_021,2016-06-03,64.85840123233305,Male,White,Medicare,Former,16.7,1.0,60.0,10.6,0,0,None,0,1,25.2,SCLC_Limited,NA,Limi,T3,N0,M0,5.8,LLL,Left,0,0,1,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,3.5,0,MSS,Chemo_IO_Combination,None,Atezolizumab,Etoposide_Platinum,None,NA,Conventional_EBRT,52.4,6,83.4,0,0,0,0,19.8,1,19.8,1,16.2,CR,1,1,3.4,13.0,-68.1,0,0,0,320.7,25.0,61.5,1,8.61,1,G3,Negative,Negative,Positive,1,71.3,56.9,0,None,1,0,1,1,3,3.6,102.8,12.7,5.3,73.3,10.2,0,None,0,2,1,0,0,0 |
| 30c54db4-155651fed-4924fe91c-04db-00027a04f22b,SITE_030,2020-12-24,54.868343772782836,Male,White,Medicare,Former,41.4,1.4,60.0,1.4,1,1,None,0,1,22.5,Squamous_Cell,Non-keratinizing,IVB,T3,N2,M1b,5.1,LLL,Right,0,0,0,0,0,0,1,0,Liver,None,None,None,None,None,0,0,0,None,0,0,0,0,0,<1%,10.4,1,MSS,Chemo_IO_Combination,None,Pembrolizumab,Carboplatin_Paclitaxel,None,NA,None,0.0,7,85.8,0,0,0,0,2.5,1,10.5,1,1.9,CR,1,1,4.2,0.8,-65.6,0,0,0,323.4,6.4,70.4,1,3.97,0,G3,Negative,Positive,Negative,4,89.4,100.0,0,None,1,1,0,1,4,4.2,291.9,11.4,2.8,238.3,18.2,0,None,0,1,0,2,0,0 |
| 1e8fe49b-d5ef403e-45bafadd1-0e49-00018d4e9be6,SITE_023,2020-08-29,67.66423601945084,Male,White,Private,Current,7.7,1.0,51.5,0.0,0,0,None,0,0,26.5,Squamous_Cell,Keratinizing,IVA,T4,N2,M1b,8.3,RUL,Left,0,0,0,0,0,0,0,0,None,L858R,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,2.7,0,MSS,Targeted_TKI,Osimertinib,None,None,None,NA,None,0.0,4,71.7,0,0,0,0,2.8,1,21.5,0,2.0,PR,1,1,0.5,5.9,-54.5,0,0,1,202.5,7.1,29.1,1,16.55,1,G2,Negative,Positive,Negative,2,70.4,73.7,1,II,1,1,0,0,3,4.8,276.3,11.3,3.0,136.6,6.3,0,None,0,1,1,3,0,0 |
| 2697f2b9-10e27a310-473c7d82b-0f2b-0001f5b7536c,SITE_040,2015-01-27,56.7756705969717,Female,White,Private,Current,29.2,1.0,60.0,0.0,0,0,None,0,0,20.3,Adenocarcinoma,Lepidic,IA,T1c,N1,M0,2.3,LLL,Left,1,0,1,0,0,0,0,0,None,None,None,None,None,None,0,1,0,None,0,0,0,0,0,<1%,9.1,0,MSS,Surgery_Adjuvant,None,None,None,Segmentectomy,R0,None,0.0,4,77.1,0,0,0,0,28.3,0,28.3,0,26.5,PD,0,0,1.2,0.0,40.7,0,0,0,128.2,25.0,45.6,0,0.0,0,G2,Positive,Negative,Negative,1,97.6,54.2,1,I,0,0,1,0,1,3.2,328.2,13.7,4.3,235.3,200.0,0,None,0,2,1,4,0,0 |
| 578380d8-2649885e9-41068a8288-080d-000471ad8aff,SITE_050,2019-02-25,59.85831944577175,Female,Black,Medicaid,Former,120.0,6.1,60.0,8.6,0,0,None,0,0,28.4,Adenocarcinoma,Solid,IVA,T2a,N1,M1a,3.9,RUL,Right,1,0,0,0,0,0,1,0,Liver,None,None,None,None,None,0,0,0,None,0,0,0,94,100,>=50%,12.6,1,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,4,98.6,1,0,0,0,6.3,1,35.8,0,4.7,PR,1,1,1.2,3.9,-43.2,0,0,1,240.1,3.5,228.1,1,7.1,0,G3,Positive,Negative,Negative,0,30.0,80.3,1,II,0,0,1,0,1,4.3,116.8,12.5,3.4,130.0,91.3,0,None,0,1,2,2,0,0 |
| 50ad199a-234bbb337-4f2074cce-0199-000418ca4cd9,SITE_040,2017-10-11,70.77181635014716,Female,Other,Medicare,Current,2.8,1.0,18.4,0.0,0,0,None,0,0,21.8,SCLC_Extensive,NA,Exte,T1a,N1,M0,0.7,RLL,Bilateral,0,1,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,33.6,1,MSS,Chemotherapy_Only,None,Atezolizumab,Etoposide_Platinum,None,NA,None,0.0,6,66.3,1,0,0,0,19.7,1,21.1,1,15.6,PD,0,0,4.0,0.0,51.8,0,0,0,293.7,7.7,3.7,0,0.0,0,G2,Negative,Negative,Positive,1,101.0,77.5,0,None,1,0,1,0,1,2.9,212.9,7.7,1.3,105.3,41.8,0,None,0,2,0,1,0,0 |
| 4db89cd8-2200c49e9-4e929d688-09cd-0003f25ff6ff,SITE_047,2016-09-13,72.27802984217618,Female,White,Medicaid,Never,0.0,0.0,0.0,0.0,0,1,None,0,0,30.1,SCLC_Extensive,NA,Exte,T1c,N2,M0,2.0,LUL,Right,1,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,11.3,1,MSS,Chemo_IO_Combination,None,Durvalumab,Etoposide_Platinum,None,NA,None,0.0,1,95.3,0,0,0,0,4.3,1,5.7,1,4.3,PD,0,0,1.5,0.0,22.7,0,0,0,237.6,11.4,73.1,0,0.0,0,G3,Negative,Negative,Positive,1,55.0,66.7,0,None,0,1,0,0,1,3.8,141.7,12.1,1.8,52.1,10.3,0,None,0,2,0,3,1,0 |
| 2e4fe028-1442f2119-48aefa078-0e02-00025a0e620f,SITE_048,2022-01-10,61.08940684758455,Male,Black,VA,Current,39.3,1.0,60.0,0.0,0,0,None,0,0,24.5,Large_Cell,NA,IVA,T2a,N2,M1b,3.8,LLL,Right,1,1,0,0,0,1,0,0,Bone,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,4.3,0,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,1,90.7,0,0,0,0,9.6,1,9.6,1,8.0,PR,1,1,2.0,0.9,-44.5,0,0,0,182.0,10.2,128.2,1,12.43,0,GX,Negative,Negative,Negative,1,76.6,57.6,0,None,0,0,1,0,1,3.7,205.0,11.7,1.8,75.3,68.9,0,None,0,0,0,0,0,0 |
| 7ad734e2-35be2722f-4170859ea6-034e-00063cedaf81,SITE_005,2020-04-03,76.3803488779408,Female,White,Private,Current,43.2,1.7,60.0,0.0,1,1,Asbestos,0,1,30.8,Squamous_Cell,Keratinizing,IIIA,T2b,N2,M0,4.3,RLL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,0,0,<1%,34.6,1,MSS,Chemo_RT,None,None,Carboplatin_Paclitaxel,None,NA,IMRT,61.8,4,79.2,0,0,0,0,11.2,1,12.3,0,8.6,SD,0,1,0.7,0.0,-2.1,0,0,1,309.0,7.6,33.8,1,2.03,0,G2,Negative,Positive,Negative,1,60.3,83.8,1,III,0,1,0,1,4,2.9,600.0,15.0,2.7,87.9,31.5,0,None,0,1,2,1,0,0 |
| 0b381cd0-4e88c9b1-421a85670-01cd-000091d97697,SITE_013,2021-05-02,77.99632370120077,Female,White,Medicare,Never,0.0,0.0,0.0,0.0,0,1,None,0,0,20.9,Adenocarcinoma,Papillary,IVA,T2a,N2,M1a,3.0,RUL,Right,0,0,0,0,1,0,0,0,Brain,L858R,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,7.7,0,MSS,Targeted_TKI,Osimertinib,None,None,None,NA,None,0.0,4,78.9,0,0,0,0,12.8,1,57.7,0,11.9,SD,0,1,0.5,0.0,-18.2,0,0,1,460.7,6.9,197.3,0,0.0,0,G2,Positive,Negative,Negative,1,101.9,87.1,0,None,1,1,1,1,3,4.3,314.8,10.0,4.8,175.7,24.0,0,None,0,0,2,2,0,0 |
| 2bda03b6-132f619fb-4838e0b22-003b-00023a123045,SITE_037,2022-02-17,80.64486668735127,Female,Asian,Medicare,Current,44.0,2.6,60.0,0.0,1,0,Asbestos,0,1,23.0,SCLC_Limited,NA,Limi,T2a,N3,M0,3.8,RLL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,7,8,1-49%,18.1,1,MSS,Chemo_IO_Combination,None,Atezolizumab,Etoposide_Platinum,None,NA,Conventional_EBRT,59.2,5,97.7,0,0,0,0,5.6,1,5.6,1,4.4,SD,0,1,1.9,0.0,16.9,0,0,0,166.5,14.5,168.8,1,11.66,0,GX,Negative,Negative,Positive,1,70.9,77.2,0,None,0,0,1,0,0,3.9,137.3,16.3,4.6,139.0,9.0,1,Hepatitis,1,1,0,1,0,1 |
| 0f1ad141-69bbb8c8-42d5073c3-0d14-0000c45ca054,SITE_030,2024-10-23,72.02942736769435,Female,White,Medicare,Current,119.5,4.6,60.0,0.0,0,0,None,0,0,27.7,SCLC_Extensive,NA,Exte,T3,N2,M0,5.6,RML,Right,0,0,1,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,100,100,>=50%,5.2,0,MSS,Chemo_IO_Combination,None,Durvalumab,Etoposide_Platinum,None,NA,None,0.0,4,92.5,1,0,0,0,2.7,1,15.0,1,2.3,CR,1,1,0.6,0.5,-80.8,0,0,0,210.8,8.5,13.4,0,0.0,0,GX,Negative,Negative,Negative,1,65.2,73.1,0,None,0,0,0,0,0,3.3,176.6,14.2,10.3,80.2,30.3,0,None,0,2,1,0,0,0 |
| 2b6282b8-12fb19309-482278828-082b-00023400a35f,SITE_003,2023-01-09,79.95257276481414,Male,Hispanic,Medicare,Current,50.6,2.1,60.0,0.0,1,0,None,0,0,31.3,SCLC_Extensive,NA,Exte,T4,N0,M0,11.5,LUL,Left,1,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,70,100,>=50%,9.8,0,MSS,Chemo_IO_Combination,None,Atezolizumab,Etoposide_Platinum,None,NA,None,0.0,4,81.9,0,0,0,0,2.0,1,5.8,1,1.5,SD,0,1,2.1,0.0,17.9,0,0,0,800.0,16.0,14.7,1,17.29,1,G1,Negative,Negative,Positive,0,95.2,59.5,0,None,0,0,1,0,0,4.0,167.2,11.9,1.7,50.0,200.0,0,None,0,1,1,0,0,1 |
| 7b1f7671-35ddc3d18-41715e6353-0767-0006409903c4,SITE_005,2021-03-14,49.132414934246455,Male,White,Medicare,Current,120.0,3.6,60.0,0.0,0,0,None,0,0,33.5,SCLC_Limited,NA,Limi,T1c,N3,M0,2.2,RLL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,4.4,0,MSS,Chemotherapy_Only,None,Atezolizumab,Etoposide_Platinum,None,NA,Conventional_EBRT,47.2,3,94.4,1,0,0,0,12.3,1,20.6,1,10.3,PD,0,0,0.8,0.0,22.0,0,0,0,283.0,10.1,38.0,0,0.0,0,G3,Negative,Negative,Positive,0,88.2,79.7,0,None,0,1,0,0,1,4.3,213.1,11.7,5.6,195.9,22.7,0,None,0,1,0,0,1,1 |
| 2ee1b93c-1482c10a5-48ca52bb4-0b93-000261766813,SITE_027,2023-10-14,63.97988778802961,Male,White,Medicaid,Former,28.0,1.0,60.0,0.9,0,0,None,0,0,26.2,Squamous_Cell,Non-keratinizing,IIIA,T2a,N3,M0,3.8,LLL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,43,48,1-49%,12.1,1,MSS,CCRT,None,Durvalumab,Carboplatin_Paclitaxel,None,NA,IMRT,63.1,4,79.2,0,0,0,0,18.1,1,29.6,0,13.2,PD,0,0,0.5,0.0,59.8,0,0,0,129.9,12.4,9.5,1,6.24,0,G2,Negative,Positive,Negative,2,69.0,61.8,0,None,1,0,1,0,2,2.9,100.0,11.2,2.6,251.2,13.5,0,None,0,1,2,3,0,1 |
| 744c5f40-32e169ac1-415ce51dc0-05f4-0005e7e0d647,SITE_031,2019-10-09,58.763450064927454,Male,White,Private,Never,0.0,0.0,0.0,0.0,0,0,None,0,0,34.3,Adenocarcinoma,Acinar,IVB,T3,N0,M1c,5.5,RUL,Left,1,0,0,0,1,1,0,0,Brain|Bone,Exon20ins,None,None,None,None,0,0,0,None,0,0,1,67,81,>=50%,18.6,1,MSS,Targeted_TKI,Afatinib,None,None,None,NA,None,0.0,1,67.4,0,0,0,0,5.1,1,10.6,1,4.8,PD,0,0,7.0,0.0,55.0,0,0,0,192.7,18.3,500.0,0,0.0,0,G3,Negative,Negative,Negative,1,57.2,51.6,0,None,0,1,0,0,1,2.5,235.5,13.1,17.9,264.8,23.3,0,None,0,2,1,2,0,0 |
| 3f5e4fbe-1bb942e33-4be1aef3a-04fb-000337ca0cad,SITE_009,2024-11-03,68.13264568071023,Female,White,Medicare,Current,29.2,1.0,60.0,0.0,1,0,Silica,0,0,24.7,Adenocarcinoma,Papillary,IVB,T3,N0,M1b,6.7,RUL,Left,0,0,1,0,1,0,1,1,Brain|Liver|Adrenal,None,None,None,None,None,0,0,0,None,0,0,0,63,100,>=50%,5.8,0,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,6,83.2,1,0,0,0,12.1,1,17.0,1,9.8,SD,0,1,1.8,0.0,7.3,0,0,0,167.6,5.8,51.8,1,19.34,0,G2,Positive,Negative,Negative,1,54.7,90.0,0,None,0,0,0,0,0,3.8,100.0,10.9,4.2,83.2,21.4,0,None,0,1,2,2,0,0 |
| 599000dc-272f00605-410cb00294-000d-00048c500b33,SITE_009,2022-08-11,61.571232417630995,Male,Hispanic,Private,Current,120.0,4.4,60.0,0.0,1,0,None,0,0,30.9,SCLC_Extensive,NA,Exte,T4,N2,M0,10.0,RLL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,5.5,0,MSS,Chemo_IO_Combination,None,Atezolizumab,Etoposide_Platinum,None,NA,None,0.0,4,85.0,0,0,0,0,5.8,1,9.2,0,4.6,SD,0,1,1.4,0.0,17.7,0,0,1,296.0,17.9,21.2,1,5.33,0,G2,Negative,Negative,Positive,3,98.0,55.5,1,II,1,0,1,0,3,3.4,100.0,12.3,3.0,274.8,8.8,0,None,0,1,1,3,1,0 |
| 3a8ca7fc-199d897e5-4afa5f7f4-0a7f-0002f92487d3,SITE_007,2021-07-03,65.42150050147754,Female,Black,Medicare,Current,37.8,1.0,60.0,0.0,0,0,None,0,0,21.8,Squamous_Cell,Keratinizing,IB,T1b,N1,M0,1.4,RUL,Left,0,1,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,44,48,1-49%,12.4,1,MSS,Surgery_Adjuvant,None,None,Carboplatin_Paclitaxel,Segmentectomy,R0,None,0.0,8,81.4,0,0,0,0,23.7,0,23.7,0,23.7,CR,1,1,8.0,73.6,-88.1,0,0,0,285.4,6.5,3.7,0,0.0,0,G2,Negative,Positive,Negative,3,82.5,41.6,0,None,0,0,0,0,0,4.5,545.0,10.3,5.4,208.4,6.6,0,None,0,1,2,1,0,0 |
| 220806e2-ee38302f-4661814a6-006e-0001ba685981,SITE_029,2024-01-11,84.88066136193846,Female,White,Medicare,Former,13.5,1.0,60.0,0.8,0,0,None,0,0,27.9,Adenocarcinoma,Acinar,IIA,T2b,N2,M0,4.3,RUL,Left,0,0,0,1,0,0,0,0,None,None,KIF5B-ALK,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,4.3,0,MSS,Surgery_Adjuvant,None,None,None,Lobectomy,R0,None,0.0,5,96.9,0,0,0,0,32.5,0,32.5,0,30.9,SD,0,1,1.1,0.0,10.7,0,0,0,178.0,2.4,27.2,0,0.0,0,G2,Positive,Negative,Negative,0,78.1,92.9,0,None,1,0,0,0,3,3.6,167.3,13.9,5.1,207.8,66.0,0,None,0,2,0,2,0,0 |
| 61d2454d-2acbfe51c-412576cfe7-0454-0004f7ad84f0,SITE_001,2020-02-24,65.3876619340064,Male,White,Medicare,Former,59.2,2.2,60.0,14.6,0,1,None,0,1,16.0,Adenocarcinoma,Papillary,IA,T4,N1,M0,10.6,RLL,Right,0,0,0,0,0,0,0,0,None,None,None,None,G12C,None,0,0,0,None,0,0,0,86,100,>=50%,2.3,0,MSS,Surgery_Adjuvant,None,None,Cisplatin_Pemetrexed,Robotic,R0,None,0.0,6,92.1,1,0,0,0,51.9,0,51.9,0,45.0,CR,1,1,8.0,57.4,-71.7,0,0,0,619.0,5.7,4.8,0,0.0,0,G2,Positive,Negative,Negative,2,83.9,44.1,1,II,0,1,1,0,2,4.0,408.8,12.8,3.4,103.0,122.5,0,None,0,1,0,1,0,1 |
| 7c0df8b6-36461ccfb-417429ea22-0f8b-00064cb5a145,SITE_029,2022-03-15,70.93102701330703,Male,Black,Private,Former,40.9,1.5,60.0,8.2,0,0,Asbestos,0,0,21.0,Large_Cell,NA,IIIA,T2a,N0,M0,3.5,RLL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,54,100,>=50%,12.4,1,MSS,Chemo_RT,None,None,Carboplatin_Paclitaxel,None,NA,IMRT,58.4,4,95.3,0,0,0,0,4.1,1,28.6,1,4.0,PD,0,0,0.8,0.0,24.8,0,0,0,255.3,4.1,50.0,1,22.99,0,G2,Negative,Negative,Negative,0,39.9,65.8,0,None,0,1,1,1,2,3.7,133.6,11.6,6.8,137.1,200.0,0,None,0,2,0,3,0,1 |
| 21bb2ec1-ec1e4748-465318c43-02ec-0001b6815fd4,SITE_024,2017-11-05,64.79344136571977,Female,Asian,Medicare,Current,52.5,3.3,60.0,0.0,0,0,None,0,0,28.1,Adenocarcinoma,Lepidic,IB,T2a,N0,M0,3.5,RML,Left,0,0,0,0,0,0,0,0,None,None,None,None,G12A,None,0,0,0,None,0,1,0,100,100,>=50%,8.2,0,MSS,Surgery_Adjuvant,None,None,None,Segmentectomy,R0,None,0.0,10,90.3,1,0,0,0,17.7,0,17.7,0,13.5,CR,1,1,1.6,92.4,-69.5,0,0,0,194.8,10.0,1.0,0,0.0,0,GX,Positive,Negative,Negative,2,69.2,54.5,0,None,0,0,1,0,1,3.0,100.0,12.0,12.9,445.4,39.9,0,None,0,2,0,2,0,0 |
| 63ae1c10-2b9c2c471-412b0a5430-01c1-00050fd76cd7,SITE_024,2024-08-16,67.71927623558992,Female,White,Private,Never,0.0,0.0,0.0,0.0,0,0,Radon,1,0,20.1,Adenocarcinoma,Solid,IVA,T4,N3,M1c,9.8,LUL,Right,0,0,0,0,0,1,1,1,Bone|Liver|Adrenal,None,None,None,None,None,0,0,0,None,0,0,1,44,62,1-49%,8.0,0,MSS,Chemo_IO_Combination,None,Nivolumab_Ipilimumab,Carboplatin_Pemetrexed,None,NA,None,0.0,7,86.2,0,1,0,0,5.2,1,8.7,0,4.6,SD,0,1,8.0,0.0,19.8,0,0,1,132.9,5.9,105.7,1,48.38,1,G3,Positive,Negative,Negative,0,69.6,60.4,0,None,0,0,0,0,0,3.8,118.5,11.1,8.5,406.0,23.9,0,None,0,3,1,4,1,0 |
| 216d091a-e9fb3fb7-464471b4e-0091-0001b2897659,SITE_034,2021-03-25,67.05715846414267,Male,White,Private,Current,37.7,1.0,60.0,0.0,0,0,None,0,0,27.9,Squamous_Cell,Keratinizing,IA,T1a,N0,M0,0.7,Central,Right,0,0,1,1,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,55,100,>=50%,14.4,1,MSS,Surgery_Adjuvant,None,None,Carboplatin_Paclitaxel,Wedge_Resection,R0,None,0.0,3,53.5,0,0,0,0,13.1,0,13.1,0,12.9,PR,1,1,1.8,150.0,-33.6,0,0,0,156.4,8.2,12.1,1,11.26,0,G3,Negative,Positive,Negative,0,92.7,107.6,0,None,0,0,0,0,0,3.1,600.0,13.1,4.0,144.2,77.7,0,None,0,2,2,2,0,0 |
| 5bc30ec6-28255676b-4113492c52-00ec-0004a8e7c015,SITE_027,2022-10-25,71.25907862674501,Male,White,Private,Current,75.5,3.3,60.0,0.0,0,1,Silica,0,0,30.1,SCLC_Limited,NA,Limi,T3,N2,M0,5.9,LUL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,10,16,1-49%,16.4,1,MSS,Chemotherapy_Only,None,Atezolizumab,Etoposide_Platinum,None,NA,Conventional_EBRT,45.7,3,78.6,1,0,0,0,15.2,1,15.2,1,13.2,PD,0,0,0.5,0.0,64.7,0,0,0,131.2,16.6,2.6,1,26.08,1,G2,Negative,Negative,Positive,3,48.6,70.4,0,None,1,0,1,0,1,3.1,100.0,10.0,15.5,166.5,5.1,0,None,0,1,1,0,0,1 |
| 64fe2ac2-2c2f32b4f-412efa8046-02ac-000520e82be1,SITE_037,2019-08-09,78.07042158769818,Female,White,Uninsured,Former,19.8,1.0,60.0,0.2,1,0,Asbestos,0,0,23.7,Squamous_Cell,Keratinizing,IVA,T4,N0,M1a,7.9,RML,Right,0,0,0,0,0,1,1,0,Bone|Liver,None,None,None,None,None,0,0,0,None,0,0,0,0,0,<1%,7.8,0,MSS,Chemotherapy_Only,None,None,Carboplatin_Paclitaxel,None,NA,None,0.0,5,71.2,0,0,0,0,3.7,1,9.4,1,3.0,PR,1,1,4.0,4.3,-43.5,0,0,0,222.5,24.3,19.7,1,9.39,1,GX,Negative,Positive,Negative,1,94.0,77.8,0,None,0,1,0,0,2,3.3,487.0,14.3,6.3,50.0,52.7,0,None,0,3,2,2,0,0 |
| 3984ad7d-192a0be6c-4ac8e0877-0ad7-0002ebbccf60,SITE_039,2023-08-30,82.65024297723163,Male,White,Private,Former,7.8,1.0,52.0,7.9,0,0,Radon,1,0,21.6,Adenocarcinoma,Papillary,IIIA,T1b,N1,M0,1.9,RUL,Left,0,0,0,0,0,0,0,0,None,None,None,None,G12A,None,0,0,0,None,0,0,0,100,100,>=50%,3.3,0,MSS,CCRT,None,Durvalumab,Carboplatin_Paclitaxel,None,NA,IMRT,60.5,6,88.2,1,0,0,0,19.5,0,19.5,0,18.4,SD,0,1,2.7,0.0,4.2,0,0,0,157.2,9.3,20.5,0,0.0,0,G2,Positive,Negative,Negative,1,107.3,84.6,0,None,1,0,0,0,1,3.2,238.1,12.8,2.1,305.6,95.4,0,None,0,3,0,0,0,0 |
| 5e5361a4-29447ab7d-411afa24ec-061a-0004ca3bf55b,SITE_047,2015-09-28,69.94139077813709,Female,White,VA,Former,10.2,1.0,60.0,9.4,1,0,None,0,1,23.9,SCLC_Limited,NA,Limi,T3,N1,M0,6.4,RUL,Right,1,1,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,0,0,<1%,5.1,0,MSS,Chemotherapy_Only,None,Atezolizumab,Etoposide_Platinum,None,NA,Conventional_EBRT,45.1,4,80.2,0,0,0,0,4.2,1,5.4,1,3.1,PR,1,1,0.7,0.5,-38.1,0,0,0,362.1,17.6,18.6,0,0.0,0,G1,Negative,Negative,Positive,2,44.1,61.7,1,III,0,0,1,0,1,3.7,212.7,11.6,4.7,232.1,93.3,0,None,0,1,0,2,0,1 |
| 22d8cfbe-f3edae33-4688a6f3a-0cfb-0001c5028cad,SITE_040,2016-02-21,72.60069541733822,Male,White,Private,Current,51.5,3.2,60.0,0.0,0,0,None,0,0,21.7,Adenocarcinoma,Papillary,IVB,T2a,N0,M1b,3.8,LUL,Left,0,1,1,0,0,1,0,0,Bone,None,None,None,G12C,None,0,0,0,None,0,0,1,100,100,>=50%,15.3,1,MSS,Targeted_TKI,Adagrasib,None,None,None,NA,None,0.0,2,83.3,0,0,0,0,4.2,1,4.2,1,3.1,PR,1,1,0.9,5.2,-58.5,0,0,0,182.7,6.4,105.2,1,14.78,0,G3,Positive,Negative,Negative,1,75.3,89.2,0,None,1,0,1,0,2,3.6,137.8,13.7,3.9,182.6,200.0,0,None,0,2,0,0,0,0 |
| 0a24faa9-4702daa0-41e6eeffb-0faa-000083e0ba9c,SITE_026,2020-01-25,56.066787162737114,Male,White,Medicare,Current,40.3,2.4,60.0,0.0,0,0,None,0,0,25.5,Squamous_Cell,Keratinizing,IVB,T4,N2,M1a,11.2,LUL,Left,0,0,0,0,1,0,0,0,Brain,None,None,None,None,None,1,0,0,None,0,0,1,25,58,1-49%,10.2,1,MSS,Targeted_TKI,Capmatinib,None,None,None,NA,None,0.0,3,86.8,0,0,0,0,5.5,1,28.0,1,5.0,SD,0,1,2.7,0.0,2.1,0,0,0,372.4,2.1,31.7,1,12.67,1,G2,Negative,Negative,Negative,0,84.0,78.0,0,None,0,0,1,0,0,3.9,127.7,13.3,3.1,103.4,8.2,0,None,0,4,2,1,0,0 |
| 0c5689ff-565dc5fa-425039dfd-089f-0000a06501fa,SITE_025,2022-04-27,66.1651709470516,Male,White,Medicare,Former,120.0,3.2,60.0,2.1,0,0,None,0,0,26.5,SCLC_Limited,NA,Limi,T4,N2,M0,11.1,RUL,Right,0,1,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,5,7,1-49%,5.5,0,MSS,Chemotherapy_Only,None,Atezolizumab,Etoposide_Platinum,None,NA,Conventional_EBRT,46.8,6,71.8,1,0,0,0,5.8,1,16.9,1,4.2,PD,0,0,6.7,0.0,57.3,0,0,0,312.9,2.9,52.2,0,0.0,0,G2,Negative,Negative,Positive,1,90.7,84.1,0,None,0,0,0,1,2,3.0,265.6,10.4,5.6,154.4,9.6,0,None,0,0,0,3,0,1 |
| 393812c0-190888341-4aba83840-012c-0002e7d8f3c7,SITE_012,2023-02-01,75.9327499163941,Male,Hispanic,Medicare,Former,30.8,1.0,60.0,2.1,0,0,None,0,0,24.6,Squamous_Cell,Non-keratinizing,IA,T4,N0,M0,8.7,RUL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,67,86,>=50%,4.5,0,MSS,Surgery_Adjuvant,None,None,Carboplatin_Paclitaxel,Lobectomy,R0,None,0.0,1,89.7,0,0,0,0,20.3,0,20.3,0,14.5,PD,0,0,3.4,0.0,69.6,0,0,0,337.9,6.3,14.9,0,0.0,0,G2,Negative,Positive,Negative,2,36.0,60.4,0,None,0,0,1,0,0,3.7,387.5,15.1,1.2,357.6,14.5,0,None,0,1,0,1,0,0 |
| 738879af-328bb53ca-415a996d0d-079a-0005ddee2dea,SITE_030,2019-05-26,75.22670206496295,Male,White,Medicare,Former,13.1,1.0,60.0,0.9,0,0,None,0,0,33.5,SCLC_Limited,NA,Limi,T1a,N0,M0,0.6,RML,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,77,100,>=50%,15.7,1,MSS,Chemotherapy_Only,None,Atezolizumab,Etoposide_Platinum,None,NA,Conventional_EBRT,58.8,6,81.1,0,0,0,0,5.9,1,6.4,0,4.8,SD,0,1,0.5,0.0,-17.5,0,0,0,383.1,14.0,33.5,1,9.78,0,G2,Negative,Negative,Positive,1,81.1,79.1,0,None,0,0,1,0,0,3.6,221.0,7.5,13.8,184.4,3.8,0,None,0,1,0,0,0,1 |
| 1054702e-724f1143-430fd508a-0702-0000d449b25d,SITE_007,2021-06-29,69.01029246155298,Male,White,Medicare,Former,120.0,3.1,60.0,5.5,0,1,None,0,0,22.8,Squamous_Cell,Keratinizing,IVB,T3,N2,M1c,6.9,RML,Right,0,0,0,0,0,1,0,0,Bone,None,None,None,None,None,0,0,0,None,0,0,0,0,0,<1%,7.4,0,MSS,Chemotherapy_Only,None,None,Carboplatin_Paclitaxel,None,NA,None,0.0,4,87.1,0,0,0,0,2.7,1,15.5,1,2.2,PD,0,0,3.0,0.0,32.4,0,0,0,662.9,6.3,4.2,1,23.99,0,G2,Negative,Positive,Negative,1,71.1,71.9,1,III,0,0,1,1,3,3.9,290.0,14.7,6.9,500.0,45.0,0,None,0,1,0,1,0,1 |
| 3a56e0a1-198602468-4af04a1e3-0e0a-0002f6696834,SITE_047,2020-07-11,75.42074261589555,Female,White,Uninsured,Current,105.0,2.7,60.0,0.0,0,0,Asbestos,0,0,32.3,Squamous_Cell,Keratinizing,IVA,T4,N2,M1b,10.8,Endobronchial,Right,0,0,0,0,1,1,0,1,Brain|Bone|Adrenal,None,None,None,None,None,0,0,0,None,0,0,1,16,13,1-49%,17.8,1,MSS,Chemo_IO_Combination,None,Atezolizumab,Carboplatin_Paclitaxel,None,NA,None,0.0,6,74.6,0,0,0,0,10.8,1,22.5,1,9.1,PR,1,1,1.1,6.2,-51.3,0,0,0,160.1,19.1,27.4,1,21.96,1,G3,Negative,Positive,Negative,1,69.9,90.1,0,None,0,0,1,0,0,3.9,161.9,12.2,1.2,241.5,55.3,0,None,0,3,0,0,0,1 |
| 5a1db8f9-276d00ed0-410e592aeb-0b8f-0004938264ac,SITE_043,2024-08-10,71.66228373544128,Male,White,Medicare,Current,70.0,1.7,60.0,0.0,0,0,None,0,0,21.3,Adenocarcinoma,Acinar,IVB,T3,N1,M1b,5.6,RUL,Left,0,0,0,0,0,1,0,0,Bone,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,19.9,1,MSS,Chemo_IO_Combination,None,Atezolizumab,Carboplatin_Pemetrexed,None,NA,None,0.0,4,65.7,0,1,0,0,3.9,1,12.5,1,3.6,PR,1,1,1.1,3.1,-51.7,0,0,0,373.5,25.0,8.1,1,27.38,1,G2,Positive,Negative,Negative,1,112.2,63.4,1,III,1,0,1,1,3,3.9,593.8,14.5,6.8,85.5,46.6,1,Colitis,1,1,1,0,0,1 |
| 19e70af0-b5514c91-44db520d0-00af-000150bb8e37,SITE_006,2021-07-15,78.40290945346355,Male,Asian,Private,Former,93.9,3.1,60.0,10.0,0,0,Radon,1,0,26.3,Adenocarcinoma,Papillary,IVA,T2b,N2,M1a,4.2,RUL,Right,0,0,0,0,0,0,0,0,None,Exon19del,None,None,None,None,0,0,0,None,0,0,0,100,100,>=50%,6.8,0,MSS,Targeted_TKI,Osimertinib,None,None,None,NA,None,0.0,5,76.1,0,0,0,0,29.4,1,46.6,1,25.6,PR,1,1,0.5,2.9,-53.2,0,0,0,298.6,3.6,97.9,1,12.32,0,G2,Positive,Negative,Negative,1,71.1,104.5,0,None,0,0,1,0,0,3.3,225.7,15.4,6.1,116.0,25.1,0,None,0,2,2,2,0,0 |
| 5c5ded18-286917ba9-411519c748-0ed1-0004b0c50a3f,SITE_040,2019-03-02,69.74891199109256,Male,White,Private,Current,21.5,1.0,60.0,0.0,0,1,None,0,0,31.3,Adenocarcinoma,Acinar,IB,T1a,N0,M0,0.6,RLL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,0,0,<1%,21.2,1,MSS,Surgery_Adjuvant,None,None,Cisplatin_Pemetrexed,Lobectomy,R0,None,0.0,7,63.7,0,0,0,0,47.5,0,47.5,0,43.4,PR,1,1,0.5,55.4,-59.5,0,0,0,416.4,25.0,22.0,0,0.0,0,G2,Positive,Negative,Negative,0,83.1,77.4,0,None,1,0,1,1,2,3.8,553.7,11.6,12.5,96.9,90.8,0,None,0,2,0,2,1,1 |
| 2729962f-112231b4a-4757cc28d-0962-0001fd1ca06a,SITE_006,2024-09-09,63.62086600207517,Male,White,Medicare,Former,12.2,1.0,60.0,33.8,1,0,None,0,0,31.1,Adenocarcinoma,Lepidic,IIIB,T4,N0,M0,9.7,RUL,Right,1,1,1,0,0,0,0,0,None,None,None,None,G12D,None,0,0,0,None,0,0,1,0,0,<1%,10.2,1,MSS,CCRT,None,Durvalumab,Carboplatin_Paclitaxel,None,NA,IMRT,60.2,7,68.7,0,0,0,0,1.1,1,34.1,0,0.8,PD,0,0,4.9,0.0,29.4,0,0,1,258.6,2.0,44.5,0,0.0,0,G2,Negative,Negative,Negative,0,72.8,70.0,0,None,0,0,1,0,0,3.5,123.6,11.7,15.0,248.3,47.6,0,None,0,2,0,2,0,1 |
| 67823202-2d48f5e0f-4136869606-0320-0005419c8a21,SITE_037,2016-01-27,70.19049194086372,Female,Hispanic,Medicare,Current,16.6,1.0,60.0,0.0,0,1,Asbestos,0,0,24.1,SCLC_Extensive,NA,Exte,T1a,N2,M0,0.9,RUL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,73,100,>=50%,11.5,1,MSS,Chemo_IO_Combination,None,Atezolizumab,Etoposide_Platinum,None,NA,None,0.0,6,90.0,0,0,0,0,7.0,0,7.0,0,5.6,CR,1,1,6.6,4.4,-71.5,0,0,0,440.5,25.0,27.5,0,0.0,0,G2,Negative,Negative,Positive,2,79.3,68.1,1,I,0,0,0,0,1,4.5,195.9,13.1,16.9,296.5,8.1,0,None,0,1,1,1,0,0 |
| 4a23dde8-206fb1159-4de6b99b8-0dde-0003c3d244cf,SITE_005,2024-11-02,39.159353429398635,Male,Asian,Medicare,Former,91.0,2.0,60.0,2.6,0,0,Asbestos,0,1,28.5,Squamous_Cell,Non-keratinizing,IVB,T1c,N2,M1a,2.1,RLL,Right,0,0,0,0,1,0,1,0,Brain|Liver,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,1.3,0,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,9,91.3,0,0,0,0,20.5,1,23.7,1,20.3,PR,1,1,7.3,24.1,-42.3,0,0,0,128.3,7.2,175.5,1,6.0,1,G1,Negative,Positive,Negative,2,84.9,71.9,1,II,0,1,0,0,3,3.9,342.3,10.2,3.7,415.6,0.2,0,None,0,1,0,2,1,0 |
| 46010eb8-1ea076709-4d2032c28-00eb-00038e0dbf5f,SITE_025,2016-07-16,70.63741449565796,Female,Asian,Medicare,Current,61.7,1.7,60.0,0.0,0,0,None,0,0,27.9,SCLC_Extensive,NA,Exte,T4,N2,M0,11.5,RML,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,3.8,0,MSS,Chemotherapy_Only,None,Atezolizumab,Etoposide_Platinum,None,NA,None,0.0,1,74.1,0,0,0,0,4.8,1,11.5,1,4.0,CR,1,1,0.5,4.7,-88.9,0,0,0,148.1,6.1,3.1,0,0.0,0,G2,Negative,Negative,Positive,1,91.1,61.9,1,II,1,0,0,0,2,3.8,215.1,11.8,6.5,121.6,12.2,0,None,0,0,0,3,1,0 |
| 16a07d94-9e636f0d-443e178bc-07d9-00012626608b,SITE_033,2017-11-18,35.0,Male,White,Private,Current,2.6,1.0,17.1,0.0,1,0,Silica,0,1,23.6,Large_Cell,NA,IVA,T4,N0,M1b,11.0,RUL,Right,0,1,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,97,>=50%,4.0,0,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,3,93.7,0,0,0,0,8.2,1,19.5,0,6.3,PD,0,0,1.4,0.0,23.7,0,0,0,184.1,7.3,17.5,1,19.99,0,GX,Negative,Negative,Negative,1,61.0,82.7,0,None,0,0,1,0,0,3.2,259.5,11.7,3.2,196.5,21.3,0,None,0,0,2,1,0,0 |
| 3b4a54cb-19f08518e-4b1defe61-054c-000302c64e56,SITE_037,2023-03-18,50.62709762964853,Female,White,Medicare,Former,47.5,3.1,60.0,9.9,0,0,None,0,0,28.8,SCLC_Limited,NA,Limi,T4,N1,M0,7.2,LUL,Right,1,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,71,100,>=50%,6.8,0,MSS,Chemo_IO_Combination,None,Atezolizumab,Etoposide_Platinum,None,NA,Conventional_EBRT,49.6,9,83.7,0,0,0,0,25.2,1,25.2,1,25.1,PR,1,1,1.9,5.2,-46.9,0,0,0,235.7,3.9,6.3,0,0.0,0,G1,Negative,Negative,Negative,1,77.7,71.8,0,None,0,0,0,0,1,3.5,122.9,10.1,8.9,320.0,21.6,1,Endocrinopathy,3,1,0,1,0,0 |
| 6da5896f-2ff86c20a-4148f09c4d-0896-00059167faaa,SITE_021,2022-05-02,71.29180170893935,Male,Black,Medicare,Current,14.2,1.0,60.0,0.0,0,0,Asbestos,0,1,34.4,Squamous_Cell,Keratinizing,IVB,T2a,N2,M1b,3.4,RLL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,10.0,1,MSS,Chemo_IO_Combination,None,Pembrolizumab,Carboplatin_Paclitaxel,None,NA,None,0.0,8,75.9,1,0,0,0,6.3,1,6.3,1,5.2,SD,0,1,1.4,0.0,-19.2,0,0,0,250.4,24.6,1.7,0,0.0,0,G1,Negative,Positive,Negative,0,78.4,103.1,0,None,0,0,1,0,1,3.9,163.6,11.6,1.0,376.1,15.4,0,None,0,0,2,1,0,1 |
| 027fc31d-117e55cc-477f4957-0c31-0000207ce880,SITE_047,2024-09-11,71.53652870403455,Female,White,Medicare,Current,120.0,3.7,60.0,0.0,0,0,None,0,0,28.1,Squamous_Cell,Keratinizing,IIA,T1b,N0,M0,1.6,RUL,Left,0,0,1,1,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,85,>=50%,10.4,1,MSS,SBRT,None,None,None,None,NA,SBRT,54.0,4,77.1,0,0,0,0,2.8,1,5.0,1,2.4,SD,0,1,0.5,0.0,-3.3,0,0,0,169.0,4.2,5.9,0,0.0,0,G3,Negative,Positive,Negative,1,45.3,65.1,0,None,1,0,0,0,1,3.8,129.3,14.0,1.8,70.9,9.0,0,None,0,2,1,0,0,0 |
| 61172aff-2a7a22cfa-41234580fd-02af-0004ee2d2efa,SITE_039,2022-06-30,55.95692658867066,Male,Black,Medicare,Former,64.1,2.2,60.0,5.2,0,0,None,0,0,28.5,Squamous_Cell,Non-keratinizing,IVB,T2a,N1,M1a,3.2,Central,Left,0,0,0,1,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,16,16,1-49%,11.7,1,MSS,Chemo_IO_Combination,None,Atezolizumab,Carboplatin_Paclitaxel,None,NA,None,0.0,5,88.4,0,0,0,0,3.3,1,25.6,1,2.5,CR,1,1,4.9,1.3,-71.3,0,0,0,149.1,4.7,82.0,1,18.99,0,G2,Negative,Positive,Negative,1,57.8,70.1,1,III,0,1,0,0,4,3.8,192.0,13.9,3.3,215.3,5.6,1,Endocrinopathy,3,2,2,1,0,0 |
| 3f12d68a-1b983ddc7-4bd38839e-0d68-000333f4e509,SITE_011,2021-05-14,60.23503060215008,Male,Asian,Medicaid,Never,0.0,0.0,0.0,0.0,1,0,None,0,0,29.0,Adenocarcinoma,Solid,IB,T1a,N2,M0,0.8,RML,Right,0,0,1,0,0,0,0,0,None,Exon19del,None,None,None,None,0,0,0,None,0,0,1,87,76,>=50%,4.9,0,MSS,Surgery_Adjuvant,None,None,Cisplatin_Pemetrexed,Lobectomy,R0,None,0.0,6,93.1,0,0,0,0,38.8,0,38.8,0,34.8,CR,1,1,0.5,49.3,-70.0,0,0,0,176.3,2.5,19.4,0,0.0,0,G2,Positive,Negative,Negative,1,91.0,65.1,0,None,0,0,1,1,2,2.9,182.3,12.1,4.3,72.5,4.3,0,None,0,0,0,2,1,0 |
| 5c175cb5-284a388f4-411446161f-05cb-0004ad2fb538,SITE_034,2018-06-18,80.02013939183425,Female,White,Medicare,Current,45.9,1.5,60.0,0.0,0,1,None,0,0,19.4,SCLC_Limited,NA,Limi,T4,N0,M0,11.4,Endobronchial,Left,1,0,0,1,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,57,100,>=50%,16.8,1,MSS,Chemo_IO_Combination,None,Atezolizumab,Etoposide_Platinum,None,NA,Conventional_EBRT,55.7,5,85.4,0,0,0,0,14.4,1,16.6,0,11.0,SD,0,1,1.0,0.0,17.2,0,0,0,104.1,4.1,15.4,1,7.06,1,G3,Negative,Negative,Negative,0,66.7,101.9,1,II,0,1,1,0,3,3.4,153.8,12.6,5.0,103.4,38.6,0,None,0,2,1,0,0,1 |
| 54e6f304-25250a51d-4feb4d90c-0f30-00044fba573b,SITE_037,2015-01-18,62.40171375005958,Female,White,Uninsured,Former,32.2,1.0,60.0,9.3,0,0,None,0,0,28.1,Adenocarcinoma,Acinar,IVA,T2b,N0,M1c,4.9,Central,Right,0,0,0,0,1,0,1,0,Brain|Liver,None,None,None,None,None,0,0,0,None,0,0,0,100,100,>=50%,46.0,1,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,9,58.0,1,0,0,0,12.3,1,12.3,1,10.9,PR,1,1,0.7,0.5,-43.5,0,0,0,211.9,4.2,50.8,1,12.44,0,G3,Negative,Negative,Negative,3,120.0,48.9,0,None,0,0,0,0,2,3.7,274.8,11.9,10.9,67.8,102.8,0,None,0,0,1,2,0,0 |
| 374ed321-18327c5e8-4a5ec7963-0d32-0002cf00b8b4,SITE_017,2016-03-28,88.30774296782836,Female,White,Private,Never,0.0,0.0,0.0,0.0,0,1,None,0,0,21.4,Adenocarcinoma,Micropapillary,IIB,T2a,N0,M0,3.3,RLL,Left,0,0,1,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,1,0,0,0,<1%,6.6,0,MSS,Surgery_Adjuvant,None,None,Cisplatin_Pemetrexed,VATS,R0,None,0.0,5,88.1,0,0,1,0,43.5,0,43.5,0,40.3,CR,1,1,4.0,39.2,-85.9,0,0,0,237.6,4.0,23.1,0,0.0,0,G2,Positive,Negative,Negative,0,92.3,73.5,0,None,1,0,0,0,1,4.4,117.6,9.0,2.8,102.3,3.1,0,None,0,1,2,1,1,0 |
| 27826826-11490d90b-476873872-0682-0002019f49f5,SITE_037,2017-12-22,66.98176139482472,Male,White,Medicare,Former,8.7,1.0,58.0,13.5,0,0,None,0,1,23.3,Squamous_Cell,Non-keratinizing,IVB,T1a,N3,M1a,0.8,RUL,Right,0,0,0,0,0,1,1,0,Bone|Liver,None,None,None,None,None,0,0,0,None,0,0,1,100,80,>=50%,5.0,0,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,6,60.5,0,0,0,0,6.8,1,21.5,1,6.1,PD,0,0,5.5,0.0,36.0,0,0,0,305.1,6.4,41.9,1,13.09,1,G3,Negative,Positive,Negative,0,83.1,77.0,1,II,0,0,0,0,1,2.9,100.0,10.5,1.8,62.2,18.3,0,None,0,0,0,1,0,0 |
| 504ba7f5-2321197b4-4f0e2f7df-0a7f-000413d78778,SITE_045,2015-05-30,70.87634368037203,Female,Black,Medicare,Current,50.8,1.4,60.0,0.0,0,1,Radon,1,0,35.7,Adenocarcinoma,Micropapillary,IVB,T2a,N0,M1b,3.3,LLL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,46,99,1-49%,4.9,0,MSS,Chemo_IO_Combination,None,Nivolumab_Ipilimumab,Carboplatin_Pemetrexed,None,NA,None,0.0,9,57.4,0,0,0,0,4.9,1,9.3,1,3.6,PR,1,1,0.5,9.1,-55.6,0,0,0,266.0,3.0,29.6,1,9.75,1,G3,Positive,Negative,Negative,1,102.2,54.0,1,III,1,0,0,0,3,3.3,150.5,14.4,3.4,73.0,65.6,0,None,0,0,1,2,0,0 |
| 11f2de6f-7da4150a-435d89b4d-0de6-0000e9554baa,SITE_041,2020-01-29,82.36030678573677,Female,Black,Private,Former,31.7,1.0,60.0,4.8,0,1,None,0,0,24.9,SCLC_Extensive,NA,Exte,T4,N0,M0,11.8,RLL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,9.7,0,MSS,Chemo_IO_Combination,None,Durvalumab,Etoposide_Platinum,None,NA,None,0.0,5,48.2,1,0,0,0,6.9,1,6.9,1,5.0,PR,1,1,0.5,8.6,-35.7,0,0,0,599.9,25.0,38.5,0,0.0,0,G1,Negative,Negative,Positive,2,88.9,114.3,1,II,0,0,0,0,2,2.9,587.7,14.9,2.9,86.3,15.1,0,None,0,2,1,1,1,1 |
| 4ac3b8e5-20b5a0e44-4e04b2aaf-0b8e-0003cbf063a8,SITE_039,2022-10-08,68.24475760383748,Female,White,Private,Former,74.8,3.6,60.0,0.9,1,0,None,0,0,22.7,SCLC_Extensive,NA,Exte,T3,N0,M0,6.5,RUL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,39,92,1-49%,5.6,0,MSS,Chemo_IO_Combination,None,Durvalumab,Etoposide_Platinum,None,NA,None,0.0,2,90.4,0,0,0,0,1.0,1,1.6,1,0.9,SD,0,1,0.5,0.0,2.0,0,0,0,367.3,6.5,11.7,0,0.0,0,GX,Negative,Negative,Negative,2,78.3,57.1,0,None,1,0,0,0,2,4.0,258.5,10.8,6.6,178.0,58.8,0,None,0,1,0,1,0,1 |
| 0c1ef4a7-54d8b092-4245cddf5-0f4a-00009d926c82,SITE_032,2024-08-16,57.47773218343739,Male,Black,Medicare,Current,17.1,1.0,60.0,0.0,0,1,None,0,1,31.2,SCLC_Extensive,NA,Exte,T1a,N0,M0,0.6,LUL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,1.9,0,MSS,Chemo_IO_Combination,None,Durvalumab,Etoposide_Platinum,None,NA,None,0.0,5,88.5,0,0,0,0,0.9,1,6.9,0,0.9,SD,0,1,2.2,0.0,-15.6,0,0,1,353.8,10.0,70.6,0,0.0,0,G2,Negative,Negative,Negative,1,49.5,72.5,1,III,0,1,1,0,3,4.4,131.2,14.7,13.0,151.5,101.2,1,Endocrinopathy,2,0,0,2,0,0 |
| 532e2c66-2464336cb-4f98a8532-02c6-000439584135,SITE_014,2019-11-23,65.95758920890424,Female,White,Private,Former,45.8,1.6,60.0,15.1,1,0,None,0,0,21.7,Adenocarcinoma,Solid,IVA,T1b,N0,M1a,1.5,RLL,Left,1,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,0,0,<1%,2.4,0,MSS,Chemotherapy_Only,None,None,Carboplatin_Pemetrexed,None,NA,None,0.0,7,51.3,1,0,0,0,4.8,1,6.9,1,3.6,PD,0,0,6.5,0.0,25.7,0,0,0,293.6,14.7,4.7,1,23.39,1,G2,Positive,Negative,Negative,1,87.0,98.9,0,None,0,0,0,0,0,4.0,250.3,10.1,12.2,55.3,36.3,0,None,0,0,3,2,1,0 |
| 507ab9be-2335b1433-4f1702d3a-0b9b-0004163b6ead,SITE_040,2023-09-29,66.66169800619413,Female,Black,Uninsured,Current,4.5,1.0,29.9,0.0,0,0,None,0,0,24.0,Adenocarcinoma,Papillary,IVA,T2a,N2,M1b,3.7,Central,Left,0,0,0,0,1,1,0,0,Brain|Bone,None,None,None,None,None,0,0,0,None,0,0,1,30,56,1-49%,22.6,1,MSS,Chemo_IO_Combination,None,Nivolumab_Ipilimumab,Carboplatin_Pemetrexed,None,NA,None,0.0,7,90.9,0,0,0,0,4.4,1,22.7,1,3.5,CR,1,1,1.1,0.5,-64.1,0,0,0,319.9,25.0,18.1,1,27.57,0,G2,Positive,Negative,Negative,1,100.1,66.0,0,None,1,0,0,0,1,4.1,187.3,11.5,9.6,500.0,9.5,0,None,0,2,1,3,1,0 |
| 0acf124e-4ba98023-4206d36ea-0124-00008c83edfd,SITE_019,2024-11-06,54.03495430408513,Female,White,Private,Former,9.7,1.0,60.0,7.3,0,1,None,0,1,31.6,SCLC_Extensive,NA,Exte,T1a,N0,M0,0.5,LLL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,28.6,1,MSS,Chemotherapy_Only,None,Atezolizumab,Etoposide_Platinum,None,NA,None,0.0,4,87.9,0,0,0,0,1.9,1,4.4,1,1.7,PD,0,0,2.6,0.0,47.5,0,0,0,219.1,15.3,74.9,0,0.0,0,G3,Negative,Negative,Positive,0,64.3,74.3,0,None,0,1,1,0,1,3.3,243.2,12.3,3.0,110.7,144.4,0,None,0,1,1,3,0,1 |
| 60f55d05-2a6b58b24-4122e0170f-05d0-0004ec75b948,SITE_027,2023-08-05,64.56959532226217,Male,Black,Private,Current,9.3,1.0,60.0,0.0,0,1,None,0,0,26.2,Squamous_Cell,Non-keratinizing,IVA,T4,N0,M1b,10.7,Central,Right,1,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,98,100,>=50%,38.1,1,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,3,56.5,1,0,0,0,2.5,1,4.8,1,2.4,SD,0,1,2.9,0.0,-28.8,0,0,0,257.2,6.1,16.7,1,29.16,1,G3,Negative,Positive,Negative,1,42.1,66.5,1,II,1,0,0,0,3,4.0,311.2,12.0,4.0,66.8,13.4,0,None,0,3,2,1,0,0 |
| 35392d4c-174903d15-49fab87e4-02d4-0002b3e74ce3,SITE_016,2019-08-25,59.94917510702435,Male,Black,Medicare,Current,18.2,1.0,60.0,0.0,0,0,None,0,0,19.0,SCLC_Extensive,NA,Exte,T3,N0,M0,5.0,LLL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,11.1,1,MSS,Chemo_IO_Combination,None,Durvalumab,Etoposide_Platinum,None,NA,None,0.0,5,95.4,0,0,0,0,2.4,1,2.4,1,2.4,PR,1,1,0.5,1.5,-42.6,0,0,0,639.6,3.1,12.0,0,0.0,0,G3,Negative,Negative,Positive,1,55.8,71.1,1,II,1,0,1,1,3,3.4,220.7,11.1,6.0,210.5,13.4,0,None,0,1,0,0,0,1 |
| 64b8b209-2c10cde40-412e2a161b-0b20-00051d610a7c,SITE_016,2018-04-02,75.78139869328062,Female,White,Private,Never,0.0,0.0,0.0,0.0,0,1,None,0,0,28.4,SCLC_Extensive,NA,Exte,T1a,N1,M0,0.4,LUL,Right,1,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,3.7,0,MSS,Chemotherapy_Only,None,Atezolizumab,Etoposide_Platinum,None,NA,None,0.0,7,74.3,1,0,0,0,3.0,1,3.2,1,2.8,SD,0,1,0.7,0.0,-16.7,0,0,0,236.3,9.7,313.0,0,0.0,0,G2,Negative,Negative,Negative,1,106.7,89.3,0,None,0,0,0,1,2,3.8,212.8,12.8,2.6,148.0,43.5,1,Colitis,1,1,0,0,0,1 |
| 05539cfd-25494aec-4ffad6f7-09cf-0000453ef8e0,SITE_008,2024-10-09,67.32881280475993,Male,White,Private,Current,83.9,3.0,60.0,0.0,1,1,None,0,0,24.2,SCLC_Extensive,NA,Exte,T3,N0,M0,5.2,RLL,Left,1,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,58,50,>=50%,6.1,0,MSS,Chemo_IO_Combination,None,Atezolizumab,Etoposide_Platinum,None,NA,None,0.0,5,91.8,0,0,0,0,2.4,1,17.2,1,1.8,PR,1,1,4.8,5.7,-59.4,0,0,0,125.7,17.3,110.2,0,0.0,0,G3,Negative,Negative,Positive,1,76.4,65.3,0,None,1,0,0,0,1,4.1,421.3,14.1,2.8,91.1,12.8,1,Pneumonitis,2,1,1,0,0,0 |
| 16f86e38-a0cb0389-444e94aa8-06e3-00012a9d98df,SITE_049,2017-06-01,64.31344038309808,Female,Asian,Medicare,Former,26.2,1.2,60.0,23.0,1,1,Asbestos,0,0,32.9,Adenocarcinoma,Acinar,IIA,T2a,N2,M0,3.2,Endobronchial,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,2.4,0,MSS,Surgery_Adjuvant,None,None,None,Lobectomy,R0,None,0.0,8,90.5,0,0,1,0,24.7,0,24.7,0,23.0,CR,1,1,0.5,5.3,-86.5,0,0,0,346.7,8.3,23.8,1,8.38,0,GX,Positive,Negative,Negative,4,101.3,30.0,1,I,1,1,1,0,3,3.7,262.4,9.6,5.8,187.6,14.4,0,None,0,2,1,0,0,0 |
| 3f3b1756-1ba9da35b-4bdb14602-0175-000336002f65,SITE_008,2019-02-11,65.99127165908553,Male,White,Medicare,Never,0.0,0.0,0.0,0.0,1,0,Asbestos,0,0,23.3,Adenocarcinoma,Micropapillary,IA,T1c,N2,M0,2.2,Endobronchial,Left,0,0,0,0,0,0,0,0,None,L858R,None,None,None,None,0,0,0,None,0,0,0,100,100,>=50%,2.3,0,MSS,Surgery_Adjuvant,None,None,Cisplatin_Pemetrexed,VATS,R0,None,0.0,12,80.5,0,0,0,0,38.6,0,38.6,0,36.9,CR,1,1,2.5,25.3,-73.9,0,0,0,379.0,7.8,6.3,0,0.0,0,G2,Positive,Negative,Negative,1,75.3,71.5,0,None,0,0,0,0,0,4.2,220.8,12.8,1.7,99.1,11.5,0,None,0,2,1,0,1,0 |
| 1817c32f-a8a6564a-44847498d-0c32-00013934e96a,SITE_005,2015-09-28,69.11965917485858,Male,Black,Private,Former,31.2,1.1,60.0,2.1,0,0,None,0,0,30.7,SCLC_Limited,NA,Limi,T2b,N2,M0,4.4,LLL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,11.4,1,MSS,Chemo_IO_Combination,None,Atezolizumab,Etoposide_Platinum,None,NA,Conventional_EBRT,48.1,4,76.9,0,0,0,0,11.7,0,11.7,0,9.4,PR,1,1,1.6,8.7,-39.4,0,0,0,264.3,8.8,1.7,0,0.0,0,G2,Negative,Negative,Positive,1,66.1,73.0,0,None,1,0,1,1,3,3.7,204.6,14.4,9.6,124.3,15.3,0,None,0,0,0,2,0,0 |
| 2a38e467-1278e3ed2-47eaaad35-0e46-000224e39942,SITE_047,2022-12-06,72.8597348970529,Female,Hispanic,Medicare,Current,3.5,1.0,23.1,0.0,0,1,None,0,0,34.0,Squamous_Cell,Non-keratinizing,IVB,T1a,N0,M1c,0.8,LLL,Left,0,0,0,0,1,1,0,0,Brain|Bone,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,14.7,1,MSS,Chemo_IO_Combination,None,Atezolizumab,Carboplatin_Paclitaxel,None,NA,None,0.0,3,64.4,0,0,0,0,1.9,1,6.9,1,1.6,SD,0,1,0.7,0.0,3.4,0,0,0,100.0,1.7,47.0,1,5.45,0,G3,Negative,Positive,Negative,3,113.4,75.1,1,II,0,0,1,0,2,3.9,151.0,11.7,3.4,357.6,27.0,0,None,0,1,1,2,0,0 |
| 548e826c-24fe590f5-4fdab8744-0826-00044b3c9f83,SITE_028,2021-06-29,57.50273382764088,Male,Asian,Medicare,Never,0.0,0.0,0.0,0.0,0,0,None,0,0,22.2,Adenocarcinoma,Acinar,IVA,T2a,N3,M1b,3.6,LUL,Left,0,0,0,0,0,0,1,0,Liver,Exon19del,None,None,None,None,0,0,0,None,0,0,0,0,0,<1%,52.6,1,MSS,Targeted_TKI,Osimertinib,None,None,None,NA,None,0.0,6,96.4,0,0,0,0,6.8,1,43.6,1,5.1,CR,1,1,1.0,10.2,-87.9,0,0,0,465.6,8.3,91.7,1,0.96,1,G3,Positive,Negative,Negative,1,68.3,69.1,0,None,0,0,1,0,0,4.7,107.5,11.4,6.5,159.8,1.0,0,None,0,0,1,0,0,0 |
| 127fc4c4-817e615d-4377f4e4c-0c4c-0000f07cfdfb,SITE_022,2015-11-06,57.10491749009792,Male,White,Medicare,Former,25.1,1.1,60.0,1.4,0,0,None,0,0,25.1,Squamous_Cell,Basaloid,IA,T4,N2,M0,7.6,RML,Left,0,0,0,1,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,22,48,1-49%,8.4,0,MSS,Surgery_Adjuvant,None,None,None,Lobectomy,R0,None,0.0,3,70.2,0,0,0,0,58.5,0,58.5,0,46.3,CR,1,1,1.9,8.4,-89.1,0,0,0,274.5,13.3,32.3,0,0.0,0,G2,Negative,Positive,Negative,1,70.5,58.2,0,None,0,0,1,1,2,4.0,280.1,10.8,5.2,214.5,17.3,0,None,0,3,0,2,0,0 |
| 56bef850-25f38ca31-41043ce8f0-0f85-000467b29c17,SITE_037,2017-03-21,77.49445254632404,Female,White,Private,Never,0.0,0.0,0.0,0.0,0,1,None,0,1,27.7,SCLC_Extensive,NA,Exte,T4,N0,M0,11.0,Central,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,2.7,0,MSS,Chemo_IO_Combination,None,Atezolizumab,Etoposide_Platinum,None,NA,None,0.0,6,68.5,0,0,0,0,4.2,1,11.2,1,4.0,SD,0,1,0.5,0.0,-13.1,0,0,0,209.5,7.1,2.6,1,1.5,1,G1,Negative,Negative,Positive,2,83.3,68.1,0,None,0,1,1,0,1,3.4,379.3,16.5,10.8,108.5,1.4,0,None,0,2,1,3,0,1 |
| 0d3c4ef6-5ca628bb-427b4ece2-04ef-0000ac100285,SITE_020,2020-07-20,63.08279971405506,Female,Other,Private,Former,27.5,1.0,60.0,1.8,0,0,Radon,1,0,22.1,Large_Cell,NA,IVB,T2a,N1,M1b,3.5,RUL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,1,0,0,None,0,0,0,0,0,<1%,8.1,0,MSS,Targeted_TKI,Capmatinib,None,None,None,NA,None,0.0,3,87.5,0,0,0,0,15.1,1,25.3,1,11.0,PD,0,0,8.0,0.0,50.5,0,0,0,443.2,18.2,24.3,1,5.44,0,G3,Negative,Negative,Negative,1,69.8,100.2,0,None,0,1,0,1,2,3.6,248.1,15.5,1.0,162.7,10.9,0,None,0,0,0,0,0,0 |
| 166c77cb-9cf7468e-443456761-077c-000123821556,SITE_007,2020-05-26,53.540000120329694,Female,White,Uninsured,Former,17.2,1.0,60.0,40.7,1,0,None,0,0,27.2,Squamous_Cell,Keratinizing,IVB,T3,N2,M1a,5.3,RUL,Left,0,0,0,0,1,0,1,0,Brain|Liver,None,None,None,None,None,0,0,0,None,0,0,0,12,15,1-49%,7.0,0,MSS,Chemo_IO_Combination,None,Pembrolizumab,Carboplatin_Paclitaxel,None,NA,None,0.0,2,81.7,0,0,0,0,6.2,1,6.2,1,5.8,PD,0,0,3.2,0.0,56.6,0,0,0,100.0,18.6,11.2,1,10.01,0,G3,Negative,Positive,Negative,2,89.0,71.3,0,None,1,0,1,1,2,4.2,265.9,11.9,10.8,93.5,33.4,1,Colitis,3,1,0,0,0,0 |
| 4b37eff5-20e878fb4-4e1a7cfdf-0eff-0003d1d72f78,SITE_037,2023-01-06,71.21622073913949,Male,White,Medicare,Former,44.2,2.5,60.0,18.3,0,0,None,0,0,25.0,Adenocarcinoma,Micropapillary,IVB,T1c,N0,M1a,2.8,RLL,Left,0,0,0,0,0,1,0,1,Bone|Adrenal,None,None,None,None,None,0,0,0,None,0,0,1,100,93,>=50%,5.8,0,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,7,86.2,1,0,0,0,16.3,1,18.1,1,11.9,CR,1,1,2.2,3.1,-66.7,0,0,0,258.8,4.9,24.4,1,24.82,0,G2,Positive,Negative,Negative,1,83.0,82.4,0,None,0,1,0,0,1,4.3,128.6,14.9,10.7,91.0,12.3,1,Hepatitis,3,1,2,1,0,0 |
| 6590dbcf-2c6f602aa-4130b2936d-0dbc-0005285b298a,SITE_009,2017-08-29,71.40201315731052,Male,White,Private,Former,28.4,1.0,60.0,3.0,0,0,None,0,0,24.9,Squamous_Cell,Non-keratinizing,IVB,T2b,N1,M1b,4.6,LUL,Right,0,1,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,12.3,1,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,1,80.5,1,0,0,0,12.8,1,22.1,1,10.1,PD,0,0,1.1,0.0,68.2,0,0,0,186.7,10.5,206.9,1,5.19,0,G3,Negative,Positive,Negative,3,83.7,55.5,1,IV,0,1,1,0,2,3.8,148.7,11.4,5.5,115.9,57.7,0,None,0,3,0,0,0,0 |
| 15d5fd8a-98d9eec7-44181f89e-0fd8-00011bdde009,SITE_028,2024-03-29,52.45820505606129,Female,Asian,Medicaid,Never,0.0,0.0,0.0,0.0,0,0,None,0,0,26.2,SCLC_Extensive,NA,Exte,T1c,N2,M0,2.3,LUL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,71,100,>=50%,3.0,0,MSS,Chemo_IO_Combination,None,Atezolizumab,Etoposide_Platinum,None,NA,None,0.0,7,82.6,1,0,0,0,1.5,1,13.1,1,1.3,SD,0,1,3.4,0.0,-18.8,0,0,0,516.0,7.6,51.8,0,0.0,0,G3,Negative,Negative,Positive,0,63.9,67.3,0,None,0,0,1,0,1,3.0,105.5,12.2,6.5,97.8,33.8,0,None,0,1,2,0,0,0 |
| 266629ed-10ccb257c-473327dc7-029e-0001f3302110,SITE_048,2019-06-11,69.18007629690426,Male,White,Private,Current,7.4,1.0,49.4,0.0,0,1,None,0,0,26.3,Adenocarcinoma,Acinar,IVB,T2b,N0,M1c,4.3,RUL,Bilateral,0,1,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,100,100,>=50%,10.2,1,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,4,86.8,1,0,0,0,13.8,1,13.8,1,9.7,PD,0,0,0.6,0.0,60.1,0,0,0,276.3,1.5,40.1,1,15.62,1,G1,Positive,Negative,Negative,2,45.1,56.0,1,III,0,0,1,0,2,3.3,176.8,10.4,6.8,276.7,0.8,0,None,0,0,1,2,1,0 |
| 766a5606-33ce85a2b-41633f0212-0560-000603665e55,SITE_047,2023-03-22,73.98803937806954,Male,White,Medicare,Former,37.7,1.1,60.0,3.7,0,0,None,0,0,26.7,Squamous_Cell,Non-keratinizing,IVB,T1b,N3,M1b,1.7,RUL,Right,0,0,0,0,0,1,0,0,Bone,None,None,None,None,None,0,0,0,None,0,0,0,0,0,<1%,16.2,1,MSS,Chemo_IO_Combination,None,Pembrolizumab,Carboplatin_Paclitaxel,None,NA,None,0.0,3,80.2,0,0,0,0,2.2,1,2.8,1,2.0,SD,0,1,1.2,0.0,-14.0,0,0,0,158.8,6.4,19.0,1,30.77,0,G2,Negative,Positive,Negative,0,60.0,92.7,0,None,0,0,1,0,0,3.9,327.5,8.8,2.4,210.1,121.1,0,None,0,2,0,2,0,0 |
| 7eadf487-376c1afb2-417c09dd95-0f48-00066ed56ae2,SITE_019,2017-05-20,70.5566712912095,Male,White,Medicare,Current,29.0,1.0,60.0,0.0,0,0,Silica,0,0,23.3,SCLC_Extensive,NA,Exte,T4,N0,M0,10.2,RUL,Left,0,0,1,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,32.4,1,MSS,Chemo_IO_Combination,None,Durvalumab,Etoposide_Platinum,None,NA,None,0.0,1,53.0,0,0,0,0,5.1,1,19.6,1,4.1,SD,0,1,0.9,0.0,-24.9,0,0,0,432.3,3.2,33.0,0,0.0,0,G2,Negative,Negative,Positive,0,61.6,47.1,0,None,1,0,0,1,3,4.1,141.4,11.3,4.7,50.0,29.2,0,None,0,0,2,3,0,1 |
| 4a60361f-208a17ada-4df20a25d-0361-0003c6e2bf9a,SITE_040,2015-05-15,73.00382409573325,Female,Asian,Uninsured,Never,0.0,0.0,0.0,0.0,0,0,None,0,0,23.5,Large_Cell,NA,IVB,T4,N0,M1b,8.7,RLL,Left,0,0,1,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,11.9,1,MSS,Chemo_IO_Combination,None,Pembrolizumab,Carboplatin_Paclitaxel,None,NA,None,0.0,1,88.3,0,0,0,0,1.4,1,8.0,1,1.3,PD,0,0,7.5,0.0,45.1,0,0,0,100.0,8.2,8.4,1,11.7,1,G3,Negative,Negative,Negative,0,80.3,78.0,0,None,0,0,0,0,1,4.3,193.0,11.6,8.4,417.6,8.6,0,None,0,1,0,0,0,0 |
| 39388bd1-1908bd2b8-4aba9a373-08bd-0002e7df19a4,SITE_031,2015-07-20,53.65944356813789,Female,White,Uninsured,Never,0.0,0.0,0.0,0.0,0,1,None,0,0,25.5,Squamous_Cell,Keratinizing,IVB,T2a,N0,M1b,3.8,RUL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,23.1,1,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,2,45.3,1,0,0,0,14.9,1,15.5,1,14.8,SD,0,1,5.8,0.0,9.5,0,0,0,315.4,12.8,39.1,1,6.6,0,G3,Negative,Positive,Negative,1,60.3,77.5,0,None,1,0,1,0,2,2.8,284.6,13.4,1.3,218.0,9.9,1,Hepatitis,3,1,0,3,0,0 |
| 2c663ad1-136cb9bb8-48532b073-03ad-00024130fca4,SITE_024,2018-09-22,70.14488147246385,Female,Asian,Private,Former,17.2,1.0,60.0,9.9,0,0,None,0,0,25.8,Large_Cell,NA,IVB,T3,N1,M1c,5.6,LUL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,0,0,<1%,6.1,0,MSS,Chemotherapy_Only,None,None,Carboplatin_Paclitaxel,None,NA,None,0.0,5,65.2,0,0,0,0,4.6,1,4.6,1,3.8,PD,0,0,1.4,0.0,52.1,0,0,0,130.1,6.2,15.9,1,7.22,0,G3,Negative,Negative,Negative,1,48.6,76.4,1,II,0,0,1,0,1,4.2,366.5,13.8,6.2,294.9,0.9,0,None,0,2,0,0,1,1 |
| 4e64d312-224c1c57f-4eb2e7936-0d31-0003fb1eb7f1,SITE_007,2024-07-11,64.12511228503075,Female,Black,Medicare,Former,1.1,1.0,7.4,5.6,0,1,None,0,0,24.0,Adenocarcinoma,Micropapillary,IVB,T1a,N3,M1b,0.6,RUL,Right,0,1,1,0,0,0,0,0,None,None,None,None,G12V,None,0,0,0,None,0,0,1,100,100,>=50%,6.9,0,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,1,82.7,1,0,0,0,9.2,1,29.3,1,6.5,PD,0,0,4.6,0.0,47.3,0,0,0,194.2,3.6,7.5,1,5.22,1,G3,Negative,Negative,Negative,0,54.4,34.5,0,None,0,0,1,0,0,4.5,100.0,12.3,4.8,133.9,27.8,0,None,0,1,1,1,0,0 |
| 4ba31e6b-21175d4ee-4e2e95b41-01e6-0003d7488b76,SITE_019,2015-06-27,62.413493492115876,Male,Other,Private,Former,22.0,1.0,60.0,3.3,0,0,Radon,1,0,27.5,Adenocarcinoma,Solid,IIIA,T3,N2,M0,5.8,RLL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,30.4,1,MSS,CCRT,None,Durvalumab,Carboplatin_Paclitaxel,None,NA,IMRT,60.7,8,87.5,1,0,0,0,32.3,0,32.3,0,30.8,SD,0,1,3.5,0.0,8.1,0,0,0,216.9,8.9,53.4,1,23.48,1,G2,Positive,Negative,Negative,1,82.0,39.6,1,II,0,0,0,1,2,2.6,157.9,10.5,7.0,60.6,53.3,0,None,0,0,0,0,0,0 |
| 25ba77a8-108194599-4712f66f8-077a-0001ea78138f,SITE_033,2018-09-08,75.27027828948741,Male,Hispanic,Medicare,Current,99.8,2.4,60.0,0.0,0,0,Radon,1,0,17.8,SCLC_Limited,NA,Limi,T1c,N3,M0,2.8,RLL,Right,0,1,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,2.6,0,MSS,Chemo_IO_Combination,None,Durvalumab,Etoposide_Platinum,None,NA,Conventional_EBRT,56.6,8,80.5,0,0,0,0,5.0,1,7.4,1,3.9,SD,0,1,3.3,0.0,2.9,0,0,0,385.7,25.0,1.4,0,0.0,0,G2,Negative,Negative,Positive,1,87.4,73.9,1,I,1,1,1,0,3,3.8,138.5,11.2,1.8,67.1,7.2,0,None,0,3,0,1,0,0 |
| 02eb3cbc-146ea925-48c1b634-03cb-000025f21593,SITE_050,2016-02-03,81.05310785140519,Male,White,Medicare,Former,74.5,3.3,60.0,3.9,0,0,Radon,1,1,22.7,SCLC_Limited,NA,Limi,T1b,N1,M0,1.2,LUL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,51,46,>=50%,6.3,0,MSS,Chemotherapy_Only,None,Atezolizumab,Etoposide_Platinum,None,NA,Conventional_EBRT,52.3,5,79.8,1,0,0,0,12.1,0,12.1,0,9.0,SD,0,1,8.0,0.0,1.3,0,0,0,736.4,1.3,10.4,1,6.63,1,G2,Negative,Negative,Positive,1,65.9,57.2,0,None,1,0,1,0,1,4.2,129.2,15.7,2.7,413.4,5.2,0,None,0,3,2,3,0,1 |
| 13644be8-87be1359-43a2ce3b8-04be-0000fc17dacf,SITE_001,2024-04-23,84.04651551870342,Male,Black,Private,Former,35.5,1.5,60.0,20.7,1,1,None,0,0,24.7,SCLC_Extensive,NA,Exte,T3,N1,M0,6.0,Central,Left,1,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,80,>=50%,24.9,1,MSS,Chemotherapy_Only,None,Durvalumab,Etoposide_Platinum,None,NA,None,0.0,4,86.4,0,0,0,0,4.2,1,4.2,1,4.0,SD,0,1,1.8,0.0,-27.0,0,0,0,100.5,8.9,41.9,0,0.0,0,G3,Negative,Negative,Positive,1,67.8,61.7,1,III,1,0,0,0,3,3.1,165.4,13.8,1.7,55.9,24.8,0,None,0,1,2,0,1,0 |
| 7ab2117c-35ade7a65-4170163474-0117-00063b0ae353,SITE_036,2021-09-30,79.49067477930609,Male,White,Private,Former,8.7,1.0,57.9,11.2,0,0,None,0,0,22.1,SCLC_Extensive,NA,Exte,T2a,N1,M0,3.5,RUL,Left,0,0,0,1,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,7.5,0,MSS,Chemotherapy_Only,None,Atezolizumab,Etoposide_Platinum,None,NA,None,0.0,4,89.9,0,0,0,0,6.5,1,6.5,1,5.0,SD,0,1,0.9,0.0,-25.5,0,0,0,305.9,4.8,87.3,0,0.0,0,GX,Negative,Negative,Positive,2,86.1,65.2,0,None,0,1,0,1,2,3.6,100.0,15.3,1.7,62.3,120.5,0,None,0,1,3,1,0,0 |
| 358619a6-176aab38b-4a0924cf2-019a-0002b7cf4d75,SITE_043,2022-08-15,65.95752527451326,Male,Other,Private,Never,0.0,0.0,0.0,0.0,0,1,None,0,0,33.3,Adenocarcinoma,Acinar,IVB,T2b,N0,M1a,4.7,RLL,Right,0,0,0,0,0,1,0,1,Bone|Adrenal,Exon19del,None,None,None,None,0,0,0,None,0,0,1,66,100,>=50%,7.0,0,MSS,Targeted_TKI,Osimertinib,None,None,None,NA,None,0.0,1,70.3,0,0,0,0,31.4,1,38.8,1,27.7,PR,1,1,2.3,37.1,-32.7,0,0,0,736.0,5.3,35.4,1,26.61,0,G2,Negative,Negative,Negative,2,78.0,55.2,0,None,0,0,1,1,1,4.1,166.7,16.1,8.0,114.5,103.2,0,None,0,1,0,2,0,0 |
| 3dbc1e78-1b024d549-4b9345b68-01e7-0003228d8c1f,SITE_048,2022-02-16,70.35084154875025,Male,White,Private,Former,60.7,2.7,60.0,20.8,0,1,None,0,1,26.1,Squamous_Cell,Basaloid,IVB,T2b,N3,M1a,4.1,LUL,Right,0,0,0,0,0,1,0,1,Bone|Adrenal,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,7.1,0,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,5,92.0,1,0,0,0,11.9,1,11.9,1,9.3,CR,1,1,1.5,0.9,-81.4,0,0,0,183.7,6.8,9.0,1,10.62,1,G3,Negative,Positive,Negative,1,96.3,52.4,1,I,1,0,0,0,3,3.5,203.9,11.2,3.0,64.7,69.6,0,None,0,1,2,0,0,0 |
| 3bca2e27-1a2874312-4b35e8a75-02e2-000309445802,SITE_022,2021-07-26,74.28481728195031,Female,Black,Private,Former,69.7,2.4,60.0,26.5,0,0,None,0,0,26.8,SCLC_Limited,NA,Limi,T1a,N1,M0,0.7,RUL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,1,0,0,None,0,0,1,100,100,>=50%,10.0,1,MSS,Chemo_IO_Combination,None,Atezolizumab,Etoposide_Platinum,None,NA,Conventional_EBRT,45.0,5,80.1,0,0,0,0,8.1,1,9.7,1,7.4,PD,0,0,1.8,0.0,58.3,0,0,0,178.1,5.6,18.9,0,0.0,0,G2,Negative,Negative,Negative,2,72.2,72.0,0,None,0,0,0,0,1,3.6,118.9,14.1,2.8,204.4,200.0,0,None,0,0,2,2,0,1 |
| 6430aafd-2bd54acec-412c9200f7-0aaf-00051678aee0,SITE_006,2022-09-25,68.15119051834489,Female,Asian,Uninsured,Former,2.0,1.0,13.0,10.7,0,0,None,0,0,23.8,Squamous_Cell,Keratinizing,IB,T1a,N1,M0,0.6,LLL,Right,0,1,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,37,58,1-49%,24.0,1,MSS,Surgery_Adjuvant,None,None,Carboplatin_Paclitaxel,Lobectomy,R0,None,0.0,5,92.1,0,0,0,0,41.7,0,41.7,0,37.3,CR,1,1,0.5,67.9,-62.8,0,0,0,275.3,12.0,28.5,0,0.0,0,G3,Negative,Positive,Negative,2,60.0,41.5,1,II,0,0,1,0,1,3.9,157.5,10.7,9.6,214.1,80.4,0,None,0,1,0,3,1,1 |
| 08507f2c-3a337a35-418f17d84-07f2-00006c167543,SITE_014,2015-01-30,68.24225978515967,Male,White,Medicare,Never,0.0,0.0,0.0,0.0,1,0,None,0,0,25.9,Squamous_Cell,Basaloid,IVB,T2b,N1,M1c,4.1,Endobronchial,Right,0,0,0,0,0,1,1,0,Bone|Liver,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,20.7,1,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,3,69.6,0,0,0,0,22.1,1,31.5,1,18.9,PR,1,1,1.4,5.8,-31.5,0,0,0,370.3,6.1,130.7,1,17.49,1,G3,Negative,Positive,Negative,1,94.6,63.9,0,None,0,0,0,0,0,3.2,202.3,14.6,3.5,190.2,113.9,0,None,0,0,0,0,0,0 |
| 0a96e58a-4a2046c7-41fc4b09e-0e58-000089a9a809,SITE_043,2023-08-25,74.82565475282372,Male,Asian,Medicare,Current,105.8,4.0,60.0,0.0,0,0,Radon,1,0,20.5,SCLC_Limited,NA,Limi,T3,N2,M0,5.5,LUL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,66,100,>=50%,9.1,0,MSS,Chemotherapy_Only,None,Durvalumab,Etoposide_Platinum,None,NA,Conventional_EBRT,53.3,4,89.8,0,0,0,0,11.1,1,18.1,1,9.6,PR,1,1,0.5,10.0,-58.0,0,0,0,340.0,1.3,60.6,0,0.0,0,G3,Negative,Negative,Positive,0,69.4,61.3,1,II,1,0,1,0,3,3.3,212.7,14.2,8.8,102.7,22.9,1,Dermatitis,2,2,0,0,0,0 |
| 234ef66a-f728bce7-469ece33e-0f66-0001cb028369,SITE_044,2022-05-24,66.43681486275365,Female,White,Medicaid,Current,112.0,3.1,60.0,0.0,0,1,None,0,0,25.2,SCLC_Extensive,NA,Exte,T1a,N0,M0,0.6,Endobronchial,Right,0,0,1,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,12,26,1-49%,24.1,1,MSS,Chemo_IO_Combination,None,Atezolizumab,Etoposide_Platinum,None,NA,None,0.0,4,49.6,0,0,0,0,6.2,1,14.4,1,4.8,CR,1,1,1.6,5.1,-84.5,0,0,0,204.5,20.6,61.2,0,0.0,0,GX,Negative,Negative,Positive,0,60.8,71.6,1,II,1,0,1,0,2,4.0,100.0,8.3,2.1,176.5,11.9,0,None,0,2,2,1,1,0 |
| 3e4ad1f7-1b40bbdc2-4bae075e5-0d1f-000329cca992,SITE_032,2022-05-22,60.07177410445021,Female,White,Medicare,Never,0.0,0.0,0.0,0.0,0,1,Silica,0,0,21.8,Adenocarcinoma,Papillary,IA,T2a,N2,M0,3.9,RLL,Left,1,1,0,0,0,0,0,0,None,L858R,None,None,None,None,0,0,0,None,0,0,0,13,29,1-49%,12.3,1,MSS,SBRT,None,None,None,None,NA,SBRT,51.7,1,89.6,0,0,0,0,3.0,1,19.1,0,2.1,SD,0,1,2.9,0.0,14.8,0,0,1,163.8,18.2,21.7,0,0.0,0,GX,Negative,Negative,Negative,1,91.1,110.2,0,None,1,0,1,0,1,4.3,284.3,13.3,3.5,432.7,110.2,0,None,0,0,1,3,1,0 |
| 55e7647d-25953bf6c-4101b62d77-0647-00045cc01a60,SITE_007,2018-12-07,63.06250587455934,Female,White,Private,Current,10.2,1.0,60.0,0.0,0,0,None,0,0,24.8,Squamous_Cell,Non-keratinizing,IVA,T2b,N2,M1a,4.7,RLL,Right,0,0,1,0,1,1,0,1,Brain|Bone|Adrenal,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,19.6,1,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,4,65.4,1,0,0,0,4.7,1,24.2,1,4.5,CR,1,1,1.2,8.1,-65.3,0,0,0,472.5,4.5,5.6,1,4.44,1,G3,Negative,Positive,Negative,3,101.1,56.3,0,None,1,0,0,1,2,4.0,287.8,10.8,2.4,62.8,4.6,1,Colitis,2,2,0,3,0,0 |
| 3ecf7c9e-1b7ac6853-4bc6e75da-07c9-00033089540d,SITE_007,2023-01-02,73.02214858847056,Male,White,Medicaid,Current,18.0,1.0,60.0,0.0,0,0,None,0,0,16.0,Adenocarcinoma,Solid,IIIA,T3,N2,M0,5.1,RUL,Right,0,0,0,0,0,0,0,0,None,L858R,None,None,None,None,0,0,0,None,0,0,1,81,100,>=50%,3.6,0,MSS,CCRT,None,Durvalumab,Carboplatin_Paclitaxel,None,NA,IMRT,64.5,5,79.5,0,0,0,0,3.0,1,42.3,1,2.9,PR,1,1,1.5,3.6,-37.4,0,0,0,166.1,7.7,3.7,0,0.0,0,G3,Positive,Negative,Negative,0,78.3,78.5,0,None,1,0,1,0,2,4.5,138.2,11.8,6.6,290.0,37.9,1,Hepatitis,1,0,0,3,0,1 |
| 38783210-18b495e71-4a9689630-0321-0002de1a8ad7,SITE_024,2018-10-25,67.02843626639958,Female,White,Medicare,Former,2.9,1.0,19.2,9.9,0,0,None,0,0,20.9,Squamous_Cell,Non-keratinizing,IA,T4,N0,M0,11.4,RUL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,43.2,1,MSS,SBRT,None,None,None,None,NA,SBRT,52.2,5,93.0,0,0,0,0,5.5,1,17.3,1,5.1,CR,1,1,0.5,3.4,-86.6,0,0,0,100.0,19.6,14.0,0,0.0,0,G3,Negative,Positive,Negative,1,56.9,75.5,1,II,0,0,0,0,3,4.0,463.6,11.2,3.9,241.0,8.1,0,None,0,0,2,2,0,0 |
| 780ab280-3484ae181-4168201780-0b28-0006188b1087,SITE_030,2015-06-28,70.23199478024921,Male,Hispanic,Medicare,Current,66.2,2.2,60.0,0.0,1,1,None,0,0,32.6,Adenocarcinoma,Acinar,IVA,T2a,N0,M1b,3.9,RUL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,11.0,1,MSS,Chemo_IO_Combination,None,Atezolizumab,Carboplatin_Pemetrexed,None,NA,None,0.0,2,95.1,1,0,0,0,4.5,1,4.5,1,4.1,PR,1,1,0.6,0.6,-59.9,0,0,0,118.3,16.9,46.5,1,23.26,1,G3,Positive,Negative,Negative,0,102.6,81.0,0,None,0,0,1,1,4,4.7,251.6,14.3,7.5,139.3,33.4,0,None,0,0,1,1,0,0 |
| 149c44cd-9045e19c-43dd4ce67-044c-00010bef7e70,SITE_002,2024-01-27,73.3657528009208,Male,White,Uninsured,Current,30.0,1.3,60.0,0.0,0,0,None,0,1,29.7,Squamous_Cell,Keratinizing,IVB,T2b,N1,M1c,4.7,RLL,Left,0,1,0,0,1,0,1,0,Brain|Liver,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,0.8,0,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,7,82.4,1,0,0,0,19.0,1,29.5,1,16.0,PD,0,0,1.5,0.0,57.4,0,0,0,183.4,21.9,11.0,0,0.0,0,G1,Negative,Negative,Negative,1,81.8,68.6,1,IV,1,0,1,0,3,3.8,234.1,11.1,5.0,164.0,30.0,0,None,0,1,2,3,0,0 |
| 492e6283-20044b196-4db8b2789-0628-0003b75b00ae,SITE_035,2017-05-06,63.43900610247271,Male,White,Medicare,Current,50.6,1.9,60.0,0.0,0,0,None,0,0,31.9,Squamous_Cell,Basaloid,IB,T2b,N2,M0,4.3,RLL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,96,100,>=50%,40.2,1,MSS,SBRT,None,None,None,None,NA,SBRT,51.6,6,93.9,0,0,0,0,3.2,1,5.2,1,2.8,SD,0,1,5.5,0.0,-4.7,0,0,0,516.1,10.0,39.9,1,26.58,1,GX,Negative,Positive,Negative,2,79.0,95.1,0,None,0,0,0,0,1,3.9,281.9,9.9,1.1,183.8,25.6,0,None,0,2,0,2,0,0 |
| 456845f8-1e5d9e9c9-4d038d1e8-045f-0003864b8d9f,SITE_028,2016-01-07,74.18435755448316,Male,Hispanic,Medicare,Current,43.6,1.3,60.0,0.0,0,1,None,0,0,32.2,Adenocarcinoma,Micropapillary,IVA,T1c,N3,M1b,2.9,RUL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,61,100,>=50%,9.1,0,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,11,85.1,0,0,0,0,8.3,0,8.3,0,7.5,CR,1,1,0.5,3.5,-67.1,0,0,0,135.1,13.7,7.7,1,4.41,0,GX,Negative,Negative,Negative,2,67.7,83.0,0,None,0,0,1,0,1,4.0,119.5,10.9,3.7,82.6,19.6,0,None,0,1,3,0,0,0 |
| 3c9b4cfa-1a83f1ad7-4b5d1e6ee-04cf-000313e2e8b9,SITE_001,2021-03-19,70.59900473285475,Male,Asian,Medicaid,Never,0.0,0.0,0.0,0.0,1,1,Radon,1,1,29.0,Adenocarcinoma,Micropapillary,IB,T1a,N2,M0,0.8,LUL,Left,1,0,0,0,0,0,0,0,None,None,None,None,G12C,None,0,0,0,None,0,1,0,84,100,>=50%,6.3,0,MSS,SBRT,None,None,None,None,NA,SBRT,58.2,6,84.3,0,0,0,0,2.7,1,23.3,1,1.9,SD,0,1,0.5,0.0,-2.1,0,0,0,523.7,22.8,9.3,1,22.93,1,G3,Negative,Negative,Negative,3,95.3,83.2,0,None,1,0,0,0,4,3.5,167.9,12.1,1.5,55.7,44.6,0,None,0,3,0,2,0,0 |
| 675f5a5d-2d39b788c-41361e0f17-05a5-00053fd796c0,SITE_005,2017-05-02,55.26927567434095,Male,White,Private,Former,55.5,2.7,60.0,1.6,0,0,None,0,0,24.0,Adenocarcinoma,Papillary,IA,T1a,N0,M0,0.7,RUL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,0,0,<1%,5.2,0,MSS,SBRT,None,None,None,None,NA,SBRT,45.4,4,97.6,0,0,0,0,0.8,1,0.8,1,0.6,SD,0,1,4.8,0.0,-25.3,0,0,0,470.3,5.6,108.8,0,0.0,0,G2,Negative,Negative,Negative,1,55.0,49.4,0,None,1,1,0,0,2,3.4,272.8,13.3,5.7,255.7,56.8,0,None,0,1,0,3,0,0 |
| 222c422e-ef35cf43-46684c68a-0422-0001bc3f5c5d,SITE_023,2023-07-30,80.70189551626932,Female,Hispanic,Medicaid,Former,25.2,1.4,60.0,7.2,0,0,None,0,0,21.3,Adenocarcinoma,Solid,IA,T4,N0,M0,9.8,RML,Left,1,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,60,65,>=50%,13.4,1,MSS,Surgery_Adjuvant,None,None,None,VATS,R2,None,0.0,3,84.1,0,0,0,0,19.4,0,19.4,0,14.9,CR,1,1,5.1,7.6,-61.3,0,0,0,273.9,10.5,50.4,1,11.55,0,G2,Positive,Negative,Negative,1,53.3,73.5,1,III,1,0,0,0,2,3.3,134.4,14.9,6.6,70.3,2.5,0,None,0,0,3,3,1,0 |
| 7a153aaa-356949aa7-416e3faffe-03aa-00063313faa9,SITE_037,2019-06-08,62.2429249343093,Male,White,Private,Never,0.0,0.0,0.0,0.0,0,0,None,0,0,31.2,SCLC_Limited,NA,Limi,T1b,N2,M0,1.1,RUL,Right,0,0,0,1,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,4.1,0,MSS,Chemotherapy_Only,None,Atezolizumab,Etoposide_Platinum,None,NA,Conventional_EBRT,56.8,8,84.9,0,0,0,0,10.5,1,10.5,1,8.5,SD,0,1,0.5,0.0,-8.3,0,0,0,100.0,1.3,13.9,1,20.42,0,G1,Negative,Negative,Positive,2,109.1,63.8,0,None,0,1,0,0,2,3.5,168.0,13.5,7.1,77.0,18.8,0,None,0,1,0,2,0,1 |
| 2a70da57-12915f862-47f528f05-0da5-000227bb1672,SITE_042,2015-01-17,51.27659423974075,Male,White,Private,Former,11.9,1.0,60.0,3.6,0,0,Asbestos,0,0,26.3,Adenocarcinoma,Papillary,IVB,T3,N0,M1b,6.4,LUL,Right,0,1,1,0,0,0,0,0,None,None,None,None,G12A,None,0,0,0,None,0,0,0,0,0,<1%,5.4,0,MSS,Chemotherapy_Only,None,None,Carboplatin_Pemetrexed,None,NA,None,0.0,5,83.8,0,0,0,0,8.5,1,8.5,1,7.9,SD,0,1,2.4,0.0,-7.5,0,0,0,135.4,2.1,7.4,0,0.0,0,G3,Positive,Negative,Negative,1,59.5,58.2,0,None,0,1,0,0,2,4.8,270.6,13.7,4.1,108.9,10.7,0,None,0,1,1,2,1,1 |
| 45c2b4f3-1e852f2a6-4d1481ed9-0b4f-00038ae3305e,SITE_022,2024-07-05,57.07208475893013,Male,White,Medicare,Current,23.8,1.0,60.0,0.0,0,0,None,0,0,37.2,Adenocarcinoma,Micropapillary,IVA,T2b,N1,M1c,4.4,LUL,Right,0,1,0,1,1,1,1,0,Brain|Bone|Liver,None,None,None,G12A,None,0,0,0,None,0,1,0,86,90,>=50%,5.5,0,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,7,70.7,0,0,0,0,30.1,0,30.1,0,24.3,PR,1,1,8.0,0.7,-45.5,0,0,0,178.3,11.0,62.7,1,1.22,1,G2,Positive,Negative,Negative,3,92.3,62.0,0,None,1,0,0,0,1,4.7,233.9,14.0,1.4,176.0,26.9,1,Hepatitis,1,1,0,3,0,0 |
| 42a564ae-1d285c0c3-4c7f02e0a-064a-000362661cdd,SITE_015,2020-02-22,57.30007097355594,Male,Asian,Private,Never,0.0,0.0,0.0,0.0,0,1,None,0,0,24.4,Adenocarcinoma,Acinar,IVB,T2a,N2,M1b,3.2,LLL,Left,1,0,1,0,0,1,1,0,Bone|Liver,Exon19del,None,None,None,None,0,0,0,None,0,0,0,0,0,<1%,6.9,0,MSS,Targeted_TKI,Osimertinib,None,None,None,NA,None,0.0,3,97.1,0,0,0,0,4.7,1,9.7,0,4.3,PR,1,1,1.3,1.9,-51.0,0,0,1,581.3,12.5,57.5,1,10.31,0,G3,Positive,Negative,Negative,0,99.8,71.1,0,None,1,0,0,1,2,3.6,202.4,14.1,5.2,110.0,10.8,0,None,0,1,2,0,0,0 |
| 6cc585a7-2f966a792-41465090f5-085a-00058607c982,SITE_049,2017-08-17,67.49564652724656,Male,White,VA,Former,7.0,1.0,46.9,24.8,0,0,None,0,0,34.9,SCLC_Limited,NA,Limi,T4,N1,M0,11.3,RUL,Right,1,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,5.7,0,MSS,Chemotherapy_Only,None,Durvalumab,Etoposide_Platinum,None,NA,Conventional_EBRT,55.4,6,68.5,0,0,0,0,10.7,1,17.8,0,10.6,PD,0,0,0.5,0.0,41.9,0,0,1,184.1,5.4,43.3,0,0.0,0,G2,Negative,Negative,Negative,0,78.8,79.3,1,IV,1,0,0,0,3,3.6,206.7,14.6,6.0,96.1,136.0,1,Endocrinopathy,3,0,0,2,1,0 |
| 382e402f-18943c14a-4a88ac08d-0402-0002da59426a,SITE_023,2021-10-08,64.39842019731074,Male,White,Private,Current,120.0,2.8,60.0,0.0,0,1,None,0,1,25.3,Adenocarcinoma,Acinar,IVB,T3,N0,M1b,5.0,RLL,Right,0,0,0,0,1,0,0,0,Brain,None,None,None,G12A,None,0,0,0,None,0,0,0,100,100,>=50%,19.4,1,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,8,86.3,0,0,0,0,10.4,1,25.2,1,10.1,PR,1,1,3.5,0.8,-36.3,0,0,0,166.3,4.5,16.2,1,8.86,0,G3,Positive,Negative,Negative,0,59.1,87.7,0,None,1,0,1,1,2,2.7,183.6,17.0,3.9,262.9,18.1,1,Dermatitis,1,2,0,3,0,0 |
| 246c6d8f-fef6feea-46d4548ad-06d8-0001d981904a,SITE_016,2020-04-20,63.800096307414364,Male,Asian,Medicare,Former,22.3,1.0,60.0,3.3,1,0,None,0,0,32.0,Squamous_Cell,Non-keratinizing,IVB,T1a,N0,M1c,1.0,Endobronchial,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,4,9,1-49%,11.5,1,MSS,Chemo_IO_Combination,None,Pembrolizumab,Carboplatin_Paclitaxel,None,NA,None,0.0,7,83.6,1,0,0,0,4.9,1,9.9,0,4.6,PR,1,1,8.0,2.2,-45.3,0,0,1,268.8,5.6,5.4,1,5.95,0,G3,Negative,Positive,Negative,2,86.3,87.0,0,None,0,0,0,0,0,3.3,306.9,14.1,4.8,121.5,88.2,1,Endocrinopathy,1,1,0,2,0,0 |
| 02c42f44-135d4add-484c8dcc-02f4-000023f6667b,SITE_023,2015-04-19,72.88716867208355,Female,White,Private,Former,13.2,1.0,60.0,4.1,1,1,None,0,1,33.6,Adenocarcinoma,Acinar,IIIA,T3,N0,M0,6.6,RUL,Right,1,0,0,1,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,9,10,1-49%,12.9,1,MSS,CCRT,None,Durvalumab,Carboplatin_Paclitaxel,None,NA,IMRT,62.2,3,94.1,0,0,0,0,23.4,1,39.6,0,22.4,PR,1,1,1.8,7.2,-56.3,0,0,0,120.9,8.6,19.7,1,5.63,0,G3,Positive,Negative,Negative,0,100.1,76.7,0,None,0,0,1,0,0,3.4,569.7,13.1,1.2,91.9,4.8,0,None,0,4,3,3,0,0 |
| 2e8d024f-145db102a-48ba706ed-0024-00025d291e0a,SITE_001,2022-08-04,70.22881593133069,Female,White,Uninsured,Current,18.0,1.0,60.0,0.0,0,0,Silica,0,1,21.4,Adenocarcinoma,Lepidic,IA,T2b,N2,M0,5.0,RLL,Right,0,0,0,0,0,0,0,0,None,None,None,None,G12C,None,0,0,0,None,0,0,1,100,100,>=50%,15.6,1,MSS,Surgery_Adjuvant,None,None,None,Lobectomy,R0,None,0.0,9,85.6,0,0,0,0,40.2,0,40.2,0,32.9,CR,1,1,4.8,2.5,-82.9,0,0,0,241.7,1.2,108.8,0,0.0,0,G2,Positive,Negative,Negative,2,81.2,72.9,0,None,0,0,1,0,0,3.6,231.9,11.6,4.7,188.1,13.2,0,None,0,1,3,0,0,0 |
| 69c3ef0b-2e45b894e-413d4bcd21-0ef0-00055ef32396,SITE_016,2019-01-04,70.00245477112072,Male,Black,Private,Former,19.1,1.0,60.0,25.5,0,0,None,0,0,23.8,Squamous_Cell,Keratinizing,IA,T2a,N0,M0,3.7,RUL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,8.3,0,MSS,Surgery_Adjuvant,None,None,None,Lobectomy,R2,None,0.0,6,89.9,0,0,0,0,39.2,1,57.7,0,36.1,CR,1,1,0.5,96.3,-80.6,0,0,1,164.1,10.7,6.7,0,0.0,0,G2,Negative,Negative,Negative,1,61.6,66.8,0,None,0,0,0,0,0,3.5,380.3,13.1,4.2,153.7,8.0,0,None,0,0,2,1,1,0 |
| 0144ef15-8e28994-43cecd3f-0ef1-000010802418,SITE_026,2021-12-29,70.89337034462258,Female,Black,Private,Never,0.0,0.0,0.0,0.0,0,0,None,0,0,21.4,Adenocarcinoma,Solid,IVA,T3,N0,M1b,6.9,RUL,Left,1,0,0,0,0,1,0,0,Bone,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,3.6,0,MSS,Chemotherapy_Only,None,None,Carboplatin_Pemetrexed,None,NA,None,0.0,4,70.8,0,0,0,0,3.7,1,6.7,1,3.3,SD,0,1,5.4,0.0,17.1,0,0,0,800.0,7.6,21.3,1,2.24,1,G1,Negative,Negative,Negative,1,80.5,68.0,0,None,1,0,1,0,2,3.9,161.0,14.8,1.9,151.0,36.3,0,None,0,2,2,1,0,0 |
| 72b5656b-322f5c5ee-4158203041-0656-0005d3362676,SITE_046,2023-12-14,72.85327934602127,Female,White,Private,Never,0.0,0.0,0.0,0.0,0,0,None,0,0,20.5,Adenocarcinoma,Solid,IVA,T3,N0,M1b,6.4,RLL,Right,0,0,0,0,0,0,1,0,Liver,None,None,None,None,None,0,0,0,None,0,1,0,63,100,>=50%,45.8,1,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,4,90.0,0,0,0,0,5.6,1,31.4,1,5.6,PR,1,1,1.9,5.6,-37.4,0,0,0,154.7,9.0,143.0,1,35.12,1,G3,Positive,Negative,Negative,2,50.1,59.5,0,None,1,0,0,0,2,4.2,142.5,10.1,6.5,193.7,3.4,0,None,0,0,1,0,0,0 |
| 457b5bae-1e65f81c3-4d072130a-05ba-00038743a7dd,SITE_037,2021-02-06,46.97444325311429,Female,White,Medicare,Current,28.3,1.0,60.0,0.0,0,0,None,0,0,29.0,SCLC_Limited,NA,Limi,T1c,N0,M0,2.6,RUL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,20.8,1,MSS,Chemotherapy_Only,None,Durvalumab,Etoposide_Platinum,None,NA,Conventional_EBRT,49.6,6,79.9,0,0,0,0,4.7,1,5.8,1,4.1,PR,1,1,2.2,2.2,-51.2,0,0,0,642.2,6.7,13.9,1,12.85,1,G3,Negative,Negative,Positive,1,57.5,65.1,0,None,0,0,1,1,1,3.4,135.1,15.0,3.2,136.7,1.5,1,Pneumonitis,3,0,0,2,0,1 |
| 11f3aea1-7da9c668-435db0be3-0aea-0000e95fde34,SITE_040,2021-09-17,63.53783660348762,Female,Other,VA,Former,28.4,1.1,60.0,39.0,1,0,None,0,0,25.1,SCLC_Extensive,NA,Exte,T4,N2,M0,10.4,LUL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,7,10,1-49%,38.5,1,MSS,Chemo_IO_Combination,None,Atezolizumab,Etoposide_Platinum,None,NA,None,0.0,6,68.4,0,0,0,0,2.2,1,8.3,0,1.8,SD,0,1,3.0,0.0,16.9,0,0,1,138.4,2.4,17.2,0,0.0,0,G2,Negative,Negative,Positive,0,70.3,77.7,0,None,0,0,0,0,1,4.5,126.6,11.6,5.3,246.4,7.9,0,None,0,2,0,1,0,1 |
| 26adcff0-10ec0af91-474096fd0-0cff-0001f6d38f37,SITE_028,2017-07-18,46.28800438735,Female,White,VA,Former,14.3,1.0,60.0,10.0,0,0,None,0,0,26.2,Squamous_Cell,Keratinizing,IVB,T3,N2,M1b,6.2,Central,Right,0,0,0,0,0,0,1,0,Liver,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,22.9,1,MSS,Chemo_IO_Combination,None,Pembrolizumab,Carboplatin_Paclitaxel,None,NA,None,0.0,6,83.6,1,0,0,0,0.5,1,21.0,0,0.5,PR,1,1,6.9,4.3,-56.5,0,0,1,279.0,3.1,4.0,1,25.56,0,G2,Negative,Positive,Negative,1,76.1,96.6,1,II,0,1,1,0,3,4.0,173.0,12.0,6.3,63.0,46.6,0,None,0,0,2,1,0,1 |
| 46eaa806-1f06a982b-4d4bff812-0a80-000399ea8855,SITE_006,2017-05-17,67.34256930457906,Female,White,Private,Never,0.0,0.0,0.0,0.0,0,0,None,0,1,28.5,Adenocarcinoma,Acinar,IIA,T2b,N1,M0,4.1,RUL,Left,0,0,1,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,21,19,1-49%,6.0,0,MSS,SBRT,None,None,None,None,NA,SBRT,50.6,4,93.3,0,0,0,0,6.5,1,15.4,1,6.0,SD,0,1,0.5,0.0,-6.4,0,0,0,314.2,25.0,42.4,1,18.73,0,G3,Negative,Negative,Negative,3,53.4,69.6,0,None,0,0,1,0,1,4.2,312.0,13.5,5.6,312.6,6.0,0,None,0,1,1,2,1,0 |
| 286899da-11adc34f7-47939cd8e-099d-00020d4fd019,SITE_020,2019-02-23,66.95598676386872,Female,White,Medicare,Former,28.9,1.3,60.0,8.3,0,0,None,0,0,17.6,SCLC_Limited,NA,Limi,T1a,N1,M0,0.4,RUL,Right,1,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,26,55,1-49%,1.1,0,MSS,Chemo_IO_Combination,None,Durvalumab,Etoposide_Platinum,None,NA,Conventional_EBRT,45.3,2,90.4,0,0,0,0,2.9,1,8.1,0,2.1,CR,1,1,0.8,4.3,-87.6,0,0,1,262.7,4.4,8.3,1,17.51,0,G3,Negative,Negative,Positive,0,79.5,59.1,0,None,0,0,0,1,2,3.6,330.8,11.4,1.8,85.8,29.9,0,None,0,1,0,2,0,1 |
| 0de5cf54-6148ab4d-429b16dfc-0cf5-0000b4ab874b,SITE_050,2023-07-10,76.93255661050196,Male,White,Private,Current,120.0,3.3,60.0,0.0,0,0,None,0,0,31.8,Adenocarcinoma,Papillary,IB,T1c,N0,M0,2.5,LLL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,25,47,1-49%,3.0,0,MSS,Surgery_Adjuvant,None,None,Cisplatin_Pemetrexed,Lobectomy,R0,None,0.0,2,75.9,0,0,0,0,8.0,0,8.0,0,7.0,PD,0,0,5.9,0.0,30.8,0,0,0,254.7,14.1,3.1,1,20.43,0,G3,Positive,Negative,Negative,0,84.4,87.5,0,None,0,0,0,1,1,4.1,155.3,13.4,3.4,55.6,7.6,0,None,0,2,0,0,1,1 |
| 553f1fad-254b9ddbc-4ffbd5f07-01fa-000454349bd0,SITE_003,2020-03-28,78.28252673085065,Male,Other,Medicare,Former,5.2,1.0,34.8,3.4,0,0,Radon,1,0,24.4,Squamous_Cell,Non-keratinizing,IIIA,T2a,N1,M0,3.2,RLL,Bilateral,0,0,0,1,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,47,78,1-49%,16.0,1,MSS,Chemo_RT,None,None,Carboplatin_Paclitaxel,None,NA,IMRT,56.1,6,85.6,0,0,0,0,10.5,1,17.3,1,9.2,SD,0,1,1.9,0.0,11.0,0,0,0,376.4,3.1,6.4,1,18.64,0,G1,Negative,Positive,Negative,2,71.1,40.0,1,II,0,0,0,0,2,4.0,170.4,10.2,19.9,92.5,1.4,0,None,0,1,4,1,1,0 |
| 560bf69f-25a53be5a-410223e3dd-0f69-00045e9b861a,SITE_044,2018-06-24,68.92636295839749,Male,White,Medicare,Current,8.5,1.0,56.9,0.0,0,0,None,0,0,28.4,Adenocarcinoma,Solid,IVB,T3,N0,M1a,6.3,Central,Left,0,0,0,0,1,1,1,0,Brain|Bone|Liver,None,None,None,None,V600E,0,0,0,None,0,1,0,0,0,<1%,8.2,0,MSS,Targeted_TKI,Dabrafenib_Trametinib,None,None,None,NA,None,0.0,5,76.8,0,0,0,0,11.4,1,11.4,1,10.1,CR,1,1,1.3,4.1,-87.0,0,0,0,301.5,7.3,25.8,1,23.38,0,GX,Negative,Negative,Negative,0,36.2,88.7,1,IV,0,0,0,0,2,4.5,200.1,14.3,11.9,120.3,72.1,0,None,0,2,0,2,0,0 |
| 0f374580-6a82e681-42da5d080-0458-0000c5ce8787,SITE_035,2022-10-16,62.24656976472945,Male,White,Private,Former,120.0,2.7,60.0,14.7,0,0,None,0,1,28.8,Adenocarcinoma,Micropapillary,IVA,T2b,N3,M1b,4.2,RML,Left,0,0,1,0,0,0,0,0,None,None,None,None,G12V,None,0,0,0,None,0,0,0,59,67,>=50%,6.2,0,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,4,84.0,0,0,0,0,5.7,1,37.4,0,5.6,PR,1,1,1.7,11.2,-48.5,0,0,1,224.4,5.2,3.0,1,23.35,1,G3,Positive,Negative,Negative,0,76.9,49.1,1,I,1,1,0,0,3,4.1,225.2,12.9,8.0,95.5,53.2,0,None,0,4,0,0,0,0 |
| 23ff77f8-fbfc47c9-46bfe67e8-077f-0001d3f9179f,SITE_015,2023-07-12,71.60903056918451,Male,White,Medicare,Former,69.0,1.9,60.0,6.9,0,0,Silica,0,0,32.2,SCLC_Extensive,NA,Exte,T3,N0,M0,6.3,LUL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,27,58,1-49%,1.0,0,MSS,Chemotherapy_Only,None,Durvalumab,Etoposide_Platinum,None,NA,None,0.0,5,64.5,0,0,0,0,1.7,1,1.7,1,1.5,SD,0,1,3.7,0.0,15.3,0,0,0,174.6,5.9,3.8,0,0.0,0,G3,Negative,Negative,Positive,2,107.7,82.5,1,III,1,0,1,1,4,4.2,268.6,12.5,5.4,83.2,18.9,0,None,0,2,1,3,0,0 |
| 1f373d1b-da82abbe-45da5b751-03d1-000195ce1a66,SITE_039,2024-01-08,61.98478244541902,Male,White,Medicaid,Current,120.0,5.0,60.0,0.0,0,1,Asbestos,0,0,25.5,SCLC_Limited,NA,Limi,T1c,N1,M0,2.8,Central,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,8.9,0,MSS,Chemotherapy_Only,None,Atezolizumab,Etoposide_Platinum,None,NA,Conventional_EBRT,57.5,5,61.1,0,0,0,0,8.6,1,27.0,1,8.2,SD,0,1,6.0,0.0,8.6,0,0,0,225.2,5.6,39.3,0,0.0,0,G1,Negative,Negative,Positive,2,83.2,64.4,0,None,0,0,1,0,0,3.5,164.1,13.0,2.2,272.1,21.4,1,Endocrinopathy,3,0,1,2,0,0 |
| 5467f5fd-24ed7b9ec-4fd37e1f7-0f5f-000449477de0,SITE_042,2017-12-27,66.98676981128818,Female,White,Private,Former,49.8,1.3,60.0,7.6,0,1,None,0,0,16.4,Large_Cell,NA,IA,T3,N0,M0,6.9,RUL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,100,100,>=50%,3.4,0,MSS,Surgery_Adjuvant,None,None,Carboplatin_Paclitaxel,Lobectomy,R0,None,0.0,7,82.8,0,0,0,0,8.6,0,8.6,0,6.9,CR,1,1,5.0,80.5,-69.0,0,0,0,223.8,23.5,18.4,1,11.06,0,G1,Negative,Negative,Negative,1,75.3,77.1,1,I,0,0,1,0,1,4.4,181.2,12.5,4.0,88.0,14.7,0,None,0,2,0,2,0,0 |
| 5d7a5367-28e5847d2-41186efa35-0536-0004bf363c42,SITE_003,2022-02-03,76.36829501112729,Female,Other,Private,Former,83.5,3.8,60.0,6.7,0,0,Asbestos,0,0,26.3,Squamous_Cell,Keratinizing,IIIA,T4,N2,M0,8.4,LLL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,13,11,1-49%,4.7,0,MSS,CCRT,None,Durvalumab,Carboplatin_Paclitaxel,None,NA,IMRT,60.0,5,90.8,0,0,0,0,10.3,1,30.1,1,7.4,PR,1,1,6.7,15.7,-39.1,0,0,0,221.7,25.0,6.7,0,0.0,0,G2,Negative,Positive,Negative,3,68.3,105.3,0,None,1,0,1,1,2,3.2,394.4,13.4,3.3,50.0,4.3,0,None,0,2,1,1,0,0 |
| 5d0e28d6-28b631ddb-41172a7a82-028d-0004b9b812e5,SITE_006,2020-11-24,61.70117221310048,Female,Black,Private,Current,3.6,1.0,24.1,0.0,0,1,None,0,1,26.9,Adenocarcinoma,Acinar,IIIA,T3,N0,M0,6.9,LUL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,100,100,>=50%,19.4,1,MSS,CCRT,None,Durvalumab,Carboplatin_Paclitaxel,None,NA,IMRT,57.0,8,56.7,1,0,0,0,13.2,1,25.3,0,10.7,SD,0,1,0.5,0.0,0.8,0,0,1,254.2,8.9,13.7,1,12.17,0,G2,Positive,Negative,Negative,2,85.4,58.6,0,None,0,1,0,0,1,3.5,174.3,12.1,4.2,120.3,142.5,0,None,0,1,0,2,1,1 |
| 78295412-349214c7f-41687bfc36-0541-00061a1944f1,SITE_034,2019-06-27,74.65394707280376,Male,White,Private,Former,79.8,2.5,60.0,6.4,0,0,None,0,1,21.3,Adenocarcinoma,Solid,IVA,T3,N3,M1c,5.9,LLL,Right,0,0,0,0,0,0,1,0,Liver,L858R,None,None,None,None,0,0,0,None,0,0,0,0,0,<1%,3.6,0,MSS,Targeted_TKI,Osimertinib,None,None,None,NA,None,0.0,10,81.7,0,0,0,0,15.4,1,31.5,1,13.2,PR,1,1,0.8,3.5,-41.4,0,0,0,120.9,5.3,161.7,1,13.22,0,GX,Negative,Negative,Negative,0,78.8,56.0,0,None,0,0,1,0,0,3.9,150.3,11.9,1.6,500.0,17.3,0,None,0,2,0,0,0,0 |
| 62630a7f-2b0b5497a-4127291f7d-00a7-0004ff07887a,SITE_050,2018-12-19,73.43531300257688,Male,White,Private,Former,33.2,1.0,60.0,3.3,0,0,Asbestos,0,0,26.7,Adenocarcinoma,Acinar,IVA,T4,N0,M1a,11.9,RUL,Right,0,1,0,0,1,1,1,0,Brain|Bone|Liver,None,KIF5B-ALK,None,None,None,0,0,0,None,0,0,1,91,100,>=50%,3.9,0,MSS,Targeted_TKI,Alectinib,None,None,None,NA,None,0.0,2,86.9,1,0,0,0,8.3,1,19.5,1,7.9,CR,1,1,0.6,28.5,-83.0,0,0,0,146.4,2.6,93.5,1,6.3,1,G3,Positive,Negative,Negative,1,87.7,73.3,0,None,0,0,1,0,0,3.2,191.9,9.0,8.7,78.4,34.6,0,None,0,1,1,3,0,0 |
| 290c0623-11f542af6-47b241269-0062-0002159c4fce,SITE_002,2016-02-23,57.929477737257194,Female,White,Medicare,Current,86.8,2.2,60.0,0.0,1,1,Asbestos,0,0,24.4,Squamous_Cell,Non-keratinizing,IVB,T1a,N2,M1a,0.7,RLL,Left,0,0,0,0,0,0,1,0,Liver,None,None,None,None,None,0,0,0,None,0,0,1,28,29,1-49%,10.7,1,MSS,Chemo_IO_Combination,None,Pembrolizumab,Carboplatin_Paclitaxel,None,NA,None,0.0,4,80.5,0,0,0,0,2.6,1,4.8,1,2.3,PR,1,1,0.5,9.6,-52.4,0,0,0,370.9,2.4,17.7,1,4.18,1,GX,Negative,Positive,Negative,2,55.3,96.4,0,None,1,1,1,0,3,3.3,208.3,15.2,1.0,86.5,9.5,0,None,0,0,3,1,0,1 |
| 0dca748f-60892fea-4295f5dad-0748-0000b347eb4a,SITE_034,2017-09-30,76.2519942180653,Female,White,Private,Former,37.8,1.0,60.0,42.0,0,0,None,0,0,20.0,SCLC_Limited,NA,Limi,T3,N2,M0,6.2,RUL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,0,0,<1%,19.8,1,MSS,Chemotherapy_Only,None,Atezolizumab,Etoposide_Platinum,None,NA,Conventional_EBRT,54.0,5,95.7,1,0,0,0,13.6,1,13.6,1,11.3,PD,0,0,7.1,0.0,64.0,0,0,0,100.0,23.6,53.5,0,0.0,0,G3,Negative,Negative,Positive,1,77.2,74.9,0,None,0,1,0,1,3,3.3,100.0,10.2,8.2,116.5,39.0,0,None,0,2,2,1,0,0 |
| 4eac9dbf-226b8503a-4ec05d93d-09db-0003fec402ba,SITE_007,2020-06-29,73.6363802810293,Female,White,Medicare,Former,0.5,1.0,3.3,13.3,0,1,None,0,0,29.0,Large_Cell,NA,IVB,T4,N0,M1a,9.9,Endobronchial,Right,0,0,0,0,1,0,0,0,Brain,None,None,None,None,None,0,0,0,None,0,0,0,0,0,<1%,6.3,0,MSS,Chemotherapy_Only,None,None,Carboplatin_Paclitaxel,None,NA,None,0.0,4,74.0,0,0,0,0,15.4,1,20.2,1,12.9,SD,0,1,0.6,0.0,-9.0,0,0,0,445.2,2.3,23.2,1,0.98,0,G1,Negative,Negative,Negative,1,66.7,72.7,0,None,0,0,0,0,1,4.0,160.5,15.7,8.3,374.9,111.9,0,None,0,1,0,2,0,0 |
| 753fe04a-334bf2207-415fbfa0de-0e04-0005f43e63c9,SITE_033,2023-11-10,67.96829593004024,Female,White,Medicaid,Never,0.0,0.0,0.0,0.0,1,0,None,0,0,23.5,Adenocarcinoma,Acinar,IA,T2b,N0,M0,4.4,RUL,Right,0,0,0,0,0,0,0,0,None,L858R,None,None,None,None,0,0,0,None,0,1,0,100,81,>=50%,33.8,1,MSS,Surgery_Adjuvant,Osimertinib,None,None,Lobectomy,R0,None,0.0,9,90.9,0,0,0,0,36.0,0,36.0,0,35.9,CR,1,1,0.5,150.0,-75.6,0,0,0,185.0,5.2,2.4,0,0.0,0,G3,Positive,Negative,Negative,1,81.7,74.7,1,III,1,0,0,0,2,3.7,247.1,12.0,20.0,119.6,25.8,0,None,0,1,0,1,0,0 |
| 7cd1e3b6-369bd39fb-417675ab22-0e3b-000656a89045,SITE_032,2023-08-29,59.7579271487373,Female,Black,Uninsured,Former,15.4,1.0,60.0,40.7,0,0,None,0,0,24.2,SCLC_Extensive,NA,Exte,T1b,N0,M0,1.9,RUL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,2.9,0,MSS,Chemotherapy_Only,None,Atezolizumab,Etoposide_Platinum,None,NA,None,0.0,8,70.8,0,0,0,0,5.7,1,5.7,1,4.2,PR,1,1,6.5,4.1,-48.9,0,0,0,563.8,8.4,1.9,1,8.32,0,G3,Negative,Negative,Positive,0,40.0,55.9,1,III,1,0,1,0,2,4.3,545.8,14.9,3.8,80.3,34.5,0,None,0,1,1,1,0,1 |
| 1d77a6ec-ce459075-45866f4c4-0a6e-00017f137a03,SITE_005,2016-11-15,58.83754282353208,Male,Hispanic,Medicare,Former,9.3,1.0,60.0,45.1,1,1,Silica,0,0,23.9,SCLC_Limited,NA,Limi,T4,N2,M0,9.6,Central,Left,0,1,1,0,0,0,0,0,None,None,None,None,G13C,None,0,0,0,None,0,0,1,25,39,1-49%,2.4,0,MSS,Chemo_IO_Combination,None,Durvalumab,Etoposide_Platinum,None,NA,Conventional_EBRT,48.1,6,84.9,0,0,0,0,12.5,1,12.5,1,9.6,SD,0,1,0.8,0.0,0.7,0,0,0,451.7,1.0,6.7,0,0.0,0,G3,Negative,Negative,Positive,1,67.9,74.9,0,None,0,0,1,0,0,4.7,153.8,14.6,3.1,184.5,75.0,0,None,0,1,0,0,0,0 |
| 1e442bfe-d3dd33f3-45acc83fa-02bf-000189763bed,SITE_035,2021-10-15,61.89220551942129,Male,White,Private,Current,55.3,3.1,60.0,0.0,1,1,None,0,1,31.6,Squamous_Cell,Non-keratinizing,IVA,T1b,N3,M1a,1.6,RML,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,6,5,1-49%,2.3,0,MSS,Chemo_IO_Combination,None,Atezolizumab,Carboplatin_Paclitaxel,None,NA,None,0.0,2,88.7,1,0,0,0,2.7,1,8.5,0,2.4,SD,0,1,0.5,0.0,-15.2,0,0,1,207.7,2.7,3.0,1,11.04,0,G3,Negative,Negative,Negative,0,84.8,65.7,0,None,0,0,1,0,1,3.9,293.7,14.4,4.9,176.5,58.0,0,None,0,2,0,3,0,0 |
| 04c9ef44-21858add-4e5dcdcc-0ef4-00003e41267b,SITE_045,2015-11-06,72.15464740127362,Male,Hispanic,Private,Former,44.2,2.1,60.0,4.7,0,0,None,0,0,25.8,Squamous_Cell,Keratinizing,IB,T2a,N0,M0,3.8,LUL,Right,0,1,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,0,0,<1%,2.0,0,MSS,Surgery_Adjuvant,None,None,Carboplatin_Paclitaxel,VATS,R1,None,0.0,2,74.8,1,0,0,0,46.8,0,46.8,0,42.6,CR,1,1,2.6,31.8,-77.6,0,0,0,218.8,2.5,27.8,0,0.0,0,G2,Negative,Positive,Negative,2,87.7,93.2,0,None,1,0,1,0,1,3.5,219.1,12.6,6.6,198.7,96.2,0,None,0,3,0,1,1,0 |
| 1214e0c8-7e922579-4363ea258-0e0c-0000eb0f6a2f,SITE_044,2021-09-29,57.92156090968672,Female,White,Private,Current,14.6,1.0,60.0,0.0,0,0,None,0,0,26.4,Squamous_Cell,Non-keratinizing,IIIB,T1b,N0,M0,1.2,RML,Left,0,0,0,1,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,22,42,1-49%,12.2,1,MSS,Chemo_RT,None,None,Carboplatin_Paclitaxel,None,NA,IMRT,65.3,5,42.1,0,0,0,0,4.2,1,19.3,0,3.5,SD,0,1,0.7,0.0,5.6,0,0,1,542.7,4.3,10.4,1,13.45,0,G3,Negative,Positive,Negative,0,74.5,84.8,1,III,1,0,0,0,2,4.0,357.8,10.1,4.2,78.5,32.5,0,None,0,2,0,1,1,0 |
| 470567dd-1f125d70c-4d5103797-067d-00039b464640,SITE_002,2018-06-02,71.15636636188876,Female,White,Uninsured,Former,21.6,1.0,60.0,6.6,0,1,None,0,0,24.0,Adenocarcinoma,Lepidic,IVB,T2a,N0,M1b,3.6,LUL,Left,0,0,0,0,1,0,0,0,Brain,None,None,None,None,None,0,0,0,None,0,0,0,100,100,>=50%,3.7,0,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,7,88.4,1,0,0,0,11.8,1,11.8,1,8.4,SD,0,1,6.7,0.0,1.7,0,0,0,462.5,9.1,33.5,1,14.17,1,G3,Positive,Negative,Negative,0,36.1,50.8,0,None,1,0,0,0,1,3.4,147.0,12.1,2.0,105.8,32.5,0,None,0,4,1,1,0,0 |
| 45fda668-1e9ef8cd9-4d1f8f338-0a66-00038de1734f,SITE_013,2019-06-30,55.20332247565527,Male,Asian,Uninsured,Former,10.0,1.0,60.0,15.3,0,0,None,0,0,28.1,Adenocarcinoma,Papillary,IVB,T2a,N0,M1b,3.3,RUL,Left,0,0,0,0,0,0,0,1,Adrenal,None,None,None,None,None,0,1,0,None,0,1,1,46,71,1-49%,2.5,0,MSS,Targeted_TKI,Selpercatinib,None,None,None,NA,None,0.0,5,73.3,1,0,0,0,4.9,1,37.8,0,4.2,SD,0,1,4.2,0.0,-6.8,0,0,1,398.0,16.8,34.1,1,11.72,0,G3,Negative,Negative,Negative,0,86.5,67.5,0,None,1,1,1,0,4,3.8,347.8,11.9,6.6,291.6,28.8,0,None,0,0,0,2,0,0 |
| 2f7a61a3-14c58ab76-48e6f24e9-061a-00026936f54e,SITE_013,2022-03-04,65.06134844783094,Female,White,Private,Former,9.1,1.0,60.0,4.1,0,1,Silica,0,0,32.1,SCLC_Limited,NA,Limi,T2a,N2,M0,3.2,RLL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,17,28,1-49%,12.7,1,MSS,Chemotherapy_Only,None,Atezolizumab,Etoposide_Platinum,None,NA,Conventional_EBRT,53.9,6,78.2,0,0,0,0,15.2,1,15.2,1,11.3,PD,0,0,0.5,0.0,20.3,0,0,0,433.6,4.3,46.0,0,0.0,0,G1,Negative,Negative,Positive,2,103.5,80.4,0,None,0,0,1,0,0,5.0,403.8,12.3,4.5,189.7,73.5,0,None,0,0,0,2,1,0 |
| 27ac9ead-115b856bc-47705dc07-09ea-000203c40ed0,SITE_023,2019-03-31,68.04165366845308,Male,White,Private,Current,4.4,1.0,29.0,0.0,0,0,None,0,1,28.9,Adenocarcinoma,Papillary,IA,T4,N0,M0,9.0,LUL,Left,0,0,0,0,0,0,0,0,None,None,None,None,G12D,None,0,0,0,None,0,0,1,100,100,>=50%,18.9,1,MSS,Surgery_Adjuvant,None,None,Cisplatin_Pemetrexed,Lobectomy,R1,None,0.0,5,68.9,0,0,0,0,23.1,0,23.1,0,16.5,PR,1,1,2.3,41.1,-47.8,0,0,0,142.1,5.1,6.6,0,0.0,0,G2,Negative,Negative,Negative,1,59.9,56.3,1,III,1,1,1,0,3,3.7,412.5,10.0,2.2,241.1,10.5,0,None,0,2,0,0,0,0 |
| 6a368ce0-2e77dda21-413ea3a6a0-08ce-000564c52767,SITE_008,2023-01-26,90.0,Male,Black,Medicare,Former,29.9,1.0,60.0,25.6,0,1,None,0,0,29.1,Adenocarcinoma,Micropapillary,IIIB,T2a,N0,M0,3.4,RLL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,100,100,>=50%,23.2,1,MSS,Chemo_RT,None,None,Carboplatin_Paclitaxel,None,NA,IMRT,62.0,8,95.3,1,0,0,0,12.4,1,26.4,1,9.9,SD,0,1,1.1,0.0,12.2,0,0,0,271.1,6.7,37.3,1,9.3,0,G3,Positive,Negative,Negative,1,67.3,54.7,0,None,0,1,0,0,2,4.0,409.0,11.9,1.4,143.7,44.5,0,None,0,1,1,0,0,0 |
| 3ae26452-19c30be3f-4b0a72cf6-0645-0002fd7f1831,SITE_043,2020-05-01,53.91550127255651,Male,White,Private,Former,12.7,1.0,60.0,6.4,0,0,None,0,0,28.7,Adenocarcinoma,Lepidic,IA,T2b,N3,M0,4.3,RML,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,20,36,1-49%,19.8,1,MSS,SBRT,None,None,None,None,NA,SBRT,48.3,5,84.2,0,0,0,0,4.6,1,5.0,1,3.4,SD,0,1,4.0,0.0,11.2,0,0,0,166.5,3.9,6.4,0,0.0,0,G2,Positive,Negative,Negative,1,89.5,64.6,1,I,0,1,0,1,5,3.7,220.4,7.0,20.0,279.7,200.0,0,None,0,2,0,2,1,0 |
| 6774c8c3-2d4317d56-41365e5a49-0c8c-000540ee31ee,SITE_039,2024-12-24,80.98413838165627,Male,Asian,VA,Current,24.6,1.0,60.0,0.0,1,1,None,0,0,19.8,Adenocarcinoma,Acinar,IA,T4,N2,M0,7.7,RUL,Left,0,0,0,0,0,0,0,0,None,None,None,None,G12V,None,0,0,0,None,0,1,0,100,100,>=50%,3.9,0,MSS,SBRT,None,None,None,None,NA,SBRT,57.7,6,86.8,1,0,0,0,7.0,1,7.0,1,5.8,CR,1,1,4.3,2.5,-79.2,0,0,0,140.2,10.3,47.2,1,14.56,0,G3,Positive,Negative,Negative,1,90.0,77.5,0,None,1,1,1,0,2,3.6,268.4,11.9,8.0,177.0,34.4,0,None,0,2,0,1,1,0 |
| 7b4a86ca-35f09af87-4171df945e-086c-000642c8d849,SITE_041,2021-05-18,68.42350293287916,Female,White,Private,Former,34.2,1.6,60.0,4.5,0,0,None,0,0,22.1,SCLC_Limited,NA,Limi,T4,N2,M0,10.4,LUL,Right,1,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,11.6,1,MSS,Chemotherapy_Only,None,Durvalumab,Etoposide_Platinum,None,NA,Conventional_EBRT,49.0,3,83.3,0,0,0,0,9.4,1,9.4,1,8.7,CR,1,1,4.6,5.4,-66.1,0,0,0,265.6,10.6,87.1,0,0.0,0,G2,Negative,Negative,Positive,2,94.7,88.6,1,II,0,0,1,0,2,4.0,162.4,12.8,6.6,108.4,3.3,0,None,0,0,0,4,0,0 |
| 289801da-11c280cf7-479c8058e-001d-00020fb81819,SITE_010,2017-12-17,70.90613322115165,Male,Asian,Private,Former,35.7,1.0,60.0,5.4,1,0,None,0,0,25.1,Large_Cell,NA,IVB,T1c,N0,M1a,2.1,RUL,Left,0,0,0,0,1,0,0,0,Brain,None,None,None,None,None,0,0,0,None,0,0,0,27,67,1-49%,14.1,1,MSS,Chemo_IO_Combination,None,Nivolumab_Ipilimumab,Carboplatin_Paclitaxel,None,NA,None,0.0,7,70.5,1,0,0,0,10.2,1,26.0,1,7.3,PR,1,1,0.5,0.9,-58.2,0,0,0,199.0,1.0,47.8,0,0.0,0,G2,Negative,Negative,Negative,1,93.3,75.7,0,None,0,0,1,0,0,3.2,100.0,10.9,4.1,232.1,13.0,0,None,0,2,0,1,0,1 |
| 19f3543d-b5a74dac-44dd9fcb7-0543-0001515b4720,SITE_001,2022-09-30,68.12430517718795,Female,White,Private,Current,9.6,1.0,60.0,0.0,0,1,None,0,0,22.7,Squamous_Cell,Keratinizing,IA,T1a,N3,M0,0.3,RML,Right,0,1,0,1,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,5.9,0,MSS,Surgery_Adjuvant,None,None,Carboplatin_Paclitaxel,Wedge_Resection,R0,None,0.0,3,81.0,0,0,0,0,28.3,0,28.3,0,24.1,PR,1,1,5.4,34.1,-41.3,0,0,0,225.2,12.3,16.2,1,7.86,0,G2,Negative,Positive,Negative,0,47.4,111.4,0,None,0,1,0,1,2,3.7,227.7,12.0,7.3,87.8,51.0,0,None,0,0,2,0,0,1 |
| 79f89b7d-355cc406c-416de9d277-09b7-0006319fe560,SITE_046,2019-01-28,71.22490477285471,Female,White,Private,Former,14.5,1.0,60.0,0.8,0,0,None,0,1,21.2,Adenocarcinoma,Solid,IVB,T3,N1,M1b,6.6,RLL,Right,0,0,0,1,1,1,0,1,Brain|Bone|Adrenal,T790M,None,None,None,None,0,0,0,None,0,0,1,74,100,>=50%,10.5,1,MSS,Targeted_TKI,Osimertinib,None,None,None,NA,None,0.0,2,80.7,0,0,0,0,6.4,1,15.0,1,5.5,SD,0,1,0.8,0.0,-5.3,0,0,0,190.6,8.2,39.7,1,3.76,0,G2,Positive,Negative,Negative,2,66.4,61.2,1,II,1,1,1,0,3,3.1,184.8,12.8,2.1,374.7,7.3,0,None,0,1,0,0,0,0 |
| 51422525-238cf0404-4f3c66f6f-0252-0004205be2e8,SITE_015,2020-05-03,65.53999150856083,Male,White,Private,Never,0.0,0.0,0.0,0.0,0,0,Radon,1,1,17.6,Adenocarcinoma,Papillary,IVA,T4,N1,M1c,9.2,RLL,Right,0,0,0,0,0,1,0,0,Bone,Exon19del,None,None,None,None,0,0,0,None,0,0,0,100,100,>=50%,2.9,0,MSS,Targeted_TKI,Osimertinib,None,None,None,NA,None,0.0,7,91.7,0,0,0,0,8.6,0,8.6,0,6.0,PR,1,1,0.5,18.5,-58.2,0,0,0,130.7,9.1,3.2,1,16.18,0,G2,Positive,Negative,Negative,1,86.3,83.8,0,None,1,0,1,1,3,4.6,324.3,14.5,5.2,271.7,4.6,0,None,0,2,1,2,0,0 |
| 253ccbb4-104a991ed-46fb6631c-0cbb-0001e416582b,SITE_033,2016-05-14,80.81347672384585,Male,Asian,Medicaid,Former,0.6,1.0,3.8,3.6,0,0,None,0,1,19.9,Squamous_Cell,Basaloid,IVB,T2b,N0,M1b,4.6,LUL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,5.1,0,MSS,Chemotherapy_Only,None,None,Carboplatin_Paclitaxel,None,NA,None,0.0,4,88.3,1,0,0,0,1.1,1,8.6,1,1.0,PD,0,0,0.6,0.0,43.4,0,0,0,571.6,19.0,2.4,1,6.55,0,G3,Negative,Positive,Negative,1,73.4,54.3,1,IV,0,0,0,0,1,4.3,308.3,14.6,5.3,124.5,2.5,0,None,0,2,1,1,0,1 |
| 4f991bae-22d2fc1c3-4eecb530a-01ba-00040ac667dd,SITE_046,2016-03-11,62.66352412986514,Female,White,Private,Never,0.0,0.0,0.0,0.0,0,0,None,0,0,24.8,Adenocarcinoma,Acinar,IB,T1b,N3,M0,1.3,RLL,Left,0,0,0,0,0,0,0,0,None,None,None,None,G12V,None,0,0,0,None,0,1,0,100,84,>=50%,12.6,1,MSS,Surgery_Adjuvant,None,None,None,Lobectomy,R0,None,0.0,4,90.4,0,0,0,0,52.9,0,52.9,0,38.5,CR,1,1,0.5,93.5,-71.2,0,0,0,264.5,1.8,35.2,1,11.87,1,G2,Positive,Negative,Negative,0,81.6,97.8,1,II,0,0,1,0,1,3.4,117.8,13.1,2.2,132.8,14.7,0,None,0,1,1,1,0,0 |
| 41ed645a-1cd7dbe77-4c5c82d0e-0645-0003590e1899,SITE_002,2020-09-29,77.75622843570285,Male,Hispanic,Medicare,Former,21.5,1.0,60.0,40.5,1,0,None,0,0,25.7,Squamous_Cell,Basaloid,IIIA,T3,N1,M0,5.0,Central,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,35.1,1,MSS,Chemo_RT,None,None,Carboplatin_Paclitaxel,None,NA,IMRT,59.0,7,96.0,0,0,0,0,2.9,1,3.1,1,2.8,PD,0,0,6.9,0.0,63.5,0,0,0,119.0,2.7,96.5,1,32.31,1,G2,Negative,Positive,Negative,2,72.7,93.8,0,None,1,0,1,0,1,2.9,600.0,12.4,4.2,160.7,200.0,0,None,0,2,1,0,0,1 |
| 73e87a91-32b5b59f8-415bb96fb3-07a9-0005e2ce3964,SITE_001,2016-11-12,60.878512357976284,Female,White,Private,Current,55.6,3.4,60.0,0.0,0,1,None,0,0,22.4,Squamous_Cell,Keratinizing,IA,T3,N2,M0,6.1,LUL,Right,1,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,25.4,1,MSS,Surgery_Adjuvant,None,None,Carboplatin_Paclitaxel,Lobectomy,R0,None,0.0,4,88.6,0,0,0,0,11.7,0,11.7,0,10.4,CR,1,1,2.8,14.1,-84.9,0,0,0,268.0,7.0,4.6,0,0.0,0,G3,Negative,Positive,Negative,3,67.2,83.4,0,None,0,1,1,0,2,4.0,243.2,13.2,3.4,133.8,9.1,0,None,0,3,0,0,0,0 |
| 20c376ce-e5583fa3-4624a646a-076c-0001a9ed087d,SITE_001,2024-12-20,66.42760745918777,Male,White,Private,Never,0.0,0.0,0.0,0.0,0,1,Radon,1,0,26.4,Adenocarcinoma,Papillary,IB,T2b,N2,M0,4.7,LLL,Right,1,0,0,0,0,0,0,0,None,None,None,None,G12C,None,0,0,0,None,0,0,1,63,79,>=50%,16.4,1,MSS,Surgery_Adjuvant,None,None,None,Lobectomy,R0,None,0.0,7,65.2,1,0,0,0,7.0,0,7.0,0,5.5,SD,0,1,6.5,0.0,13.3,0,0,0,523.6,1.2,20.5,1,9.84,0,G3,Positive,Negative,Negative,1,70.6,44.2,0,None,1,0,1,1,2,3.8,105.4,16.1,2.6,327.5,74.7,0,None,0,0,0,1,0,0 |
| 7ee5a1b1-378476bd8-417cb0e513-0a1b-000671a93604,SITE_008,2023-07-21,56.81635575324292,Female,White,Private,Current,1.5,1.0,9.9,0.0,0,1,None,0,0,24.0,Large_Cell,NA,IIB,T4,N2,M0,11.7,LLL,Right,1,1,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,93,100,>=50%,9.7,0,MSS,SBRT,None,None,None,None,NA,SBRT,48.0,3,80.7,0,0,0,0,7.1,1,7.1,1,6.9,PR,1,1,8.0,1.3,-59.1,0,0,0,395.2,6.2,34.0,0,0.0,0,G2,Negative,Negative,Negative,0,54.8,83.2,0,None,1,0,0,0,1,4.9,113.1,13.5,3.1,107.4,13.2,0,None,0,0,0,1,1,0 |
| 77d04694-346b1ee0d-416770d3bc-0469-00061593958b,SITE_003,2022-01-02,71.32272534330144,Female,White,Private,Current,72.8,1.8,60.0,0.0,0,0,None,0,0,30.9,Adenocarcinoma,Papillary,IIB,T3,N2,M0,6.3,RUL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,1,2,1-49%,8.4,0,MSS,Surgery_Adjuvant,None,None,Cisplatin_Pemetrexed,Wedge_Resection,R2,None,0.0,12,95.6,0,0,0,0,8.9,1,40.5,0,7.3,CR,1,1,4.3,20.0,-80.2,0,0,1,188.8,14.5,9.6,0,0.0,0,G3,Negative,Negative,Negative,0,62.0,58.9,0,None,0,1,1,0,2,4.5,100.0,13.0,1.4,60.2,11.2,0,None,0,0,0,2,0,0 |
| 17213e36-a1e8b37b-44563baa2-03e3-00012cb028c5,SITE_041,2022-05-05,80.72869659080207,Male,Hispanic,Private,Current,91.0,2.3,60.0,0.0,0,1,None,0,0,25.3,Squamous_Cell,Non-keratinizing,IB,T3,N3,M0,6.4,Endobronchial,Left,0,1,0,0,0,0,0,0,None,None,None,None,G12D,None,0,0,0,None,0,0,1,0,0,<1%,2.5,0,MSS,SBRT,None,None,None,None,NA,SBRT,53.8,6,84.0,1,0,0,0,4.9,1,19.0,0,3.8,SD,0,1,7.2,0.0,-18.4,0,0,1,191.1,10.1,13.4,1,13.9,0,G2,Negative,Positive,Negative,1,73.8,79.3,0,None,0,0,0,0,1,4.1,293.5,14.6,9.4,127.1,43.6,0,None,0,1,0,0,0,0 |
| 1511de74-937d152d-43f359b5c-0de7-000111e84beb,SITE_031,2020-12-12,66.26511629170189,Male,White,Private,Current,33.5,1.0,60.0,0.0,1,0,Radon,1,0,29.1,Large_Cell,NA,IB,T3,N0,M0,5.7,LLL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,83,100,>=50%,4.3,0,MSS,SBRT,None,None,None,None,NA,SBRT,45.5,3,92.6,0,0,0,0,1.7,1,7.6,1,1.4,PR,1,1,0.6,0.7,-36.1,0,0,0,151.6,7.9,41.9,0,0.0,0,G3,Negative,Negative,Negative,1,74.1,48.7,1,I,1,0,1,0,2,3.5,153.9,12.6,13.4,233.1,2.0,0,None,0,0,1,1,0,0 |
| 443e7bac-1ddb561b5-4ccbb7304-07ba-0003772c47c3,SITE_050,2015-08-09,65.12958586231287,Female,Black,Medicaid,Current,72.9,1.9,60.0,0.0,0,0,None,0,0,26.9,Squamous_Cell,Non-keratinizing,IVB,T3,N0,M1a,5.6,LUL,Right,0,0,0,0,1,1,1,0,Brain|Bone|Liver,None,None,None,None,None,0,0,0,None,0,0,1,13,16,1-49%,4.4,0,MSS,Chemo_IO_Combination,None,Nivolumab_Ipilimumab,Carboplatin_Paclitaxel,None,NA,None,0.0,5,72.5,0,0,0,0,6.3,0,6.3,0,5.6,CR,1,1,0.5,3.5,-60.9,0,0,0,168.8,6.1,22.9,0,0.0,0,G1,Negative,Negative,Negative,1,85.2,76.3,1,II,0,0,1,0,1,3.7,131.6,10.8,2.3,272.8,200.0,0,None,0,1,0,4,1,0 |
| 05bfa194-283d6b0d-4113ee4bc-0a19-00004abb348b,SITE_041,2018-12-03,56.4111388508547,Male,White,Medicare,Current,24.8,1.0,60.0,0.0,0,0,None,0,0,19.7,SCLC_Extensive,NA,Exte,T2b,N2,M0,4.5,RUL,Right,1,0,0,0,0,0,0,0,None,None,Other,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,15.1,1,MSS,Chemotherapy_Only,None,Atezolizumab,Etoposide_Platinum,None,NA,None,0.0,9,92.0,0,0,0,0,1.0,1,24.1,1,1.0,SD,0,1,1.1,0.0,-2.1,0,0,0,175.8,5.2,23.0,1,3.77,0,G2,Negative,Negative,Positive,1,69.9,66.3,1,III,0,0,1,0,1,4.0,145.2,13.4,9.7,158.9,45.0,0,None,0,0,3,2,0,1 |
| 263f02f4-10bb914ad-472bd08dc-002f-0001f133266b,SITE_049,2019-12-15,64.82171979125307,Male,White,Uninsured,Former,13.2,1.0,60.0,5.4,1,0,None,0,0,25.6,Squamous_Cell,Basaloid,IIB,T2a,N1,M0,3.8,RUL,Right,0,1,0,1,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,5,12,1-49%,21.1,1,MSS,Surgery_Adjuvant,None,None,Carboplatin_Paclitaxel,Lobectomy,R0,None,0.0,5,85.0,0,0,1,0,20.8,1,53.9,0,18.7,CR,1,1,3.7,17.6,-60.6,0,0,1,117.4,5.0,6.2,0,0.0,0,G2,Negative,Positive,Negative,1,105.2,59.5,1,III,0,0,0,0,2,4.0,172.4,12.8,4.4,101.5,97.2,0,None,0,0,0,4,0,0 |
| 37b142ad-185d8d2bc-4a713c807-042a-0002d40062d0,SITE_012,2024-02-23,51.86845453264549,Male,White,Private,Former,2.5,1.0,16.9,4.7,0,0,None,0,0,20.4,Adenocarcinoma,Acinar,IVB,T3,N2,M1a,5.4,LUL,Right,1,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,27,29,1-49%,17.5,1,MSS,Chemo_IO_Combination,None,Nivolumab_Ipilimumab,Carboplatin_Pemetrexed,None,NA,None,0.0,1,89.9,0,0,0,0,2.7,1,8.4,0,2.7,PR,1,1,2.6,5.5,-45.2,0,0,0,196.0,8.9,19.3,1,28.16,0,G3,Negative,Negative,Negative,0,97.1,81.5,0,None,0,0,1,0,2,3.4,267.2,12.1,4.4,144.5,13.6,1,Dermatitis,1,1,0,0,0,0 |
| 7c146cb3-3648ef8e6-41743d4619-06cb-00064d09851e,SITE_015,2017-03-12,58.32765912617114,Male,Hispanic,Medicare,Former,2.0,1.0,13.6,9.0,0,0,Radon,1,1,25.5,Adenocarcinoma,Papillary,IB,T2b,N2,M0,4.6,RLL,Left,1,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,26.2,1,MSS,Surgery_Adjuvant,None,None,Cisplatin_Pemetrexed,Lobectomy,R0,None,0.0,4,95.5,0,0,0,0,52.8,0,52.8,0,52.1,CR,1,1,2.6,7.0,-87.7,0,0,0,290.6,2.1,12.5,1,12.74,1,G1,Positive,Negative,Negative,3,66.0,71.2,1,III,0,1,0,0,2,3.1,100.0,13.6,1.8,100.2,42.3,0,None,0,3,1,1,0,0 |
| 7f062998-3792b2329-417d127cc8-0299-000673501cbf,SITE_043,2019-12-19,69.15446743803679,Female,Black,Medicare,Former,73.4,2.7,60.0,8.6,0,0,None,0,0,22.6,Squamous_Cell,Keratinizing,IIIA,T2a,N1,M0,3.8,LUL,Left,1,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,60,100,>=50%,9.6,0,MSS,Chemo_RT,None,None,Carboplatin_Paclitaxel,None,NA,IMRT,61.0,1,79.4,1,0,0,0,4.2,1,23.7,1,3.2,SD,0,1,3.8,0.0,-23.7,0,0,0,198.9,23.8,13.3,1,14.18,0,G3,Negative,Positive,Negative,1,78.6,68.7,0,None,0,1,1,0,2,4.8,117.3,8.9,3.0,50.0,81.4,0,None,0,0,2,1,0,0 |
| 1365a92e-87c7a043-43a30fb8a-0a92-0000fc29975d,SITE_013,2018-06-09,79.53062537854326,Female,White,Private,Former,110.6,5.9,60.0,1.2,0,0,None,0,1,27.7,Adenocarcinoma,Micropapillary,IVB,T1b,N2,M1b,2.0,RLL,Left,0,0,0,0,0,1,0,0,Bone,L858R,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,3.7,0,MSS,Targeted_TKI,Osimertinib,None,None,None,NA,None,0.0,5,90.9,0,0,0,0,12.2,1,34.9,0,11.9,CR,1,1,0.8,16.6,-71.6,0,0,0,272.8,4.1,10.5,0,0.0,0,G3,Positive,Negative,Negative,3,96.8,83.8,1,I,0,0,0,0,1,3.8,252.8,11.4,6.5,89.0,17.5,0,None,0,0,1,3,0,0 |
| 72227b0c-31ef15d55-4156677124-07b0-0005cbc03fa3,SITE_003,2016-05-05,90.0,Male,Black,Private,Current,31.7,1.0,60.0,0.0,1,0,None,0,1,20.0,Squamous_Cell,Non-keratinizing,IIIB,T3,N0,M0,6.1,LUL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,47,100,1-49%,8.6,0,MSS,Chemo_RT,None,None,Carboplatin_Paclitaxel,None,NA,IMRT,61.5,4,73.9,0,0,0,0,3.3,1,5.9,1,2.4,SD,0,1,1.0,0.0,-1.8,0,0,0,550.6,11.5,19.4,1,4.41,0,G2,Negative,Positive,Negative,1,63.5,102.5,1,III,0,1,1,0,3,4.0,148.9,10.7,2.3,201.6,5.4,0,None,0,1,1,3,0,1 |
| 0ba38e44-5178e3dd-422eaaacc-08e4-0000974e397b,SITE_034,2016-01-12,61.427441691826445,Female,White,Medicare,Never,0.0,0.0,0.0,0.0,0,0,Radon,1,0,26.1,SCLC_Extensive,NA,Exte,T3,N2,M0,6.8,RUL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,45,63,1-49%,4.7,0,MSS,Chemo_IO_Combination,None,Durvalumab,Etoposide_Platinum,None,NA,None,0.0,5,85.9,0,0,0,0,3.7,1,18.5,1,3.6,SD,0,1,2.2,0.0,-12.8,0,0,0,612.7,7.9,7.1,1,3.22,0,G2,Negative,Negative,Positive,0,61.5,76.4,0,None,0,1,0,0,3,3.4,268.0,11.0,2.7,126.2,4.9,0,None,0,3,0,2,0,1 |
| 5fd26338-29ec0b689-411f7729a8-0633-0004ddaf09df,SITE_041,2018-08-26,80.63535148813168,Male,White,Medicare,Current,89.3,3.2,60.0,0.0,0,0,None,0,0,28.6,Squamous_Cell,Basaloid,IIIA,T2a,N0,M0,3.0,RUL,Left,1,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,100,100,>=50%,16.3,1,MSS,CCRT,None,Durvalumab,Carboplatin_Paclitaxel,None,NA,IMRT,58.9,6,97.1,0,0,0,0,4.7,1,22.8,0,3.7,PD,0,0,2.9,0.0,33.5,0,0,1,236.5,2.9,20.4,1,2.89,0,G2,Negative,Positive,Negative,1,98.4,43.1,1,II,0,1,1,0,2,4.5,156.2,12.2,3.1,123.3,10.7,1,Pneumonitis,2,1,3,1,0,0 |
| 6c3e052c-2f5b22435-4144ba0f84-0052-00057f264343,SITE_049,2015-10-28,69.31564856381566,Male,White,Private,Former,41.0,1.1,60.0,10.7,0,1,None,0,0,30.1,Squamous_Cell,Keratinizing,IIIC,T2a,N2,M0,3.3,RUL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,100,100,>=50%,6.5,0,MSS,Chemo_RT,None,None,Carboplatin_Paclitaxel,None,NA,IMRT,61.0,3,94.0,0,0,0,0,11.1,1,56.4,0,8.6,SD,0,1,0.9,0.0,15.9,0,0,1,380.0,20.8,13.0,1,6.11,0,G2,Negative,Positive,Negative,4,87.4,47.1,1,III,0,1,0,1,5,4.3,440.3,10.7,1.0,288.3,28.2,0,None,0,2,1,2,0,1 |
| 72057d03-31e266b16-4156107709-07d0-0005ca47592e,SITE_047,2015-09-03,65.56314735590944,Female,White,Private,Never,0.0,0.0,0.0,0.0,0,0,Silica,0,0,22.6,Adenocarcinoma,Micropapillary,IVA,T1c,N3,M1a,2.4,LLL,Left,0,1,0,0,0,1,0,0,Bone,L858R,None,None,None,None,0,0,0,None,0,0,0,0,0,<1%,8.3,0,MSI-L,Targeted_TKI,Osimertinib,None,None,None,NA,None,0.0,6,93.8,0,0,0,0,0.5,1,35.4,0,0.5,PR,1,1,0.5,23.2,-59.5,0,0,1,225.1,17.6,6.6,1,22.45,0,GX,Positive,Negative,Negative,2,94.3,73.1,0,None,0,0,0,0,0,3.8,222.4,15.9,5.6,83.2,15.7,0,None,0,0,0,3,0,0 |
| 1c98f58f-c82eb6ea-455cae0ad-0f58-000173c4784a,SITE_007,2018-07-04,71.10964729139845,Female,Asian,VA,Never,0.0,0.0,0.0,0.0,1,1,None,0,0,26.1,Adenocarcinoma,Solid,IIIA,T4,N0,M0,11.8,LUL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,16.8,1,MSS,Chemo_RT,None,None,Carboplatin_Paclitaxel,None,NA,IMRT,63.0,6,87.1,1,0,0,0,24.8,1,24.8,1,18.7,SD,0,1,1.5,0.0,-16.4,0,0,0,191.7,2.1,1.9,1,33.18,1,G1,Positive,Negative,Negative,1,80.7,88.4,0,None,0,0,1,1,1,3.9,369.9,13.4,7.0,88.3,9.6,0,None,0,0,2,2,0,0 |
| 725c75a1-320873768-41571560e3-075a-0005ceb1f934,SITE_039,2017-01-07,67.58820659495962,Male,Other,Private,Former,67.1,2.1,60.0,1.2,0,0,Radon,1,1,26.8,Squamous_Cell,Non-keratinizing,IIIB,T4,N0,M0,10.8,Central,Bilateral,1,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,4.6,0,MSS,CCRT,None,Durvalumab,Carboplatin_Paclitaxel,None,NA,IMRT,59.2,3,62.8,0,0,0,0,15.3,1,38.9,0,14.6,SD,0,1,3.1,0.0,-7.7,0,0,1,140.0,7.0,62.6,1,31.22,0,G2,Negative,Negative,Negative,0,70.4,74.2,1,III,0,0,0,0,1,3.9,259.5,10.9,5.8,181.0,55.5,0,None,0,1,0,2,0,0 |
| 0ed87658-67eb3c69-42c896308-0765-0000c0fe027f,SITE_043,2020-07-18,68.04875939331608,Male,Hispanic,Uninsured,Former,37.8,1.1,60.0,2.3,1,0,Asbestos,0,0,33.0,SCLC_Extensive,NA,Exte,T2b,N0,M0,4.4,LLL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,25,33,1-49%,21.5,1,MSS,Chemo_IO_Combination,None,Durvalumab,Etoposide_Platinum,None,NA,None,0.0,3,97.2,1,0,0,0,5.2,1,21.6,0,3.8,PD,0,0,2.4,0.0,51.1,0,0,0,255.5,8.7,49.2,0,0.0,0,G2,Negative,Negative,Positive,1,50.8,80.2,0,None,0,1,1,0,1,3.8,267.5,9.0,8.7,96.8,10.1,1,Hepatitis,1,2,0,2,0,0 |
| 4269f364-1d0e5a7bd-4c73dda2c-0f36-00035f615c1b,SITE_035,2015-03-06,63.12083495314664,Male,Asian,Medicaid,Never,0.0,0.0,0.0,0.0,0,1,None,0,0,19.3,Adenocarcinoma,Solid,IIIC,T2a,N1,M0,3.4,LLL,Left,0,1,0,1,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,96,100,>=50%,2.7,0,MSS,CCRT,None,Durvalumab,Carboplatin_Paclitaxel,None,NA,IMRT,62.5,5,86.5,1,0,0,0,10.4,1,33.0,0,8.6,SD,0,1,1.9,0.0,-23.6,0,0,0,420.8,1.4,7.6,1,12.31,1,G3,Positive,Negative,Negative,0,77.5,71.1,0,None,0,0,0,0,0,4.1,137.5,11.3,3.3,96.5,8.2,0,None,0,2,1,0,0,0 |
| 3c1a0f72-1a4b66c1f-4b44e2e56-00f7-00030d52c8d1,SITE_041,2018-01-06,53.71795823191092,Female,White,Medicaid,Former,36.1,1.4,60.0,0.6,0,0,None,0,1,21.9,SCLC_Extensive,NA,Exte,T3,N1,M0,6.8,RLL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,100,100,>=50%,11.9,1,MSS,Chemo_IO_Combination,None,Atezolizumab,Etoposide_Platinum,None,NA,None,0.0,3,67.9,0,0,0,0,2.6,1,7.0,1,2.5,CR,1,1,1.5,5.4,-73.4,0,0,0,129.4,1.4,45.5,0,0.0,0,G2,Negative,Negative,Positive,1,97.2,87.4,1,II,0,1,1,0,2,4.0,359.1,11.8,15.9,376.0,82.2,0,None,0,0,1,2,1,0 |
| 28705cf8-11b128ac9-4795116e8-05cf-00020db4b89f,SITE_042,2019-07-13,52.33556057604022,Male,Black,Medicare,Former,17.1,1.0,60.0,15.3,0,0,None,0,0,38.6,SCLC_Extensive,NA,Exte,T2b,N0,M0,4.8,LLL,Bilateral,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,32,76,1-49%,8.3,0,MSS,Chemo_IO_Combination,None,Durvalumab,Etoposide_Platinum,None,NA,None,0.0,6,31.6,0,0,0,0,6.1,1,9.7,1,5.4,PD,0,0,2.8,0.0,37.8,0,0,0,212.0,3.8,5.9,0,0.0,0,G2,Negative,Negative,Positive,3,97.4,81.9,0,None,0,1,1,0,1,3.7,223.2,11.2,2.5,78.0,45.9,1,Hepatitis,1,4,4,1,0,0 |
| 02d4a32a-13d07627-487de97e-0a32-000024cc4929,SITE_023,2024-08-16,73.20582639117166,Male,White,Private,Former,37.7,1.0,60.0,12.6,0,1,None,0,1,24.8,Adenocarcinoma,Papillary,IVB,T4,N3,M1b,8.2,Central,Right,0,0,0,1,1,0,1,0,Brain|Liver,None,None,None,G13C,None,0,0,0,None,0,0,0,0,0,<1%,19.0,1,MSS,Chemo_IO_Combination,None,Nivolumab_Ipilimumab,Carboplatin_Pemetrexed,None,NA,None,0.0,3,89.3,0,0,0,0,9.5,1,18.3,1,8.4,SD,0,1,5.5,0.0,-18.0,0,0,0,206.9,2.6,13.9,1,3.53,1,G1,Positive,Negative,Negative,1,94.3,55.7,0,None,0,0,1,0,1,3.2,124.4,17.0,3.8,95.6,3.2,1,Hepatitis,1,1,0,3,0,0 |
| 62d14daa-2b3b91fa7-412873e8fe-04da-000504a0f1a9,SITE_003,2021-05-05,64.37134914418573,Female,White,Medicare,Former,12.0,1.0,60.0,4.3,0,0,None,0,1,17.5,Adenocarcinoma,Papillary,IIIA,T1a,N0,M0,0.9,LLL,Left,0,0,0,1,0,0,0,0,None,None,None,None,G12C,None,0,0,0,None,0,0,0,39,84,1-49%,2.6,0,MSS,Chemo_RT,None,None,Carboplatin_Paclitaxel,None,NA,IMRT,60.3,6,73.3,0,0,0,0,8.8,1,26.8,1,8.8,SD,0,1,0.5,0.0,0.6,0,0,0,276.8,3.2,10.6,0,0.0,0,GX,Positive,Negative,Negative,2,89.2,79.2,1,II,1,0,0,0,3,3.8,100.0,9.2,3.6,193.1,2.7,0,None,0,1,1,1,1,0 |
| 2af467b6-12caed5fb-480dd3722-067b-00022e694445,SITE_023,2023-10-20,61.33715545326642,Male,White,Medicare,Former,2.3,1.0,15.3,10.8,0,0,Silica,0,0,23.4,Adenocarcinoma,Papillary,IVB,T1a,N1,M1a,0.7,RUL,Left,1,0,1,1,0,1,0,0,Bone,None,None,None,None,None,0,0,0,None,0,0,0,88,99,>=50%,2.3,0,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,6,62.4,0,0,0,0,19.7,1,19.7,1,14.0,SD,0,1,7.0,0.0,-13.8,0,0,0,279.0,2.6,14.4,1,8.26,0,G3,Negative,Negative,Negative,1,114.8,47.3,0,None,1,0,0,0,2,4.2,214.9,12.6,5.1,144.1,3.8,0,None,0,2,1,2,0,0 |
| 54b150f7-250d936c2-4fe13f2e5-050f-00044d011c92,SITE_011,2018-06-07,67.08080345386996,Male,White,Medicare,Former,30.7,1.1,60.0,22.3,0,0,None,0,0,16.0,Adenocarcinoma,Micropapillary,IA,T2b,N2,M0,4.0,LUL,Left,1,0,0,0,0,0,0,0,None,None,None,None,G12C,None,0,0,0,None,0,0,0,69,100,>=50%,17.7,1,MSS,SBRT,None,None,None,None,NA,SBRT,47.4,8,95.6,0,0,0,0,1.5,1,5.3,1,1.2,PR,1,1,4.3,12.6,-49.7,0,0,0,320.1,6.7,43.6,1,3.43,0,G1,Positive,Negative,Negative,0,47.1,79.2,0,None,1,0,1,0,1,4.1,425.8,12.2,3.8,65.1,19.2,0,None,0,1,0,1,0,0 |
| 34821621-16f8e9ae8-49d864263-0162-0002aa9b1fb4,SITE_006,2019-06-30,74.55185640269846,Male,Other,Private,Never,0.0,0.0,0.0,0.0,0,0,None,0,0,27.1,Adenocarcinoma,Acinar,IIB,T1b,N0,M0,1.6,RUL,Left,0,0,0,1,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,100,100,>=50%,6.3,0,MSS,Surgery_Adjuvant,None,None,None,Lobectomy,R0,None,0.0,4,68.6,0,0,0,0,15.6,0,15.6,0,11.5,CR,1,1,1.5,12.4,-73.6,0,0,0,631.7,3.6,12.4,0,0.0,0,G3,Positive,Negative,Negative,0,79.2,67.5,0,None,0,0,1,0,1,4.5,127.3,12.0,4.2,432.9,117.6,0,None,0,2,1,0,1,0 |
| 2fd40436-14ecc1d7b-48f7c0ca2-0043-00026dc436c5,SITE_007,2019-03-15,68.71345745875078,Male,Asian,Private,Never,0.0,0.0,0.0,0.0,0,0,None,0,0,29.6,Squamous_Cell,Keratinizing,IIIB,T2b,N0,M0,4.3,RUL,Right,1,1,0,0,0,0,0,0,None,None,EML4-ALK,None,None,None,0,0,0,None,0,0,1,0,0,<1%,8.3,0,MSS,CCRT,None,Durvalumab,Carboplatin_Paclitaxel,None,NA,IMRT,54.2,6,93.4,0,0,0,0,12.5,1,14.4,1,9.4,SD,0,1,4.6,0.0,-5.1,0,0,0,158.3,18.0,13.4,1,13.42,0,G3,Negative,Positive,Negative,2,58.1,74.6,0,None,0,0,0,0,0,4.5,125.2,8.6,2.8,92.2,176.1,0,None,0,1,2,3,1,0 |
| 71722506-31a1f032b-4154566f12-0250-0005c2cbe155,SITE_035,2023-11-13,60.76747810191081,Male,White,Private,Former,3.9,1.0,26.3,1.9,0,0,None,0,0,21.9,Adenocarcinoma,Papillary,IIIB,T3,N3,M0,5.7,LUL,Right,0,0,0,0,0,0,0,0,None,None,None,None,G12V,None,0,0,0,None,0,0,0,100,100,>=50%,5.0,0,MSS,Chemo_RT,None,None,Carboplatin_Paclitaxel,None,NA,IMRT,58.5,4,81.9,0,0,0,0,13.0,1,13.8,1,9.9,SD,0,1,4.6,0.0,16.7,0,0,0,154.0,8.5,49.0,1,12.43,1,G2,Positive,Negative,Negative,1,102.9,77.2,1,II,1,0,1,1,3,4.2,171.0,12.4,3.3,128.1,61.9,0,None,0,0,1,2,0,1 |
| 0c177bd8-54a462e9-424467388-07bd-00009d3149ff,SITE_026,2024-08-02,78.64978307866502,Female,White,Private,Current,22.7,1.0,60.0,0.0,0,0,None,0,1,23.9,Squamous_Cell,Non-keratinizing,IVB,T1b,N2,M1a,1.6,LLL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,20.5,1,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,1,96.5,1,0,0,0,12.5,0,12.5,0,11.1,PR,1,1,1.4,8.3,-59.3,0,0,0,276.9,13.9,21.6,1,5.04,1,GX,Negative,Positive,Negative,1,65.1,76.5,1,II,1,0,0,0,2,3.9,347.4,12.9,1.0,192.9,200.0,0,None,0,0,1,3,0,0 |
| 5e497a43-2940257d6-411adc6ec9-07a4-0004c9bb356e,SITE_027,2024-08-13,82.0022622783255,Female,Black,Medicare,Current,0.9,1.0,5.9,0.0,0,0,Asbestos,0,1,30.2,SCLC_Limited,NA,Limi,T2a,N0,M0,3.6,RUL,Left,0,1,1,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,11.8,1,MSS,Chemo_IO_Combination,None,Durvalumab,Etoposide_Platinum,None,NA,Conventional_EBRT,50.0,2,80.5,0,0,0,0,3.8,1,9.5,0,3.0,SD,0,1,0.5,0.0,-4.4,0,0,1,505.9,1.9,9.9,1,5.18,1,G2,Negative,Negative,Positive,0,93.2,94.7,0,None,0,0,1,0,0,4.0,100.0,13.9,7.9,500.0,27.2,0,None,0,3,1,2,0,0 |
| 5f96cd4e-29d1f9d23-411ec467ea-0cd4-0004daa86cfd,SITE_038,2022-07-07,71.69828822556711,Female,White,Medicaid,Current,38.2,1.3,60.0,0.0,0,0,None,0,0,18.1,Adenocarcinoma,Acinar,IIIA,T3,N2,M0,5.5,RUL,Left,1,0,0,1,0,0,0,0,None,None,EML4-ALK,None,None,None,0,0,0,None,0,0,0,100,100,>=50%,11.2,1,MSS,CCRT,None,Durvalumab,Carboplatin_Paclitaxel,None,NA,IMRT,65.1,2,79.5,1,0,0,0,14.4,1,14.4,1,12.9,SD,0,1,2.6,0.0,-4.9,0,0,0,117.8,4.5,26.8,1,12.81,1,G3,Positive,Negative,Negative,1,66.9,72.5,1,II,1,0,0,0,3,3.5,144.7,13.5,2.2,116.1,106.0,0,None,0,2,2,0,0,0 |
| 30a38f55-15478eb54-491eaadff-08f5-0002784e4758,SITE_028,2020-01-11,76.24980335776885,Female,Asian,Medicare,Former,15.1,1.0,60.0,4.8,0,0,None,0,0,20.1,SCLC_Limited,NA,Limi,T4,N1,M0,10.6,Central,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,74,100,>=50%,3.1,0,MSS,Chemo_IO_Combination,None,Durvalumab,Etoposide_Platinum,None,NA,Conventional_EBRT,53.3,6,81.6,0,0,0,0,15.5,1,17.7,1,14.3,SD,0,1,0.7,0.0,13.0,0,0,0,288.8,8.2,66.1,0,0.0,0,G3,Negative,Negative,Positive,0,82.6,75.0,1,II,0,0,1,0,2,4.2,121.2,14.9,3.2,85.5,8.5,1,Dermatitis,2,4,0,0,0,0 |
| 21984e62-eb2a24af-464c8eb26-04e6-0001b4bbfb01,SITE_032,2020-05-28,78.7986199697312,Male,Other,Medicare,Former,5.3,1.0,35.4,1.1,0,0,None,0,0,25.0,Adenocarcinoma,Papillary,IVA,T2a,N0,M1a,3.1,RUL,Left,0,0,1,0,0,0,1,1,Liver|Adrenal,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,14.2,1,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,4,83.6,0,0,0,0,1.8,1,25.4,0,1.5,CR,1,1,1.2,24.0,-76.1,0,0,1,221.3,10.6,71.3,0,0.0,0,G3,Positive,Negative,Negative,0,73.0,93.3,0,None,1,0,0,1,2,4.5,265.4,8.4,2.1,200.1,1.9,1,Endocrinopathy,1,2,0,1,0,0 |
| 00ade6f2-4c1509f-4209b4d6-0e6f-000008d4ba51,SITE_005,2024-10-18,77.73594350584288,Male,White,Private,Former,21.4,1.3,60.0,0.2,0,0,None,0,0,22.6,Adenocarcinoma,Lepidic,IIA,T1b,N2,M0,1.1,RUL,Left,0,0,1,0,0,0,0,0,None,Exon19del,None,None,None,None,0,0,0,None,0,1,0,42,58,1-49%,3.7,0,MSS,Surgery_Adjuvant,Osimertinib,None,None,Wedge_Resection,R0,None,0.0,7,73.8,0,0,1,0,20.6,0,20.6,0,17.8,PR,1,1,1.6,39.0,-59.4,0,0,0,375.1,4.4,4.1,1,9.97,0,G3,Negative,Negative,Negative,2,74.8,102.3,1,II,0,0,0,0,1,4.3,186.5,12.0,6.7,500.0,12.6,0,None,0,1,1,1,0,0 |
| 77e97e4a-347627407-4167bc7ade-07e4-000616db69c9,SITE_043,2017-11-04,72.83394218256993,Female,White,Private,Current,20.1,1.0,60.0,0.0,0,0,Radon,1,1,24.7,SCLC_Limited,NA,Limi,T2b,N1,M0,4.7,LLL,Right,0,1,1,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,5.0,0,MSS,Chemotherapy_Only,None,Durvalumab,Etoposide_Platinum,None,NA,Conventional_EBRT,54.8,9,87.2,0,0,0,0,11.3,1,37.4,0,8.3,CR,1,1,2.1,7.2,-84.2,0,0,1,335.0,4.9,4.4,1,17.82,1,G2,Negative,Negative,Positive,2,81.0,71.7,0,None,0,0,0,1,2,4.1,168.5,17.0,3.1,161.0,16.6,0,None,0,0,0,1,0,0 |
| 794f43bb-3512ada1e-416bedcb31-043b-000629067086,SITE_023,2018-06-19,72.6842969472114,Male,White,Private,Current,59.0,1.6,60.0,0.0,0,0,None,0,0,20.3,Large_Cell,NA,IVB,T2a,N0,M1b,3.3,LLL,Left,0,1,1,0,0,1,1,0,Bone|Liver,None,None,None,None,None,0,0,0,None,0,0,0,100,100,>=50%,2.6,0,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,5,72.0,0,0,0,0,9.2,1,9.2,1,8.5,SD,0,1,0.5,0.0,-0.7,0,0,0,250.7,5.4,66.6,1,24.92,1,G2,Negative,Negative,Negative,2,91.6,63.8,0,None,0,0,1,0,1,3.7,183.1,14.6,1.0,125.1,200.0,1,Pneumonitis,3,1,2,1,0,0 |
| 1ed81fb1-d7e8ddd8-45c885f13-01fb-000190f99c04,SITE_008,2023-12-19,71.93677544679177,Female,White,Private,Current,100.9,4.3,60.0,0.0,0,0,None,0,0,27.0,SCLC_Extensive,NA,Exte,T3,N3,M0,6.6,LUL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,91,100,>=50%,7.8,0,MSS,Chemo_IO_Combination,None,Atezolizumab,Etoposide_Platinum,None,NA,None,0.0,3,97.4,0,0,0,0,3.4,1,12.6,0,2.8,SD,0,1,5.3,0.0,8.2,0,0,1,312.2,5.8,14.2,1,7.9,1,G2,Negative,Negative,Positive,2,73.0,64.6,0,None,0,0,1,1,2,3.6,296.6,9.6,5.5,187.7,20.1,0,None,0,1,0,4,0,0 |
| 0415a94a-1c97a107-4c40fbde-0a94-0000351998c9,SITE_041,2018-11-11,56.575292091803085,Female,White,Private,Current,56.3,2.2,60.0,0.0,0,0,None,0,1,25.3,SCLC_Limited,NA,Limi,T2b,N0,M0,4.3,LUL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,30,47,1-49%,23.5,1,MSS,Chemo_IO_Combination,None,Durvalumab,Etoposide_Platinum,None,NA,Conventional_EBRT,49.5,7,50.8,0,0,0,0,18.7,1,18.7,1,17.8,SD,0,1,1.1,0.0,-23.3,0,0,0,176.1,25.0,1.4,1,1.57,0,GX,Negative,Negative,Negative,1,91.0,79.2,1,II,0,0,1,1,3,3.7,351.0,12.7,2.7,50.0,4.4,0,None,0,1,0,0,0,0 |
| 0fb6882c-6dfdb935-42f239884-0882-0000cc44ea43,SITE_037,2017-05-08,73.65686999016606,Male,White,Private,Former,5.1,1.0,34.0,1.7,0,0,None,0,0,28.5,SCLC_Limited,NA,Limi,T1c,N0,M0,2.5,RLL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,11.1,1,MSS,Chemo_IO_Combination,None,Durvalumab,Etoposide_Platinum,None,NA,Conventional_EBRT,48.1,7,71.3,0,0,0,0,26.0,1,31.0,1,22.3,PD,0,0,3.7,0.0,30.6,0,0,0,365.1,9.5,8.4,0,0.0,0,G2,Negative,Negative,Positive,1,93.7,68.7,0,None,0,0,0,0,0,3.4,334.4,10.4,4.4,102.6,85.4,0,None,0,2,2,2,0,0 |
| 08a88577-3c9ba642-419f99065-0857-0000708ec712,SITE_003,2020-08-07,54.119767274297736,Male,White,Private,Current,10.7,1.0,60.0,0.0,0,0,None,0,0,26.9,Adenocarcinoma,Micropapillary,IA,T3,N0,M0,6.4,RUL,Bilateral,1,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,12,12,1-49%,6.1,0,MSS,Surgery_Adjuvant,None,None,None,VATS,R0,None,0.0,7,64.5,0,0,0,0,35.2,0,35.2,0,32.0,CR,1,1,5.8,104.2,-87.4,0,0,0,489.4,7.6,11.9,0,0.0,0,G2,Positive,Negative,Negative,1,67.5,44.0,0,None,0,0,1,0,0,3.9,267.1,11.6,8.0,50.0,6.4,0,None,0,0,0,2,0,0 |
| 6a61e669-2e8ad4ce0-413f25b33b-0e66-000566f8b35c,SITE_010,2018-04-02,59.451305176311976,Male,White,Medicare,Current,120.0,3.4,60.0,0.0,0,1,Radon,1,0,26.9,Adenocarcinoma,Papillary,IIIB,T2b,N2,M0,4.1,LLL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,0,0,<1%,10.0,0,MSS,CCRT,None,Durvalumab,Carboplatin_Paclitaxel,None,NA,IMRT,63.2,9,67.9,0,0,0,0,41.2,1,58.1,0,33.3,SD,0,1,0.8,0.0,-9.4,0,0,1,257.3,2.7,13.8,1,26.91,0,G1,Positive,Negative,Negative,0,108.9,90.0,0,None,1,1,1,0,2,2.5,400.2,16.5,2.2,119.6,24.9,0,None,0,1,0,2,0,1 |
| 722a278e-31f2714e3-41567e76aa-0278-0005cc24023d,SITE_001,2023-11-26,79.38386814417683,Male,White,Private,Former,20.9,1.0,60.0,10.0,0,0,Radon,1,0,19.5,SCLC_Limited,NA,Limi,T1b,N2,M0,2.0,LLL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,80,100,>=50%,9.9,0,MSS,Chemotherapy_Only,None,Durvalumab,Etoposide_Platinum,None,NA,Conventional_EBRT,49.2,5,47.6,0,0,0,0,1.6,1,6.3,1,1.3,SD,0,1,3.7,0.0,5.0,0,0,0,199.5,2.8,50.3,1,32.79,1,G2,Negative,Negative,Positive,2,88.4,85.0,0,None,0,0,0,0,0,3.5,125.7,14.4,4.3,109.1,74.9,0,None,0,2,0,2,1,0 |
| 139ed20b-8957be4e-43adc7621-0d20-0000ff10aa96,SITE_014,2024-02-01,74.98209154559487,Male,Black,Private,Current,20.4,1.0,60.0,0.0,0,0,None,0,0,28.2,SCLC_Limited,NA,Limi,T2b,N3,M0,4.3,RML,Right,1,0,0,0,0,0,0,0,None,None,None,None,None,None,1,0,0,None,0,0,1,52,45,>=50%,9.6,0,MSS,Chemo_IO_Combination,None,Atezolizumab,Etoposide_Platinum,None,NA,Conventional_EBRT,58.5,3,84.7,0,0,0,0,3.2,1,9.2,1,2.6,SD,0,1,3.7,0.0,-12.2,0,0,0,227.6,6.2,6.6,1,22.87,1,G2,Negative,Negative,Negative,2,67.2,90.3,0,None,1,0,1,0,1,3.8,243.2,9.5,2.6,50.0,5.0,0,None,0,2,2,3,0,0 |
| 5f952893-29d141c06-411ebf79b9-0289-0004da930f7e,SITE_005,2018-01-21,81.1302837520157,Male,White,Private,Never,0.0,0.0,0.0,0.0,0,0,None,0,0,24.5,SCLC_Extensive,NA,Exte,T4,N0,M0,7.1,RML,Right,0,0,0,0,0,0,0,0,None,None,None,None,G12V,None,0,0,0,None,0,0,1,0,0,<1%,10.6,1,MSS,Chemo_IO_Combination,None,Atezolizumab,Etoposide_Platinum,None,NA,None,0.0,6,80.7,0,0,0,0,1.1,1,2.4,1,0.9,SD,0,1,1.1,0.0,1.5,0,0,0,363.2,18.3,61.7,1,4.44,0,GX,Negative,Negative,Positive,1,86.1,93.5,0,None,0,1,0,0,1,5.0,600.0,11.0,8.9,165.3,195.6,1,Pneumonitis,1,1,0,2,1,1 |
| 16f24390-a09fd8f1-444d6cab0-0439-00012a4d6e57,SITE_036,2020-04-16,64.41909335497073,Female,Asian,Medicare,Current,67.3,1.4,60.0,0.0,0,1,None,0,0,25.3,Squamous_Cell,Keratinizing,IA,T3,N2,M0,6.0,RML,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,3.5,0,MSS,Surgery_Adjuvant,None,None,Carboplatin_Paclitaxel,Robotic,R0,None,0.0,7,91.3,1,0,0,0,16.8,0,16.8,0,14.3,PD,0,0,3.1,0.0,38.2,0,0,0,239.6,6.3,28.3,0,0.0,0,G2,Negative,Positive,Negative,1,93.7,75.0,0,None,0,0,0,1,1,3.8,100.0,12.5,4.7,215.0,108.9,0,None,0,1,1,1,0,0 |
| 2f00b455-14904ee54-48d021cff-0b45-000263092858,SITE_027,2024-10-31,56.05363600787071,Female,White,Medicare,Current,65.0,3.2,60.0,0.0,0,0,None,0,1,30.7,Squamous_Cell,Basaloid,IVB,T1c,N1,M1b,2.8,RUL,Right,1,1,0,0,0,1,0,1,Bone|Adrenal,None,None,None,None,None,0,0,0,None,0,0,0,56,65,>=50%,9.9,0,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,3,94.8,0,0,0,0,14.1,1,14.1,1,13.3,SD,0,1,0.5,0.0,17.8,0,0,0,134.3,6.5,4.3,0,0.0,0,G2,Negative,Positive,Negative,0,85.6,76.2,0,None,0,0,1,1,3,3.8,153.4,12.0,4.4,132.2,34.1,1,Pneumonitis,1,1,4,1,0,0 |
| 4cb89347-2190c06f2-4e629b9d5-0934-0003e55f7aa2,SITE_050,2022-06-02,64.71584662783174,Female,White,Private,Never,0.0,0.0,0.0,0.0,1,0,None,0,0,22.8,Large_Cell,NA,IVB,T3,N0,M1b,5.8,RML,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,0,0,<1%,1.9,0,MSS,Chemotherapy_Only,None,None,Carboplatin_Paclitaxel,None,NA,None,0.0,4,91.4,1,0,0,0,2.0,1,3.1,1,1.4,PR,1,1,0.7,0.6,-45.2,0,0,0,393.9,4.1,13.7,1,3.95,1,G1,Negative,Negative,Negative,0,78.6,88.1,0,None,1,1,0,0,2,3.4,119.4,13.1,1.9,59.3,200.0,0,None,0,0,1,3,0,0 |
| 5c268fa1-2850ded68-411473aee3-08fa-0004adf54b34,SITE_038,2017-02-26,67.96929732378545,Male,White,Private,Current,5.6,1.0,37.4,0.0,0,0,None,0,0,32.1,Squamous_Cell,Keratinizing,IVA,T1c,N0,M1a,2.8,RUL,Left,0,0,0,0,0,1,0,1,Bone|Adrenal,None,None,None,None,None,0,0,0,None,0,0,0,0,0,<1%,15.2,1,MSS,Chemo_IO_Combination,None,Atezolizumab,Carboplatin_Paclitaxel,None,NA,None,0.0,3,92.9,0,0,0,0,4.3,1,12.5,0,4.2,PR,1,1,0.5,2.3,-49.1,0,0,1,149.7,1.8,36.4,1,13.24,1,G3,Negative,Positive,Negative,1,30.0,52.6,0,None,1,0,1,0,1,4.7,231.4,11.0,7.6,317.1,11.3,0,None,0,0,0,1,0,0 |
| 6ff1a621-30f9b8ae8-414fd4f263-0a62-0005af456fb4,SITE_031,2020-11-26,67.75039280523009,Male,Black,Uninsured,Never,0.0,0.0,0.0,0.0,0,1,None,0,1,32.5,SCLC_Extensive,NA,Exte,T2b,N2,M0,4.7,LLL,Right,1,0,0,0,0,0,0,0,None,None,None,None,G12C,None,0,0,0,None,0,0,0,100,100,>=50%,3.3,0,MSS,Chemotherapy_Only,None,Atezolizumab,Etoposide_Platinum,None,NA,None,0.0,9,77.8,1,0,0,0,8.1,1,8.1,1,7.9,PD,0,0,0.7,0.0,46.3,0,0,0,302.6,10.5,21.1,0,0.0,0,G3,Negative,Negative,Negative,3,57.6,66.4,0,None,0,1,1,0,2,3.4,411.1,11.8,8.3,463.3,66.1,1,Dermatitis,1,2,0,2,0,0 |
| 05bb8272-2820911f-411328756-0827-00004a859fd1,SITE_026,2021-03-12,77.76996454818867,Male,White,Medicare,Current,36.1,1.0,60.0,0.0,0,0,None,0,0,29.4,SCLC_Extensive,NA,Exte,T2b,N0,M0,4.1,RML,Right,0,0,0,0,0,0,0,0,None,None,None,None,G12C,None,0,0,0,None,0,0,1,100,100,>=50%,26.0,1,MSS,Chemotherapy_Only,None,Atezolizumab,Etoposide_Platinum,None,NA,None,0.0,9,73.6,0,0,0,0,4.0,1,6.4,1,3.1,CR,1,1,2.8,10.4,-60.7,0,0,0,100.0,6.0,31.7,1,7.69,1,G2,Negative,Negative,Positive,0,87.2,71.1,1,II,0,0,0,1,3,4.8,262.1,10.9,2.6,188.7,30.5,0,None,0,0,1,1,0,0 |
| 1924c568-b00165d9-44b6e5038-0c56-000146de064f,SITE_003,2021-07-13,63.567930962467265,Male,White,Medicare,Current,5.0,1.0,33.2,0.0,0,0,None,0,0,21.6,Squamous_Cell,Keratinizing,IIIB,T1c,N2,M0,2.8,LUL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,81,90,>=50%,1.0,0,MSS,CCRT,None,Durvalumab,Carboplatin_Paclitaxel,None,NA,IMRT,57.2,4,87.3,0,0,0,0,8.2,0,8.2,0,6.0,SD,0,1,0.9,0.0,-8.7,0,0,0,258.3,10.6,9.9,0,0.0,0,G2,Negative,Positive,Negative,3,57.2,86.8,1,II,0,0,1,1,2,3.4,179.7,11.8,5.0,120.0,7.7,0,None,0,1,0,2,0,0 |
| 23e7b4d6-fb55f1db-46bb71e82-0b4d-0001d2c42ee5,SITE_004,2015-04-02,70.34432748212778,Female,White,Medicare,Current,72.7,1.9,60.0,0.0,0,0,None,0,0,16.2,SCLC_Limited,NA,Limi,T2a,N1,M0,3.9,LUL,Right,0,0,0,1,0,0,0,0,None,None,None,None,G12D,None,0,0,0,None,0,0,1,100,100,>=50%,40.7,1,MSS,Chemo_IO_Combination,None,Atezolizumab,Etoposide_Platinum,None,NA,Conventional_EBRT,57.0,4,89.0,0,0,0,0,6.9,1,6.9,1,6.0,PD,0,0,0.5,0.0,69.9,0,0,0,236.5,8.4,39.1,0,0.0,0,G2,Negative,Negative,Positive,1,84.2,63.4,0,None,0,0,0,1,2,4.3,263.2,13.9,6.8,120.9,8.1,0,None,0,1,1,1,1,1 |
| 27b8afa5-1160ccd84-4772a0eef-0afa-00020460eb68,SITE_031,2017-12-28,57.60804208037124,Male,Other,Medicaid,Current,3.1,1.0,20.9,0.0,0,1,None,0,0,30.9,SCLC_Limited,NA,Limi,T4,N0,M0,11.1,LLL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,16,38,1-49%,2.1,0,MSS,Chemo_IO_Combination,None,Atezolizumab,Etoposide_Platinum,None,NA,Conventional_EBRT,55.4,3,92.5,0,0,0,0,13.9,0,13.9,0,10.0,PD,0,0,3.8,0.0,42.2,0,1,0,100.0,3.4,12.5,0,0.0,0,G1,Negative,Negative,Positive,1,90.9,60.6,0,None,1,0,1,0,1,3.8,173.3,13.1,20.0,192.5,200.0,0,None,0,4,1,1,0,0 |
| 7fbf607b-37e3ba35e-417f3e2171-0607-00067cb7e646,SITE_001,2023-07-17,71.27801414141622,Male,White,Medicaid,Never,0.0,0.0,0.0,0.0,0,0,None,0,0,26.5,Adenocarcinoma,Micropapillary,IIIC,T1c,N3,M0,2.7,Endobronchial,Right,0,0,0,0,0,0,0,0,None,L858R,None,None,None,None,0,0,0,None,0,0,0,49,57,1-49%,3.1,0,MSS,CCRT,None,Durvalumab,Carboplatin_Paclitaxel,None,NA,IMRT,65.4,5,70.9,0,0,0,0,15.5,0,15.5,0,11.9,PR,1,1,1.2,8.3,-30.3,0,0,0,289.0,8.8,426.4,1,23.74,1,G3,Negative,Negative,Negative,0,73.0,65.1,0,None,0,0,1,0,0,3.5,220.8,11.1,5.9,156.6,98.4,0,None,0,2,2,3,0,0 |
| 63820071-2b88e0318-412a860153-0007-00050d9a05c4,SITE_003,2017-05-31,67.02953122676355,Female,White,Private,Former,30.7,1.0,60.0,7.9,1,0,None,0,0,22.6,SCLC_Extensive,NA,Exte,T4,N2,M0,9.5,RLL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,77,100,>=50%,11.8,1,MSS,Chemo_IO_Combination,None,Atezolizumab,Etoposide_Platinum,None,NA,None,0.0,2,89.5,0,0,0,0,6.1,1,7.2,1,5.2,SD,0,1,4.2,0.0,-7.2,0,0,0,141.1,2.6,4.1,0,0.0,0,G3,Negative,Negative,Positive,0,43.2,79.5,0,None,1,0,1,1,2,4.3,273.0,14.8,4.5,192.7,76.3,1,Pneumonitis,2,2,1,1,0,0 |
| 29036e84-11f18059d-47b0a4b8c-06e8-0002152c9cbb,SITE_011,2017-12-29,59.87677328629708,Male,Asian,Medicare,Former,83.2,3.9,60.0,5.3,0,0,Asbestos,0,1,31.3,Squamous_Cell,Non-keratinizing,IVB,T3,N1,M1a,5.2,RUL,Bilateral,0,0,1,0,1,0,0,0,Brain,None,None,None,None,None,1,0,0,None,0,0,0,100,100,>=50%,15.8,1,MSS,Targeted_TKI,Capmatinib,None,None,None,NA,None,0.0,6,58.5,0,0,0,0,7.6,0,7.6,0,6.7,SD,0,1,8.0,0.0,-22.5,0,0,0,255.3,8.8,500.0,1,16.95,0,G2,Negative,Positive,Negative,1,61.7,70.9,0,None,0,0,1,0,0,4.5,481.3,14.6,4.0,194.4,7.9,0,None,0,2,1,1,0,0 |
| 7c64ceee-366c1a883-41752e6cca-0cee-0006511e821d,SITE_045,2018-03-23,64.7596210593389,Male,White,Private,Never,0.0,0.0,0.0,0.0,0,1,None,0,0,22.1,SCLC_Limited,NA,Limi,T2b,N2,M0,4.7,LLL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,7.0,0,MSS,Chemotherapy_Only,None,Atezolizumab,Etoposide_Platinum,None,NA,Conventional_EBRT,47.2,3,76.1,0,0,0,0,16.2,1,21.4,1,12.3,PD,0,0,5.2,0.0,59.0,0,0,0,199.2,7.0,6.4,0,0.0,0,G3,Negative,Negative,Negative,1,87.3,48.8,0,None,0,0,0,0,1,3.7,250.8,12.5,4.2,95.3,58.1,0,None,0,0,0,2,0,0 |
| 3fe94a92-1bf6109ff-4bfbbdfb6-04a9-00033ed8c971,SITE_023,2016-10-09,65.2503304081054,Male,White,Medicare,Former,23.3,1.0,60.0,8.9,0,0,None,0,1,24.1,Adenocarcinoma,Micropapillary,IIIA,T1b,N1,M0,1.9,RUL,Left,0,0,0,0,0,0,0,0,None,None,None,None,G12C,None,0,0,0,None,0,0,0,32,61,1-49%,20.2,1,MSS,Chemo_RT,None,None,Carboplatin_Paclitaxel,None,NA,IMRT,60.3,4,90.1,0,0,0,0,1.8,1,7.4,0,1.8,SD,0,1,1.2,0.0,19.5,0,0,1,116.7,25.0,92.3,0,0.0,0,G2,Positive,Negative,Negative,1,97.6,51.9,0,None,0,0,0,1,3,3.8,223.4,12.0,7.7,90.6,11.6,0,None,0,1,0,0,0,0 |
| 40184985-1c0aa02a4-4c048dc8f-0498-0003413bbbc8,SITE_036,2016-07-21,64.43352627129758,Female,Asian,Private,Former,49.7,3.3,60.0,18.8,0,0,None,0,1,28.4,SCLC_Extensive,NA,Exte,T1b,N2,M0,1.5,RUL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,83,>=50%,4.4,0,MSS,Chemo_IO_Combination,None,Atezolizumab,Etoposide_Platinum,None,NA,None,0.0,4,84.7,0,0,0,0,4.6,1,13.9,1,3.5,SD,0,1,0.9,0.0,-26.5,0,0,0,145.1,3.7,54.2,1,9.2,1,G1,Negative,Negative,Positive,1,37.5,74.2,1,III,0,0,0,0,1,3.6,554.3,16.0,2.4,125.4,200.0,0,None,0,0,2,1,1,0 |
| 3783719f-184981b5a-4a68a54dd-0719-0002d1acc51a,SITE_021,2018-06-20,83.827741801543,Female,White,Private,Former,35.5,1.6,60.0,8.4,0,0,None,0,0,21.0,Squamous_Cell,Non-keratinizing,IVA,T1b,N0,M1a,1.3,RUL,Right,0,0,0,0,0,0,0,1,Adrenal,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,6.3,0,MSS,Chemotherapy_Only,None,None,Carboplatin_Paclitaxel,None,NA,None,0.0,5,59.5,0,0,0,0,4.7,1,12.3,1,3.5,CR,1,1,0.5,8.3,-72.6,0,0,0,151.0,2.6,6.7,0,0.0,0,G3,Negative,Positive,Negative,0,76.5,74.7,0,None,1,0,0,0,1,3.9,100.0,15.7,8.6,196.5,123.9,0,None,0,1,2,2,0,0 |
| 126b3bbd-80eea22c-43741b337-03bb-0000ef7208a0,SITE_009,2023-09-27,66.06476297807514,Male,White,Uninsured,Former,80.0,2.9,60.0,13.9,0,0,None,0,0,25.5,Adenocarcinoma,Papillary,IA,T2b,N1,M0,4.8,Central,Left,0,0,1,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,44,83,1-49%,6.9,0,MSS,Surgery_Adjuvant,None,None,None,Segmentectomy,R0,None,0.0,12,65.3,0,0,0,0,17.4,0,17.4,0,13.0,CR,1,1,1.6,44.5,-67.7,0,0,0,399.9,5.3,41.2,1,25.65,0,G3,Positive,Negative,Negative,1,48.6,72.4,1,II,1,0,1,0,3,3.3,191.3,9.5,1.5,58.2,79.8,0,None,0,0,0,0,0,0 |
| 7799847c-345329f65-4166cc8d74-0847-000612cbba53,SITE_019,2015-01-06,64.6829869533153,Female,White,Medicaid,Current,120.0,3.4,60.0,0.0,0,0,None,0,0,30.9,SCLC_Extensive,NA,Exte,T4,N0,M0,11.7,RUL,Right,1,0,1,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,5.6,0,MSS,Chemo_IO_Combination,None,Durvalumab,Etoposide_Platinum,None,NA,None,0.0,5,82.6,0,0,0,0,4.4,1,7.2,1,4.3,PR,1,1,1.4,3.2,-58.3,0,0,0,371.6,12.0,11.1,0,0.0,0,G2,Negative,Negative,Positive,2,76.6,64.5,0,None,1,0,1,0,1,2.5,138.3,14.9,7.1,129.4,68.5,0,None,0,3,0,1,0,0 |
| 01c8aa0d-c7ca65c-4559fe27-0aa0-00001730a2b0,SITE_005,2017-10-30,47.074215902703656,Female,White,Private,Former,50.6,1.3,60.0,6.4,1,0,None,0,1,26.9,Adenocarcinoma,Papillary,IB,T4,N1,M0,8.9,RLL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,63,100,>=50%,1.6,0,MSS,Surgery_Adjuvant,None,None,None,Segmentectomy,R0,None,0.0,1,77.3,0,0,0,0,19.5,0,19.5,0,18.8,CR,1,1,3.7,51.9,-66.3,0,0,0,733.1,1.0,27.9,1,3.99,0,G2,Positive,Negative,Negative,1,72.2,84.6,0,None,0,0,0,0,1,2.9,177.8,15.9,8.7,145.2,17.6,0,None,0,0,1,2,0,0 |
| 164ec24a-9c275007-442ec46de-0c24-000121ffddc9,SITE_039,2015-08-10,58.50503015619496,Female,Hispanic,VA,Current,103.6,2.9,60.0,0.0,0,1,None,0,0,31.6,Squamous_Cell,Non-keratinizing,IIIA,T1a,N1,M0,0.6,RLL,Right,0,0,1,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,8.8,0,MSS,CCRT,None,Durvalumab,Carboplatin_Paclitaxel,None,NA,IMRT,60.7,4,74.8,0,0,0,0,7.5,0,7.5,0,5.3,SD,0,1,1.2,0.0,-20.6,0,0,0,189.4,14.9,24.0,0,0.0,0,G2,Negative,Positive,Negative,0,117.5,77.9,0,None,1,0,0,0,2,3.7,271.0,13.8,7.9,110.8,41.7,0,None,0,0,0,1,0,0 |
| 1d655e69-cdc594e0-458301b3b-05e6-00017e25cb5c,SITE_010,2020-08-11,64.50080246766464,Male,Black,Private,Former,17.3,1.0,60.0,0.5,0,0,None,0,0,31.1,SCLC_Extensive,NA,Exte,T1c,N0,M0,2.5,LUL,Left,0,1,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,13,12,1-49%,8.1,0,MSS,Chemo_IO_Combination,None,Durvalumab,Etoposide_Platinum,None,NA,None,0.0,7,97.7,0,0,0,0,6.0,1,7.0,1,5.5,PD,0,0,0.5,0.0,46.8,0,0,0,186.4,6.3,13.2,1,26.68,0,G2,Negative,Negative,Positive,2,65.3,77.4,1,III,0,0,1,0,2,3.3,327.1,11.6,5.4,344.3,200.0,1,Hepatitis,4,1,0,1,1,1 |
| 23c00549-fa402500-46b400fdb-0054-0001d0c044bc,SITE_019,2017-07-03,60.48439957632189,Male,White,Private,Former,31.6,1.0,60.0,5.3,0,1,Asbestos,0,1,26.0,SCLC_Extensive,NA,Exte,T1b,N3,M0,1.7,RML,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,100,100,>=50%,23.8,1,MSS,Chemotherapy_Only,None,Atezolizumab,Etoposide_Platinum,None,NA,None,0.0,4,83.6,0,0,0,0,4.0,1,12.2,1,2.9,CR,1,1,1.3,0.7,-78.7,0,0,0,261.8,3.0,12.0,0,0.0,0,G2,Negative,Negative,Positive,0,93.9,77.9,0,None,0,0,0,0,0,3.7,154.4,11.8,5.9,310.8,40.4,0,None,0,1,0,2,0,0 |
| 10df8ce9-761cda60-4329ea6bb-08ce-0000db5a27dc,SITE_050,2022-11-30,80.12622213708907,Female,White,Medicaid,Former,23.9,1.0,60.0,19.6,0,0,None,0,0,16.0,Squamous_Cell,Non-keratinizing,IIIA,T4,N0,M0,8.3,Central,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,2.8,0,MSS,CCRT,None,Durvalumab,Carboplatin_Paclitaxel,None,NA,IMRT,61.0,2,85.6,0,0,0,0,35.4,0,35.4,0,25.6,PR,1,1,3.6,5.4,-35.3,0,0,0,204.9,5.5,30.2,1,6.65,1,G3,Negative,Positive,Negative,2,93.2,97.6,0,None,0,0,1,0,0,3.5,279.9,15.9,3.4,190.4,5.7,0,None,0,0,0,4,0,0 |
| 024c8f3f-1017eaba-46e5adbd-08f3-00001de3463a,SITE_030,2020-11-05,65.43309113373593,Male,Black,Private,Former,107.0,4.1,60.0,9.2,0,0,None,0,1,21.0,Squamous_Cell,Keratinizing,IA,T1c,N0,M0,2.8,LLL,Right,0,1,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,5.1,0,MSS,Surgery_Adjuvant,None,None,Carboplatin_Paclitaxel,VATS,R0,None,0.0,9,92.4,0,0,0,0,52.0,0,52.0,0,37.6,CR,1,1,0.5,54.5,-68.7,0,0,0,182.9,4.1,6.8,0,0.0,0,G2,Negative,Positive,Negative,1,71.5,55.6,1,IV,0,0,0,0,1,3.4,127.9,14.2,2.0,429.3,131.9,0,None,0,4,0,1,0,0 |
| 56bd84f8-25f2ea2c9-4104388ee8-084f-0004679fc09f,SITE_023,2022-10-31,79.2402203685234,Female,Black,Private,Former,68.0,2.1,60.0,45.6,0,0,None,0,0,29.4,Squamous_Cell,Non-keratinizing,IIIC,T1b,N0,M0,1.8,RLL,Left,0,0,1,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,26.7,1,MSS,CCRT,None,Durvalumab,Carboplatin_Paclitaxel,None,NA,IMRT,57.3,12,78.4,1,0,0,0,15.6,1,49.7,0,14.8,SD,0,1,2.7,0.0,8.6,0,0,1,251.4,2.8,7.1,0,0.0,0,G3,Negative,Positive,Negative,2,77.1,65.3,0,None,0,0,0,0,0,3.5,105.6,13.6,5.3,251.4,7.2,0,None,0,0,0,1,0,1 |
| 7c1258e4-364806e3d-4174370aac-058e-00064cee839b,SITE_028,2021-05-06,67.5861940234785,Female,White,Medicare,Former,15.0,1.0,60.0,10.0,0,1,None,0,0,19.0,Adenocarcinoma,Solid,IIB,T3,N2,M0,6.6,RLL,Right,0,0,0,0,0,0,0,0,None,None,None,None,G12D,None,0,0,0,None,0,0,1,38,47,1-49%,11.8,1,MSS,SBRT,None,None,None,None,NA,SBRT,47.7,11,78.9,0,0,0,0,1.6,1,22.4,1,1.3,SD,0,1,5.3,0.0,2.1,0,0,0,347.9,1.6,63.2,0,0.0,0,GX,Negative,Negative,Negative,0,75.0,66.6,1,II,0,0,1,0,1,4.3,207.6,17.0,4.7,160.8,19.2,0,None,0,2,0,4,0,0 |
| 0f98351f-6d2973da-42ec89f5d-0351-0000cabab29a,SITE_040,2019-05-20,67.35366444600498,Male,Hispanic,Private,Former,18.8,1.0,60.0,16.4,0,1,None,0,0,24.5,Adenocarcinoma,Acinar,IVB,T2b,N0,M1b,4.6,LLL,Right,1,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,14.8,1,MSS,Chemo_IO_Combination,None,Pembrolizumab,Carboplatin_Pemetrexed,None,NA,None,0.0,7,83.4,0,0,0,0,13.6,1,13.6,1,11.8,SD,0,1,4.8,0.0,14.7,0,0,0,100.0,13.3,33.6,1,23.95,1,G2,Positive,Negative,Negative,2,61.6,92.1,1,III,0,0,0,0,1,3.9,179.6,10.5,8.6,111.5,9.9,0,None,0,2,2,3,0,1 |
| 25f4dd97-109b20f22-471de98c5-0dd9-0001ed6f40b2,SITE_013,2023-08-09,66.15643374673124,Female,White,Private,Former,120.0,4.9,60.0,18.1,0,0,None,0,0,27.5,Large_Cell,NA,IIIC,T1c,N1,M0,2.9,LLL,Right,1,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,0,0,<1%,13.6,1,MSS,CCRT,None,Durvalumab,Carboplatin_Paclitaxel,None,NA,IMRT,58.2,2,88.3,0,0,0,0,2.1,1,29.9,0,1.5,CR,1,1,2.4,4.1,-73.2,0,0,1,183.8,4.7,4.2,1,4.86,0,G3,Negative,Negative,Negative,2,60.1,66.0,0,None,0,0,0,0,0,4.6,422.1,12.3,4.1,117.1,0.4,1,Endocrinopathy,1,0,2,3,0,0 |
| 40cf6b50-1c5abef31-4c26e41f0-06b5-00034a887317,SITE_032,2019-10-05,67.03606439040387,Female,Asian,Private,Former,11.0,1.0,60.0,7.7,0,0,None,0,0,32.6,SCLC_Limited,NA,Limi,T3,N2,M0,6.2,RLL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,10,24,1-49%,13.6,1,MSS,Chemo_IO_Combination,None,Atezolizumab,Etoposide_Platinum,None,NA,Conventional_EBRT,47.2,7,79.9,0,0,0,0,12.6,1,27.2,1,12.2,SD,0,1,0.9,0.0,-3.6,0,0,0,121.3,5.4,6.0,0,0.0,0,G2,Negative,Negative,Positive,0,67.6,59.3,1,IV,0,0,1,0,1,3.9,580.7,12.9,5.0,186.5,26.1,0,None,0,0,0,0,0,0 |
| 76b865bf-33f0ac83a-416429313d-065b-0006075d2aba,SITE_044,2024-06-29,83.32855252897366,Female,White,Medicare,Former,20.4,1.0,60.0,6.5,1,0,None,0,0,23.4,SCLC_Limited,NA,Limi,T1a,N0,M0,0.9,RLL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,46.5,1,MSS,Chemotherapy_Only,None,Atezolizumab,Etoposide_Platinum,None,NA,Conventional_EBRT,50.7,7,82.5,0,0,0,0,0.8,1,14.2,0,0.8,PD,0,0,2.4,0.0,43.9,0,0,0,226.6,14.5,1.5,1,10.84,1,G3,Negative,Negative,Positive,0,54.5,70.3,1,III,1,0,1,0,2,2.8,147.8,12.1,5.5,118.7,200.0,0,None,0,1,0,3,0,0 |
| 58dd976b-26e0f23ee-410a98c641-0976-00048340b076,SITE_029,2024-12-09,44.96369809586343,Male,White,Private,Current,18.3,1.0,60.0,0.0,0,1,None,0,0,23.1,SCLC_Limited,NA,Limi,T1a,N3,M0,0.6,RUL,Left,1,0,1,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,43,36,1-49%,9.8,0,MSS,Chemotherapy_Only,None,Atezolizumab,Etoposide_Platinum,None,NA,Conventional_EBRT,48.1,3,73.1,0,0,0,0,4.1,1,22.2,0,3.2,PD,0,0,2.4,0.0,55.0,0,0,1,303.8,7.7,59.8,0,0.0,0,G3,Negative,Negative,Positive,2,66.0,73.7,1,I,0,0,0,0,1,3.3,100.0,8.8,6.7,59.7,32.5,0,None,0,2,0,3,0,0 |
| 621273d7-2ae812ae2-4126375b85-073d-0004faefe1f2,SITE_023,2020-11-19,47.985315427832546,Female,Black,Private,Former,1.1,1.0,7.2,10.0,0,1,None,0,0,25.8,Adenocarcinoma,Papillary,IA,T1a,N0,M0,0.5,RUL,Right,1,1,0,0,0,0,0,0,None,None,EML4-ALK,None,None,None,0,0,0,None,0,0,0,0,0,<1%,3.6,0,MSS,SBRT,None,None,None,None,NA,SBRT,54.0,4,76.0,0,0,0,0,3.2,1,7.9,1,2.9,PD,0,0,2.8,0.0,39.2,0,0,0,427.7,2.1,45.9,0,0.0,0,G3,Positive,Negative,Negative,1,71.5,91.1,1,I,0,0,1,0,2,3.9,101.1,14.5,8.7,118.1,200.0,0,None,0,2,3,1,0,0 |
| 4a62076f-208ae340a-4df26164d-0076-0003c6fa60aa,SITE_008,2021-09-28,61.83987710496692,Female,Asian,Medicare,Current,35.7,1.4,60.0,0.0,1,1,None,0,0,27.6,Squamous_Cell,Keratinizing,IIA,T2a,N2,M0,3.5,RUL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,78,92,>=50%,16.0,1,MSS,SBRT,None,None,None,None,NA,SBRT,52.7,7,91.0,0,0,0,0,9.3,1,9.3,1,8.4,SD,0,1,0.5,0.0,-12.5,0,0,0,197.0,12.7,5.4,1,13.72,0,G2,Negative,Negative,Negative,1,77.9,65.9,1,II,0,0,1,0,1,3.9,131.9,11.0,2.3,274.9,16.0,0,None,0,1,0,2,0,0 |
| 35616dbb-175aa001e-4a0244931-06db-0002b5f29286,SITE_013,2017-07-22,67.1380148784069,Female,White,Private,Current,21.5,1.0,60.0,0.0,0,0,None,0,0,25.3,Adenocarcinoma,Papillary,IA,T4,N0,M0,12.0,RUL,Right,0,0,0,0,0,0,0,0,None,L858R,None,None,None,None,0,0,0,None,0,1,0,75,100,>=50%,5.4,0,MSS,SBRT,None,None,None,None,NA,SBRT,47.2,6,99.0,0,0,0,0,9.2,1,9.2,1,9.1,PD,0,0,0.6,0.0,29.6,0,0,0,258.0,24.2,43.8,1,52.34,0,G3,Negative,Negative,Negative,0,83.0,61.0,1,III,0,0,1,1,3,3.5,222.2,11.0,7.3,50.0,28.0,0,None,0,0,3,0,1,0 |
| 19923fa1-b2ffbd68-44cb6bee3-03fa-00014c6d3b34,SITE_048,2023-02-21,73.55599203525811,Female,White,Private,Current,5.3,1.0,35.2,0.0,0,0,None,0,0,30.7,Squamous_Cell,Keratinizing,IA,T2b,N2,M0,4.2,RUL,Right,0,0,0,0,0,0,0,0,None,None,Other,None,None,None,0,0,0,None,0,0,1,0,0,<1%,8.2,0,MSS,Surgery_Adjuvant,None,None,Carboplatin_Paclitaxel,VATS,R2,None,0.0,7,80.8,0,0,0,0,45.2,0,45.2,0,38.2,PR,1,1,4.8,65.4,-56.0,0,0,0,105.5,11.1,217.6,0,0.0,0,G3,Negative,Positive,Negative,0,71.5,57.4,0,None,0,0,1,1,3,3.4,175.8,11.8,3.9,344.4,17.2,0,None,0,1,1,1,0,0 |
| 6ea1da8d-3066cf9dc-414be58fa7-0da8-00059e381930,SITE_028,2021-09-17,71.49432838126101,Female,Asian,Medicare,Current,0.7,1.0,4.7,0.0,1,0,Asbestos,0,0,22.4,Squamous_Cell,Basaloid,IVB,T3,N2,M1b,5.8,Central,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,0,0,<1%,12.6,1,MSS,Chemo_IO_Combination,None,Atezolizumab,Carboplatin_Paclitaxel,None,NA,None,0.0,4,95.7,1,0,0,0,8.0,1,8.0,1,6.1,CR,1,1,0.6,3.5,-70.1,0,0,0,159.1,3.7,3.2,1,11.85,0,G3,Negative,Positive,Negative,2,61.2,66.5,0,None,0,0,1,1,4,3.5,106.8,12.0,7.0,209.4,22.0,0,None,0,1,2,2,0,1 |
| 66ed8d6e-2d07ede03-4134c8a84a-08d6-00053a102e9d,SITE_016,2024-01-08,63.349663827634586,Male,White,Medicare,Never,0.0,0.0,0.0,0.0,0,0,Asbestos,0,1,26.5,SCLC_Limited,NA,Limi,T2a,N0,M0,3.7,LLL,Right,0,1,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,97,100,>=50%,4.3,0,MSS,Chemo_IO_Combination,None,Atezolizumab,Etoposide_Platinum,None,NA,Conventional_EBRT,54.8,9,82.6,1,0,0,0,6.5,1,21.4,1,5.2,PR,1,1,0.7,0.5,-34.1,0,0,0,271.4,2.3,9.6,1,35.41,1,G3,Negative,Negative,Negative,0,82.7,113.0,0,None,0,1,0,0,2,3.7,489.3,12.3,12.6,128.9,35.0,0,None,0,1,0,0,0,0 |
| 0336852c-167da435-49a38f84-0852-000029c4c343,SITE_021,2017-09-01,76.68091508579674,Male,White,Private,Former,22.1,1.0,60.0,17.6,1,0,None,0,0,28.0,Adenocarcinoma,Solid,IVA,T3,N0,M1c,6.8,LLL,Left,0,0,0,0,0,0,1,0,Liver,None,None,None,G12V,None,0,0,0,None,0,0,1,24,50,1-49%,5.7,0,MSS,Chemo_IO_Combination,None,Atezolizumab,Carboplatin_Pemetrexed,None,NA,None,0.0,1,78.8,0,1,0,0,21.4,1,22.3,0,19.1,PD,0,0,0.5,0.0,26.5,0,0,0,124.0,3.6,3.1,1,19.9,1,G3,Positive,Negative,Negative,0,89.2,78.1,1,III,0,1,1,1,4,3.8,279.1,14.4,1.0,176.4,193.5,0,None,0,1,1,4,1,0 |
| 5b9275f8-2810139c9-4112b761e8-075f-0004a66ffd9f,SITE_029,2022-11-14,76.78685632995095,Male,White,Medicaid,Former,68.7,1.9,60.0,13.9,0,0,None,0,0,24.2,Adenocarcinoma,Lepidic,IIIC,T4,N0,M0,9.7,LUL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,100,100,>=50%,13.8,1,MSS,CCRT,None,Durvalumab,Carboplatin_Paclitaxel,None,NA,IMRT,60.7,4,75.4,0,0,0,0,13.1,1,26.3,1,11.1,PD,0,0,1.9,0.0,60.9,0,0,0,454.2,8.0,62.7,1,2.16,1,G1,Positive,Negative,Negative,0,66.3,81.6,0,None,0,0,1,1,1,3.3,482.8,14.8,10.5,264.2,5.7,0,None,0,3,0,3,0,1 |
| 0acd3aba-4b9c9b17-42067b02e-03ab-00008c6bfb79,SITE_027,2019-09-13,68.74854939707987,Male,White,Medicare,Current,61.7,1.9,60.0,0.0,0,0,None,0,0,29.8,Adenocarcinoma,Solid,IVA,T2a,N0,M1a,3.5,LUL,Right,1,0,0,0,0,1,1,1,Bone|Liver|Adrenal,None,None,None,None,None,0,0,0,None,0,0,0,100,100,>=50%,5.5,0,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,11,97.4,0,0,0,0,16.5,0,16.5,0,11.9,SD,0,1,2.6,0.0,-14.1,0,0,0,317.9,23.1,17.9,0,0.0,0,G2,Positive,Negative,Negative,2,57.3,72.0,1,I,0,0,0,0,1,3.9,100.0,12.0,4.1,151.4,20.3,0,None,0,3,1,3,1,0 |
| 5e970720-2962131e1-411bc51560-0072-0004cdab5ca7,SITE_035,2016-11-06,76.145246938625,Male,White,Private,Former,10.9,1.0,60.0,13.2,0,0,None,0,0,26.7,SCLC_Limited,NA,Limi,T4,N3,M0,11.3,RUL,Right,0,0,0,1,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,21.7,1,MSS,Chemo_IO_Combination,None,Durvalumab,Etoposide_Platinum,None,NA,Conventional_EBRT,45.3,4,93.7,0,0,0,0,11.2,1,20.6,1,10.5,PR,1,1,0.5,13.4,-30.9,0,0,0,155.7,4.0,12.5,0,0.0,0,G3,Negative,Negative,Positive,1,67.0,74.2,1,II,0,0,1,0,2,3.9,378.5,11.3,2.5,262.2,50.6,1,Pneumonitis,2,2,1,0,0,0 |
| 69b8db08-2e40dfd39-413d2a9118-0db0-00055e631f6f,SITE_013,2016-09-16,69.59013000260522,Female,White,Medicare,Former,14.4,1.0,60.0,1.8,0,0,None,0,0,29.5,Squamous_Cell,Non-keratinizing,IVB,T3,N2,M1b,6.3,LUL,Right,1,0,0,0,1,0,0,0,Brain,None,None,None,None,None,0,0,0,None,0,0,1,94,81,>=50%,3.7,0,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,7,83.0,0,0,0,0,5.9,1,14.9,0,5.7,PD,0,0,8.0,0.0,40.3,0,0,1,116.6,4.4,26.4,1,38.33,0,G1,Negative,Negative,Negative,1,71.7,84.6,0,None,0,0,1,0,1,3.7,186.0,12.2,3.3,247.3,137.0,0,None,0,3,2,2,0,0 |
| 10c6801a-756d80b7-43253804e-0801-0000da148159,SITE_033,2020-08-13,61.665911245562604,Male,Hispanic,Medicare,Current,26.6,1.0,60.0,0.0,0,0,None,0,0,26.9,Adenocarcinoma,Papillary,IVA,T3,N2,M1a,6.9,RML,Right,1,0,0,0,1,0,1,0,Brain|Liver,None,None,None,None,None,0,0,0,None,0,0,1,82,87,>=50%,3.7,0,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,8,96.5,0,0,0,0,6.6,1,18.8,0,5.6,PR,1,1,4.4,3.9,-48.4,0,0,1,170.8,16.7,10.3,1,6.25,0,G3,Positive,Negative,Negative,1,95.6,81.0,0,None,1,0,0,0,1,3.5,164.7,10.7,2.2,164.9,0.8,0,None,0,1,1,3,0,0 |
| 3787ef01-184b78908-4a697cd03-0ef0-0002d1e72314,SITE_023,2018-03-11,73.62925997050004,Female,White,Medicare,Never,0.0,0.0,0.0,0.0,0,0,None,0,0,27.7,Adenocarcinoma,Acinar,IVB,T1c,N3,M1b,2.5,LUL,Right,1,0,0,0,1,0,1,0,Brain|Liver,None,None,None,None,None,0,0,1,None,0,0,1,100,82,>=50%,50.2,1,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,6,58.8,0,0,0,0,14.5,0,14.5,0,12.4,PR,1,1,0.5,3.9,-56.0,0,0,0,156.1,5.2,12.4,1,2.64,0,G3,Positive,Negative,Negative,1,87.5,77.6,0,None,1,0,1,0,2,4.1,202.8,12.4,6.4,76.2,2.5,1,Pneumonitis,1,0,3,0,1,0 |
| 0fd72a25-6ee22704-42f857e6f-02a2-0000cded23e8,SITE_048,2016-01-07,68.05082466449744,Female,Black,Medicare,Former,3.8,1.0,25.5,5.2,0,0,Radon,1,0,23.2,Large_Cell,NA,IIA,T3,N2,M0,5.9,Endobronchial,Right,1,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,47,82,1-49%,2.3,0,MSS,Surgery_Adjuvant,None,None,Carboplatin_Paclitaxel,Segmentectomy,R0,None,0.0,3,54.1,0,0,1,0,39.7,0,39.7,0,33.7,CR,1,1,0.5,6.4,-65.8,0,0,0,133.2,25.0,27.9,1,21.59,1,G3,Negative,Negative,Negative,0,74.9,72.3,1,II,0,0,1,0,2,4.5,141.2,10.6,2.2,140.0,21.3,0,None,0,1,1,2,0,1 |
| 489cb424-1fc48ecfd-4d9d61c6c-0b42-0003aff525db,SITE_008,2019-04-09,67.01272854416763,Male,Other,Medicare,Current,40.8,2.7,60.0,0.0,0,1,None,0,0,23.2,Adenocarcinoma,Micropapillary,IVB,T2b,N2,M1a,4.8,Central,Right,0,1,1,1,1,1,0,0,Brain|Bone,None,Other,None,None,None,0,0,0,None,0,1,1,100,100,>=50%,8.8,0,MSS,Targeted_TKI,Alectinib,None,None,None,NA,None,0.0,8,79.6,1,0,0,0,16.8,0,16.8,0,14.5,PR,1,1,0.5,5.2,-38.4,0,0,0,121.1,6.6,9.7,1,10.63,1,G3,Positive,Negative,Negative,1,109.2,66.4,1,III,0,0,0,0,1,3.6,186.5,16.8,10.4,50.0,107.7,0,None,0,2,1,1,1,0 |
| 76ba5ea2-33f18966f-41642f1be6-05ea-00060776ce41,SITE_008,2021-07-11,80.99305893580096,Female,Black,VA,Never,0.0,0.0,0.0,0.0,1,0,None,0,0,31.5,SCLC_Limited,NA,Limi,T4,N0,M0,11.6,RUL,Left,0,1,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,61,100,>=50%,47.8,1,MSS,Chemotherapy_Only,None,Atezolizumab,Etoposide_Platinum,None,NA,Conventional_EBRT,46.2,8,94.7,0,0,0,0,10.6,0,10.6,0,7.7,PR,1,1,1.2,3.3,-55.4,0,0,0,218.1,18.8,11.4,0,0.0,0,G1,Negative,Negative,Positive,0,74.4,78.8,0,None,0,0,1,0,0,3.5,321.6,12.8,7.3,193.9,9.8,0,None,0,2,0,2,0,1 |
| 0a59eef7-487588c2-41f0dcce5-0eef-000086912292,SITE_024,2018-03-10,43.716714778869175,Female,White,Medicare,Former,11.9,1.0,60.0,12.1,1,1,None,0,0,28.9,Large_Cell,NA,IIIA,T4,N0,M0,9.6,LLL,Left,0,0,1,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,8.8,0,MSS,CCRT,None,Durvalumab,Carboplatin_Paclitaxel,None,NA,IMRT,65.5,7,84.4,0,0,0,0,20.4,0,20.4,0,16.9,SD,0,1,5.6,0.0,-24.9,0,0,0,352.9,10.0,16.6,1,6.75,0,G3,Negative,Negative,Negative,3,100.4,73.3,0,None,0,1,1,0,1,4.0,100.0,11.4,5.3,115.4,54.8,0,None,0,3,0,2,0,0 |
| 32e3d79e-1643ae553-498ab86da-0d79-00029591f30d,SITE_026,2024-07-19,53.53200038348409,Female,White,Medicaid,Current,85.2,2.1,60.0,0.0,0,1,None,0,0,21.4,Adenocarcinoma,Solid,IVB,T2a,N0,M1a,3.5,RUL,Left,0,1,0,0,0,1,0,0,Bone,None,None,None,None,None,0,0,0,None,0,1,0,29,49,1-49%,30.3,1,MSS,Chemo_IO_Combination,None,Nivolumab_Ipilimumab,Carboplatin_Pemetrexed,None,NA,None,0.0,4,68.9,1,1,0,0,4.9,1,9.6,1,4.1,SD,0,1,7.5,0.0,-8.8,0,0,0,171.5,13.0,22.4,1,9.66,0,G3,Positive,Negative,Negative,2,97.0,106.1,0,None,0,0,0,1,1,3.2,423.5,13.9,1.1,102.6,200.0,1,Endocrinopathy,1,1,0,3,0,0 |
| 7c8f368f-367ea7dea-4175ada3ad-0368-00065345c54a,SITE_035,2022-10-16,55.722830949443484,Male,White,Medicare,Never,0.0,0.0,0.0,0.0,0,1,None,0,1,26.8,Adenocarcinoma,Lepidic,IB,T4,N0,M0,9.3,RUL,Right,0,0,0,0,0,0,0,0,None,Exon19del,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,16.2,1,MSS,Surgery_Adjuvant,Osimertinib,None,None,Lobectomy,R1,None,0.0,4,73.8,0,0,0,1,29.1,0,29.1,0,29.1,CR,1,1,0.5,110.5,-70.1,0,0,0,305.7,6.4,41.3,0,0.0,0,G2,Positive,Negative,Negative,2,95.7,88.8,0,None,0,0,1,0,1,3.2,243.8,10.0,1.8,219.9,20.4,0,None,0,1,0,1,0,0 |
| 26857c9a-10da66837-4739075ce-07c9-0001f4c753d9,SITE_021,2020-02-15,63.54902384809635,Female,White,Medicaid,Former,41.8,2.3,60.0,6.5,0,0,Radon,1,0,16.0,SCLC_Extensive,NA,Exte,T4,N0,M0,9.8,RUL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,9.0,0,MSS,Chemo_IO_Combination,None,Durvalumab,Etoposide_Platinum,None,NA,None,0.0,2,81.6,0,0,0,0,5.4,1,11.2,1,3.9,PR,1,1,1.7,9.4,-39.2,0,0,0,207.7,6.8,40.4,0,0.0,0,G2,Negative,Negative,Positive,2,80.8,61.2,0,None,0,0,0,0,0,3.5,189.6,11.1,4.2,69.3,14.3,0,None,0,0,0,2,1,1 |
| 10ec7a20-767756e1-432c56e60-07a2-0000dc0233a7,SITE_046,2024-05-04,64.58122238722271,Female,Hispanic,Uninsured,Former,15.0,1.0,60.0,25.3,1,0,Asbestos,0,1,23.4,Adenocarcinoma,Solid,IIIA,T2b,N0,M0,4.2,RUL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,1,0,100,100,>=50%,8.0,0,MSS,CCRT,None,Durvalumab,Carboplatin_Paclitaxel,None,NA,IMRT,57.1,8,41.4,0,0,0,0,9.0,1,9.4,0,7.2,SD,0,1,8.0,0.0,-18.1,0,0,1,332.3,10.3,3.3,1,7.66,0,G3,Positive,Negative,Negative,0,77.1,53.3,0,None,0,0,1,0,1,4.0,319.8,13.3,4.4,158.7,40.8,0,None,0,1,0,0,0,1 |
| 3e89ec08-1b5c57439-4bb9dc418-0ec0-00032d00fc6f,SITE_024,2019-04-30,52.68040634615605,Female,Asian,Private,Current,66.3,1.4,60.0,0.0,0,0,None,0,1,30.3,Squamous_Cell,Keratinizing,IIIA,T1a,N0,M0,0.6,LUL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,1.3,0,MSS,CCRT,None,Durvalumab,Carboplatin_Paclitaxel,None,NA,IMRT,63.5,4,87.4,0,0,0,0,31.3,1,31.3,1,26.6,PD,0,0,0.7,0.0,56.7,0,0,0,165.1,14.0,108.8,1,15.44,1,G2,Negative,Positive,Negative,2,75.1,65.6,1,II,0,0,0,0,1,3.4,240.3,12.8,8.7,121.0,26.3,0,None,0,2,0,2,1,0 |
| 41125a51-1c7807838-4c3370ef3-05a5-00034dee9624,SITE_007,2016-05-24,57.64099869304715,Female,White,Private,Never,0.0,0.0,0.0,0.0,1,0,None,0,0,25.4,SCLC_Limited,NA,Limi,T1b,N1,M0,1.8,RLL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,6.8,0,MSS,Chemo_IO_Combination,None,Atezolizumab,Etoposide_Platinum,None,NA,Conventional_EBRT,45.7,8,74.2,0,0,0,0,4.1,1,20.2,1,3.9,PD,0,0,1.6,0.0,53.3,0,0,0,281.6,11.3,21.6,0,0.0,0,G2,Negative,Negative,Positive,1,90.3,54.7,0,None,0,0,1,0,0,3.8,157.6,14.6,1.0,133.2,29.5,1,Colitis,1,1,1,3,0,0 |
| 54d8bc09-251ed2440-4fe8a341b-0bc0-00044f018c7c,SITE_006,2015-05-11,58.82200405402608,Female,White,Medicare,Current,91.5,3.0,60.0,0.0,0,0,None,0,0,26.5,SCLC_Extensive,NA,Exte,T1a,N0,M0,0.3,RUL,Right,0,1,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,100,100,>=50%,11.1,1,MSS,Chemotherapy_Only,None,Durvalumab,Etoposide_Platinum,None,NA,None,0.0,5,93.7,0,0,0,0,6.4,1,23.9,1,5.3,PR,1,1,0.7,0.5,-32.7,0,0,0,259.8,1.8,13.5,1,3.88,0,G2,Negative,Negative,Positive,2,60.8,64.7,0,None,1,1,1,0,2,2.8,136.1,7.0,2.6,176.0,15.3,1,Colitis,1,0,1,2,0,0 |
| 28288d62-1191bddaf-47879a826-08d6-00020a0f2e01,SITE_049,2024-05-16,90.0,Male,Hispanic,Private,Current,31.4,1.0,60.0,0.0,0,0,None,0,0,16.0,SCLC_Extensive,NA,Exte,T1a,N0,M0,0.9,Endobronchial,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,11.1,1,MSS,Chemotherapy_Only,None,Atezolizumab,Etoposide_Platinum,None,NA,None,0.0,2,93.9,1,0,0,0,3.2,1,9.8,1,2.5,SD,0,1,0.5,0.0,7.1,0,0,0,483.6,9.1,6.8,0,0.0,0,G3,Negative,Negative,Positive,3,70.3,56.5,0,None,0,0,0,0,0,4.1,424.0,14.1,8.1,443.2,13.7,1,Colitis,3,1,3,3,0,0 |
| 7a51dce6-3583d0a4b-416ef596b2-0dce-0006362837b5,SITE_007,2024-08-04,84.1165485035979,Female,White,Medicare,Former,12.9,1.0,60.0,0.6,0,1,None,0,0,24.2,SCLC_Limited,NA,Limi,T4,N0,M0,11.2,LUL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,80.0,1,MSS,Chemo_IO_Combination,None,Atezolizumab,Etoposide_Platinum,None,NA,Conventional_EBRT,47.5,5,74.2,0,0,0,0,15.9,1,19.0,0,13.7,PD,0,0,1.4,0.0,49.3,0,0,1,323.6,4.4,218.5,0,0.0,0,G2,Negative,Negative,Negative,1,105.0,66.8,0,None,0,0,1,0,0,4.5,100.0,11.4,3.5,188.5,4.5,1,Pneumonitis,2,0,0,2,0,0 |
| 42b0df85-1d2d61ca4-4c8129e8f-0df8-000362fb59c8,SITE_048,2022-05-22,63.08838053199583,Male,Asian,Medicare,Former,120.0,3.3,60.0,3.7,1,0,None,0,0,27.5,Adenocarcinoma,Acinar,IVA,T1b,N1,M1c,2.0,RLL,Left,0,0,0,0,1,0,1,0,Brain|Liver,None,None,None,None,None,0,0,0,None,0,1,0,41,98,1-49%,11.6,1,MSS,Chemo_IO_Combination,None,Pembrolizumab,Carboplatin_Pemetrexed,None,NA,None,0.0,3,77.2,0,0,0,0,6.0,1,32.2,0,4.8,PR,1,1,6.3,6.6,-50.1,0,0,0,278.1,4.8,341.0,1,4.33,0,G2,Positive,Negative,Negative,1,86.2,67.0,1,II,0,0,1,0,2,3.3,181.6,10.2,3.2,335.3,50.4,0,None,0,1,0,2,1,0 |
| 24aa451c-100a7e3c5-46dfecf54-0451-0001dca58273,SITE_014,2016-01-11,63.54595874208541,Female,White,Uninsured,Former,80.9,2.8,60.0,0.5,0,0,None,0,0,28.1,Adenocarcinoma,Solid,IVB,T3,N2,M1b,5.9,LUL,Right,0,0,0,0,1,1,0,0,Brain|Bone,None,None,None,None,None,0,0,0,None,0,0,1,8,9,1-49%,15.9,1,MSS,Chemo_IO_Combination,None,Pembrolizumab,Carboplatin_Pemetrexed,None,NA,None,0.0,8,87.9,0,0,0,0,10.9,1,25.5,1,9.4,SD,0,1,1.8,0.0,18.0,0,0,0,117.3,10.7,188.6,1,11.8,0,G3,Negative,Negative,Negative,1,92.2,74.4,0,None,0,0,0,0,0,4.0,100.0,9.1,1.4,342.8,4.2,0,None,0,0,2,3,0,0 |
| 7aea99cf-35c6a34aa-4170bfcd6d-099c-00063de9cf8a,SITE_005,2017-12-07,56.0825620267112,Male,Black,Private,Current,97.6,2.2,60.0,0.0,0,0,None,0,0,30.3,SCLC_Limited,NA,Limi,T3,N2,M0,6.9,LUL,Right,1,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,25.8,1,MSS,Chemo_IO_Combination,None,Atezolizumab,Etoposide_Platinum,None,NA,Conventional_EBRT,52.0,2,84.7,0,0,0,0,4.2,1,28.2,1,3.8,SD,0,1,3.0,0.0,17.3,0,0,0,188.2,25.0,23.2,0,0.0,0,G1,Negative,Negative,Positive,2,53.0,68.7,1,II,1,0,0,0,2,3.7,255.7,11.4,9.4,235.5,5.9,0,None,0,3,2,1,0,1 |
| 76601f63-33ca0dbb6-4163205e29-01f6-000602e1980e,SITE_016,2015-05-30,48.872761074359964,Male,Asian,Medicare,Former,44.7,1.8,60.0,3.5,0,0,None,0,0,25.1,Squamous_Cell,Keratinizing,IIIB,T3,N0,M0,6.9,RLL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,3,5,1-49%,14.7,1,MSS,Chemo_RT,None,None,Carboplatin_Paclitaxel,None,NA,IMRT,59.1,6,93.2,1,0,0,0,10.4,1,19.9,1,9.0,SD,0,1,3.2,0.0,-13.2,0,0,0,164.0,6.1,30.4,1,21.84,0,G2,Negative,Positive,Negative,1,67.2,57.6,1,I,1,1,1,1,4,3.9,190.8,15.7,3.2,50.0,3.3,0,None,0,2,0,2,0,0 |
| 3fe4a1a2-1bf406b6f-4bfade4e6-0a1a-00033e9c3541,SITE_031,2015-07-07,65.88963822911902,Female,White,Private,Former,41.8,1.3,60.0,0.1,0,0,Radon,1,0,25.3,Squamous_Cell,Basaloid,IA,T1b,N0,M0,1.6,LUL,Bilateral,0,0,0,1,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,51,92,>=50%,8.4,0,MSS,Surgery_Adjuvant,None,None,None,Lobectomy,R0,None,0.0,7,88.8,0,0,0,0,42.7,0,42.7,0,37.7,CR,1,1,1.1,89.3,-66.8,0,0,0,162.2,25.0,120.2,0,0.0,0,G2,Negative,Positive,Negative,1,81.0,91.4,1,III,0,0,0,0,2,3.7,107.3,14.4,9.6,128.5,12.3,0,None,0,2,0,2,0,0 |
| 032e9887-16462bb2-498bc995-0988-0000295dbee2,SITE_022,2017-06-17,57.52040615918175,Male,White,Medicare,Never,0.0,0.0,0.0,0.0,0,1,None,0,0,20.0,SCLC_Extensive,NA,Exte,T2b,N0,M0,4.9,Central,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,8.4,0,MSS,Chemo_IO_Combination,None,Atezolizumab,Etoposide_Platinum,None,NA,None,0.0,6,85.6,0,0,0,0,5.7,1,8.6,1,4.0,PR,1,1,0.7,5.2,-39.1,0,0,0,246.6,3.1,15.0,0,0.0,0,G2,Negative,Negative,Positive,2,74.3,78.4,0,None,0,0,1,0,1,3.6,129.7,15.8,12.5,77.1,20.9,0,None,0,0,2,3,0,0 |
| 4c686705-216dad124-4e539350f-0670-0003e14d3b48,SITE_040,2020-09-19,66.19391994921091,Female,Asian,Private,Current,47.6,1.6,60.0,0.0,0,0,Asbestos,0,0,25.1,Adenocarcinoma,Solid,IVA,T3,N0,M1c,6.9,RML,Right,0,1,0,0,0,0,0,1,Adrenal,None,None,None,None,None,0,0,0,Overexpression,0,0,1,100,100,>=50%,6.6,0,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,10,66.5,0,0,0,0,15.3,1,15.3,1,13.7,PR,1,1,8.0,18.0,-56.8,0,0,0,276.0,19.8,38.5,1,5.73,0,G2,Positive,Negative,Negative,0,52.9,63.3,1,II,1,0,0,0,2,3.4,204.8,12.3,11.3,500.0,3.9,1,Colitis,3,1,3,1,0,0 |
| 4710babd-1f1751b2c-4d5323037-0bab-00039bd97ba0,SITE_031,2015-08-28,51.79804443408696,Male,White,Medicare,Former,7.2,1.0,48.1,41.0,1,0,None,0,0,20.3,Squamous_Cell,Keratinizing,IA,T2b,N1,M0,4.7,RLL,Right,1,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,100,100,>=50%,13.5,1,MSS,SBRT,None,None,None,None,NA,SBRT,46.6,4,67.2,0,0,0,0,5.1,1,6.6,1,5.1,SD,0,1,8.0,0.0,16.3,0,0,0,281.5,10.4,26.4,1,13.11,0,G2,Negative,Positive,Negative,1,88.7,57.8,1,II,0,0,1,0,2,3.3,231.0,12.7,4.4,81.3,13.5,0,None,0,0,4,1,1,0 |
| 12f87e72-84cb751f-438e97b56-07e7-0000f69e6bd1,SITE_021,2024-11-02,59.76124264605255,Female,White,Medicare,Current,37.5,1.1,60.0,0.0,0,0,Radon,1,0,17.7,Adenocarcinoma,Micropapillary,IVA,T1b,N3,M1a,1.3,RUL,Left,0,0,0,0,1,0,0,0,Brain,None,None,None,G12V,None,0,0,0,None,0,0,1,0,0,<1%,7.7,0,MSS,Chemotherapy_Only,None,None,Carboplatin_Pemetrexed,None,NA,None,0.0,6,46.9,1,0,0,0,2.7,1,21.8,1,2.3,PR,1,1,3.8,1.9,-42.5,0,0,0,459.8,8.7,200.8,1,10.65,0,G2,Negative,Negative,Negative,1,94.4,48.5,1,III,1,0,0,0,2,4.3,100.0,9.3,3.2,60.4,25.6,0,None,0,0,0,0,0,1 |
| 512618b1-2380aacd8-4f3724a13-018b-00041eef4104,SITE_032,2019-07-20,68.4119574053769,Female,White,Medicare,Former,7.6,1.0,50.8,10.0,1,0,None,0,0,21.1,Squamous_Cell,Keratinizing,IVA,T3,N0,M1a,6.6,Central,Left,1,1,0,0,1,0,0,1,Brain|Adrenal,None,None,None,None,None,0,0,0,None,0,0,0,88,100,>=50%,15.8,1,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,4,84.1,0,0,0,0,6.0,1,14.9,0,5.6,PR,1,1,0.5,7.8,-49.3,0,0,1,311.6,22.3,112.6,1,26.99,1,G1,Negative,Positive,Negative,1,69.9,47.4,0,None,0,1,1,0,1,3.0,140.8,9.3,3.0,50.0,1.9,0,None,0,1,0,3,0,0 |
| 6b9f1fad-2f159ddbc-4142dd5f07-01fa-000577149bd0,SITE_049,2017-08-21,70.47899117894741,Male,White,Medicare,Current,11.9,1.0,60.0,0.0,0,1,None,0,0,32.8,Adenocarcinoma,Micropapillary,IA,T1a,N0,M0,0.8,RML,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,56,67,>=50%,3.6,0,MSS,Surgery_Adjuvant,None,None,Cisplatin_Pemetrexed,Lobectomy,R1,None,0.0,7,91.1,0,0,0,0,23.4,0,23.4,0,20.2,CR,1,1,2.3,45.4,-75.0,0,0,0,132.4,4.4,17.0,1,7.93,0,G2,Negative,Negative,Negative,0,89.3,88.8,0,None,1,1,1,0,3,3.8,217.1,12.2,17.8,79.7,6.4,0,None,0,1,0,1,1,0 |
| 0d8e0bce-5ee252a3-428aa236a-00bc-0000b036997d,SITE_021,2020-02-27,70.96598360804914,Female,Black,Private,Never,0.0,0.0,0.0,0.0,0,1,None,0,0,24.8,Adenocarcinoma,Papillary,IIIB,T2b,N2,M0,4.1,RML,Left,0,0,0,0,0,0,0,0,None,None,EML4-ALK,None,None,None,0,0,0,None,0,0,0,0,0,<1%,10.3,1,MSS,CCRT,None,Durvalumab,Carboplatin_Paclitaxel,None,NA,IMRT,59.2,7,93.0,0,0,0,0,6.8,1,20.3,0,6.2,CR,1,1,8.0,1.9,-83.1,0,0,1,270.8,20.5,125.2,1,29.48,1,G1,Positive,Negative,Negative,0,111.5,87.1,0,None,0,0,1,1,2,3.8,366.8,9.7,3.9,159.8,200.0,0,None,0,3,1,2,0,0 |
| 5c95d60c-28818da55-4115c18224-0d60-0004b39bdea3,SITE_008,2022-11-24,54.45535465050814,Male,White,Private,Never,0.0,0.0,0.0,0.0,1,1,Radon,1,0,27.0,Adenocarcinoma,Micropapillary,IVA,T2a,N1,M1c,3.6,Endobronchial,Right,0,0,0,0,1,0,1,0,Brain|Liver,L858R,None,None,None,None,0,0,0,None,0,1,0,74,100,>=50%,36.5,1,MSS,Targeted_TKI,Osimertinib,None,None,None,NA,None,0.0,5,71.0,0,0,0,0,7.7,1,13.7,1,6.1,PR,1,1,0.5,20.3,-37.4,0,0,0,327.7,6.3,20.0,1,0.77,1,G2,Positive,Negative,Negative,1,102.5,62.7,0,None,1,0,1,0,3,3.8,304.8,10.8,9.4,285.0,6.9,0,None,0,3,0,0,0,0 |
| 11f6a5dd-7dbe890c-435e3f197-0a5d-0000e9866c40,SITE_021,2018-02-14,75.11951443628783,Female,White,Private,Current,15.8,1.0,60.0,0.0,1,1,None,0,0,23.7,Large_Cell,NA,IVB,T1c,N0,M1a,3.0,LUL,Left,0,1,0,0,1,1,1,0,Brain|Bone|Liver,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,7.4,0,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,8,90.6,0,0,0,0,7.3,1,27.0,1,7.3,PR,1,1,2.2,20.9,-33.7,0,0,0,459.9,4.4,10.4,1,15.61,1,G1,Negative,Negative,Negative,1,70.7,93.9,0,None,0,0,0,0,0,4.1,159.6,12.6,6.3,78.1,58.1,1,Pneumonitis,3,3,0,2,0,0 |
| 5fd98a08-29ef2c639-411f8c9e18-08a0-0004de0c026f,SITE_043,2015-06-23,59.39798888228242,Female,Hispanic,VA,Current,57.9,1.8,60.0,0.0,1,1,None,0,0,17.9,SCLC_Limited,NA,Limi,T4,N0,M0,11.8,RUL,Right,1,0,1,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,47.4,1,MSS,Chemo_IO_Combination,None,Atezolizumab,Etoposide_Platinum,None,NA,Conventional_EBRT,49.7,7,77.6,0,0,0,0,6.3,1,42.0,0,4.8,PD,0,0,3.2,0.0,20.4,0,0,0,226.5,2.6,14.3,0,0.0,0,G2,Negative,Negative,Positive,3,55.1,81.9,0,None,0,0,1,1,1,3.6,330.1,15.0,3.4,299.7,9.4,0,None,0,0,3,1,1,0 |
| 35a589bb-17786c41e-4a0f09d31-089b-0002b967fe86,SITE_011,2015-07-06,73.01215018876941,Female,White,Uninsured,Former,28.8,1.0,60.0,8.7,1,0,Asbestos,0,0,30.2,Squamous_Cell,Keratinizing,IVB,T1b,N3,M1c,1.5,RML,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,100,100,>=50%,10.5,1,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,5,95.2,0,0,0,0,10.2,1,36.8,0,7.6,PR,1,1,0.9,3.5,-36.6,0,0,0,227.6,25.0,24.0,1,21.06,1,G3,Negative,Positive,Negative,2,79.1,75.3,1,I,1,1,1,0,4,4.1,171.1,12.5,3.8,142.8,27.1,0,None,0,1,0,2,0,0 |
| 00d55a7f-5d5797a-42800f7d-05a7-00000ad5987a,SITE_048,2023-07-07,66.89893257212717,Male,White,Private,Former,28.7,1.0,60.0,9.0,0,0,None,0,0,16.2,SCLC_Extensive,NA,Exte,T4,N0,M0,8.6,RLL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,8.6,0,MSS,Chemo_IO_Combination,None,Atezolizumab,Etoposide_Platinum,None,NA,None,0.0,6,81.7,0,0,0,0,6.1,1,10.4,1,4.4,SD,0,1,2.0,0.0,-24.6,0,0,0,419.7,18.4,7.8,0,0.0,0,GX,Negative,Negative,Negative,1,117.2,85.8,0,None,1,0,1,0,1,4.8,100.0,9.8,10.3,110.9,6.1,0,None,0,0,0,2,1,0 |
| 7bad7cbf-361be693a-417308763d-07cb-000647cf55ba,SITE_030,2016-02-12,53.9243187587595,Male,Black,Private,Former,43.1,1.9,60.0,3.9,0,0,Radon,1,1,23.5,Adenocarcinoma,Acinar,IVA,T4,N2,M1a,10.7,Endobronchial,Bilateral,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,55,61,>=50%,10.0,1,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,8,63.2,0,0,0,0,18.5,1,40.2,0,15.9,PR,1,1,3.4,1.7,-48.7,0,0,1,267.5,5.0,10.8,1,17.88,0,G2,Negative,Negative,Negative,0,99.1,81.9,0,None,1,0,1,0,4,3.7,411.8,8.9,4.6,164.6,1.2,0,None,0,1,1,2,0,0 |
| 153e8471-94b59f18-43fbb8d53-0847-0001142cb9c4,SITE_031,2021-05-08,63.99612180647871,Female,Hispanic,Private,Former,28.5,1.3,60.0,2.0,1,0,None,0,0,25.8,Adenocarcinoma,Acinar,IIIA,T2a,N2,M0,3.3,RLL,Left,1,0,0,0,0,0,0,0,None,Exon19del,None,None,None,None,0,0,0,None,0,1,0,0,0,<1%,6.8,0,MSS,CCRT,None,Durvalumab,Carboplatin_Paclitaxel,None,NA,IMRT,58.8,2,90.9,0,0,0,0,19.2,1,20.7,0,17.0,SD,0,1,3.0,0.0,-13.8,0,0,0,110.0,11.4,3.6,1,6.57,0,G3,Positive,Negative,Negative,3,74.9,74.5,1,II,1,1,1,1,4,2.8,251.8,12.7,3.3,347.4,10.4,0,None,0,1,3,0,0,0 |
| 4c4b1f54-2160ddb4d-4e4e15dfc-01f5-0003dfd0974b,SITE_016,2018-11-04,70.47095554960579,Female,White,Medicare,Former,50.4,2.0,60.0,10.9,0,1,None,0,0,27.0,SCLC_Extensive,NA,Exte,T1c,N0,M0,2.9,RUL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,100,100,>=50%,1.5,0,MSS,Chemo_IO_Combination,None,Durvalumab,Etoposide_Platinum,None,NA,None,0.0,5,95.1,0,0,0,0,4.0,1,11.3,1,3.6,PD,0,0,4.0,0.0,63.8,0,0,0,100.0,8.2,7.5,1,3.41,1,G1,Negative,Negative,Positive,0,103.1,68.2,0,None,0,1,0,1,2,3.7,220.1,11.2,2.5,153.0,39.0,0,None,0,1,3,3,0,1 |
| 173a59d5-a29874d4-445af0d7f-059d-00012df68fd8,SITE_047,2022-10-08,72.8231711145087,Male,Asian,Private,Current,3.1,1.0,20.6,0.0,0,0,None,0,0,22.7,Adenocarcinoma,Solid,IVB,T1b,N2,M1c,1.8,LUL,Right,1,0,0,0,0,1,0,0,Bone,None,None,None,G12V,None,0,0,0,Exon20ins,1,0,0,45,62,1-49%,19.9,1,MSS,Chemo_IO_Combination,None,Nivolumab_Ipilimumab,Carboplatin_Pemetrexed,None,NA,None,0.0,5,66.2,0,0,0,0,17.6,0,17.6,0,13.2,SD,0,1,2.5,0.0,-0.2,0,0,0,614.2,5.6,26.6,1,10.01,1,G2,Negative,Negative,Negative,3,96.0,70.3,0,None,0,0,1,0,1,3.7,201.2,12.7,5.6,76.3,55.6,0,None,0,0,0,2,0,0 |
| 776d4e0f-343fd226a-416647ea2d-04e0-0006108cf6ca,SITE_002,2015-08-09,65.66061497427802,Male,White,Private,Former,20.4,1.0,60.0,1.5,0,1,None,0,0,17.7,SCLC_Extensive,NA,Exte,T4,N0,M0,8.4,RLL,Right,0,1,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,64.9,1,MSS,Chemo_IO_Combination,None,Atezolizumab,Etoposide_Platinum,None,NA,None,0.0,6,82.3,1,0,0,0,5.4,1,9.1,1,4.8,SD,0,1,4.0,0.0,16.8,0,0,0,103.9,16.0,70.1,0,0.0,0,G2,Negative,Negative,Positive,3,40.8,46.3,0,None,0,0,1,0,0,4.0,233.1,12.1,3.1,191.4,24.9,0,None,0,0,1,1,0,1 |
| 5e817389-2958a28c0-411b845a9b-0738-0004cc92ddfc,SITE_015,2023-12-21,81.55189946071,Male,White,Private,Current,29.8,1.0,60.0,0.0,0,0,None,0,0,22.4,Adenocarcinoma,Lepidic,IVB,T3,N0,M1b,5.9,RUL,Right,0,0,0,0,0,0,0,1,Adrenal,None,None,None,None,V600E,0,0,0,None,0,0,0,0,0,<1%,13.9,1,MSS,Targeted_TKI,Dabrafenib_Trametinib,None,None,None,NA,None,0.0,6,79.7,1,0,0,0,11.3,0,11.3,0,8.4,CR,1,1,0.8,2.0,-85.9,0,0,0,225.1,4.5,60.1,1,23.67,1,G2,Positive,Negative,Negative,3,94.1,59.2,0,None,0,0,1,0,0,2.8,201.1,12.4,6.8,189.6,6.3,0,None,0,1,3,1,1,0 |
| 66f54c69-2d0b516e0-4134dfe53b-04c6-00053a74e15c,SITE_021,2021-12-23,76.57135232437231,Female,Hispanic,Private,Never,0.0,0.0,0.0,0.0,0,1,None,0,0,22.6,SCLC_Extensive,NA,Exte,T1a,N0,M0,0.8,Central,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,14.7,1,MSS,Chemotherapy_Only,None,Durvalumab,Etoposide_Platinum,None,NA,None,0.0,5,88.0,0,0,0,0,3.1,1,4.1,1,2.8,PR,1,1,3.0,2.0,-46.3,0,0,0,380.5,1.3,33.6,0,0.0,0,G3,Negative,Negative,Positive,1,77.1,100.8,0,None,0,0,0,0,1,4.0,173.4,14.9,20.0,132.4,79.9,0,None,0,0,1,3,0,1 |
| 374e64dd-18324c20c-4a5eb2e97-064d-0002cefb1f40,SITE_024,2019-06-28,64.56178589420234,Male,Hispanic,Private,Never,0.0,0.0,0.0,0.0,0,0,None,0,0,22.5,Adenocarcinoma,Solid,IIIB,T2b,N3,M0,4.8,RUL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,1,1,100,100,>=50%,7.7,0,MSS,Chemo_RT,None,None,Carboplatin_Paclitaxel,None,NA,IMRT,65.8,3,85.5,0,0,0,0,4.6,1,7.3,1,3.6,SD,0,1,4.9,0.0,-14.1,0,0,0,101.3,9.1,3.2,1,9.82,0,G2,Negative,Negative,Negative,0,59.4,58.8,0,None,1,0,0,0,1,3.6,144.5,14.6,6.4,273.9,6.8,0,None,0,0,0,3,0,0 |
| 3bd3290a-1a2c61f47-4b3797b1e-0290-000309b91589,SITE_024,2017-01-25,74.12615721530098,Male,White,Private,Current,4.7,1.0,31.1,0.0,0,0,Asbestos,0,0,30.4,SCLC_Extensive,NA,Exte,T1a,N0,M0,0.9,Central,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,94,>=50%,25.6,1,MSS,Chemotherapy_Only,None,Atezolizumab,Etoposide_Platinum,None,NA,None,0.0,4,88.4,0,0,0,0,6.3,1,7.1,1,5.2,PR,1,1,0.5,1.4,-45.9,0,0,0,142.5,7.8,7.1,0,0.0,0,G3,Negative,Negative,Positive,1,76.6,42.4,0,None,0,0,1,0,1,4.2,208.2,13.2,15.8,50.0,7.5,1,Colitis,3,2,1,3,0,1 |
| 5130c7e5-238557744-4f39257af-0c7e-00041f7a26a8,SITE_008,2024-10-06,85.37103810928778,Female,White,Medicare,Former,24.6,1.0,60.0,0.5,0,0,Radon,1,0,20.5,Squamous_Cell,Keratinizing,IIIC,T2b,N0,M0,4.5,LLL,Left,0,0,1,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,8.7,0,MSS,CCRT,None,Durvalumab,Carboplatin_Paclitaxel,None,NA,IMRT,57.3,3,92.5,0,0,0,0,4.6,1,13.0,1,3.7,PD,0,0,1.9,0.0,61.4,0,0,0,131.2,4.6,15.8,1,21.24,1,G3,Negative,Positive,Negative,1,82.5,86.5,0,None,0,0,1,0,2,3.5,128.9,10.7,2.7,183.9,4.6,1,Pneumonitis,2,0,1,3,0,0 |
| 647320f2-2bf25e69f-412d5962d6-020f-000519d8ac51,SITE_012,2018-01-07,85.62460370743875,Male,White,Medicare,Current,25.1,1.4,60.0,0.0,0,0,None,0,0,27.4,SCLC_Extensive,NA,Exte,T2b,N3,M0,4.5,RUL,Left,0,0,0,1,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,32,38,1-49%,11.5,1,MSS,Chemo_IO_Combination,None,Durvalumab,Etoposide_Platinum,None,NA,None,0.0,5,72.5,0,0,0,0,10.7,1,10.7,1,8.7,SD,0,1,4.5,0.0,6.4,0,0,0,602.2,3.6,63.8,0,0.0,0,G3,Negative,Negative,Positive,1,60.7,76.0,0,None,1,0,0,0,1,4.2,113.2,11.4,7.2,237.6,10.6,0,None,0,0,1,1,0,0 |
| 6c69d369-2f6e4c7e0-41453d7a3b-0d36-0005815fbc5c,SITE_005,2019-11-26,55.33400113218627,Female,White,Private,Never,0.0,0.0,0.0,0.0,0,0,None,0,1,26.7,Adenocarcinoma,Papillary,IVB,T1a,N0,M1b,0.9,LLL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,100,100,>=50%,2.2,0,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,3,95.8,0,0,0,0,8.2,1,11.7,0,7.6,PR,1,1,2.0,9.1,-51.6,0,0,1,671.2,2.1,10.3,0,0.0,0,G2,Positive,Negative,Negative,1,72.8,76.9,0,None,1,0,1,0,2,3.0,229.3,14.0,10.8,62.2,12.9,0,None,0,3,1,1,0,0 |
| 024879c9-ffb5480-46d96d5b-079c-00001dae2f3c,SITE_029,2018-12-09,58.19793544400707,Male,Hispanic,Medicare,Current,49.2,2.0,60.0,0.0,0,1,None,0,0,30.3,Squamous_Cell,Keratinizing,IA,T4,N3,M0,10.1,LLL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,5.6,0,MSS,SBRT,None,None,None,None,NA,SBRT,48.1,4,81.6,0,0,0,0,1.3,1,4.3,1,1.3,CR,1,1,0.5,13.3,-75.5,0,0,0,169.5,5.5,4.6,0,0.0,0,G2,Negative,Negative,Negative,1,69.0,69.5,1,III,1,0,0,0,3,3.8,327.0,15.1,11.8,60.9,31.2,0,None,0,3,0,3,0,0 |
| 54ef9434-2528d0d6d-4fecebc9c-0943-0004502a86ab,SITE_018,2017-04-21,81.10672847397159,Female,Asian,Medicare,Current,15.8,1.0,60.0,0.0,0,0,Radon,1,0,25.4,SCLC_Extensive,NA,Exte,T1c,N2,M0,2.5,LUL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,57,100,>=50%,12.6,1,MSS,Chemo_IO_Combination,None,Durvalumab,Etoposide_Platinum,None,NA,None,0.0,2,85.9,0,0,0,0,3.2,1,8.0,0,2.7,PR,1,1,0.5,0.6,-36.6,0,0,1,326.9,3.7,114.2,0,0.0,0,G3,Negative,Negative,Positive,1,89.3,86.6,1,III,0,0,1,0,2,3.3,134.5,10.0,11.0,270.1,2.6,0,None,0,1,2,1,1,1 |
| 0df86e34-61cb036d-429e94a9c-06e3-0000b59d98ab,SITE_029,2019-03-01,56.94633001704244,Female,White,Medicare,Current,43.9,1.3,60.0,0.0,0,0,None,0,1,29.6,Squamous_Cell,Basaloid,IIB,T2b,N1,M0,4.4,LUL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,20.4,1,MSS,SBRT,None,None,None,None,NA,SBRT,57.3,6,77.3,1,0,0,0,5.1,1,7.6,1,4.2,CR,1,1,1.8,2.7,-69.1,0,0,0,285.4,16.0,8.3,1,9.97,0,G2,Negative,Positive,Negative,1,69.6,96.5,1,II,0,0,0,0,1,3.6,146.8,15.6,4.5,300.3,10.1,0,None,0,2,0,2,0,0 |
| 24daf2a3-101fca276-46e90d7e9-0f2a-0001df1e524e,SITE_030,2016-07-06,54.43585923372905,Female,White,Uninsured,Never,0.0,0.0,0.0,0.0,0,0,None,0,0,25.2,Adenocarcinoma,Acinar,IVB,T3,N2,M1a,5.4,RUL,Left,1,1,0,0,0,1,0,0,Bone,L858R,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,20.9,1,MSS,Targeted_TKI,Osimertinib,None,None,None,NA,None,0.0,2,70.1,0,0,0,0,3.5,1,7.2,1,2.8,PR,1,1,3.8,34.8,-51.6,0,0,0,212.6,11.2,5.2,1,12.58,1,G3,Positive,Negative,Negative,1,44.4,63.7,0,None,0,0,0,0,1,5.0,100.0,10.9,8.4,335.6,6.0,0,None,0,0,0,2,1,0 |
| 6a2ab783-2e72b0496-413e802689-0b78-0005642b51ae,SITE_036,2015-01-07,62.38115575835906,Male,White,Private,Former,54.7,3.1,60.0,4.4,0,0,None,0,0,28.0,Large_Cell,NA,IIIA,T4,N2,M0,11.0,RUL,Left,1,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,100,>=50%,2.2,0,MSS,Chemo_RT,None,None,Carboplatin_Paclitaxel,None,NA,IMRT,61.4,3,79.9,0,0,0,0,3.7,1,17.6,0,3.3,PD,0,0,3.3,0.0,40.3,0,0,0,108.5,5.0,26.4,1,3.18,1,G2,Negative,Negative,Negative,0,66.9,82.1,0,None,1,1,1,0,2,3.3,103.7,13.8,2.2,97.9,38.1,0,None,0,1,0,0,0,1 |
| 2010d0cf-e075b5aa-46032726d-0d0c-0001a0da9a8a,SITE_028,2017-11-24,70.99215374000856,Female,White,Medicaid,Former,47.2,1.0,60.0,9.3,0,0,Radon,1,1,19.2,Squamous_Cell,Keratinizing,IVB,T2a,N0,M1b,3.2,LLL,Right,0,0,0,0,0,0,1,1,Liver|Adrenal,None,None,None,None,None,0,0,0,None,0,0,0,0,0,<1%,2.4,0,MSS,Chemotherapy_Only,None,None,Carboplatin_Paclitaxel,None,NA,None,0.0,6,73.9,0,0,0,0,10.2,1,26.8,1,8.5,SD,0,1,0.8,0.0,-2.2,0,0,0,775.7,11.2,18.9,0,0.0,0,G3,Negative,Positive,Negative,1,58.0,89.9,1,III,1,0,1,0,2,3.6,105.7,17.0,13.8,167.4,31.6,0,None,0,3,1,1,0,1 |
| 65fe1a33-2c9f2b766-4131fa4e99-01a3-00052de7549e,SITE_033,2016-02-14,66.02723128719458,Female,Black,Medicare,Former,12.8,1.0,60.0,1.0,0,0,Radon,1,0,16.0,Squamous_Cell,Non-keratinizing,IIIB,T4,N3,M0,11.4,RUL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,88,91,>=50%,15.3,1,MSS,CCRT,None,Durvalumab,Carboplatin_Paclitaxel,None,NA,IMRT,58.3,5,41.3,0,0,0,0,7.8,1,29.5,0,7.3,PR,1,1,4.3,26.6,-55.7,0,0,1,100.0,6.8,11.0,1,28.04,0,G3,Negative,Positive,Negative,2,51.7,62.8,1,II,0,0,1,1,2,3.2,326.1,9.3,2.3,181.3,4.3,0,None,0,1,1,1,0,0 |
| 3b43d6f3-19edae0a6-4b1cb84d9-0d6f-00030271ea5e,SITE_030,2019-02-22,60.81964560614688,Male,White,Medicare,Former,52.2,2.4,60.0,18.4,0,0,None,0,0,27.7,Squamous_Cell,Non-keratinizing,IIA,T2a,N3,M0,4.0,RUL,Left,1,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,4.6,0,MSS,Surgery_Adjuvant,None,None,None,Lobectomy,R0,None,0.0,2,81.3,0,0,1,0,16.0,1,56.9,0,14.1,CR,1,1,8.0,10.7,-77.7,0,0,1,272.1,6.0,20.1,0,0.0,0,G2,Negative,Positive,Negative,2,96.2,96.2,1,II,0,1,0,0,2,3.6,100.0,13.5,10.8,53.3,42.0,0,None,0,0,2,0,0,0 |
| 1dc72bfd-d07233ec-4595583f7-02bf-0001831d3be0,SITE_033,2023-08-16,60.594981613617165,Male,White,Private,Never,0.0,0.0,0.0,0.0,0,0,Asbestos,0,0,27.9,SCLC_Extensive,NA,Exte,T4,N3,M0,9.2,RLL,Right,0,0,1,1,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,20.2,1,MSS,Chemo_IO_Combination,None,Durvalumab,Etoposide_Platinum,None,NA,None,0.0,5,83.4,1,0,0,0,1.5,1,7.8,0,1.3,SD,0,1,1.5,0.0,9.0,0,0,1,177.0,7.1,6.6,0,0.0,0,G3,Negative,Negative,Negative,2,89.5,89.8,0,None,1,0,1,1,2,3.7,252.0,11.9,9.3,163.1,18.6,1,Hepatitis,1,1,2,1,1,0 |
| 2ac88389-12b7b98c0-480598a9b-0838-00022c2eadfc,SITE_031,2016-08-16,60.23279788807927,Male,White,Private,Former,48.1,1.3,60.0,8.3,0,1,None,0,0,28.1,Adenocarcinoma,Acinar,IVA,T1c,N2,M1c,2.1,RUL,Right,0,0,0,0,0,1,1,1,Bone|Liver|Adrenal,None,None,None,G12D,None,0,0,0,None,0,0,0,81,73,>=50%,2.1,0,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,6,85.2,0,0,0,0,9.2,1,32.2,1,9.1,CR,1,1,3.3,1.2,-64.3,0,0,0,405.1,25.0,10.9,1,31.56,1,G3,Negative,Negative,Negative,1,57.6,52.1,0,None,1,0,1,0,1,3.4,175.5,13.4,9.3,161.3,66.0,0,None,0,2,1,0,0,0 |
| 43f04208-1db91ce39-4cbd0c618-0420-000373335a6f,SITE_016,2015-01-05,58.64465852774005,Female,Other,Private,Former,15.6,1.0,60.0,26.8,0,1,None,0,0,23.6,Adenocarcinoma,Solid,IIIA,T3,N1,M0,5.8,LLL,Left,0,0,0,1,0,0,0,0,None,None,None,None,None,V600E,0,0,0,None,0,1,0,100,100,>=50%,8.3,0,MSS,Chemo_RT,None,None,Carboplatin_Paclitaxel,None,NA,IMRT,58.3,3,96.9,0,0,0,0,11.0,1,11.0,1,7.7,PD,0,0,0.5,0.0,59.3,0,0,0,373.5,12.4,19.2,1,41.65,0,G1,Positive,Negative,Negative,2,52.2,97.5,0,None,1,0,0,0,1,4.6,271.1,11.3,19.0,232.1,7.6,0,None,0,2,1,0,0,0 |
| 61f057ab-2ad9265ae-4125d10701-057a-0004f93473b6,SITE_013,2016-02-10,88.67551233412259,Female,White,VA,Former,10.6,1.0,60.0,0.4,0,0,Asbestos,0,0,32.7,SCLC_Extensive,NA,Exte,T1a,N1,M0,0.6,LLL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,59,100,>=50%,8.8,0,MSS,Chemo_IO_Combination,None,Atezolizumab,Etoposide_Platinum,None,NA,None,0.0,3,80.7,0,0,0,0,7.1,1,7.1,1,6.5,SD,0,1,4.2,0.0,11.1,0,0,0,150.0,5.8,1.7,0,0.0,0,G1,Negative,Negative,Positive,1,73.2,53.0,0,None,0,0,0,0,0,4.4,358.9,7.5,9.4,105.3,48.7,0,None,0,1,1,1,0,1 |
| 4d91ed29-21efd7c20-4e8b5c77b-0ed2-0003f0690b1c,SITE_040,2020-01-29,69.82635517626277,Female,White,Medicare,Former,15.0,1.0,60.0,0.2,1,1,None,0,1,23.9,SCLC_Extensive,NA,Exte,T4,N0,M0,8.8,LLL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,100,83,>=50%,13.9,1,MSS,Chemo_IO_Combination,None,Atezolizumab,Etoposide_Platinum,None,NA,None,0.0,10,91.9,1,0,0,0,16.0,1,16.0,1,13.2,SD,0,1,0.7,0.0,4.9,0,0,0,164.8,15.1,63.2,0,0.0,0,G3,Negative,Negative,Positive,2,51.2,61.0,1,III,0,0,1,1,3,3.3,197.4,11.0,1.8,314.3,73.5,0,None,0,0,0,2,0,1 |
| 7773e101-3442b2708-41665ba303-0e10-000610e26d14,SITE_018,2017-09-30,75.42421101684502,Female,White,Private,Former,6.9,1.0,46.2,3.0,0,1,None,0,0,27.9,Squamous_Cell,Non-keratinizing,IA,T4,N1,M0,8.3,RUL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,3.6,0,MSS,Surgery_Adjuvant,None,None,None,Segmentectomy,R0,None,0.0,6,79.6,0,0,0,0,17.8,1,34.2,0,13.1,CR,1,1,3.0,36.5,-62.9,0,0,1,112.7,14.7,3.9,1,26.34,0,G3,Negative,Negative,Negative,0,70.6,82.9,0,None,1,0,1,0,2,4.2,353.1,13.2,6.8,155.7,22.3,0,None,0,2,1,3,1,0 |
| 6f1211ed-3097e7d7c-414d3635c7-011e-0005a3eae910,SITE_028,2019-11-22,62.353764052870225,Female,White,Medicare,Current,32.8,1.0,60.0,0.0,1,1,Radon,1,0,28.7,Large_Cell,NA,IIIA,T2a,N2,M0,3.9,RLL,Left,0,0,0,0,0,0,0,0,None,None,EML4-ALK,None,None,None,0,0,0,None,0,0,1,95,100,>=50%,1.5,0,MSS,Chemo_RT,None,None,Carboplatin_Paclitaxel,None,NA,IMRT,65.7,4,72.6,0,0,0,0,3.8,1,41.4,1,2.8,PR,1,1,0.5,9.3,-52.8,0,0,0,269.7,9.1,6.5,1,9.68,1,GX,Negative,Negative,Negative,2,76.3,88.7,0,None,0,0,1,0,1,3.6,434.8,15.2,1.2,414.0,200.0,0,None,0,0,1,1,1,0 |
| 606de377-2a3013842-412149aa65-0e37-0004e5948d12,SITE_010,2015-04-17,65.23341156673254,Male,White,Private,Former,29.7,1.4,60.0,0.3,0,0,Asbestos,0,0,33.7,Adenocarcinoma,Micropapillary,IVA,T2b,N2,M1c,4.6,LLL,Right,1,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,100,100,>=50%,10.5,1,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,4,96.5,0,0,0,0,3.9,1,7.0,1,3.5,CR,1,1,3.5,4.2,-66.9,0,0,0,349.1,5.7,66.7,1,18.23,0,G3,Positive,Negative,Negative,0,80.5,73.6,0,None,0,0,1,0,1,3.2,392.7,13.3,4.2,232.3,42.0,0,None,0,0,2,2,1,0 |
| 4d329d86-21c624eab-4e797d892-09d8-0003eb91ffd5,SITE_022,2018-04-30,60.22123717698163,Male,White,Private,Former,23.8,1.0,60.0,16.1,1,1,None,0,1,24.6,Adenocarcinoma,Lepidic,IIB,T2b,N0,M0,4.7,RLL,Right,0,0,0,0,0,0,0,0,None,None,None,None,G12V,None,0,0,0,None,0,0,1,0,0,<1%,14.5,1,MSS,Surgery_Adjuvant,None,None,Cisplatin_Pemetrexed,Lobectomy,R0,None,0.0,6,57.1,0,0,1,0,20.1,1,33.3,0,15.0,CR,1,1,0.5,22.1,-78.1,0,0,1,196.2,5.4,39.8,0,0.0,0,G2,Positive,Negative,Negative,0,81.1,61.9,0,None,1,1,1,0,2,3.4,143.2,15.4,3.3,175.3,200.0,0,None,0,0,2,2,0,1 |
| 2519fed0-103b5f7b1-46f4dfc70-0fed-0001e251f097,SITE_027,2019-02-05,41.80877081826758,Female,White,Medicare,Former,14.0,1.0,60.0,13.2,0,1,None,0,0,23.1,Squamous_Cell,Non-keratinizing,IA,T1c,N1,M0,2.2,LUL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,0,0,<1%,22.3,1,MSS,Surgery_Adjuvant,None,None,None,Lobectomy,R0,None,0.0,5,87.9,0,0,0,0,17.1,0,17.1,0,16.4,CR,1,1,5.8,12.0,-61.8,0,0,0,216.5,3.1,22.3,1,11.0,0,G1,Negative,Positive,Negative,1,60.9,67.8,0,None,1,0,0,0,1,3.2,100.0,11.5,7.0,73.0,200.0,0,None,0,1,0,2,0,0 |
| 34cf252a-171aa0427-49e6d6f7e-0252-0002ae84e329,SITE_032,2019-04-24,53.90891186994527,Male,White,Medicare,Current,4.3,1.0,29.0,0.0,0,0,Asbestos,0,1,19.3,Squamous_Cell,Non-keratinizing,IIA,T3,N2,M0,6.9,LUL,Left,1,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,67,100,>=50%,6.5,0,MSS,SBRT,None,None,None,None,NA,SBRT,48.5,5,98.0,0,0,0,0,3.4,1,24.5,1,2.7,CR,1,1,0.5,4.5,-68.4,0,0,0,635.2,8.5,2.6,0,0.0,0,G3,Negative,Positive,Negative,0,76.3,65.9,0,None,0,1,0,0,3,4.3,188.2,11.4,2.5,67.2,1.6,0,None,0,1,3,4,0,0 |
| 0f37ed93-6a877f06-42da7c8b9-0ed9-0000c5d7107e,SITE_027,2020-07-04,49.79912254018625,Female,Asian,Medicare,Former,91.5,4.0,60.0,5.3,0,1,None,0,0,33.0,Squamous_Cell,Non-keratinizing,IIIA,T3,N1,M0,5.7,RLL,Right,1,0,0,1,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,100,100,>=50%,18.1,1,MSS,Chemo_RT,None,None,Carboplatin_Paclitaxel,None,NA,IMRT,63.1,3,80.4,0,0,0,0,19.4,1,19.4,1,15.6,PD,0,0,1.4,0.0,41.2,0,0,0,390.8,4.5,9.7,1,29.67,1,G2,Negative,Positive,Negative,1,98.0,85.5,0,None,1,0,0,0,2,3.4,219.0,13.2,2.6,387.8,113.0,0,None,0,2,3,2,0,0 |
| 2fe54342-14f44d6cf-48fafc9c6-0434-00026ea46a61,SITE_019,2022-10-20,45.62705410945973,Female,White,Medicare,Former,34.2,1.2,60.0,2.0,0,0,Silica,0,0,27.9,Adenocarcinoma,Papillary,IVB,T2b,N3,M1b,4.9,RML,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,63,87,>=50%,14.0,1,MSS,Immunotherapy_Only,None,Pembrolizumab,None,None,NA,None,0.0,8,94.0,1,0,0,0,3.3,1,13.0,1,3.0,PD,0,0,5.6,0.0,27.7,0,0,0,480.0,5.2,15.5,0,0.0,0,GX,Negative,Negative,Negative,2,37.3,65.5,0,None,1,0,1,0,1,4.4,100.0,11.7,6.4,251.3,43.6,0,None,0,0,0,2,0,0 |
| 7696a479-33e1e7f50-4163c3ed6b-0a47-000605a65a2c,SITE_049,2019-09-02,55.64408974416803,Male,Black,Medicare,Current,60.7,2.5,60.0,0.0,0,0,None,0,0,28.0,SCLC_Extensive,NA,Exte,T1b,N2,M0,1.3,LUL,Left,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,1,34,46,1-49%,29.7,1,MSS,Chemo_IO_Combination,None,Durvalumab,Etoposide_Platinum,None,NA,None,0.0,7,76.8,1,0,0,0,10.2,1,10.2,1,7.8,PR,1,1,2.0,9.7,-57.5,0,0,0,100.0,12.2,16.9,0,0.0,0,G3,Negative,Negative,Negative,1,80.9,61.6,0,None,0,0,1,0,0,3.9,206.5,14.7,10.2,125.1,28.9,0,None,0,1,4,3,0,0 |
| 36834de0-17d972121-4a389e9a0-04de-0002c4aaf467,SITE_026,2023-05-29,79.58707895412549,Female,White,Medicaid,Former,71.5,3.5,60.0,8.1,0,0,None,0,0,40.0,SCLC_Extensive,NA,Exte,T4,N0,M0,7.7,RUL,Right,0,0,0,0,0,0,0,0,None,None,None,None,None,None,0,0,0,None,0,0,0,100,85,>=50%,8.6,0,MSS,Chemotherapy_Only,None,Durvalumab,Etoposide_Platinum,None,NA,None,0.0,2,72.8,0,0,0,0,11.5,0,11.5,0,8.1,PD,0,0,0.5,0.0,45.0,0,0,0,321.7,25.0,79.0,0,0.0,0,GX,Negative,Negative,Positive,2,53.8,48.4,1,I,0,1,1,0,2,3.6,100.0,9.7,4.5,115.6,7.5,0,None,0,2,1,2,0,0 |
|
|
